Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Schizophrenia

  Free Subscription


Articles published in Schizophr Res

Retrieve available abstracts of 1606 articles:
HTML format



Single Articles


    July 2021
  1. YANG K, Hua J, Etyemez S, Paez A, et al
    Volumetric alteration of olfactory bulb and immune-related molecular changes in olfactory epithelium in first episode psychosis patients.
    Schizophr Res. 2021;235:9-11.
    PubMed    


  2. KREIS I, Zhang L, Moritz S, Pfuhl G, et al
    Spared performance but increased uncertainty in schizophrenia: Evidence from a probabilistic decision-making task.
    Schizophr Res. 2021 Jul 13. pii: S0920-9964(21)00246.
    PubMed     Abstract available


  3. KOHLER-FORSBERG O, Madsen T, Behrendt-Moller I, Nordentoft M, et al
    The 10-year trajectories of auditory hallucinations among 496 patients with a first schizophrenia-spectrum disorder: Findings from the OPUS cohort.
    Schizophr Res. 2021 Jul 13. pii: S0920-9964(21)00245.
    PubMed     Abstract available


  4. YOON JH, Maddock RJ, Laufer J, Minzenberg MJ, et al
    Absence of altered in vivo concentration of dorsolateral prefrontal cortex GABA in recent onset schizophrenia.
    Schizophr Res. 2021 Jul 9. pii: S0920-9964(21)00230.
    PubMed    


  5. BROWNE J, Mohamed S
    Evaluation of disparities in impact of mental health intensive case management on 6-month symptoms, functioning, and quality of life between black and white veterans diagnosed with schizophrenia.
    Schizophr Res. 2021 Jul 8. pii: S0920-9964(21)00255.
    PubMed     Abstract available


  6. ALBINANA C, Boelt SG, Cohen AS, Zhu Z, et al
    Developmental exposure to vitamin D deficiency and subsequent risk of schizophrenia.
    Schizophr Res. 2021 Jul 8. pii: S0920-9964(21)00216.
    PubMed     Abstract available


  7. XI YB, Guo F, Liu WM, Fu YF, et al
    Triple network hypothesis-related disrupted connections in schizophrenia: A spectral dynamic causal modeling analysis with functional magnetic resonance imaging.
    Schizophr Res. 2021;233:89-96.
    PubMed     Abstract available


  8. DE CATES AN, Catone G, Marwaha S, Bebbington P, et al
    Self-harm, suicidal ideation, and the positive symptoms of psychosis: Cross-sectional and prospective data from a national household survey.
    Schizophr Res. 2021;233:80-88.
    PubMed     Abstract available


  9. KHACHADOURIAN V, Zaks N, Lin E, Reichenberg A, et al
    Advanced paternal age and risk of schizophrenia in offspring - Review of epidemiological findings and potential mechanisms.
    Schizophr Res. 2021;233:72-79.
    PubMed     Abstract available


  10. POOLE-WRIGHT K, Gaughran F, Murray R, Chalder T, et al
    Fatigue in psychosis.
    Schizophr Res. 2021 Jul 6. pii: S0920-9964(21)00244.
    PubMed    


  11. GROSSMAN MJ, Bowie CR
    Money talks: The influence of extrinsic motivators on social cognition in early episode psychosis.
    Schizophr Res. 2021;233:52-59.
    PubMed     Abstract available


  12. HOY KE, Coyle H, Gainsford K, Hill AT, et al
    Investigating neurophysiological markers of impaired cognition in schizophrenia.
    Schizophr Res. 2021;233:34-43.
    PubMed     Abstract available


  13. O'DONOGHUE B, Castagnini E, Langstone A, Mifsud N, et al
    Sedentary behaviour in young people presenting with a first episode of psychosis before and during the covid-19 pandemic restrictions.
    Schizophr Res. 2021;233:31-33.
    PubMed    


  14. BURKHARDT E, Berger M, Yolken RH, Lin A, et al
    Toxoplasma gondii, Herpesviridae and long-term risk of transition to first-episode psychosis in an ultra high-risk sample.
    Schizophr Res. 2021;233:24-30.
    PubMed     Abstract available


  15. SALGADO-PINEDA P, Fuentes-Claramonte P, Spanlang B, Pomes A, et al
    Neural correlates of disturbance in the sense of agency in schizophrenia: An fMRI study using the 'enfacement' paradigm.
    Schizophr Res. 2021 Jul 1. pii: S0920-9964(21)00243.
    PubMed     Abstract available


  16. IGATA R, Tesen H, Konishi Y, Ikenouchi A, et al
    Prisoner's dilemma game in recovered schizophrenia patients, compared with healthy controls: Preliminary findings.
    Schizophr Res. 2021 Jul 1. pii: S0920-9964(21)00253.
    PubMed    


    June 2021
  17. XIE Y, Xi Y, Cui LB, Li C, et al
    Altered functional connectivity of the dentate nuclei in patients with schizophrenia.
    Schizophr Res. 2021;233:16-23.
    PubMed     Abstract available


  18. BONFILS KA, Luther L, Lysaker PH
    Metacognition & social cognition differentially influence experiential & expressive negative symptoms in schizophrenia.
    Schizophr Res. 2021;233:13-15.
    PubMed    


  19. FUSAR-POLI P, Salazar de Pablo G
    Antipsychotics and Attenuated Psychosis Syndrome: Transdiagnostic assessment and discontinuation strategies.
    Schizophr Res. 2021 Jun 30. pii: S0920-9964(21)00242.
    PubMed    


  20. BANEA OC, Bandeira Dos Santos LG, Marcu S, Stefannson SB, et al
    Network signatures of rTMS treatment in patients with schizophrenia and auditory verbal hallucination during an auditory-motor task using HD-EEG.
    Schizophr Res. 2021 Jun 30. pii: S0920-9964(21)00214.
    PubMed    


  21. GAO Y, Li M, Huang AS, Anderson AW, et al
    Lower functional connectivity of white matter during rest and working memory tasks is associated with cognitive impairments in schizophrenia.
    Schizophr Res. 2021 Jun 29. pii: S0920-9964(21)00225.
    PubMed     Abstract available


  22. HU M, Qian X, Liu S, Koh AJ, et al
    Structural and diffusion MRI based schizophrenia classification using 2D pretrained and 3D naive Convolutional Neural Networks.
    Schizophr Res. 2021 Jun 28. pii: S0920-9964(21)00223.
    PubMed     Abstract available


  23. BHATTACHARYYA U, Bhatia T, Deshpande SN, Thelma BK, et al
    Association of g-quadruplex variants with schizophrenia symptoms.
    Schizophr Res. 2021 Jun 26. pii: S0920-9964(21)00220.
    PubMed    


  24. HU Y, Xu L, Gan R, Wu G, et al
    A potential objective marker in first-episode schizophrenia based on abnormal niacin response.
    Schizophr Res. 2021 Jun 26. pii: S0920-9964(21)00240.
    PubMed     Abstract available


  25. CLAYSON PE, Joshi YB, Thomas ML, Tarasenko M, et al
    The viability of the frequency following response characteristics for use as biomarkers of cognitive therapeutics in schizophrenia.
    Schizophr Res. 2021 Jun 26. pii: S0920-9964(21)00234.
    PubMed     Abstract available


  26. RUBIO JM, Lencz T, Barber A, Moyett A, et al
    Striatal functional connectivity in psychosis relapse: A hypothesis generating study.
    Schizophr Res. 2021 Jun 25. pii: S0920-9964(21)00222.
    PubMed     Abstract available


  27. BARLATI S, Morena D, Nibbio G, Cacciani P, et al
    Internalized stigma among people with schizophrenia: Relationship with socio-demographic, clinical and medication-related features.
    Schizophr Res. 2021 Jun 25. pii: S0920-9964(21)00219.
    PubMed     Abstract available


  28. KRONICK J, Sabesan P, Burhan AM, Palaniyappan L, et al
    Assessment of treatment resistance criteria in non-invasive brain stimulation studies of schizophrenia.
    Schizophr Res. 2021 Jun 25. pii: S0920-9964(21)00221.
    PubMed     Abstract available


  29. YESILKAYA UH, Sen M, Karamustafalioglu N
    New variants and new symptoms in COVID-19: First episode psychosis and Cotard's Syndrome two months after infection with the B.1.1.7 variant of coronavirus.
    Schizophr Res. 2021 Jun 16. pii: S0920-9964(21)00213.
    PubMed    


  30. METZAK PD, Farris MS, Placsko T, Braun A, et al
    Social functioning and brain imaging in individuals at clinical high-risk for psychosis: A systematic review.
    Schizophr Res. 2021;233:3-12.
    PubMed     Abstract available


  31. CORTES-BRIONES JA, Tapia-Rivas NI, D'Souza DC, Estevez PA, et al
    Going deep into schizophrenia with artificial intelligence.
    Schizophr Res. 2021 Jun 5. pii: S0920-9964(21)00179.
    PubMed     Abstract available


  32. BOMMERSBACH TJ, Rhee TG, Stefanovics EA, Rosenheck RA, et al
    Comparison of Black and white individuals who report diagnoses of schizophrenia in a national sample of US adults: Discrimination and service use.
    Schizophr Res. 2021 Jun 1. pii: S0920-9964(21)00178.
    PubMed     Abstract available


    May 2021
  33. LISOWAY AJ, Chen CC, Zai CC, Tiwari AK, et al
    Toward personalized medicine in schizophrenia: Genetics and epigenetics of antipsychotic treatment.
    Schizophr Res. 2021;232:112-124.
    PubMed     Abstract available


  34. ZHANG YJ, Pu CC, Wang YM, Zhang RT, et al
    Social brain network correlates with real-life social network in individuals with schizophrenia and social anhedonia.
    Schizophr Res. 2021;232:77-84.
    PubMed     Abstract available


  35. SENGUTTA M, Karow A, Moritz S
    Deconstruction of a screening questionnaire for prodromal psychosis to reduce false positive responses.
    Schizophr Res. 2021;232:107-108.
    PubMed    


  36. FORTEA A, Batalla A, Radua J, van Eijndhoven P, et al
    Cortical gray matter reduction precedes transition to psychosis in individuals at clinical high-risk for psychosis: A voxel-based meta-analysis.
    Schizophr Res. 2021;232:98-106.
    PubMed     Abstract available


  37. WANG D, Zhuo K, Sun Y, Xiang Q, et al
    Middle temporal corpus callosum impairment as a predictor of eight-week treatment outcome of drug-naive first-episode psychosis patients: A pilot longitudinal study.
    Schizophr Res. 2021;232:95-97.
    PubMed    


  38. HEGELSTAD WTV, Berg AO, Bjornestad J, Gismervik K, et al
    Childhood interpersonal trauma and premorbid social adjustment as predictors of symptom remission in first episode psychosis.
    Schizophr Res. 2021;232:87-94.
    PubMed     Abstract available


  39. WELLESLEY WESLEY E, Patel I, Kadra-Scalzo G, Pritchard M, et al
    Gender disparities in clozapine prescription in a cohort of treatment-resistant schizophrenia in the South London and Maudsley case register.
    Schizophr Res. 2021;232:68-76.
    PubMed     Abstract available


  40. MOXAM AB, McClellan EJ, Cagande C, Calkins ME, et al
    Few primary care pediatricians screen for psychosis but many are willing.
    Schizophr Res. 2021;232:65-67.
    PubMed    


  41. CHESLACK-POSTAVA K, Brown AS
    Prenatal infection and schizophrenia: A decade of further progress.
    Schizophr Res. 2021 May 17. pii: S0920-9964(21)00174.
    PubMed     Abstract available


  42. DEL RE EC
    The 2020 World Congress of Psychiatric Genetics: Schizophrenia highlights with an eye on sex differences.
    Schizophr Res. 2021;232:63-64.
    PubMed    


  43. BARTOLI F, Cioni RM, Callovini T, Cavaleri D, et al
    The kynurenine pathway in schizophrenia and other mental disorders: Insight from meta-analyses on the peripheral blood levels of tryptophan and related metabolites.
    Schizophr Res. 2021;232:61-62.
    PubMed    


  44. TARGUM SD, Pendergrass JC, Murphy C
    Audio-digital recordings to assess ratings reliability in clinical trials of schizophrenia.
    Schizophr Res. 2021;232:54-60.
    PubMed     Abstract available


  45. KAHN RS, Silverman BL, DiPetrillo L, Graham C, et al
    A phase 3, multicenter study to assess the 1-year safety and tolerability of a combination of olanzapine and samidorphan in patients with schizophrenia: Results from the ENLIGHTEN-2 long-term extension.
    Schizophr Res. 2021;232:45-53.
    PubMed     Abstract available


  46. TIIHONEN J, Koskuvi M, Lahteenvuo M, Trontti K, et al
    Molecular signaling pathways underlying schizophrenia.
    Schizophr Res. 2021;232:33-41.
    PubMed     Abstract available


  47. SEVERANCE EG, Yolken RH
    Binning bugs and beyond: The state of the schizophrenia microbiome.
    Schizophr Res. 2021 May 15. pii: S0920-9964(21)00162.
    PubMed    


  48. VANES LD, Murray RM, Nosarti C
    Adult outcome of preterm birth: Implications for neurodevelopmental theories of psychosis.
    Schizophr Res. 2021 May 15. pii: S0920-9964(21)00152.
    PubMed     Abstract available


  49. SARRE A, Abdel-Ahad P, Meilland A, Renard U, et al
    Verbal hallucinations in deaf schizophrenia patients.
    Schizophr Res. 2021;232:31-32.
    PubMed    


  50. MAYORAL-VAN SON J, Juncal-Ruiz M, Ortiz-Garcia de la Foz V, Vazquez-Bourgon J, et al
    Long-term clinical and functional outcome after antipsychotic discontinuation in early phases of non-affective psychosis: Results from the PAFIP-10 cohort.
    Schizophr Res. 2021;232:28-30.
    PubMed    


  51. WRIGHT AC, Browne J, Skiest H, Bhiku K, et al
    The relationship between conventional clinical assessments and momentary assessments of symptoms and functioning in schizophrenia spectrum disorders: A systematic review.
    Schizophr Res. 2021;232:11-27.
    PubMed     Abstract available


  52. GEBICKE-HAERTER PJ, Leonardi-Essmann F, Haerter JO, Rossner MJ, et al
    Differential gene regulation in the anterior cingulate cortex and superior temporal cortex in schizophrenia: A molecular network approach.
    Schizophr Res. 2021;232:1-10.
    PubMed     Abstract available


  53. NASKAR C
    Understanding the effect of various factors on clozapine serum levels in Indian population.
    Schizophr Res. 2021;231:178.
    PubMed    


  54. OREPIC P, Rognini G, Kannape OA, Faivre N, et al
    Sensorimotor conflicts induce somatic passivity and louden quiet voices in healthy listeners.
    Schizophr Res. 2021;231:170-177.
    PubMed     Abstract available


  55. MISAWA F, Okumura Y, Takeuchi Y, Fujii Y, et al
    Neuroleptic malignant syndrome associated with long-acting injectable versus oral second-generation antipsychotics: Analyses based on a spontaneous reporting system database in Japan.
    Schizophr Res. 2021;231:42-46.
    PubMed     Abstract available


    April 2021
  56. KIDD SA, Mutschler C, Lichtenstein S, Yan S, et al
    Randomized trial of a brief peer support intervention for individuals with schizophrenia transitioning from hospital to community.
    Schizophr Res. 2021;231:214-220.
    PubMed     Abstract available


  57. RUNGE K, Fiebich BL, Kuzior H, Saliba SW, et al
    An observational study investigating cytokine levels in the cerebrospinal fluid of patients with schizophrenia spectrum disorders.
    Schizophr Res. 2021;231:205-213.
    PubMed     Abstract available


  58. TEEUW J, Ori APS, Brouwer RM, de Zwarte SMC, et al
    Accelerated aging in the brain, epigenetic aging in blood, and polygenic risk for schizophrenia.
    Schizophr Res. 2021;231:189-197.
    PubMed     Abstract available


  59. WANG C, Oughourlian T, Tishler TA, Anwar F, et al
    Cortical morphometric correlational networks associated with cognitive deficits in first episode schizophrenia.
    Schizophr Res. 2021;231:179-188.
    PubMed     Abstract available


  60. BROWNE J, Wright AC, Berry K, Mueser KT, et al
    The alliance-outcome relationship in individual psychosocial treatment for schizophrenia and early psychosis: A meta-analysis.
    Schizophr Res. 2021;231:154-163.
    PubMed     Abstract available


  61. MEKORI-DOMACHEVSKY E, Taler M, Weinberger R, Guri Y, et al
    Neutrophils to lymphocytes ratio and psychosis in 22q11.2 deletion syndrome - Clinical and scientific implications.
    Schizophr Res. 2021;231:164-169.
    PubMed     Abstract available


  62. PINHO S, Rocha V, Vieira-Coelho MA
    Effectiveness of multimodal interventions focused on smoking cessation in patients with schizophrenia: A systematic review.
    Schizophr Res. 2021;231:145-153.
    PubMed     Abstract available


  63. DICKERSON F, Origoni A, Katsafanas E, Squire A, et al
    Randomized controlled trial of an adjunctive sulforaphane nutraceutical in schizophrenia.
    Schizophr Res. 2021;231:142-144.
    PubMed    


  64. HOGERZEIL SJ, Hoek HW, van Hemert AM
    The impact of study design on schizophrenia incidence estimates: A systematic review of Northern European studies 2008-2019.
    Schizophr Res. 2021;231:134-141.
    PubMed     Abstract available


  65. AJNAKINA O, Stubbs B, Francis E, Gaughran F, et al
    Employment and relationship outcomes in first-episode psychosis: A systematic review and meta-analysis of longitudinal studies.
    Schizophr Res. 2021;231:122-133.
    PubMed     Abstract available


  66. FRAGUAS D, Diaz-Caneja CM, Pina-Camacho L, Winter van Rossum I, et al
    The role of depression in the prediction of a "late" remission in first-episode psychosis: An analysis of the OPTiMiSE study.
    Schizophr Res. 2021;231:100-107.
    PubMed     Abstract available


  67. TAO B, Xiao Y, Yang B, Zeng J, et al
    Morphological alterations of the corpus callosum in antipsychotic-naive first-episode schizophrenia before and 1-year after treatment.
    Schizophr Res. 2021;231:115-121.
    PubMed     Abstract available


  68. FREEDMAN R, Hunter SK, Law AJ, Clark AM, et al
    Choline, folic acid, Vitamin D, and fetal brain development in the psychosis spectrum.
    Schizophr Res. 2021 Apr 7. pii: S0920-9964(21)00128.
    PubMed     Abstract available


  69. GIBBONS RD, Chattopadhyay I, Meltzer H, Kane JM, et al
    Development of a computerized adaptive diagnostic screening tool for psychosis.
    Schizophr Res. 2021 Apr 6. pii: S0920-9964(21)00140.
    PubMed     Abstract available


  70. SOUSA AE, Ryan JD, Lepage M
    A feasibility pilot study on using unitization to circumvent relational memory impairments in schizophrenia.
    Schizophr Res. 2021;231:98-99.
    PubMed    


  71. RAO NP, Ramachandran P, Jacob A, Joseph A, et al
    Add on yoga treatment for negative symptoms of schizophrenia: A multi-centric, randomized controlled trial.
    Schizophr Res. 2021;231:90-97.
    PubMed     Abstract available


  72. MAITRA R, Pollak TA, Pritchard M, Shergill S, et al
    Stem cell transplant in psychotic disorders: Immunological cause or cure?
    Schizophr Res. 2021;230:50-52.
    PubMed    


  73. WILLIAMS MJ
    The only difference between a jail and a psychiatric hospital is a pillow.
    Schizophr Res. 2021;230:100.
    PubMed     Abstract available


    March 2021
  74. PRUESSNER M, King S, Veru F, Schalinski I, et al
    Impact of childhood trauma on positive and negative symptom remission in first episode psychosis.
    Schizophr Res. 2021;231:82-89.
    PubMed     Abstract available


  75. KOSHIYAMA D, Miyakoshi M, Tanaka-Koshiyama K, Joshi YB, et al
    Abnormal phase discontinuity of alpha- and theta-frequency oscillations in schizophrenia.
    Schizophr Res. 2021;231:73-81.
    PubMed     Abstract available


  76. ADELINO MPM, Nunes MV, Nunes MFQ, Costa ER Jr, et al
    Treatment-resistant schizophrenia - A RCT on the effectiveness of repeated-dose sodium nitroprusside.
    Schizophr Res. 2021;231:70-72.
    PubMed     Abstract available


  77. YANG J, Kang C, Wu C, Lin Y, et al
    Pharmacogenetic associations of NRG1 polymorphisms with neurocognitive performance and clinical symptom response to risperidone in the untreated schizophrenia.
    Schizophr Res. 2021;231:67-69.
    PubMed     Abstract available


  78. SAPERSTEIN AM, Choi CJ, Jahshan C, Lynch DA, et al
    Predicting response to cognitive training for schizophrenia using results from two studies with different outcomes.
    Schizophr Res. 2021;231:61-66.
    PubMed     Abstract available


  79. WOLF RC, Kubera KM, Waddington JL, Schmitgen MM, et al
    A neurodevelopmental signature of parkinsonism in schizophrenia.
    Schizophr Res. 2021;231:54-60.
    PubMed     Abstract available


  80. ZITO MF, Subotnik KL, Ventura J, Kern RS, et al
    Awareness of illness is associated with better social and nonsocial cognition in recent-onset schizophrenia.
    Schizophr Res. 2021;231:51-53.
    PubMed    


  81. SUHAS S
    COVID 19 vaccination of persons with schizophrenia in India - Need for imperative action!
    Schizophr Res. 2021;231:49-50.
    PubMed    


  82. HUANG TY, Deng WF, Li XP, Chen HQ, et al
    Higher prevalence of coronary artery calcification in schizophrenia patients.
    Schizophr Res. 2021;231:47-48.
    PubMed    


  83. HAINING K, Brunner G, Gajwani R, Gross J, et al
    The relationship between cognitive deficits and impaired short-term functional outcome in clinical high-risk for psychosis participants: A machine learning and modelling approach.
    Schizophr Res. 2021;231:24-31.
    PubMed     Abstract available


  84. SCHEFFLER F, Du Plessis S, Asmal L, Kilian S, et al
    Cannabis use and hippocampal subfield volumes in males with a first episode of a schizophrenia spectrum disorder and healthy controls.
    Schizophr Res. 2021;231:13-21.
    PubMed     Abstract available


  85. DAMIANI S, Scalabrini A, Ku HL, Lane TJ, et al
    From local to global and back: An exploratory study on cross-scale desynchronization in schizophrenia and its relation to thought disorders.
    Schizophr Res. 2021;231:10-12.
    PubMed    


  86. O'DONOGHUE B, Nelson B, Francey S, McGorry P, et al
    Response to 'Diagnostic uncertainty, antipsychotic dosing, and optimal psychosocial interventions: Unanswered questions in first-episode psychosis'.
    Schizophr Res. 2021;231:1-2.
    PubMed    


  87. NASIB LG, Gangadin SS, Rossum IW, Boudewijns ZSRM, et al
    The effect of prednisolone on symptom severity in schizophrenia: A placebo-controlled, randomized controlled trial.
    Schizophr Res. 2021;230:79-86.
    PubMed     Abstract available


  88. PURUSHOTHAMAN D, Jacob AA, Kumar V, Varambally S, et al
    The dilemma of self vs others' interest: Altruistic behaviour in schizophrenia and the role of vasopressin.
    Schizophr Res. 2021;230:77-78.
    PubMed    


  89. PERRY BI, Zammit S, Jones PB, Khandaker GM, et al
    Childhood inflammatory markers and risks for psychosis and depression at age 24: Examination of temporality and specificity of association in a population-based prospective birth cohort.
    Schizophr Res. 2021;230:69-76.
    PubMed     Abstract available


  90. PAWELCZYK T, Grancow-Grabka M, Zurner N, Pawelczyk A, et al
    Omega-3 fatty acids reduce cardiometabolic risk in first-episode schizophrenia patients treated with antipsychotics: Findings from the OFFER randomized controlled study.
    Schizophr Res. 2021;230:61-68.
    PubMed     Abstract available


  91. WANG DD, Hu XW, Jiang J, Sun LY, et al
    Attenuated and delayed niacin skin flushing in schizophrenia and affective disorders: A potential clinical auxiliary diagnostic marker.
    Schizophr Res. 2021;230:53-60.
    PubMed     Abstract available


  92. YAN W, Zhao M, Fu Z, Pearlson GD, et al
    Mapping relationships among schizophrenia, bipolar and schizoaffective disorders: A deep classification and clustering framework using fMRI time series.
    Schizophr Res. 2021 Mar 3. pii: S0920-9964(21)00077.
    PubMed     Abstract available


  93. WANG J, Kochunov P, Sampath H, Hatch KS, et al
    White matter brain aging in relationship to schizophrenia and its cognitive deficit.
    Schizophr Res. 2021;230:9-16.
    PubMed     Abstract available


  94. MOJTABAI R
    Estimating the prevalence of schizophrenia in the United States using the multiplier method.
    Schizophr Res. 2021;230:48-49.
    PubMed    


  95. TSANG A, Bucci S, Branitsky A, Kaptan S, et al
    The relationship between appraisals of voices (auditory verbal hallucinations) and distress in voice-hearers with schizophrenia-spectrum diagnoses: A meta-analytic review.
    Schizophr Res. 2021;230:38-47.
    PubMed     Abstract available


  96. JACOB MS, Roach BJ, Hamilton HK, Carrion RE, et al
    Visual cortical plasticity and the risk for psychosis: An interim analysis of the North American Prodrome Longitudinal Study.
    Schizophr Res. 2021;230:26-37.
    PubMed     Abstract available


  97. CHUNG AK, Chan WM, Law JK, Tse CY, et al
    Ketamine abusers with SLC6A3 rs393795 genotype showed a preliminary association with psychosis and schizophrenia: A pilot case-control study.
    Schizophr Res. 2021;230:24-25.
    PubMed    


  98. DURAND D, Strassnig MT, Moore RC, Depp CA, et al
    Self-reported social functioning and social cognition in schizophrenia and bipolar disorder: Using ecological momentary assessment to identify the origin of bias.
    Schizophr Res. 2021;230:17-23.
    PubMed     Abstract available


  99. ENACHE D, Nikkheslat N, Fathalla D, Morgan BP, et al
    Peripheral immune markers and antipsychotic non-response in psychosis.
    Schizophr Res. 2021;230:1-8.
    PubMed     Abstract available


  100. YAEGASHI H, Misawa F, Noda H, Fujii Y, et al
    Risk of withdrawal of consent for treatment with long-acting injectable versus oral antipsychotics: A meta-analysis of randomized controlled trials.
    Schizophr Res. 2021;229:94-101.
    PubMed     Abstract available


    February 2021
  101. SEVERANCE EG, Leister F, Lea A, Yang S, et al
    Complement C4 associations with altered microbial biomarkers exemplify gene-by-environment interactions in schizophrenia.
    Schizophr Res. 2021 Feb 23. pii: S0920-9964(21)00071.
    PubMed     Abstract available


  102. SHAD MU
    Is high-dose maintenance therapy effective in treatment-refractory psychosis? A case series.
    Schizophr Res. 2021;229:38-42.
    PubMed    


  103. JOHNSON KA, Guyer M, Ongur D, Friedman-Yakoobian M, et al
    Early intervention in psychosis: Building a strategic roadmap for Massachusetts.
    Schizophr Res. 2021;229:43-45.
    PubMed    


  104. NOYAN H, Erdag E, Tuzun E, Yaylim I, et al
    Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1beta levels in patients with schizophrenia spectrum disorder and their siblings.
    Schizophr Res. 2021;229:27-37.
    PubMed     Abstract available


  105. SUHAS S, Kumar V, Venkatasubramanian G
    Therapeutic drug monitoring of clozapine in Indian patients with schizophrenia - Authors response.
    Schizophr Res. 2021;229:25-26.
    PubMed    


  106. MEHTA UM, Keshavan MS
    Hindsight 2020: Emerging research trends in schizophrenia.
    Schizophr Res. 2021;229:22-24.
    PubMed    


  107. PARIS G, Bighelli I, Deste G, Siafis S, et al
    Short-acting intramuscular second-generation antipsychotic drugs for acutely agitated patients with schizophrenia spectrum disorders. A systematic review and network meta-analysis.
    Schizophr Res. 2021;229:3-11.
    PubMed     Abstract available


  108. HANLON FM, Dodd AB, Ling JM, Shaff NA, et al
    The clinical relevance of gray matter atrophy and microstructural brain changes across the psychosis continuum.
    Schizophr Res. 2021;229:12-21.
    PubMed     Abstract available


  109. MC GLANAGHY E, Turner D, Davis GA, Sharpe H, et al
    A network meta-analysis of psychological interventions for schizophrenia and psychosis: Impact on symptoms.
    Schizophr Res. 2021;228:447-459.
    PubMed     Abstract available


  110. KULKARNI G, Mehta UM, Das S, Arunachal G, et al
    Novel CTSF Indel in a patient with Kufs disease and resistant schizophrenia: A case report.
    Schizophr Res. 2021;228:435-437.
    PubMed    


  111. GAIGL G, Taumer E, Merz K, Zoscher S, et al
    Multifactorial barriers in the implementation of schizophrenia and psychosocial therapies guidelines: A quantitative study across different professions.
    Schizophr Res. 2021;228:425-434.
    PubMed     Abstract available


  112. OH J, Nam H, Park S, Chae JH, et al
    Decreased cardiovascular death in schizophrenia patients treated with antipsychotics: A Korean national cohort study.
    Schizophr Res. 2021;228:417-424.
    PubMed     Abstract available


  113. PUNTIS S, Oliver D, Fusar-Poli P
    Third external replication of an individualised transdiagnostic prediction model for the automatic detection of individuals at risk of psychosis using electronic health records.
    Schizophr Res. 2021;228:403-409.
    PubMed     Abstract available


  114. DAR S, Liebenthal E, Pan H, Smith T, et al
    Abnormal semantic processing of threat words associated with excitement and hostility symptoms in schizophrenia.
    Schizophr Res. 2021;228:394-402.
    PubMed     Abstract available


  115. HIGGINS A, Lewandowski KE, Liukasemsarn S, Hall MH, et al
    Longitudinal relationships between mismatch negativity, cognitive performance, and real-world functioning in early psychosis.
    Schizophr Res. 2021;228:385-393.
    PubMed     Abstract available


  116. HERNIMAN SE, Cotton SM, Allott KA, Phillips LJ, et al
    The psychometric validity of the Montgomery-Asberg Depression Rating Scale (MADRS) in recent onset schizophrenia spectrum disorders.
    Schizophr Res. 2021;228:373-381.
    PubMed     Abstract available


  117. DUFVA YE, Westman H, Khilbom U, Sullivan PF, et al
    Swedish large-scale schizophrenia study: Why do patients and healthy controls participate?
    Schizophr Res. 2021;228:360-366.
    PubMed     Abstract available


  118. DIAZ-CUTRARO L, Garcia-Mieres H, Lopez-Carrilero R, Ferrer M, et al
    Jumping to conclusions is differently associated with specific subtypes of delusional experiences: An exploratory study in first-episode psychosis.
    Schizophr Res. 2021;228:357-359.
    PubMed    


  119. MCGORRY PD, Mei C, Hartmann J, Yung AR, et al
    Intervention strategies for ultra-high risk for psychosis: Progress in delaying the onset and reducing the impact of first-episode psychosis.
    Schizophr Res. 2021;228:344-356.
    PubMed     Abstract available


  120. BERRY C, Newcombe H, Strauss C, Rammou A, et al
    Validation of the Hamilton Program for Schizophrenia Voices Questionnaire: Associations with emotional distress and wellbeing, and invariance across diagnosis and sex.
    Schizophr Res. 2021;228:336-343.
    PubMed     Abstract available


  121. VER LOREN VAN THEMAAT AH, Hemager N, Korsgaard Johnsen L, Klee Burton B, et al
    Development of visual attention from age 7 to age 12 in children with familial high risk for schizophrenia or bipolar disorder.
    Schizophr Res. 2021;228:327-335.
    PubMed     Abstract available


  122. KEEFE RSE
    Where do we cut the bell-shaped curve of CIAS?
    Schizophr Res. 2021;228:633-634.
    PubMed    


  123. KOLBAEK P, Dines D, Hansen J, Opler M, et al
    Standardized training in the rating of the six-item Positive And Negative Syndrome Scale (PANSS-6).
    Schizophr Res. 2021;228:438-446.
    PubMed     Abstract available


  124. LAHTEENVUO M, Taipale H, Tanskanen A, Mittendorfer-Rutz E, et al
    Effectiveness of pharmacotherapies for delusional disorder in a Swedish national cohort of 9076 patients.
    Schizophr Res. 2021;228:367-372.
    PubMed     Abstract available


  125. DAS D, Peng X, Lam AN, Bader JS, et al
    Transcriptome analysis of human induced excitatory neurons supports a strong effect of clozapine on cholesterol biosynthesis.
    Schizophr Res. 2021;228:324-326.
    PubMed     Abstract available


  126. SUMNER PJ, Rossell SL, Tan EJ
    On the assessment of subjective formal thought disorder.
    Schizophr Res. 2021;228:58-59.
    PubMed    


  127. SUHAS S, Nagpal M, Rao NP, Kumar V, et al
    Echo of reading - The forgotten psychopathology: A case report.
    Schizophr Res. 2021;228:602-603.
    PubMed    


  128. RABINOWITZ J, Opler M, Rabinowitz AA, Negash S, et al
    Consistency checks to improve measurement with the Personal and Social Performance Scale (PSP).
    Schizophr Res. 2021;228:529-533.
    PubMed     Abstract available


    January 2021
  129. MOYA LACASA C, Rayner T, Hagen MM, Yang W, et al
    Anti-cyomegalovirus antibodies in schizophrenia and related disorders: A systematic review and meta-analysis.
    Schizophr Res. 2021;228:322-323.
    PubMed    


  130. BOLBECKER AR, Apthorp D, Bartolomeo LA, O'Donnell BF, et al
    Postural sway in first-degree relatives of individuals with schizophrenia.
    Schizophr Res. 2021;228:319-321.
    PubMed    


  131. LAVEBRATT C, Stiernborg M, Kumar P, Yacaman-Mendez D, et al
    Physical exercise is associated with a reduction in inflammatory biomarkers in first-episode psychosis: A pilot study of CRP, SAA, sICAM-1 and sVCAM-1.
    Schizophr Res. 2021;228:316-318.
    PubMed    


  132. KALINKOVICH A, Pouyrovsky M, Nasyrova R, Livshits G, et al
    Biased activation of inflammation pro-resolving receptors as an evolving supportive strategy in schizophrenia treatment.
    Schizophr Res. 2021;228:295-297.
    PubMed    


  133. MEHTA UM, Naik SS, Thirthalli J
    Global visuospatial processing - a screening tool to predict cognition in schizophrenia.
    Schizophr Res. 2021;228:311-313.
    PubMed    


  134. BORNHEIMER LA, Wojtalik JA, Li J, Cobia D, et al
    Suicidal ideation in first-episode psychosis: Considerations for depression, positive symptoms, clinical insight, and cognition.
    Schizophr Res. 2021;228:298-304.
    PubMed     Abstract available


  135. CHAN SKW, Liu T, Wong AOY, Wong GHY, et al
    Self-referential gaze perception of patients with schizophrenia and its relationship with symptomatology and cognitive functions.
    Schizophr Res. 2021;228:288-294.
    PubMed     Abstract available


  136. KOSHIYAMA D, Miyakoshi M, Thomas ML, Joshi YB, et al
    Unique contributions of sensory discrimination and gamma synchronization deficits to cognitive, clinical, and psychosocial functional impairments in schizophrenia.
    Schizophr Res. 2021;228:280-287.
    PubMed     Abstract available


  137. HARE SM, Adhikari BM, Du X, Garcia L, et al
    Local versus long-range connectivity patterns of auditory disturbance in schizophrenia.
    Schizophr Res. 2021;228:262-270.
    PubMed     Abstract available


  138. GRIFFITHS SL, Wood SJ, Fowler D, Freemantle N, et al
    Improved social functioning following social recovery therapy in first episode psychosis: Do social cognition and neurocognition change following therapy, and do they predict treatment response?
    Schizophr Res. 2021;228:249-255.
    PubMed     Abstract available


  139. ZENG J, Zhang W, Xiao Y, Fu G, et al
    Pretreatment abnormalities in white matter integrity predict one-year clinical outcome in first episode schizophrenia.
    Schizophr Res. 2021;228:241-248.
    PubMed     Abstract available


  140. TIRUPATI S
    The risk for Torsades de Pointes and polypharmacy in schizophrenia.
    Schizophr Res. 2021;228:239-240.
    PubMed    


  141. MOSCHOPOULOS N, Nimatoudis I, Kaprinis S, Iliadou V, et al
    Could early diagnosis and rehabilitation of Auditory Processing Disorder in schizophrenia have a positive effect on cognition?
    Schizophr Res. 2021;228:237-238.
    PubMed    


  142. BRUINS J, Pijnenborg GHM, Wunderink L, Visser E, et al
    The association of cannabis use with quality of life and psychosocial functioning in psychosis.
    Schizophr Res. 2021;228:229-234.
    PubMed     Abstract available


  143. CAMPANA M, Falkai P, Siskind D, Hasan A, et al
    Characteristics and definitions of ultra-treatment-resistant schizophrenia - A systematic review and meta-analysis.
    Schizophr Res. 2021;228:218-226.
    PubMed     Abstract available


  144. DICKERSON F, Katsafanas E, Origoni A, Squire A, et al
    Exposure to Epstein Barr virus and cognitive functioning in individuals with schizophrenia.
    Schizophr Res. 2021;228:193-197.
    PubMed     Abstract available


  145. BIGSETH TT, Fredriksen M, Egeland J, Andersen E, et al
    Elevated levels of soluble urokinase plasminogen activator receptor as a low-grade inflammation marker in schizophrenia: A case-control study.
    Schizophr Res. 2021;228:190-192.
    PubMed    


  146. CORRELL CU, Vanover KE, Davis RE, Chen R, et al
    Safety and tolerability of lumateperone 42 mg: An open-label antipsychotic switch study in outpatients with stable schizophrenia.
    Schizophr Res. 2021;228:198-205.
    PubMed     Abstract available


  147. ADDINGTON J, Santesteban-Echarri O, Braun A, Lecomte T, et al
    Assessing social functioning in youth at clinical high-risk for psychosis.
    Schizophr Res. 2021;228:188-189.
    PubMed    


  148. SZESZKO PR, McNamara RK, Gallego JA, Malhotra AK, et al
    Longitudinal investigation of the relationship between omega-3 polyunsaturated fatty acids and neuropsychological functioning in recent-onset psychosis: A randomized clinical trial.
    Schizophr Res. 2021;228:180-187.
    PubMed     Abstract available


  149. ALLE MC, Berna F, Danion JM, Berntsen D, et al
    Unraveling the role of retrieval deficits in autobiographical memory impairment in schizophrenia: A comparison of involuntary and voluntary autobiographical memories.
    Schizophr Res. 2021;228:89-96.
    PubMed     Abstract available


  150. POPE LG, Manseau MW, Kelley ME, Compton MT, et al
    Symptomatology and neurocognition among first-episode psychosis patients with and without cannabis use in the three months prior to first hospitalization.
    Schizophr Res. 2021;228:83-88.
    PubMed     Abstract available


  151. SCHOONOVER KE, Farmer CB, Morgan CJ, Sinha V, et al
    Abnormalities in the copper transporter CTR1 in postmortem hippocampus in schizophrenia: A subregion and laminar analysis.
    Schizophr Res. 2021;228:60-73.
    PubMed     Abstract available


  152. MUKKU SSR, Nadella RK, Sivakumar PT, Sinha P, et al
    Is late onset schizophrenia a forerunner of Frontotemporal dementia? - A case series.
    Schizophr Res. 2021;228:56-57.
    PubMed    


  153. PENNEY D, El-Baalbaki G, Lepage M
    Prevalence and severity of posttraumatic stress symptoms in psychosis: Associations with affective and patient-centered variables in those referred for psychological services.
    Schizophr Res. 2021;228:53-55.
    PubMed    


  154. ABPLANALP SJ, Gold A, Gonzalez R, Doshi S, et al
    Feasibility of using smartphones to capture speech during social interactions in schizophrenia.
    Schizophr Res. 2021;228:51-52.
    PubMed    


  155. LINCOLN SH, Johnson T, Winters A, Laquidara J, et al
    Social exclusion and rejection across the psychosis spectrum: A systematic review of empirical research.
    Schizophr Res. 2021;228:43-50.
    PubMed     Abstract available


  156. SPARK J, Gaweda L, Allott K, Hartmann JA, et al
    Distinguishing schizophrenia spectrum from non-spectrum disorders among young patients with first episode psychosis and at high clinical risk: The role of basic self-disturbance and neurocognition.
    Schizophr Res. 2021;228:19-28.
    PubMed     Abstract available


  157. VILA-BADIA R, Butjosa A, Del Cacho N, Serra-Arumi C, et al
    Types, prevalence and gender differences of childhood trauma in first-episode psychosis. What is the evidence that childhood trauma is related to symptoms and functional outcomes in first episode psychosis? A systematic review.
    Schizophr Res. 2021;228:159-179.
    PubMed     Abstract available


  158. BOGE K, Hahne I, Bergmann N, Wingenfeld K, et al
    Mindfulness-based group therapy for in-patients with schizophrenia spectrum disorders - Feasibility, acceptability, and preliminary outcomes of a rater-blinded randomized controlled trial.
    Schizophr Res. 2021;228:134-144.
    PubMed     Abstract available


  159. SCHOONOVER KE, Roberts RC
    Markers of copper transport in the cingulum bundle in schizophrenia.
    Schizophr Res. 2021;228:124-133.
    PubMed     Abstract available


  160. HEDBERG M, Imbeault S, Erhardt S, Schwieler L, et al
    Disrupted sensorimotor gating in first-episode psychosis patients is not affected by short-term antipsychotic treatment.
    Schizophr Res. 2021;228:118-123.
    PubMed     Abstract available


  161. SENDI MSE, Pearlson GD, Mathalon DH, Ford JM, et al
    Multiple overlapping dynamic patterns of the visual sensory network in schizophrenia.
    Schizophr Res. 2021;228:103-111.
    PubMed     Abstract available


  162. ZHANG Y, Geyfman A, Coffman B, Gill K, et al
    Distinct alterations in resting-state electroencephalogram during eyes closed and eyes open and between morning and evening are present in first-episode psychosis patients.
    Schizophr Res. 2021;228:36-42.
    PubMed     Abstract available


  163. SMESNY S, Berberich D, Gussew A, Schonfeld N, et al
    Alterations of neurometabolism in the dorsolateral prefrontal cortex and thalamus in transition to psychosis patients change under treatment as usual - A two years follow-up (1)H/(31)P-MR-spectroscopy study.
    Schizophr Res. 2021;228:7-18.
    PubMed     Abstract available


  164. SECCOMANDI B, Agbedjro D, Bell M, Keefe RSE, et al
    Exploring the role of age as a moderator of cognitive remediation for people with schizophrenia.
    Schizophr Res. 2021;228:29-35.
    PubMed     Abstract available


  165. KIMURA M, Oda Y, Oishi K, Yoshino K, et al
    Effects of repeated electroconvulsive shocks on dopamine supersensitivity psychosis model rats.
    Schizophr Res. 2021;228:1-6.
    PubMed     Abstract available


  166. STRAUSS GP, Pelletier-Baldelli A, Visser KF, Walker EF, et al
    Reprint of: A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis.
    Schizophr Res. 2021;227:63-71.
    PubMed     Abstract available


  167. MALHI GS, Bell E, Hamilton A, Morris G, et al
    Early intervention for risk syndromes: What are the real risks?
    Schizophr Res. 2021;227:4-9.
    PubMed    


    December 2020
  168. ELLERSGAARD D, Gregersen M, Spang KS, Christiani C, et al
    Psychotic experiences in seven-year-old children with familial high risk of schizophrenia or bipolar disorder in: The Danish High Risk and Resilience Study - VIA 7; A population-based cohort study.
    Schizophr Res. 2020 Dec 9. pii: S0920-9964(20)30589.
    PubMed     Abstract available


  169. BOUET V, Percelay S, Leroux E, Diarra B, et al
    A new 3-hit mouse model of schizophrenia built on genetic, early and late factors.
    Schizophr Res. 2020 Dec 7. pii: S0920-9964(20)30583.
    PubMed     Abstract available


  170. MITTAL VA, Addington JM
    Embracing heterogeneity creates new opportunities for understanding and treating those at clinical-high risk for psychosis.
    Schizophr Res. 2020 Dec 4. pii: S0920-9964(20)30554.
    PubMed    


  171. LI X, Guo X, Fan X, Feng T, et al
    Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments (SMART-CAT) in first-episode schizophrenia patients: Rationale and trial design.
    Schizophr Res. 2020 Dec 2. pii: S0920-9964(20)30529.
    PubMed     Abstract available


  172. WUNDERINK L, van Bebber J, Sytema S, Boonstra N, et al
    Reprint of: Negative symptoms predict high relapse rates and both predict less favorable functional outcome in first episode psychosis, independent of treatment strategy.
    Schizophr Res. 2020 Dec 2. pii: S0920-9964(20)30590.
    PubMed     Abstract available


  173. YEE CI, Vargas T, Mittal VA, Haase CM, et al
    Adaptability and cohesion in youth at clinical high-risk for psychosis: A multi-informant approach.
    Schizophr Res. 2020 Dec 1. pii: S0920-9964(20)30579.
    PubMed     Abstract available


    November 2020
  174. JABAR LSA, Sorensen HJ, Nordentoft M, Hjorthoj C, et al
    Associations between duration of untreated psychosis and domains of positive and negative symptoms persist after 10 years of follow-up: A secondary analysis from the OPUS trial.
    Schizophr Res. 2020 Nov 30. pii: S0920-9964(20)30567.
    PubMed     Abstract available


  175. KONSZTOWICZ S, Gelencser CR, Otis C, Schmitz N, et al
    Self-concept and Engagement in LiFe (SELF): A waitlist-controlled pilot study of a novel psychological intervention to target illness engulfment in enduring schizophrenia and related psychoses.
    Schizophr Res. 2020 Nov 30. pii: S0920-9964(20)30568.
    PubMed     Abstract available


  176. PIERRE JM
    Diagnostic uncertainty, antipsychotic dosing, and optimal psychosocial interventions: Unanswered questions in first-episode psychosis.
    Schizophr Res. 2020 Nov 27. pii: S0920-9964(20)30582.
    PubMed    


  177. BERENDSEN S, Kapitein P, Schirmbeck F, van Tricht MJ, et al
    Pre-training inter-rater reliability of clinical instruments in an international psychosis research project.
    Schizophr Res. 2020 Nov 23. pii: S0920-9964(20)30429.
    PubMed    


  178. DIJKSTRA AA, Gami-Patel P, Rozemuller AJM, Bugiani M, et al
    Reduction of GABA subunit theta-containing cortical neurons in schizophrenia.
    Schizophr Res. 2020 Nov 23. pii: S0920-9964(20)30577.
    PubMed    


  179. CADENHEAD KS, Stone WS
    Commentary: Special issue on "Biomarkers in the attenuated psychosis syndrome".
    Schizophr Res. 2020 Nov 23. pii: S0920-9964(20)30575.
    PubMed    


  180. ZHANG H, Wang D, Chen J, Wang Y, et al
    Rare variations in the SHANK3 gene confers susceptibility to schizophrenia in Uygur Chinese population.
    Schizophr Res. 2020 Nov 21. pii: S0920-9964(20)30576.
    PubMed    


  181. SCHULTZE-LUTTER F, Schimmelmann BG, Michel C
    Clinical high-risk of and conversion to psychosis in the community: A 3-year follow-up of a cohort study.
    Schizophr Res. 2020 Nov 21. pii: S0920-9964(20)30572.
    PubMed    


  182. LAWRENCE RE, Appelbaum PS, Lieberman JA
    A historical review of placebo-controlled, relapse prevention trials in schizophrenia: The loss of clinical equipoise.
    Schizophr Res. 2020 Nov 21. pii: S0920-9964(20)30562.
    PubMed     Abstract available


  183. SEMENNOV IV, Zhilyaeva TV, Kasyanov ED, Mishanov GA, et al
    Association of tetrahydrobiopterin deficiency with disturbances in one-carbon metabolism in patients with schizophrenia.
    Schizophr Res. 2020 Nov 21. pii: S0920-9964(20)30563.
    PubMed    


  184. FUSAR-POLI P, Oliver D, Spada G, Estrade A, et al
    The case for improved transdiagnostic detection of first-episode psychosis: Electronic health record cohort study.
    Schizophr Res. 2020 Nov 21. pii: S0920-9964(20)30571.
    PubMed     Abstract available


  185. PARLAR ME, Heinrichs RW
    Cognitive decline and impairment in schizophrenia spectrum disorders reconsidered.
    Schizophr Res. 2020 Nov 21. pii: S0920-9964(20)30560.
    PubMed     Abstract available


  186. ZOPF R, Boulton K, Langdon R, Rich AN, et al
    Perception of visual-tactile asynchrony, bodily perceptual aberrations, and bodily illusions in schizophrenia.
    Schizophr Res. 2020 Nov 21. pii: S0920-9964(20)30578.
    PubMed     Abstract available


  187. NASLUND JA, Hswen Y
    Person-based machine learning: Accounting for patient experience to explain the nature of schizophrenia.
    Schizophr Res. 2020 Nov 20. pii: S0920-9964(20)30569.
    PubMed    


  188. BITSCH F, Berger P, Nagels A, Falkenberg I, et al
    Characterizing the theory of mind network in schizophrenia reveals a sparser network structure.
    Schizophr Res. 2020 Nov 20. pii: S0920-9964(20)30566.
    PubMed     Abstract available


  189. FUJIKAWA R, Yamada J, Jinno S
    Subclass imbalance of parvalbumin-expressing GABAergic neurons in the hippocampus of a mouse ketamine model for schizophrenia, with reference to perineuronal nets.
    Schizophr Res. 2020 Nov 20. pii: S0920-9964(20)30555.
    PubMed     Abstract available


  190. TSO IF, Angstadt M, Rutherford S, Peltier S, et al
    Dynamic causal modeling of eye gaze processing in schizophrenia.
    Schizophr Res. 2020 Nov 20. pii: S0920-9964(20)30551.
    PubMed     Abstract available


  191. FERNANDEZ-LINSENBARTH I, Planchuelo-Gomez A, Diez A, Arjona-Valladares A, et al
    Neurobiological underpinnings of cognitive subtypes in psychoses: A cross-diagnostic cluster analysis.
    Schizophr Res. 2020 Nov 18. pii: S0920-9964(20)30552.
    PubMed     Abstract available


  192. REFISCH A, Chung HY, Komatsuzaki S, Schumann A, et al
    A common variation in HCN1 is associated with heart rate variability in schizophrenia.
    Schizophr Res. 2020 Nov 18. pii: S0920-9964(20)30556.
    PubMed     Abstract available


  193. ZHANG X, Liu W, Guo F, Li C, et al
    Disrupted structural covariance network in first episode schizophrenia patients: Evidence from a large sample MRI-based morphometric study.
    Schizophr Res. 2020 Nov 14. pii: S0920-9964(20)30501.
    PubMed     Abstract available


  194. GAEBEL W, Stricker J, Hasan A, Falkai P, et al
    The revised DGPPN and APA schizophrenia guidelines: Guideline quality and recommendations for long-term antipsychotic treatment.
    Schizophr Res. 2020 Nov 14. pii: S0920-9964(20)30530.
    PubMed    


  195. HAARSMA J, Kok P, Browning M
    The promise of layer-specific neuroimaging for testing predictive coding theories of psychosis.
    Schizophr Res. 2020 Nov 13. pii: S0920-9964(20)30496.
    PubMed     Abstract available


  196. SANDSTEN KE, Parnas J
    Altered self-recognition in schizophrenia - A reply to critics.
    Schizophr Res. 2020 Nov 13. pii: S0920-9964(20)30494.
    PubMed    


  197. LAGAN S, Camacho E, Torous J
    Is there a clinically relevant, publicly accessible app for that? Exploring the clinical relevance and availability of mobile apps for schizophrenia and psychosis.
    Schizophr Res. 2020 Nov 13. pii: S0920-9964(20)30525.
    PubMed    


  198. INTSON K, Geissah S, McCullumsmith RE, Ramsey AJ, et al
    A role for endothelial NMDA receptors in the pathophysiology of schizophrenia.
    Schizophr Res. 2020 Nov 11. pii: S0920-9964(20)30491.
    PubMed     Abstract available


  199. GREENWOOD TA, Swerdlow NR, Sprock J, Calkins ME, et al
    Heritability of acoustic startle magnitude and latency from the consortium on the genetics of schizophrenia.
    Schizophr Res. 2020 Nov 11. pii: S0920-9964(20)30500.
    PubMed     Abstract available


  200. MALASPINA D, Gonen O, Rhodes H, Hoffman KW, et al
    Hippocampal metabolite concentrations in schizophrenia vary in association with rare gene variants in the TRIO gene.
    Schizophr Res. 2020 Nov 9. pii: S0920-9964(20)30498.
    PubMed    


  201. PATEL RS, Sreeram V, Vadukapuram R, Baweja R, et al
    Do cannabis use disorders increase medication non-compliance in schizophrenia?: United States Nationwide inpatient cross-sectional study.
    Schizophr Res. 2020 Nov 9. pii: S0920-9964(20)30499.
    PubMed     Abstract available


    October 2020
  202. JUTLA A, Califano A, Dishy G, Hesson H, et al
    Neurodevelopmental predictors of conversion to schizophrenia and other psychotic disorders in adolescence and young adulthood in clinical high risk individuals.
    Schizophr Res. 2020 Oct 31. pii: S0920-9964(20)30495.
    PubMed    


  203. CARRION RE, Auther AM, McLaughlin D, Addington J, et al
    Social decline in the psychosis prodrome: Predictor potential and heterogeneity of outcome.
    Schizophr Res. 2020 Oct 30. pii: S0920-9964(20)30464.
    PubMed     Abstract available


  204. YU L, Fang X, Chen Y, Wang Y, et al
    Efficacy of transcranial direct current stimulation in ameliorating negative symptoms and cognitive impairments in schizophrenia: A systematic review and meta-analysis.
    Schizophr Res. 2020 Oct 28. pii: S0920-9964(20)30493.
    PubMed     Abstract available


  205. NAGENDRA A, Halverson TF, Pinkham AE, Harvey PD, et al
    Neighborhood socioeconomic status and racial disparities in schizophrenia: An exploration of domains of functioning.
    Schizophr Res. 2020 Oct 24. pii: S0920-9964(20)30478.
    PubMed     Abstract available


  206. SKLAR AL, Coffman BA, Haas G, Ghuman A, et al
    Inefficient visual search strategies in the first-episode schizophrenia spectrum.
    Schizophr Res. 2020 Oct 20. pii: S0920-9964(20)30473.
    PubMed     Abstract available


  207. PEREZ MM, Tercero BA, Penn DL, Pinkham AE, et al
    Overconfidence in social cognitive decision making: Correlations with social cognitive and neurocognitive performance in participants with schizophrenia and healthy individuals.
    Schizophr Res. 2020 Oct 20. pii: S0920-9964(20)30492.
    PubMed     Abstract available


  208. RAPADO-CASTRO M, Whittle S, Pantelis C, Thompson A, et al
    Does cortical brain morphology act as a mediator between childhood trauma and transition to psychosis in young individuals at ultra-high risk?
    Schizophr Res. 2020 Oct 15. pii: S0920-9964(20)30475.
    PubMed     Abstract available


  209. GOLDRING A, Borne S, Hefner A, Thanju A, et al
    The psychometric properties of the Self-Evaluation of Negative Symptoms Scale (SNS) in treatment-resistant schizophrenia (TRS).
    Schizophr Res. 2020 Oct 15. pii: S0920-9964(20)30436.
    PubMed     Abstract available


  210. EGERTON A, Grace AA, Stone J, Bossong MG, et al
    Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development.
    Schizophr Res. 2020 Oct 15. pii: S0920-9964(20)30471.
    PubMed     Abstract available


  211. SPENCER HM, Dudley R, Freeston MH, Turkington D, et al
    What are the essential ingredients of a CBT case conceptualization for voices and delusions in schizophrenia spectrum disorders? A study of expert consensus.
    Schizophr Res. 2020 Oct 14. pii: S0920-9964(20)30484.
    PubMed     Abstract available


  212. BHATTACHARYYA S, Schoeler T, Patel R, di Forti M, et al
    Individualized prediction of 2-year risk of relapse as indexed by psychiatric hospitalization following psychosis onset: Model development in two first episode samples.
    Schizophr Res. 2020 Oct 14. pii: S0920-9964(20)30474.
    PubMed     Abstract available


  213. FRITZE S, Thieme CE, Kubera KM, Northoff G, et al
    Brainstem alterations contribute to catatonia in schizophrenia spectrum disorders.
    Schizophr Res. 2020 Oct 9. pii: S0920-9964(20)30483.
    PubMed     Abstract available


  214. WHITTON AE, Merchant JT, Lewandowski KE
    Dissociable mechanisms underpinning effort-cost decision-making across the psychosis spectrum.
    Schizophr Res. 2020 Oct 9. pii: S0920-9964(20)30472.
    PubMed     Abstract available


  215. MISHRA R, Mathur R, Verma R
    Altered self-recognition in schizophrenia.
    Schizophr Res. 2020 Oct 9. pii: S0920-9964(20)30469.
    PubMed    


  216. TERNOVOY S, Ustyuzhanin D, Morozova Y, Shariya M, et al
    Functional MRI evince the safety and efficacy of umbilical cord blood cells therapy in patients with schizophrenia.
    Schizophr Res. 2020 Oct 9. pii: S0920-9964(20)30486.
    PubMed    


  217. BUCHANAN A, Sint K, Stefanovics E, Rosenheck R, et al
    An 18-month longitudinal study of suicidality in patients diagnosed with schizophrenia.
    Schizophr Res. 2020 Oct 9. pii: S0920-9964(20)30477.
    PubMed     Abstract available


  218. WORTHINGTON MA, Walker EF, Addington J, Bearden CE, et al
    Incorporating cortisol into the NAPLS2 individualized risk calculator for prediction of psychosis.
    Schizophr Res. 2020 Oct 9. pii: S0920-9964(20)30480.
    PubMed     Abstract available


  219. CORCORAN CM
    Commentary on "Lower speech connectedness linked to incidence of psychosis in people at clinical high risk": The promise of graph theory and network neuroscience.
    Schizophr Res. 2020 Oct 9. pii: S0920-9964(20)30482.
    PubMed    


  220. PARRISH EM, Depp CA, Moore RC, Harvey PD, et al
    Emotional determinants of life-space through GPS and ecological momentary assessment in schizophrenia: What gets people out of the house?
    Schizophr Res. 2020;224:67-73.
    PubMed     Abstract available


  221. FENG T, McEvoy JP, Miller BJ
    Longitudinal study of inflammatory markers and psychopathology in schizophrenia.
    Schizophr Res. 2020;224:58-66.
    PubMed     Abstract available


    September 2020
  222. TORII Y, Iritani S, Sekiguchi H, Habuchi C, et al
    The accumulation of advanced glycation end-products in a schizophrenic patient with a glyoxalase 1 frameshift mutation: An autopsy study.
    Schizophr Res. 2020 Sep 29. pii: S0920-9964(20)30470.
    PubMed    


  223. WEZENBERG BN, Hagen JM, Sutterland AL, Schrantee A, et al
    Association between Advanced Glycation End products and brain volumes in recent onset psychosis.
    Schizophr Res. 2020 Sep 29. pii: S0920-9964(20)30468.
    PubMed    


  224. PUJOL N, Mane A, Berge D, Mezquida G, et al
    Influence of BDNF and MTHFR polymorphisms on hippocampal volume in first-episode psychosis.
    Schizophr Res. 2020 Sep 25. pii: S0920-9964(20)30430.
    PubMed     Abstract available


  225. PARK YW, Choi D, Lee J, Ahn SS, et al
    Differentiating patients with schizophrenia from healthy controls by hippocampal subfields using radiomics.
    Schizophr Res. 2020 Sep 25. pii: S0920-9964(20)30467.
    PubMed     Abstract available


  226. MORRENS M, De Picker L, Kampen JK, Coppens V, et al
    Blood-based kynurenine pathway alterations in schizophrenia spectrum disorders: A meta-analysis.
    Schizophr Res. 2020 Sep 24. pii: S0920-9964(20)30465.
    PubMed     Abstract available


  227. MARKOVIC A, Buckley A, Driver DI, Dillard-Broadnax D, et al
    Sleep spindle activity in childhood onset schizophrenia: Diminished and associated with clinical symptoms.
    Schizophr Res. 2020 Sep 23. pii: S0920-9964(20)30450.
    PubMed     Abstract available


  228. FRIEDMAN-YAKOOBIAN MS, Parrish EM, Eack SM, Keshavan MS, et al
    Neurocognitive and social cognitive training for youth at clinical high risk (CHR) for psychosis: A randomized controlled feasibility trial.
    Schizophr Res. 2020 Sep 22. pii: S0920-9964(20)30461.
    PubMed     Abstract available


  229. HUMPSTON C, Harrow M, Rosen C
    Behind the opaque curtain: A 20-year longitudinal study of dissociative and first-rank symptoms in schizophrenia-spectrum psychoses, other psychoses and non-psychotic disorders.
    Schizophr Res. 2020 Sep 19. pii: S0920-9964(20)30412.
    PubMed     Abstract available


  230. PRUETT BS, Meador-Woodruff JH
    Evidence for altered energy metabolism, increased lactate, and decreased pH in schizophrenia brain: A focused review and meta-analysis of human postmortem and magnetic resonance spectroscopy studies.
    Schizophr Res. 2020 Sep 18. pii: S0920-9964(20)30459.
    PubMed     Abstract available


  231. SPENCER TJ, Thompson B, Oliver D, Diederen K, et al
    Lower speech connectedness linked to incidence of psychosis in people at clinical high risk.
    Schizophr Res. 2020 Sep 17. pii: S0920-9964(20)30458.
    PubMed     Abstract available


  232. NAKAMURA R, Asami T, Yoshimi A, Kato D, et al
    Illness management and recovery program induced neuroprotective effects on language network in schizophrenia.
    Schizophr Res. 2020 Sep 16. pii: S0920-9964(20)30454.
    PubMed    


  233. PETROVIC-VAN DER DEEN FS, Cunningham R, Manuel J, Gibb S, et al
    Exploring indigenous ethnic inequities in first episode psychosis in New Zealand - A national cohort study.
    Schizophr Res. 2020 Sep 15. pii: S0920-9964(20)30460.
    PubMed     Abstract available


  234. KINNUNEN L, Nordstrom T, Niemela M, Rasanen S, et al
    Parental somatic illnesses and their association with prodromal symptoms of psychosis among offspring.
    Schizophr Res. 2020 Sep 15. pii: S0920-9964(20)30448.
    PubMed    


  235. DANEAULT JG, Shah JL
    Unpacking the phenomenon of declining transition rates to first episode psychosis: The dyad of science and service reform in action.
    Schizophr Res. 2020 Sep 14. pii: S0920-9964(20)30388.
    PubMed    


  236. CALKINS ME, Woods SW, Bearden CE, Liu L, et al
    Concordance and factor structure of subthreshold positive symptoms in youth at clinical high risk for psychosis.
    Schizophr Res. 2020 Sep 14. pii: S0920-9964(20)30442.
    PubMed     Abstract available


  237. GAMA MARQUES J, Bento A
    Homeless, nameless and helpless: John Doe syndrome in treatment resistant schizophrenia.
    Schizophr Res. 2020 Sep 12. pii: S0920-9964(20)30455.
    PubMed    


  238. BRIEND F, Nathou C, Delcroix N, Dollfus S, et al
    A new toolbox to compare target localizations for non-invasive brain stimulation: An application of rTMS treatment for auditory hallucinations in schizophrenia.
    Schizophr Res. 2020 Sep 12. pii: S0920-9964(20)30457.
    PubMed     Abstract available


  239. HARVEY PD, Horan WP, Atkins AS, Stevens H, et al
    Factor structure of cognitive performance and functional capacity in schizophrenia: Evidence for differences across functional capacity measures.
    Schizophr Res. 2020 Sep 11. pii: S0920-9964(20)30438.
    PubMed     Abstract available


  240. SARAC C, Bilgrami ZR, Haas SS, Herrera SN, et al
    Processing speed and brain volume in individuals at clinical high-risk for psychosis with comorbid eating disorders: A brief report.
    Schizophr Res. 2020 Sep 11. pii: S0920-9964(20)30453.
    PubMed    


  241. BURRER A, Caravaggio F, Manoliu A, Plitman E, et al
    Apathy is not associated with reduced ventral striatal volume in patients with schizophrenia.
    Schizophr Res. 2020 Sep 11. pii: S0920-9964(20)30446.
    PubMed     Abstract available


  242. FAAY MDM, van Baal GCM, Arango C, Diaz-Caneja CM, et al
    Hostility and aggressive behaviour in first episode psychosis: Results from the OPTiMiSE trial.
    Schizophr Res. 2020 Sep 11. pii: S0920-9964(20)30449.
    PubMed     Abstract available


  243. REMPFER MV, McDowd JM, Brown CE
    Longitudinal stability of learning potential in people with schizophrenia: A 2.5 year follow-up.
    Schizophr Res. 2020 Sep 4. pii: S0920-9964(20)30447.
    PubMed    


  244. RAJALU BM, Jayarajan D, Muliyala KP, Sharma P, et al
    Self-reported tobacco use and urine cotinine levels in persons with schizophrenia.
    Schizophr Res. 2020 Sep 4. pii: S0920-9964(20)30452.
    PubMed    


    August 2020
  245. NEILL E, Tan EJ, Toh WL, Selvendra A, et al
    Examining which factors influence age of onset in males and females with schizophrenia.
    Schizophr Res. 2020 Aug 31. pii: S0920-9964(20)30439.
    PubMed     Abstract available


  246. WUTHRICH F, Pavlidou A, Stegmayer K, Eisenhardt S, et al
    Nonverbal communication remains untouched: No beneficial effect of symptomatic improvement on poor gesture performance in schizophrenia.
    Schizophr Res. 2020 Aug 31. pii: S0920-9964(20)30441.
    PubMed     Abstract available


  247. GLENTHOJ LB, Mariegaard LS, Fagerlund B, Jepsen JRM, et al
    Cognitive remediation plus standard treatment versus standard treatment alone for individuals at ultra-high risk of developing psychosis: Results of the FOCUS randomised clinical trial.
    Schizophr Res. 2020 Aug 29. pii: S0920-9964(20)30444.
    PubMed     Abstract available


  248. SON S, Arai M, Miyata J, Toriumi K, et al
    Enhanced carbonyl stress and disrupted white matter integrity in schizophrenia.
    Schizophr Res. 2020 Aug 22. pii: S0920-9964(20)30435.
    PubMed     Abstract available


  249. PERRY BI, Jones HJ, Richardson TG, Zammit S, et al
    Common mechanisms for type 2 diabetes and psychosis: Findings from a prospective birth cohort.
    Schizophr Res. 2020 Aug 19. pii: S0920-9964(20)30434.
    PubMed     Abstract available


  250. VAN ASSCHE L, Emsell L, Claes L, Van de Ven L, et al
    Hippocampal volume as a vulnerability marker for late onset psychosis: Associations with memory function and childhood trauma.
    Schizophr Res. 2020 Aug 17. pii: S0920-9964(20)30432.
    PubMed    


  251. KODESH A, Goldberg Y, Rotstein A, Weinstein G, et al
    Risk of dementia and death in very-late-onset schizophrenia-like psychosis: A national cohort study.
    Schizophr Res. 2020 Aug 14. pii: S0920-9964(20)30413.
    PubMed     Abstract available


  252. DAVIDSON L
    Commentary on "Relationships between psychiatric symptoms, functioning and personal recovery in psychosis" by Best et al.
    Schizophr Res. 2020 Aug 10. pii: S0920-9964(20)30431.
    PubMed    


  253. ERSHOVA ES, Malinovskaya EM, Golimbet VE, Lezheiko TV, et al
    Copy number variations of satellite III (1q12) and ribosomal repeats in health and schizophrenia.
    Schizophr Res. 2020 Aug 6. pii: S0920-9964(20)30415.
    PubMed     Abstract available


  254. HIDESE S, Ota M, Matsuo J, Ishida I, et al
    Association between obesity and white matter microstructure impairments in patients with schizophrenia: A whole-brain magnetic resonance imaging study.
    Schizophr Res. 2020 Aug 5. pii: S0920-9964(20)30395.
    PubMed     Abstract available


  255. DAVIS BJ, Lysaker PH, Salyers MP, Minor KS, et al
    The insight paradox in schizophrenia: A meta-analysis of the relationship between clinical insight and quality of life.
    Schizophr Res. 2020 Aug 3. pii: S0920-9964(20)30403.
    PubMed     Abstract available


  256. HWANG WJ, Cho KIK, Kwak YB, Lee J, et al
    Intact thalamic microstructure in asymptomatic relatives of schizophrenia patients with high genetic loading.
    Schizophr Res. 2020 Aug 3. pii: S0920-9964(20)30394.
    PubMed     Abstract available


  257. LANGER AI, Schmidt C, Vergara R, Mayol-Troncoso R, et al
    Examining the effect of a mindfulness based program for the improvement of cognitive function in an early stage of schizophrenia. A random controlled trial.
    Schizophr Res. 2020 Aug 3. pii: S0920-9964(20)30398.
    PubMed    


  258. RAJKUMAR RP
    The DOSMD challenge and the COVID-19 conundrum.
    Schizophr Res. 2020;222:475-476.
    PubMed    


  259. GROVER S, Mishra E, Chakrabarti S, Mehra A, et al
    Telephonic monitoring of patients on clozapine in the resource-poor setting during the COVID-19 pandemic.
    Schizophr Res. 2020;222:489-490.
    PubMed    


    July 2020
  260. BALZAN RP, Moritz S
    Cognitive biases and psychosis: From bench to bedside.
    Schizophr Res. 2020 Jul 30. pii: S0920-9964(20)30400.
    PubMed    


  261. RAGLAND JD, Liu XL, Williams AB, Tully LM, et al
    Retrieval practice facilitation of family psychoeducation in people with early psychosis.
    Schizophr Res. 2020 Jul 29. pii: S0920-9964(20)30402.
    PubMed     Abstract available


  262. MISIAK B, Wisniewski M, Lis M, Samochowiec J, et al
    Glucose homeostasis in unaffected first-degree relatives of schizophrenia patients: A systematic review and meta-analysis.
    Schizophr Res. 2020 Jul 29. pii: S0920-9964(20)30397.
    PubMed     Abstract available


  263. O'HARE KJM, Korhonen T, Latvala A, Kaprio J, et al
    Association of subclinical psychosis with suicidal ideation: A twin study.
    Schizophr Res. 2020 Jul 28. pii: S0920-9964(20)30396.
    PubMed     Abstract available


  264. AVERY SN, McHugo M, Armstrong K, Blackford JU, et al
    Habituation during encoding: A new approach to the evaluation of memory deficits in schizophrenia.
    Schizophr Res. 2020 Jul 28. pii: S0920-9964(20)30393.
    PubMed     Abstract available


  265. YANG Y, Ning X, Wang X, Wang J, et al
    Triglyceride/glucose index is a reliable predictor of insulin resistance in schizophrenia.
    Schizophr Res. 2020 Jul 27. pii: S0920-9964(20)30392.
    PubMed    


  266. BANNAI D, Lutz O, Lizano P
    Neuroimaging considerations when investigating choroid plexus morphology in idiopathic psychosis.
    Schizophr Res. 2020 Jul 27. pii: S0920-9964(20)30399.
    PubMed    


  267. SYDNOR VJ, Roalf DR
    A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: Implications for studies of psychosis risk.
    Schizophr Res. 2020 Jul 25. pii: S0920-9964(20)30380.
    PubMed     Abstract available


  268. ALI SA, Moyett A, Argyelan M, Barber AD, et al
    The effects of lorazepam on cortico-striatal connectivity in schizophrenia.
    Schizophr Res. 2020 Jul 24. pii: S0920-9964(20)30390.
    PubMed    


  269. PETROS N, Cullen AE, Fusar-Poli P, Mechelli A, et al
    Towards standardising the assessment of good outcome in people at clinical high risk for psychosis: A collaborative approach.
    Schizophr Res. 2020 Jul 24. pii: S0920-9964(20)30391.
    PubMed    


  270. TORII Y, Iritani S, Marui T, Sekiguchi H, et al
    Morphological alteration of myelin-oligodendrocytes in a schizophrenic patient with 22q11.2 deletion syndrome: An autopsy study.
    Schizophr Res. 2020 Jul 22. pii: S0920-9964(20)30389.
    PubMed    


  271. CUI H, Giuliano AJ, Zhang T, Xu L, et al
    Cognitive dysfunction in a psychotropic medication-naive, clinical high-risk sample from the ShangHai-At-Risk-for-Psychosis (SHARP) study: Associations with clinical outcomes.
    Schizophr Res. 2020 Jul 18. pii: S0920-9964(20)30370.
    PubMed     Abstract available


  272. LINDENMAYER JP, Goldring A, Borne S, Khan A, et al
    Assessing instrumental activities of daily living (iADL) with a game-based assessment for individuals with schizophrenia.
    Schizophr Res. 2020 Jul 17. pii: S0920-9964(20)30387.
    PubMed     Abstract available


  273. WANG Y, Wei Y, Edmiston EK, Womer FY, et al
    Altered structural connectivity and cytokine levels in Schizophrenia and Genetic high-risk individuals: Associations with disease states and vulnerability.
    Schizophr Res. 2020 Jul 16. pii: S0920-9964(20)30298.
    PubMed     Abstract available


  274. JANSEN JE, Gleeson J, Bendall S, Rice S, et al
    Acceptance-and mindfulness-based interventions for persons with psychosis: Authors reply.
    Schizophr Res. 2020 Jul 16. pii: S0920-9964(20)30374.
    PubMed    


  275. GOTRA MY, Hill SK, Gershon ES, Tamminga CA, et al
    Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorder.
    Schizophr Res. 2020 Jul 13. pii: S0920-9964(20)30385.
    PubMed     Abstract available


  276. EACK SM, Keshavan MS
    Cognition, negative symptoms, and functional outcome in psychosis.
    Schizophr Res. 2020 Jul 6. pii: S0920-9964(20)30381.
    PubMed    


  277. KARPINSKI P, Samochowiec J, Sasiadek MM, Laczmanski L, et al
    Analysis of global gene expression at seven brain regions of patients with schizophrenia.
    Schizophr Res. 2020 Jul 3. pii: S0920-9964(20)30384.
    PubMed     Abstract available


  278. HABTEWOLD TD, Liemburg EJ, Islam MA, de Zwarte SMC, et al
    Association of schizophrenia polygenic risk score with data-driven cognitive subtypes: A six-year longitudinal study in patients, siblings and controls.
    Schizophr Res. 2020 Jul 3. pii: S0920-9964(20)30272.
    PubMed     Abstract available


  279. CHAUMETTE B, Sengupta SM, Lepage M, Malla A, et al
    A polymorphism in the glutamate metabotropic receptor 7 is associated with cognitive deficits in the early phases of psychosis.
    Schizophr Res. 2020 Jul 2. pii: S0920-9964(20)30371.
    PubMed     Abstract available


    June 2020
  280. BEST MW, Law H, Pyle M, Morrison AP, et al
    Relationships between psychiatric symptoms, functioning and personal recovery in psychosis.
    Schizophr Res. 2020 Jun 30. pii: S0920-9964(20)30378.
    PubMed     Abstract available


  281. MATHESON GJ, Plaven-Sigray P, Louzolo A, Borg J, et al
    Dopamine D1 receptor availability is not associated with delusional ideation measures of psychosis proneness.
    Schizophr Res. 2020 Jun 29. pii: S0920-9964(20)30345.
    PubMed     Abstract available


  282. CHATURVEDI R, Kraus M, Keefe RSE
    A new measure of authentic auditory emotion recognition: Application to patients with schizophrenia.
    Schizophr Res. 2020 Jun 29. pii: S0920-9964(19)30550.
    PubMed     Abstract available


  283. BECHI M, Crespi SA, Agostoni G, Prudenziati F, et al
    The role of agency in schizophrenia: A pilot study on gaze agency.
    Schizophr Res. 2020 Jun 28. pii: S0920-9964(20)30377.
    PubMed    


  284. WADDINGTON JL
    Early intervention services for psychosis in the metaphorical 'trenches' of contemporary care: Already known from the real trenches of WW1?
    Schizophr Res. 2020 Jun 28. pii: S0920-9964(20)30373.
    PubMed    


  285. GARCIA-MIERES H, Usall J, Feixas G, Ochoa S, et al
    Gender differences in the complexity of personal identity in psychosis.
    Schizophr Res. 2020 Jun 27. pii: S0920-9964(20)30376.
    PubMed    


  286. PURUSHOTHAMAN D, Jacob A, Kumar V, Varambally S, et al
    "To co-operate or not?" Risky co-operative behavior in Schizophrenia and the effect of vasopressin.
    Schizophr Res. 2020 Jun 27. pii: S0920-9964(20)30365.
    PubMed     Abstract available


  287. CANAL-RIVERO M, Ruiz-Veguilla M, Labad J, Ayesa-Arriola R, et al
    Predictors of weight acquisition induced by antipsychotic treatment and its relationship with age in a sample of first episode non-affective psychosis patients: A three-year follow-up study.
    Schizophr Res. 2020 Jun 26. pii: S0920-9964(20)30363.
    PubMed    


  288. LEON-ORTIZ P, Reyes-Madrigal F, Kochunov P, Gomez-Cruz G, et al
    White matter alterations and the conversion to psychosis: A combined diffusion tensor imaging and glutamate (1)H MRS study.
    Schizophr Res. 2020 Jun 25. pii: S0920-9964(20)30358.
    PubMed     Abstract available


  289. LARSEN KM, Dzafic I, Darke H, Pertile H, et al
    Aberrant connectivity in auditory precision encoding in schizophrenia spectrum disorder and across the continuum of psychotic-like experiences.
    Schizophr Res. 2020 Jun 25. pii: S0920-9964(20)30341.
    PubMed     Abstract available


  290. KAFADAR E, Mittal VA, Strauss GP, Chapman HC, et al
    Modeling perception and behavior in individuals at clinical high risk for psychosis: Support for the predictive processing framework.
    Schizophr Res. 2020 Jun 24. pii: S0920-9964(20)30224.
    PubMed     Abstract available


  291. LASALVIA A, Vita A, Bellomo A, Tusconi M, et al
    Renaming schizophrenia? A survey among psychiatrists, mental health service users and family members in Italy.
    Schizophr Res. 2020 Jun 24. pii: S0920-9964(20)30157.
    PubMed     Abstract available


  292. WOOD L, Williams C, Billings J, Johnson S, et al
    A systematic review and meta-analysis of cognitive behavioural informed psychological interventions for psychiatric inpatients with psychosis.
    Schizophr Res. 2020 Jun 22. pii: S0920-9964(20)30152.
    PubMed     Abstract available


  293. CHAVES CB, Vieira-Coelho MA
    Clinical trials with monoclonal antibodies in schizophrenia.
    Schizophr Res. 2020 Jun 22. pii: S0920-9964(20)30278.
    PubMed    


  294. OLIVER D, Spada G, Colling C, Broadbent M, et al
    Real-world implementation of precision psychiatry: Transdiagnostic risk calculator for the automatic detection of individuals at-risk of psychosis.
    Schizophr Res. 2020 Jun 19. pii: S0920-9964(20)30259.
    PubMed     Abstract available


  295. POLETTI M, Raballo A
    Disembodiment and schizophrenia: Looking at the motor roots of minimal self disorders in a developmental perspective.
    Schizophr Res. 2020 Jun 18. pii: S0920-9964(20)30359.
    PubMed    


  296. FERRARELLI F
    Ketamine, NMDA hypofunction, and sleep oscillatory abnormalities in schizophrenia.
    Schizophr Res. 2020 Jun 18. pii: S0920-9964(20)30361.
    PubMed    


  297. SABOUR S
    Clozapine screening in people taking clozapine: Understanding diagnostic accuracy in schizophrenia.
    Schizophr Res. 2020 Jun 18. pii: S0920-9964(20)30364.
    PubMed    


  298. MAGUIRE J, Sizer H, Mifsud N, O'Donoghue B, et al
    Outcomes for migrants with a first episode of psychosis: A systematic review.
    Schizophr Res. 2020 Jun 16. pii: S0920-9964(20)30302.
    PubMed     Abstract available


  299. DONDE C, Achim AM, Brunelin J, Poulet E, et al
    A meta-analysis of craving studies in schizophrenia spectrum disorders.
    Schizophr Res. 2020 Jun 15. pii: S0920-9964(20)30300.
    PubMed     Abstract available


  300. KOCH E, Rosenthal B, Lundquist A, Chen CH, et al
    Interactome overlap between schizophrenia and cognition.
    Schizophr Res. 2020 Jun 13. pii: S0920-9964(20)30346.
    PubMed     Abstract available


  301. SONI S, Muthukrishnan SP, Sood M, Kaur S, et al
    Altered parahippocampal gyrus activation and its connectivity with resting-state network areas in schizophrenia: An EEG study.
    Schizophr Res. 2020 Jun 10. pii: S0920-9964(20)30177.
    PubMed     Abstract available


  302. HASSON-OHAYON I, Scholte-Stalenhoef AN, Schirmbeck F, de Haan L, et al
    Insight, personality, and symptoms among individuals with psychosis: Cross-sectional and longitudinal relationships.
    Schizophr Res. 2020 Jun 8. pii: S0920-9964(20)30296.
    PubMed     Abstract available


  303. SANTESTEBAN-ECHARRI O, Haffey P, Kim G, Tang J, et al
    A mobile-based app to monitor cannabis use among youth at clinical high risk (CHR) for psychosis: Feasibility and acceptability of LooseLeaf.
    Schizophr Res. 2020 Jun 8. pii: S0920-9964(20)30285.
    PubMed    


  304. STRAUSS GP, Pelletier-Baldelli A, Visser KF, Walker EF, et al
    A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis.
    Schizophr Res. 2020 Jun 7. pii: S0920-9964(20)30226.
    PubMed     Abstract available


  305. GARCIA-MIERES H, De Jesus-Romero R, Ochoa S, Feixas G, et al
    Beyond the cognitive insight paradox: Self-reflectivity moderates the relationship between depressive symptoms and general psychological distress in psychosis.
    Schizophr Res. 2020 Jun 6. pii: S0920-9964(20)30279.
    PubMed     Abstract available


  306. CASTELNOVO A, Aquilino D, Parabiaghi A, D'Agostino A, et al
    Could CBT sustain long-term remission without antipsychotic medication in schizophrenia?
    Schizophr Res. 2020 Jun 6. pii: S0920-9964(20)30340.
    PubMed    


  307. SADH K, Mehta UM, Muralidharan K, Shankar NS, et al
    Understanding the role of language in patients with psychosis and hearing impairment, experiencing auditory verbal hallucinations.
    Schizophr Res. 2020 Jun 6. pii: S0920-9964(20)30343.
    PubMed    


  308. UZER-KREMERS L, Bralet MC, Angerville B, Jeanblanc J, et al
    Is self-compassion linked to treatment adherence in schizophrenia?
    Schizophr Res. 2020 Jun 6. pii: S0920-9964(20)30338.
    PubMed    


  309. SUHAS S, Kumar V, Damodharan D, Sharma P, et al
    Do Indian patients with schizophrenia need half the recommended clozapine dose to achieve therapeutic serum level? An exploratory study.
    Schizophr Res. 2020 Jun 6. pii: S0920-9964(20)30337.
    PubMed     Abstract available


  310. VAN DER VEN E, Scodes J, Basaraba C, Pauselli L, et al
    Trajectories of occupational and social functioning in people with recent-onset non-affective psychosis enrolled in specialized early intervention services across New York state.
    Schizophr Res. 2020 Jun 5. pii: S0920-9964(20)30331.
    PubMed     Abstract available


  311. BOLDRINI T, Pontillo M, Tanzilli A, Giovanardi G, et al
    An attachment perspective on the risk for psychosis: Clinical correlates and the predictive value of attachment patterns and mentalization.
    Schizophr Res. 2020 Jun 5. pii: S0920-9964(20)30332.
    PubMed     Abstract available


  312. GROVER S, Shouan A, Chakrabarti S, Sahoo S, et al
    Effectiveness of ECT in Management of Depression in patients with schizophrenia: An Open Labelled Study.
    Schizophr Res. 2020 Jun 5. pii: S0920-9964(20)30254.
    PubMed    


  313. ZEPPILLO T, Schulmann A, Macciardi F, Hjelm BE, et al
    Functional impairment of cortical AMPA receptors in schizophrenia.
    Schizophr Res. 2020 Jun 5. pii: S0920-9964(20)30147.
    PubMed     Abstract available


  314. MORITZ S, Scheunemann J, Ludtke T, Westermann S, et al
    Prolonged rather than hasty decision-making in schizophrenia using the box task. Must we rethink the jumping to conclusions account of paranoia?
    Schizophr Res. 2020 Jun 5. pii: S0920-9964(20)30336.
    PubMed     Abstract available


  315. KUBOTA M, Moriguchi S, Takahata K, Nakajima S, et al
    Treatment effects on neurometabolite levels in schizophrenia: A systematic review and meta-analysis of proton magnetic resonance spectroscopy studies.
    Schizophr Res. 2020 Jun 3. pii: S0920-9964(20)30180.
    PubMed     Abstract available


  316. BASAVARAJU R, Ithal D, Ramalingaiah AH, Thirthalli J, et al
    "Apathetic to hypomanic/manic": A case series-illustration of emergent mood symptoms during intermittent theta burst stimulation (iTBS) of cerebellar vermis in schizophrenia with predominant negative symptoms.
    Schizophr Res. 2020 Jun 3. pii: S0920-9964(20)30291.
    PubMed    


  317. DEAN B, Pavey G, Scarr E
    Higher levels of alpha7 nicotinic receptors, but not choline acetyltransferase, in the dorsolateral prefrontal cortex from a sub-group of patients with schizophrenia.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30288.
    PubMed     Abstract available


  318. CHANG CK, Chen PH, Pan CH, Su SS, et al
    Antipsychotic medications and the progression of upper respiratory infection to pneumonia in patients with schizophrenia.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30265.
    PubMed     Abstract available


  319. BARTH C, Jorgensen KN, Wortinger LA, Nerland S, et al
    Trajectories of brain volume change over 13 years in chronic schizophrenia.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30266.
    PubMed    


  320. HERNANDEZ-GARCIA M, Martin-Gomez C, Gomez-Garcia M, Gomez-Pilar J, et al
    Abnormal self-experiences related to a hypersynchronic brain state in schizophrenia.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30167.
    PubMed    


  321. LUTZ O, Lizano P, Mothi SS, Zeng V, et al
    Do neurobiological differences exist between paranoid and non-paranoid schizophrenia? Findings from the bipolar schizophrenia network on intermediate phenotypes study.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30087.
    PubMed     Abstract available


  322. ZAHEER J, Olfson M, Mallia E, Lam JSH, et al
    Predictors of suicide at time of diagnosis in schizophrenia spectrum disorder: A 20-year total population study in Ontario, Canada.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30232.
    PubMed     Abstract available


  323. SCHNELL T, Moritz S
    Less self-stigmatization and more empowerment in patients with schizophrenia and comorbid cannabis use disorder compared to non-comorbid schizophrenia.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30268.
    PubMed    


  324. COUSTALS N, Martelli C, Brunet-Lecomte M, Petillion A, et al
    Chronic smoking and cognition in patients with schizophrenia: A meta-analysis.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30182.
    PubMed     Abstract available


  325. XI C, Liu ZN, Yang J, Zhang W, et al
    Schizophrenia patients and their healthy siblings share decreased prefronto-thalamic connectivity but not increased sensorimotor-thalamic connectivity.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30252.
    PubMed     Abstract available


  326. DEVYLDER JE
    Letter to the editor re: "Delay discounting abnormalities are seen in first-episode schizophrenia but not in bipolar disorder" by Wang et al.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30215.
    PubMed    


  327. KELLEHER E, McNamara P, Dunne J, Fitzmaurice B, et al
    Prevalence of N-Methyl-d-Aspartate Receptor antibody (NMDAR-Ab) encephalitis in patients with first episode psychosis and treatment resistant schizophrenia on clozapine, a population based study.
    Schizophr Res. 2020 Jun 1. pii: S0920-9964(19)30530.
    PubMed     Abstract available


  328. CORCORAN CM, Mittal VA, Bearden CE, E Gur R, et al
    Language as a biomarker for psychosis: A natural language processing approach.
    Schizophr Res. 2020 Jun 1. pii: S0920-9964(20)30247.
    PubMed     Abstract available


  329. IFTENI P, Dima L, Teodorescu A
    Long-acting injectable antipsychotics treatment during COVID-19 pandemic - A new challenge.
    Schizophr Res. 2020;220:265-266.
    PubMed    


    May 2020
  330. CHWA WJ, Tishler TA, Raymond C, Tran C, et al
    Association between cortical volume and gray-white matter contrast with second generation antipsychotic medication exposure in first episode male schizophrenia patients.
    Schizophr Res. 2020 May 31. pii: S0920-9964(20)30207.
    PubMed     Abstract available


  331. WOODWARD ML, Lin J, Gicas KM, Su W, et al
    Medial temporal lobe cortical changes in response to exercise interventions in people with early psychosis: A randomized controlled trial.
    Schizophr Res. 2020 May 30. pii: S0920-9964(20)30297.
    PubMed     Abstract available


  332. MEISEBERG J, Moritz S
    Biases in diagnostic terminology: Clinicians choose different symptom labels depending on whether the same case is framed as depression or schizophrenia.
    Schizophr Res. 2020 May 28. pii: S0920-9964(20)30161.
    PubMed     Abstract available


  333. OH SJ, Fan X
    Current understanding on the role of nitric oxide and therapeutic potential of NO supplementation in schizophrenia.
    Schizophr Res. 2020 May 28. pii: S0920-9964(20)30304.
    PubMed    


  334. MARINO L, Scodes J, Richkin T, Alves-Bradford JM, et al
    Persistent cannabis use among young adults with early psychosis receiving coordinated specialty care in the United States.
    Schizophr Res. 2020 May 28. pii: S0920-9964(20)30289.
    PubMed     Abstract available


  335. LIU J, Lim MSM, Ng BT, Chong SA, et al
    Global emotion dysregulation and maladaptive cognitive emotion regulation strategies mediate the effects of severe trauma on depressive and positive symptoms in early non-affective psychosis.
    Schizophr Res. 2020 May 27. pii: S0920-9964(20)30294.
    PubMed     Abstract available


  336. ALMULLA AF, Al-Hakeim HK, Abed MS, Carvalho AF, et al
    Chronic fatigue and fibromyalgia symptoms are key components of deficit schizophrenia and are strongly associated with activated immune-inflammatory pathways.
    Schizophr Res. 2020 May 26. pii: S0920-9964(20)30255.
    PubMed     Abstract available


  337. RADUA J, Davies C, Fusar-Poli P
    Evaluation of variability in individual response to treatments in the clinical high-risk state for psychosis: A meta-analysis.
    Schizophr Res. 2020 May 26. pii: S0920-9964(20)30262.
    PubMed     Abstract available


  338. NICHOLS J, Gannon JM, Conlogue J, Sarpal D, et al
    Ensuring care for clozapine-treated schizophrenia patients during the COVID-19 pandemic.
    Schizophr Res. 2020 May 26. pii: S0920-9964(20)30333.
    PubMed    


  339. FERRARELLI F
    Sleep disturbances in schizophrenia and psychosis.
    Schizophr Res. 2020 May 26. pii: S0920-9964(20)30274.
    PubMed    


  340. WANG X, Lu F, Duan X, Han S, et al
    Frontal white matter abnormalities reveal the pathological basis underlying negative symptoms in antipsychotic-naive, first-episode patients with adolescent-onset schizophrenia: Evidence from multimodal brain imaging.
    Schizophr Res. 2020 May 24. pii: S0920-9964(20)30293.
    PubMed     Abstract available


  341. COSTANTINI M, Salone A, Martinotti G, Fiori F, et al
    Body representations and basic symptoms in schizophrenia.
    Schizophr Res. 2020 May 24. pii: S0920-9964(20)30292.
    PubMed     Abstract available


  342. MONGAN D, Sabherwal S, Susai SR, Focking M, et al
    Peripheral complement proteins in schizophrenia: A systematic review and meta-analysis of serological studies.
    Schizophr Res. 2020 May 24. pii: S0920-9964(20)30290.
    PubMed     Abstract available


  343. LANG X, Wang DM, Du XD, Jia QF, et al
    Elevated activity of plasma superoxide dismutase in never-treated first-episode schizophrenia patients: Associated with depressive symptoms.
    Schizophr Res. 2020 May 22. pii: S0920-9964(20)30286.
    PubMed     Abstract available


  344. TAKAHASHI T, Tsugawa S, Nakajima S, Plitman E, et al
    Thalamic and striato-pallidal volumes in schizophrenia patients and individuals at risk for psychosis: A multi-atlas segmentation study.
    Schizophr Res. 2020 May 21. pii: S0920-9964(20)30223.
    PubMed     Abstract available


  345. SCORIELS L, Genaro LT, Mororo LGC, Keffer S, et al
    Auditory versus visual neuroscience-informed cognitive training in schizophrenia: Effects on cognition, symptoms and quality of life.
    Schizophr Res. 2020 May 21. pii: S0920-9964(20)30269.
    PubMed     Abstract available


  346. BAYTUNCA BM, Kalyoncu T, Ozbaran B, Kose S, et al
    Reduced blood agmatine level in early-onset schizophrenia.
    Schizophr Res. 2020 May 20. pii: S0920-9964(20)30258.
    PubMed    


  347. KLINE ER
    Commentary: Expressed emotion as a mechanistic target in psychosis early intervention.
    Schizophr Res. 2020 May 20. pii: S0920-9964(20)30263.
    PubMed    


  348. GRAY R, Shrestha M, Brown E
    Acceptance- and mindfulness-based interventions for persons with psychosis: Potential errors in reported meta-analyses.
    Schizophr Res. 2020 May 19. pii: S0920-9964(20)30273.
    PubMed    


  349. LEI G, Liu F, Liu P, Jiao T, et al
    Does genetic mouse model of constitutive Hint1 deficiency exhibit schizophrenia-like behaviors?
    Schizophr Res. 2020 May 18. pii: S0920-9964(20)30270.
    PubMed     Abstract available


  350. DEAN DJ, Woodward N, Walther S, McHugo M, et al
    Cognitive motor impairments and brain structure in schizophrenia spectrum disorder patients with a history of catatonia.
    Schizophr Res. 2020 May 15. pii: S0920-9964(20)30264.
    PubMed     Abstract available


  351. WANG SP, Wang JD, Chang JH, Wu BJ, et al
    Frailty affects employment outcomes in patients with schizophrenia in noncompetitive employment: A 4-year longitudinal study.
    Schizophr Res. 2020 May 10. pii: S0920-9964(20)30233.
    PubMed     Abstract available


  352. FORMICA MJC, Phillips LJ, Hartmann JA, Yung AR, et al
    Has improved treatment contributed to the declining rate of transition to psychosis in ultra-high-risk cohorts?
    Schizophr Res. 2020 May 10. pii: S0920-9964(20)30235.
    PubMed     Abstract available


  353. WOODS SW, Bearden CE, Sabb FW, Stone WS, et al
    Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit.
    Schizophr Res. 2020 May 10. pii: S0920-9964(20)30227.
    PubMed     Abstract available


  354. KUMARI V, Ettinger U
    Controlled sleep deprivation as an experimental medicine model of schizophrenia: An update.
    Schizophr Res. 2020 May 8. pii: S0920-9964(20)30175.
    PubMed     Abstract available


  355. PILLNY M, Schlier B, Lincoln TM
    "I just don't look forward to anything". How anticipatory pleasure and negative beliefs contribute to goal-directed activity in patients with negative symptoms of psychosis.
    Schizophr Res. 2020 May 7. pii: S0920-9964(20)30170.
    PubMed     Abstract available


  356. MONTAGNESE M, Knolle F, Haarsma J, Griffin JD, et al
    Reinforcement learning as an intermediate phenotype in psychosis? Deficits sensitive to illness stage but not associated with polygenic risk of schizophrenia in the general population.
    Schizophr Res. 2020 May 7. pii: S0920-9964(20)30229.
    PubMed     Abstract available


  357. BROWN E, Gray R, Lo Monaco S, O'Donoghue B, et al
    The potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic research.
    Schizophr Res. 2020 May 6. pii: S0920-9964(20)30257.
    PubMed     Abstract available


  358. FRAJMAN A, Maggio N, Muler I, Haroutunian V, et al
    Gene expression meta-analysis reveals the down-regulation of three GABA receptor subunits in the superior temporal gyrus of patients with schizophrenia.
    Schizophr Res. 2020 May 3. pii: S0920-9964(20)30234.
    PubMed     Abstract available


    April 2020
  359. DEVOE DJ, Lu L, Cannon TD, Cadenhead KS, et al
    Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study.
    Schizophr Res. 2020 Apr 30. pii: S0920-9964(20)30211.
    PubMed     Abstract available


  360. YEE N, Matheson S, Korobanova D, Large M, et al
    A meta-analysis of the relationship between psychosis and any type of criminal offending, in both men and women.
    Schizophr Res. 2020 Apr 29. pii: S0920-9964(20)30216.
    PubMed     Abstract available


  361. FROHLICH F, Lustenberger C
    Neuromodulation of sleep rhythms in schizophrenia: Towards the rational design of non-invasive brain stimulation.
    Schizophr Res. 2020 Apr 27. pii: S0920-9964(20)30210.
    PubMed     Abstract available


  362. VIOLEAU L, Valery KM, Fournier T, Prouteau A, et al
    How continuum beliefs can reduce stigma of schizophrenia: The role of perceived similarities.
    Schizophr Res. 2020 Apr 27. pii: S0920-9964(20)30221.
    PubMed     Abstract available


  363. OLIVER D, Spada G, Englund A, Chesney E, et al
    Real-world digital implementation of the Psychosis Polyrisk Score (PPS): A pilot feasibility study.
    Schizophr Res. 2020 Apr 24. pii: S0920-9964(20)30222.
    PubMed     Abstract available


  364. YOLKEN R, Prandovszky E, Severance EG, Hatfield G, et al
    The oropharyngeal microbiome is altered in individuals with schizophrenia and mania.
    Schizophr Res. 2020 Apr 23. pii: S0920-9964(20)30113.
    PubMed     Abstract available


  365. KELLY JR, Minuto C, Cryan JF, Clarke G, et al
    The role of the gut microbiome in the development of schizophrenia.
    Schizophr Res. 2020 Apr 23. pii: S0920-9964(20)30086.
    PubMed     Abstract available


  366. SUBOTNIK KL, Ventura J, Hellemann GS, Zito MF, et al
    Relationship of poor insight to neurocognition, social cognition, and psychiatric symptoms in schizophrenia: A meta-analysis.
    Schizophr Res. 2020 Apr 22. pii: S0920-9964(20)30148.
    PubMed     Abstract available


  367. VALIENTE-PALLEJA A, Torrell H, Alonso Y, Vilella E, et al
    Increased blood lactate levels during exercise and mitochondrial DNA alterations converge on mitochondrial dysfunction in schizophrenia.
    Schizophr Res. 2020 Apr 21. pii: S0920-9964(20)30181.
    PubMed     Abstract available


  368. LUCKHOFF H, Asmal L, Kilian S, Scheffler F, et al
    Sex versus gender as risk factors for the age of onset of schizophrenia spectrum disorders.
    Schizophr Res. 2020 Apr 20. pii: S0920-9964(20)30219.
    PubMed    


  369. WATERS F, Chiu VW, Dragovic M, Ree M, et al
    Different patterns of treatment response to Cognitive-Behavioural Therapy for Insomnia (CBT-I) in psychosis.
    Schizophr Res. 2020 Apr 18. pii: S0920-9964(20)30165.
    PubMed     Abstract available


  370. KURTULMUS A, Elbay A, Ozdemir MH
    Response to commentary "Retinal nerve fiber layer analysis in unaffected first-degree relatives of schizophrenia patients".
    Schizophr Res. 2020 Apr 18. pii: S0920-9964(20)30208.
    PubMed    


  371. SHEFFIELD JM, Rogers BP, Blackford JU, Heckers S, et al
    Insula functional connectivity in schizophrenia.
    Schizophr Res. 2020 Apr 16. pii: S0920-9964(20)30179.
    PubMed     Abstract available


  372. FERNANDEZ-SOTOS P, Garcia-Martinez B, Ricarte JJ, Latorre JM, et al
    Electroencephalographic spectral analysis from a wireless low-cost brain-computer interface for symptom capture of auditory verbal hallucinations in schizophrenia.
    Schizophr Res. 2020 Apr 16. pii: S0920-9964(20)30218.
    PubMed    


  373. RABALLO A, Poletti M, Preti A, McGorry P, et al
    Clinical high risk for psychosis in children and adolescents: A meta-analysis of transition prevalences.
    Schizophr Res. 2020 Apr 16. pii: S0920-9964(20)30174.
    PubMed     Abstract available


  374. BARRY AB, Koeppel JA, Ho BC
    Impulsive decision making, brain cortical thickness and familial schizophrenia risk.
    Schizophr Res. 2020 Apr 15. pii: S0920-9964(20)30206.
    PubMed     Abstract available


  375. VERNAL DL, Boldsen SK, Lauritsen MB, Correll CU, et al
    Long-term outcome of early-onset compared to adult-onset schizophrenia: A nationwide Danish register study.
    Schizophr Res. 2020 Apr 13. pii: S0920-9964(20)30155.
    PubMed     Abstract available


  376. VIHER PV, Stegmayer K, Federspiel A, Bohlhalter S, et al
    Altered diffusion in motor white matter tracts in psychosis patients with catatonia.
    Schizophr Res. 2020 Apr 12. pii: S0920-9964(20)30120.
    PubMed     Abstract available


  377. MINICHINO A, Brondino N, Solmi M, Del Giovane C, et al
    The gut-microbiome as a target for the treatment of schizophrenia: A systematic review and meta-analysis of randomised controlled trials of add-on strategies.
    Schizophr Res. 2020 Apr 12. pii: S0920-9964(20)30101.
    PubMed     Abstract available


  378. QIAN N, Lipkin RM, Kaszowska A, Silipo G, et al
    Computational modeling of excitatory/inhibitory balance impairments in schizophrenia.
    Schizophr Res. 2020 Apr 11. pii: S0920-9964(20)30133.
    PubMed     Abstract available


  379. PAQUIN V, Lemire M, King S
    Ecosystem approaches to the risk for schizophrenia.
    Schizophr Res. 2020 Apr 10. pii: S0920-9964(20)30168.
    PubMed    


  380. CHAN SKW, Chan HYV, Pang HH, Hui CLM, et al
    Ten-year trajectory and outcomes of negative symptoms of patients with first-episode schizophrenia spectrum disorders.
    Schizophr Res. 2020 Apr 8. pii: S0920-9964(20)30172.
    PubMed     Abstract available


  381. PARDO-DE-SANTAYANA G, Vazquez-Bourgon J, Gomez-Revuelta M, Ayesa-Arriola R, et al
    Duration of active psychosis during early phases of the illness and functional outcome: The PAFIP 10-year follow-up study.
    Schizophr Res. 2020 Apr 7. pii: S0920-9964(20)30112.
    PubMed     Abstract available


  382. NAKONEZNY PA, Lindow JC, Stroup TS, McEvoy JP, et al
    A single assessment with the Brief Adherence Rating Scale (BARS) discriminates responders to long-acting injectable antipsychotic treatment in patients with schizophrenia.
    Schizophr Res. 2020 Apr 5. pii: S0920-9964(20)30164.
    PubMed     Abstract available


  383. YANG LH, Ruiz B, Mandavia AD, Grivel MM, et al
    Advancing study of cognitive impairments for antipsychotic-naive psychosis comparing high-income versus low- and middle-income countries with a focus on urban China: Systematic review of cognition and study methodology.
    Schizophr Res. 2020 Apr 5. pii: S0920-9964(20)30060.
    PubMed     Abstract available


  384. LI XB, Jiang WL, Wen YJ, Wang CM, et al
    The attenuated visual scanpaths of patients with schizophrenia whilst recognizing emotional facial expressions are worsened in natural social scenes.
    Schizophr Res. 2020 Apr 4. pii: S0920-9964(20)30150.
    PubMed     Abstract available


  385. COWAN HR
    Is schizophrenia research relevant during the COVID-19 pandemic?
    Schizophr Res. 2020 Apr 4. pii: S0920-9964(20)30209.
    PubMed     Abstract available


  386. JALLES C, Chendo I, Levy P, Reimao S, et al
    Neuromelanin changes in first episode psychosis with substance abuse.
    Schizophr Res. 2020 Apr 3. pii: S0920-9964(20)30140.
    PubMed    


  387. WYSOKINSKI A
    Successful replacement of electroconvulsive treatment (ECT) with transcranial direct current stimulation (tDCS) in severe, treatment-refractory catatonic schizophrenia: Case study.
    Schizophr Res. 2020 Apr 2. pii: S0920-9964(20)30171.
    PubMed    


  388. PELIZZA L, Poletti M, Azzali S, Paterlini F, et al
    Suicide risk in young people at Ultra-High Risk (UHR) of psychosis: Findings from a 2-year longitudinal study.
    Schizophr Res. 2020 Apr 2. pii: S0920-9964(20)30163.
    PubMed     Abstract available


  389. BANNAI D, Lizano P
    Identifying retinal layer endophenotypes for schizophrenia.
    Schizophr Res. 2020 Apr 1. pii: S0920-9964(20)30166.
    PubMed    


  390. XAVIER G, Santoro ML, Ota VK, Spindola LM, et al
    Blood gene expression changes after Risperidone treatment in an antipsychotic-naive cohort of first episode of psychosis patients.
    Schizophr Res. 2020 Apr 1. pii: S0920-9964(20)30139.
    PubMed    


  391. TOROUS J, Keshavan M
    COVID-19, mobile health and serious mental illness.
    Schizophr Res. 2020;218:36-37.
    PubMed    


    March 2020
  392. KIM SJ, Jung DU, Moon JJ, Jeon DW, et al
    Effects of an extrinsic motivator on the evaluation of cognitive and daily living functions in patients with schizophrenia.
    Schizophr Res. 2020 Mar 30. pii: S0920-9964(20)30142.
    PubMed     Abstract available


  393. EGER G, Reuven Y, Dreiher J, Shvartzman P, et al
    Effects of country of origin and wave of immigration on prevalence of schizophrenia among first and second-generation immigrants: A 30-year retrospective study.
    Schizophr Res. 2020 Mar 27. pii: S0920-9964(20)30149.
    PubMed     Abstract available


  394. ACOSTA FJ, Navarro S, Cabrera B, Ramallo-Farina Y, et al
    Painful insight vs. usable insight in schizophrenia. Do they have different influences on suicidal behavior?
    Schizophr Res. 2020 Mar 27. pii: S0920-9964(20)30151.
    PubMed     Abstract available


  395. UMEH A, Kumar J, Francis ST, Liddle PF, et al
    Global fMRI signal at rest relates to symptom severity in schizophrenia.
    Schizophr Res. 2020 Mar 25. pii: S0920-9964(20)30141.
    PubMed    


  396. EMSLEY R
    Guest editorial: Special issue on maintenance treatment in schizophrenia.
    Schizophr Res. 2020 Mar 24. pii: S0920-9964(20)30135.
    PubMed    


  397. CASTELNOVO A, Zago M, Casetta C, Zangani C, et al
    Slow wave oscillations in Schizophrenia First-Degree Relatives: A confirmatory analysis and feasibility study on slow wave traveling.
    Schizophr Res. 2020 Mar 24. pii: S0920-9964(20)30131.
    PubMed     Abstract available


  398. LIANG S, Deng W, Li X, Wang Q, et al
    Aberrant posterior cingulate connectivity classify first-episode schizophrenia from controls: A machine learning study.
    Schizophr Res. 2020 Mar 24. pii: S0920-9964(20)30128.
    PubMed     Abstract available


  399. BREBION G, Stephan-Otto C, Cuevas-Esteban J, Usall J, et al
    Impaired memory for temporal context in schizophrenia patients with hallucinations and thought disorganisation.
    Schizophr Res. 2020 Mar 24. pii: S0920-9964(20)30116.
    PubMed     Abstract available


  400. RANGASWAMY T, Cohen A
    Invited commentary from a LAMIC country: Thirty-five years of schizophrenia - the Madras Longitudinal study.
    Schizophr Res. 2020 Mar 23. pii: S0920-9964(20)30132.
    PubMed    


  401. KOSTOVA R, Cecere R, Thut G, Uhlhaas PJ, et al
    Targeting cognition in schizophrenia trough transcranial direct current stimulation: A systematic review and perspective.
    Schizophr Res. 2020 Mar 21. pii: S0920-9964(20)30105.
    PubMed     Abstract available


  402. CHANG WH, Chen KC, Tseng HH, Chiu NT, et al
    Bridging the associations between dopamine, brain volumetric variation and IQ in drug-naive schizophrenia.
    Schizophr Res. 2020 Mar 20. pii: S0920-9964(20)30108.
    PubMed     Abstract available


  403. LI K, Sweeney JA, Hu XP
    Context-dependent dynamic functional connectivity alteration of lateral occipital cortex in schizophrenia.
    Schizophr Res. 2020 Mar 19. pii: S0920-9964(20)30126.
    PubMed     Abstract available


  404. LUTHER L, Suor JH, Rosen C, Jobe TH, et al
    Clarifying the direction of impact of negative symptoms and neurocognition on prospective work functioning in psychosis: A 20-year longitudinal study.
    Schizophr Res. 2020 Mar 19. pii: S0920-9964(20)30115.
    PubMed     Abstract available


  405. FERRO DESIDERI L, Vagge A, Nicolo M, Traverso CE, et al
    "Retinal nerve fiber layer analysis in unaffected first-degree relatives of schizophrenia patients".
    Schizophr Res. 2020 Mar 18. pii: S0920-9964(20)30130.
    PubMed    


  406. COENTRE R, Levy P
    Early intervention in psychosis: The first national survey in Portugal.
    Schizophr Res. 2020 Mar 16. pii: S0920-9964(20)30122.
    PubMed    


  407. STEIN F, Lemmer G, Schmitt S, Brosch K, et al
    Factor analyses of multidimensional symptoms in a large group of patients with major depressive disorder, bipolar disorder, schizoaffective disorder and schizophrenia.
    Schizophr Res. 2020 Mar 16. pii: S0920-9964(20)30114.
    PubMed     Abstract available


  408. IFRAH C, Ospina LH, Shagalow S, Beck-Felts K, et al
    Cognitive insight and autonomic regulation during daily functioning in individuals with schizophrenia.
    Schizophr Res. 2020 Mar 13. pii: S0920-9964(20)30117.
    PubMed    


  409. MALLAWAARACHCHI SR, Amminger GP, Farhall J, Bolt LK, et al
    Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial.
    Schizophr Res. 2020 Mar 11. pii: S0920-9964(20)30111.
    PubMed     Abstract available


  410. ARDIZZI M, Ambrosecchia M, Buratta L, Ferri F, et al
    The motor roots of minimal self disorders in schizophrenia.
    Schizophr Res. 2020 Mar 11. pii: S0920-9964(20)30110.
    PubMed    


  411. WERNER MCF, Wirgenes KV, Haram M, Bettella F, et al
    Indicated association between polygenic risk score and treatment-resistance in a naturalistic sample of patients with schizophrenia spectrum disorders.
    Schizophr Res. 2020 Mar 11. pii: S0920-9964(20)30109.
    PubMed     Abstract available


  412. WORTHINGTON MA, Petkova E, Freudenreich O, Cather C, et al
    Air pollution and hippocampal atrophy in first episode schizophrenia.
    Schizophr Res. 2020 Mar 10. pii: S0920-9964(20)30104.
    PubMed     Abstract available


  413. SAPERSTEIN AM, Lynch DA, Qian M, Medalia A, et al
    How does awareness of cognitive impairment impact motivation and treatment outcomes during cognitive remediation for schizophrenia?
    Schizophr Res. 2020 Mar 7. pii: S0920-9964(20)30103.
    PubMed     Abstract available


  414. LINDGREN M, Holm M, Markkula N, Dickerson F, et al
    Serological evidence of infections does not predict subsequent late-onset psychosis in the general population.
    Schizophr Res. 2020 Mar 7. pii: S0920-9964(20)30102.
    PubMed    


  415. KWAKERNAAK S, van Mens K, Cahn W, Janssen R, et al
    Using machine learning to predict mental healthcare consumption in non-affective psychosis.
    Schizophr Res. 2020 Mar 5. pii: S0920-9964(20)30023.
    PubMed     Abstract available


    February 2020
  416. ZIPURSKY RB, Odejayi G, Agid O, Remington G, et al
    You say "schizophrenia" and I say "psychosis": Just tell me when I can come off this medication.
    Schizophr Res. 2020 Feb 27. pii: S0920-9964(20)30085.
    PubMed     Abstract available


  417. HUI CLM, Lam BST, Lee EHM, Chan SKW, et al
    Perspective on medication decisions following remission from first-episode psychosis.
    Schizophr Res. 2020 Feb 27. pii: S0920-9964(20)30083.
    PubMed     Abstract available


  418. REDDY-THOOTKUR M, Kraguljac NV, Lahti AC
    The role of glutamate and GABA in cognitive dysfunction in schizophrenia and mood disorders - A systematic review of magnetic resonance spectroscopy studies.
    Schizophr Res. 2020 Feb 24. pii: S0920-9964(20)30077.
    PubMed     Abstract available


  419. SCHORETSANITIS G, Mendelowitz A, Malur C, Braga RJ, et al
    Lack of ECT effects on clozapine plasma levels in patients with treatment-resistant schizophrenia: Pharmacokinetic evidence from a randomized clinical trial.
    Schizophr Res. 2020 Feb 24. pii: S0920-9964(20)30084.
    PubMed    


  420. BEZDICEK O, Michalec J, Kalisova L, Kufa T, et al
    Profile of cognitive deficits in schizophrenia and factor structure of the Czech MATRICS Consensus Cognitive Battery.
    Schizophr Res. 2020 Feb 20. pii: S0920-9964(20)30080.
    PubMed     Abstract available


  421. KELSVEN S, de la Fuente-Sandoval C, Achim CL, Reyes-Madrigal F, et al
    Immuno-inflammatory changes across phases of early psychosis: The impact of antipsychotic medication and stage of illness.
    Schizophr Res. 2020 Feb 20. pii: S0920-9964(20)30019.
    PubMed     Abstract available


  422. VERMA M, Sahoo S, Nehra R, Grover S, et al
    Does clozapine improves cognition in patients with treatment resistant schizophrenia?: An exploratory study.
    Schizophr Res. 2020 Feb 13. pii: S0920-9964(20)30078.
    PubMed    


  423. FREEDMAN R, Olsen-Dufour AM, Olincy A
    P50 inhibitory sensory gating in schizophrenia: analysis of recent studies.
    Schizophr Res. 2020 Feb 12. pii: S0920-9964(20)30079.
    PubMed     Abstract available


  424. ROLF R, Sokolov AN, Rattay TW, Fallgatter AJ, et al
    Face pareidolia in schizophrenia.
    Schizophr Res. 2020 Feb 10. pii: S0920-9964(20)30035.
    PubMed     Abstract available


  425. FAHIRA A, Wang D, Wang K, Wadood A, et al
    Functional annotation of regulatory single nucleotide polymorphisms associated with schizophrenia.
    Schizophr Res. 2020 Feb 7. pii: S0920-9964(19)30590.
    PubMed    


  426. HUMMER TA, Yung MG, Goni J, Conroy SK, et al
    Functional network connectivity in early-stage schizophrenia.
    Schizophr Res. 2020 Feb 6. pii: S0920-9964(20)30039.
    PubMed     Abstract available


  427. MURRAY RM, Mondelli V, Stilo SA, Trotta A, et al
    The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study.
    Schizophr Res. 2020 Feb 6. pii: S0920-9964(20)30027.
    PubMed     Abstract available


  428. MAGIONCALDA P, Martino M, Conio B, Lee HC, et al
    Intrinsic brain activity of subcortical-cortical sensorimotor system and psychomotor alterations in schizophrenia and bipolar disorder: A preliminary study.
    Schizophr Res. 2020 Feb 3. pii: S0920-9964(20)30025.
    PubMed     Abstract available


  429. TOENDER A, Vestergaard M, Munk-Olsen T, Larsen JT, et al
    Risk of diabetic complications and subsequent mortality among individuals with schizophrenia and diabetes - a population-based register study.
    Schizophr Res. 2020 Feb 3. pii: S0920-9964(20)30040.
    PubMed     Abstract available


    January 2020
  430. BENESH JL, Mueller TM, Meador-Woodruff JH
    AMPA receptor subunit localization in schizophrenia anterior cingulate cortex.
    Schizophr Res. 2020 Jan 31. pii: S0920-9964(20)30041.
    PubMed     Abstract available


  431. ROBERTS RC, McCollum LA, Schoonover KE, Mabry SJ, et al
    Ultrastructural evidence for glutamatergic dysregulation in schizophrenia.
    Schizophr Res. 2020 Jan 31. pii: S0920-9964(20)30032.
    PubMed     Abstract available


  432. MANOACH DS, Mylonas D, Baxter B
    Targeting sleep oscillations to improve memory in schizophrenia.
    Schizophr Res. 2020 Jan 31. pii: S0920-9964(20)30026.
    PubMed     Abstract available


  433. RAMSAY IS, Roach BJ, Fryer S, Fisher M, et al
    Increased global cognition correlates with increased thalamo-temporal connectivity in response to targeted cognitive training for recent onset schizophrenia.
    Schizophr Res. 2020 Jan 29. pii: S0920-9964(20)30036.
    PubMed     Abstract available


  434. SANDSTEN KE, Nordgaard J, Kjaer TW, Gallese V, et al
    Altered self-recognition in patients with schizophrenia.
    Schizophr Res. 2020 Jan 29. pii: S0920-9964(20)30038.
    PubMed     Abstract available


  435. BITANIHIRWE BKY, Woo TW
    A conceptualized model linking matrix metalloproteinase-9 to schizophrenia pathogenesis.
    Schizophr Res. 2020 Jan 27. pii: S0920-9964(19)30585.
    PubMed     Abstract available


  436. HUO L, Zhang G, Du XD, Jia Q, et al
    The prevalence, risk factors and clinical correlates of diabetes mellitus in Chinese patients with schizophrenia.
    Schizophr Res. 2020 Jan 24. pii: S0920-9964(19)30599.
    PubMed     Abstract available


  437. PENNEY D, Joober R, Malla A, Lepage M, et al
    Understanding sex differences in cognitive insight across first-and-multiple episode psychosis.
    Schizophr Res. 2020 Jan 21. pii: S0920-9964(19)30594.
    PubMed     Abstract available


  438. CLELLAND CL, Kantrowitz JT, Choo T, Clelland JD, et al
    Adjunctive sapropterin dihydrochloride treatment in schizophrenia: A positive proof-of-concept, rater-blind, randomized, multivitamin-controlled study.
    Schizophr Res. 2020 Jan 21. pii: S0920-9964(19)30609.
    PubMed    


  439. CARRENO F, Helfer VE, Staudt KJ, Paese K, et al
    Quetiapine lipid core nanocapsules restore prepulse inhibition deficits in a neurodevelopmental model of schizophrenia in male and female rats.
    Schizophr Res. 2020 Jan 20. pii: S0920-9964(20)30024.
    PubMed     Abstract available


  440. TASMIM S, Dada O, Wang KZ, Bani-Fatemi A, et al
    Early-life stressful events and suicide attempt in schizophrenia: Machine learning models.
    Schizophr Res. 2020 Jan 20. pii: S0920-9964(19)30568.
    PubMed     Abstract available


  441. MCGINTY J, Upthegrove R
    Depressive symptoms during first episode psychosis and functional outcome: A systematic review and meta-analysis.
    Schizophr Res. 2020 Jan 19. pii: S0920-9964(19)30581.
    PubMed     Abstract available


  442. ANDREOU D, Saetre P, Fors BM, Nilsson BM, et al
    Cardiac left ventricular ejection fraction in men and women with schizophrenia on long-term antipsychotic treatment.
    Schizophr Res. 2020 Jan 17. pii: S0920-9964(19)30612.
    PubMed     Abstract available


  443. WANG J, Jiang Y, Tang Y, Xia M, et al
    Altered functional connectivity of the thalamus induced by modified electroconvulsive therapy for schizophrenia.
    Schizophr Res. 2020 Jan 16. pii: S0920-9964(19)30614.
    PubMed     Abstract available


  444. ZHOU D, Xiao X, Li M
    The schizophrenia risk isoform ZNF804A(E3E4) affects dendritic spine.
    Schizophr Res. 2020 Jan 16. pii: S0920-9964(19)30608.
    PubMed    


  445. ORTIZ BB, Higuchi CH, Noto C, Joyce DW, et al
    A symptom combination predicting treatment-resistant schizophrenia - A strategy for real-world clinical practice.
    Schizophr Res. 2020 Jan 16. pii: S0920-9964(20)30017.
    PubMed     Abstract available


  446. DUAN X, Hu M, Huang X, Dong X, et al
    Effects of risperidone monotherapy on the default-mode network in antipsychotic-naive first-episode schizophrenia: Posteromedial cortex heterogeneity and relationship with the symptom improvements.
    Schizophr Res. 2020 Jan 15. pii: S0920-9964(20)30018.
    PubMed     Abstract available


  447. BLACKBURN KM, Ivleva EI, Weir RA, Kim M, et al
    NMDA receptor antibody seropositivity in psychosis: A pilot study from the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP).
    Schizophr Res. 2020 Jan 14. pii: S0920-9964(20)30020.
    PubMed    


  448. KU BS, Pauselli L, Manseau M, Compton MT, et al
    Neighborhood-level predictors of age at onset and duration of untreated psychosis in first-episode psychotic disorders.
    Schizophr Res. 2020 Jan 14. pii: S0920-9964(19)30606.
    PubMed     Abstract available


  449. KURTULMUS A, Elbay A, Parlakkaya FB, Kilicarslan T, et al
    An investigation of retinal layer thicknesses in unaffected first-degree relatives of schizophrenia patients.
    Schizophr Res. 2020 Jan 14. pii: S0920-9964(19)30604.
    PubMed     Abstract available


  450. THOMPSON E, Spirito A, Frazier E, Thompson A, et al
    Suicidal thoughts and behavior (STB) and psychosis-risk symptoms among psychiatrically hospitalized adolescents.
    Schizophr Res. 2020 Jan 13. pii: S0920-9964(19)30607.
    PubMed     Abstract available


  451. REED AC, Lee J, Green MF, Hamilton HK, et al
    Associations between physiological responses to social-evaluative stress and daily functioning in first-episode schizophrenia.
    Schizophr Res. 2020 Jan 13. pii: S0920-9964(19)30610.
    PubMed     Abstract available


  452. BELVEDERI MURRI M, Folesani F, Costa S, Biancosino B, et al
    Screening for cognitive impairment in non-affective psychoses: A comparison between the SCIP and the MoCA.
    Schizophr Res. 2020 Jan 13. pii: S0920-9964(20)30022.
    PubMed     Abstract available


  453. SURBECK W, Hanggi J, Scholtes F, Viher PV, et al
    Anatomical integrity within the inferior fronto-occipital fasciculus and semantic processing deficits in schizophrenia spectrum disorders.
    Schizophr Res. 2020 Jan 13. pii: S0920-9964(19)30595.
    PubMed     Abstract available


  454. LEROY A, Amad A, D'Hondt F, Pins D, et al
    Reward anticipation in schizophrenia: A coordinate-based meta-analysis.
    Schizophr Res. 2020 Jan 13. pii: S0920-9964(19)30611.
    PubMed     Abstract available


  455. MILLER M, Zemon V, Nolan-Kenney R, Balcer LJ, et al
    Optical coherence tomography of the retina in schizophrenia: Inter-device agreement and relations with perceptual function.
    Schizophr Res. 2020 Jan 11. pii: S0920-9964(19)30481.
    PubMed     Abstract available


  456. MARTIN D, Croft J, Pitt A, Strelchuk D, et al
    Systematic review and meta-analysis of the relationship between genetic risk for schizophrenia and facial emotion recognition.
    Schizophr Res. 2020 Jan 11. pii: S0920-9964(19)30601.
    PubMed     Abstract available


  457. LI J, Zhang X, Tang X, Xiao W, et al
    Neurotrophic factor changes are essential for predict electroconvulsive therapy outcome in schizophrenia.
    Schizophr Res. 2020 Jan 10. pii: S0920-9964(19)30470.
    PubMed     Abstract available


  458. MCCLAIN L, Mansour H, Ibrahim I, Klei L, et al
    Age dependent association of inbreeding with risk for schizophrenia in Egypt.
    Schizophr Res. 2020 Jan 9. pii: S0920-9964(19)30474.
    PubMed     Abstract available


  459. SURTI TS, Vinogradov S, Bell MD, Wexler BE, et al
    Improvement on visual cognitive training exercises in schizophrenia is present but less robust than in healthy individuals.
    Schizophr Res. 2020 Jan 9. pii: S0920-9964(19)30528.
    PubMed    


  460. WANG L, Chen X, Wu Y, He K, et al
    Intermittent theta burst stimulation (iTBS) adjustment effects of schizophrenia: Results from an exploratory outcome of a randomized double-blind controlled study.
    Schizophr Res. 2020 Jan 8. pii: S0920-9964(19)30578.
    PubMed    


  461. VER LOREN VAN THEMAAT AH, Uddin MJ, Christiani CJ, Hemager N, et al
    Odor identification in 7-year-old children at familial high risk of schizophrenia or bipolar disorder - the Danish high risk and resilience study VIA 7.
    Schizophr Res. 2020 Jan 8. pii: S0920-9964(19)30598.
    PubMed     Abstract available


  462. AHUJA S, Gupta RK, Damodharan D, Philip M, et al
    Effect of music listening on P300 event-related potential in patients with schizophrenia: A pilot study.
    Schizophr Res. 2020 Jan 7. pii: S0920-9964(19)30596.
    PubMed     Abstract available


  463. SAARINEN AIL, Huhtaniska S, Pudas J, Bjornholm L, et al
    Structural and functional alterations in the brain gray matter among first-degree relatives of schizophrenia patients: A multimodal meta-analysis of fMRI and VBM studies.
    Schizophr Res. 2020 Jan 7. pii: S0920-9964(19)30593.
    PubMed     Abstract available


  464. FERRARELLI F, Mathalon D
    The prodromal phase: Time to broaden the scope beyond transition to psychosis?
    Schizophr Res. 2020 Jan 7. pii: S0920-9964(19)30605.
    PubMed    


  465. GERSTENBERG M, Furrer M, Tesler N, Franscini M, et al
    Reduced sleep spindle density in adolescent patients with early-onset schizophrenia compared to major depressive disorder and healthy controls.
    Schizophr Res. 2020 Jan 7. pii: S0920-9964(19)30567.
    PubMed     Abstract available


  466. WANG H, Lesh TA, Maddock RJ, Fassbender C, et al
    Delay discounting abnormalities are seen in first-episode schizophrenia but not in bipolar disorder.
    Schizophr Res. 2020 Jan 2. pii: S0920-9964(19)30570.
    PubMed     Abstract available


  467. VELLIGAN DI, Maples NJ, Pokorny JJ, Wright C, et al
    Assessment of adherence to oral antipsychotic medications: What has changed over the past decade?
    Schizophr Res. 2020;215:17-24.
    PubMed     Abstract available


  468. BLESS JJ, Hjelmervik H, Torsheim T, Gudmundsen M, et al
    Temporal signatures of auditory verbal hallucinations: An app-based experience sampling study.
    Schizophr Res. 2020;215:442-444.
    PubMed    


  469. SPOOV J, Bredbacka PE, Stenman UH
    Separation of positive and disorganization symptoms by prolactin response to 12.5 mug intravenous TRH.
    Schizophr Res. 2020;215:449-450.
    PubMed    


  470. VOSTRIKOV VM, Uranova NA
    Reduced density of oligodendrocytes and oligodendrocyte clusters in the caudate nucleus in major psychiatric illnesses.
    Schizophr Res. 2020;215:211-216.
    PubMed     Abstract available


  471. HAJDUK M, Achim AM, Brunet-Gouet E, Mehta UM, et al
    How to move forward in social cognition research? Put it into an international perspective.
    Schizophr Res. 2020;215:463-464.
    PubMed    


  472. HARVEY PD, Saoud JB, Luthringer R, Moroz S, et al
    Effects of Roluperidone (MIN-101) on two dimensions of the negative symptoms factor score: Reduced emotional experience and reduced emotional expression.
    Schizophr Res. 2020;215:352-356.
    PubMed     Abstract available


    December 2019
  473. LEVESQUE IS, Abdel-Baki A
    Homeless youth with first-episode psychosis: A 2-year outcome study.
    Schizophr Res. 2019 Dec 31. pii: S0920-9964(19)30466.
    PubMed     Abstract available


  474. VERU-LESMES F, Rho A, Joober R, Iyer S, et al
    Socioeconomic deprivation and blood lipids in first-episode psychosis patients with minimal antipsychotic exposure: Implications for cardiovascular risk.
    Schizophr Res. 2019 Dec 30. pii: S0920-9964(19)30589.
    PubMed     Abstract available


  475. THIBAUDEAU E, Achim AM, Parent C, Turcotte M, et al
    A meta-analysis of the associations between theory of mind and neurocognition in schizophrenia.
    Schizophr Res. 2019 Dec 30. pii: S0920-9964(19)30587.
    PubMed     Abstract available


  476. KOREN D, Tzivoni Y, Schalit L, Adres M, et al
    Basic self-disorders in adolescence predict schizophrenia spectrum disorders in young adulthood: A 7-year follow-up study among non-psychotic help-seeking adolescents.
    Schizophr Res. 2019 Dec 27. pii: S0920-9964(19)30592.
    PubMed     Abstract available


  477. MIN B, Kim M, Lee J, Byun JI, et al
    Prediction of individual responses to electroconvulsive therapy in patients with schizophrenia: Machine learning analysis of resting-state electroencephalography.
    Schizophr Res. 2019 Dec 26. pii: S0920-9964(19)30582.
    PubMed     Abstract available


  478. LEE TH, Kim M, Hwang WJ, Kim T, et al
    Relationship between resting-state theta phase-gamma amplitude coupling and neurocognitive functioning in patients with first-episode psychosis.
    Schizophr Res. 2019 Dec 26. pii: S0920-9964(19)30580.
    PubMed     Abstract available


  479. TAYLOR JH, Asabere N, Calkins ME, Moore TM, et al
    Characteristics of youth with reported family history of psychosis spectrum symptoms in the Philadelphia Neurodevelopmental Cohort.
    Schizophr Res. 2019 Dec 26. pii: S0920-9964(19)30591.
    PubMed     Abstract available


  480. TARCIJONAS G, Foran W, Blazer A, Eack SM, et al
    Independent support for corticopallidal contributions to schizophrenia-related functional impairment.
    Schizophr Res. 2019 Dec 24. pii: S0920-9964(19)30576.
    PubMed     Abstract available


  481. WANG LL, Yan C, Shao YX, Lv QY, et al
    Revisiting anticipatory hedonic processing in patients with schizophrenia: An examination between representation activation and maintenance.
    Schizophr Res. 2019 Dec 24. pii: S0920-9964(19)30583.
    PubMed     Abstract available


  482. WROBLEWSKI A, He Y, Straube B
    Dynamic Causal Modelling suggests impaired effective connectivity in patients with schizophrenia spectrum disorders during gesture-speech integration.
    Schizophr Res. 2019 Dec 24. pii: S0920-9964(19)30575.
    PubMed     Abstract available


  483. GIANNITELLI M, Levinson DF, Cohen D, Xavier J, et al
    Developmental and symptom profiles in early-onset psychosis.
    Schizophr Res. 2019 Dec 21. pii: S0920-9964(19)30463.
    PubMed     Abstract available


  484. MOTE J, Fulford D
    Ecological momentary assessment of everyday social experiences of people with schizophrenia: A systematic review.
    Schizophr Res. 2019 Dec 21. pii: S0920-9964(19)30428.
    PubMed     Abstract available


  485. YOUN S, Phillips LJ, Amminger GP, Berger G, et al
    Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomes.
    Schizophr Res. 2019 Dec 19. pii: S0920-9964(19)30554.
    PubMed     Abstract available


  486. WUNDERINK L, van Bebber J, Sytema S, Boonstra N, et al
    Negative symptoms predict high relapse rates and both predict less favorable functional outcome in first episode psychosis, independent of treatment strategy.
    Schizophr Res. 2019 Dec 19. pii: S0920-9964(19)30571.
    PubMed     Abstract available


  487. YOVIENE SYKES LA, Ferrara M, Addington J, Bearden CE, et al
    Predictive validity of conversion from the clinical high risk syndrome to frank psychosis.
    Schizophr Res. 2019 Dec 19. pii: S0920-9964(19)30572.
    PubMed     Abstract available


  488. LIN CH, Chou PH, Chou W, Chien TW, et al
    Using the Kano model to display the most cited authors and affiliated countries in schizophrenia research.
    Schizophr Res. 2019 Dec 17. pii: S0920-9964(19)30493.
    PubMed     Abstract available


  489. KLEIN-PETERSEN AW, Kohler-Forsberg O, Benros ME
    Infections, antibiotic treatment and the mircrobiome in relation to schizophrenia.
    Schizophr Res. 2019 Dec 16. pii: S0920-9964(19)30540.
    PubMed     Abstract available


  490. ARIOKA Y, Hirata A, Kushima I, Aleksic B, et al
    Characterization of a schizophrenia patient with a rare RELN deletion by combining genomic and patient-derived cell analyses.
    Schizophr Res. 2019 Dec 14. pii: S0920-9964(19)30473.
    PubMed     Abstract available


  491. VAKHRUSHEVA J, Khan S, Chang R, Hansen M, et al
    Lexical analysis of emotional responses to "real-world" experiences in individuals with schizophrenia.
    Schizophr Res. 2019 Dec 13. pii: S0920-9964(19)30552.
    PubMed     Abstract available


  492. PAROLA A, Simonsen A, Bliksted V, Fusaroli R, et al
    Voice patterns in schizophrenia: A systematic review and Bayesian meta-analysis.
    Schizophr Res. 2019 Dec 13. pii: S0920-9964(19)30538.
    PubMed     Abstract available


  493. ITHAL D, Arumugham SS, Kumar CN, Venkatapura RJ, et al
    Comparison of cognitive adverse effects and efficacy of 2 pulse widths (0.5 ms and 1.5 ms) of brief pulse bilateral electroconvulsive therapy in patients with schizophrenia - A randomized single blind controlled trial.
    Schizophr Res. 2019 Dec 12. pii: S0920-9964(19)30569.
    PubMed    


  494. YUEN HP, Mackinnon A, Nelson B
    Dynamic prediction systems of transition to psychosis using joint modelling: extensions to the base system.
    Schizophr Res. 2019 Dec 12. pii: S0920-9964(19)30566.
    PubMed     Abstract available


  495. YEE CI, Gupta T, Mittal VA, Haase CM, et al
    Coping with family stress in individuals at clinical high-risk for psychosis.
    Schizophr Res. 2019 Dec 12. pii: S0920-9964(19)30564.
    PubMed     Abstract available


  496. FULLER-THOMSON E, Mehta R
    Could a gene-environment interaction between NAPRT1 risk allele and pre-natal niacin deficiency explain 4 medical mysteries of schizophrenia research?
    Schizophr Res. 2019 Dec 12. pii: S0920-9964(19)30556.
    PubMed    


  497. RAINTEAU N, Salesse RN, Macgregor A, Macioce V, et al
    Why you can't be in sync with schizophrenia patients.
    Schizophr Res. 2019 Dec 12. pii: S0920-9964(19)30561.
    PubMed     Abstract available


  498. WAITE F, Sheaves B, Isham L, Reeve S, et al
    Sleep and schizophrenia: From epiphenomenon to treatable causal target.
    Schizophr Res. 2019 Dec 10. pii: S0920-9964(19)30523.
    PubMed     Abstract available


  499. PORFFY LA, Bell V, Coutrot A, Wigton R, et al
    In the eye of the beholder? Oxytocin effects on eye movements in schizophrenia.
    Schizophr Res. 2019 Dec 10. pii: S0920-9964(19)30551.
    PubMed     Abstract available


  500. GONG J, Cui LB, Xi YB, Zhao YS, et al
    Predicting response to electroconvulsive therapy combined with antipsychotics in schizophrenia using multi-parametric magnetic resonance imaging.
    Schizophr Res. 2019 Dec 8. pii: S0920-9964(19)30553.
    PubMed     Abstract available


  501. NARITA Z, Stickley A, DeVylder J, Yokoi Y, et al
    Effect of multi-session prefrontal transcranial direct current stimulation on cognition in schizophrenia: A systematic review and meta-analysis.
    Schizophr Res. 2019 Dec 7. pii: S0920-9964(19)30509.
    PubMed     Abstract available


  502. MYIN-GERMEYS I
    Real-life social interactions in schizophrenia.
    Schizophr Res. 2019 Dec 6. pii: S0920-9964(19)30549.
    PubMed    


  503. VITA A, Perin AP, Cavanna M, Cobelli F, et al
    Negative symptom severity at discharge from an index hospitalization and subsequent use of psychiatric care resources: A retrospective 1-year follow-up study on 450 patients with schizophrenia spectrum disorders.
    Schizophr Res. 2019 Dec 6. pii: S0920-9964(19)30559.
    PubMed     Abstract available


  504. WEITTENHILLER LP, Painter JM, Moran EK, Kring AM, et al
    The discrepancy between momentary and remembered pleasure in schizophrenia.
    Schizophr Res. 2019 Dec 6. pii: S0920-9964(19)30533.
    PubMed    


  505. BARKER V, Walker RM, Evans KL, Lawrie SM, et al
    Methylation of glucocorticoid receptor (NR3C1), BDNF and oxytocin receptor genes in association with childhood maltreatment in schizophrenia and schizoaffective disorder.
    Schizophr Res. 2019 Dec 5. pii: S0920-9964(19)30557.
    PubMed    


  506. KANG Y, Zhang W, Lv Y, Cai S, et al
    Effects of the 5-HT2A and DRD3 genotypes on cortical morphology and functional connectivity density in drug-naive first episode schizophrenia.
    Schizophr Res. 2019 Dec 5. pii: S0920-9964(19)30565.
    PubMed     Abstract available


  507. RODRIGUEZ-TOSCANO E, Lopez G, Mayoral M, Lewis S, et al
    A longitudinal comparison of two neurocognitive test batteries in patients with schizophrenia and healthy volunteers: Time effects on neuropsychological performance and their relation to functional outcome.
    Schizophr Res. 2019 Dec 5. pii: S0920-9964(19)30525.
    PubMed     Abstract available


  508. JOHN J, Bhattacharyya U, Yadav N, Kukshal P, et al
    Multiple rare inherited variants in a four generation schizophrenia family offer leads for complex mode of disease inheritance.
    Schizophr Res. 2019 Dec 5. pii: S0920-9964(19)30548.
    PubMed     Abstract available


  509. AKBARIAN S
    Special volume: The genomics and epigenomics of schizophrenia.
    Schizophr Res. 2019 Dec 5. pii: S0920-9964(19)30563.
    PubMed    


  510. SAARINEN A, Lieslehto J, Kiviniemi V, Hakli J, et al
    Symptomatic psychosis risk and physiological fluctuation in functional MRI data.
    Schizophr Res. 2019 Dec 3. pii: S0920-9964(19)30535.
    PubMed     Abstract available


  511. CHUNG J, Miller BJ
    Meta-analysis of comorbid diabetes and family history of diabetes in non-affective psychosis.
    Schizophr Res. 2019 Dec 2. pii: S0920-9964(19)30497.
    PubMed     Abstract available


  512. MURALIDHARAN A, Finch A, Bowie CR, Harvey PD, et al
    Older versus middle-aged adults with schizophrenia: Executive functioning and community outcomes.
    Schizophr Res. 2019 Dec 2. pii: S0920-9964(19)30499.
    PubMed    


  513. GAEBEL W, Stricker J, Riesbeck M
    The long-term antipsychotic treatment of schizophrenia: A selective review of clinical guidelines and clinical case examples.
    Schizophr Res. 2019 Dec 2. pii: S0920-9964(19)30484.
    PubMed     Abstract available


  514. SHIWAKU H, Nakano Y, Kato M, Takahashi H, et al
    Detection of autoantibodies against GABAARalpha1 in patients with schizophrenia.
    Schizophr Res. 2019 Dec 2. pii: S0920-9964(19)30438.
    PubMed     Abstract available


  515. ZITO MF, Marder SR
    Rethinking the risks and benefits of long-term maintenance in schizophrenia.
    Schizophr Res. 2019 Dec 2. pii: S0920-9964(19)30492.
    PubMed     Abstract available


  516. SAUGO E, Lasalvia A, Bonetto C, Cristofalo D, et al
    Dietary habits and physical activity in first-episode psychosis patients treated in community services. Effect on early anthropometric and cardio-metabolic alterations.
    Schizophr Res. 2019 Dec 2. pii: S0920-9964(19)30508.
    PubMed     Abstract available


  517. POWERS AR, Addington J, Perkins DO, Bearden CE, et al
    Duration of the psychosis prodrome.
    Schizophr Res. 2019 Dec 2. pii: S0920-9964(19)30486.
    PubMed     Abstract available


  518. TAKAHASHI S, Keeser D, Rauchmann BS, Schneider-Axmann T, et al
    Effect of aerobic exercise combined with cognitive remediation on cortical thickness and prediction of social adaptation in patients with schizophrenia.
    Schizophr Res. 2019 Dec 2. pii: S0920-9964(19)30502.
    PubMed     Abstract available


  519. BAYTUNCA MB, Ongur D
    Plasma spermine levels in patients with schizophrenia and bipolar disorder: A preliminary study.
    Schizophr Res. 2019 Dec 2. pii: S0920-9964(19)30547.
    PubMed    


  520. GIL-BERROZPE GJ, Sanchez-Torres AM, Garcia de Jalon E, Moreno-Izco L, et al
    Utility of the MoCA for cognitive impairment screening in long-term psychosis patients.
    Schizophr Res. 2019 Dec 2. pii: S0920-9964(19)30489.
    PubMed     Abstract available


  521. HAN S, Cui Q, Guo X, Fan YS, et al
    Disconnectivity between the raphe nucleus and subcortical dopamine-related regions contributes altered salience network in schizophrenia.
    Schizophr Res. 2019 Dec 2. pii: S0920-9964(19)30504.
    PubMed     Abstract available


  522. KIRCHER T, Krautheim J, Straube B
    "Automatic outgroup categorisation" and limbic brain activation: A mechanism underlying psychosis risk in migrants and city dwellers.
    Schizophr Res. 2019 Dec 2. pii: S0920-9964(19)30507.
    PubMed    


    November 2019
  523. HENNIG T, Schlier B, Lincoln TM
    Sleep and psychotic symptoms: An actigraphy and diary study with young adults with low and elevated psychosis proneness.
    Schizophr Res. 2019 Nov 30. pii: S0920-9964(19)30417.
    PubMed     Abstract available


  524. BERENDSEN S, van der Veen NM, van Tricht MJ, de Haan L, et al
    Psychometric properties of the DSM-5 Clinician-Rated Dimensions of Psychosis Symptom Severity.
    Schizophr Res. 2019 Nov 30. pii: S0920-9964(19)30494.
    PubMed     Abstract available


  525. MASSA N, Owens AV, Harmon W, Bhattacharya A, et al
    Relationship of prolonged acoustic startle latency to diagnosis and biotype in the bipolar-schizophrenia network on intermediate phenotypes (B-SNIP) cohort.
    Schizophr Res. 2019 Nov 30. pii: S0920-9964(19)30511.
    PubMed     Abstract available


  526. WILSON RS, Yung AR, Morrison AP
    Comorbidity rates of depression and anxiety in first episode psychosis: A systematic review and meta-analysis.
    Schizophr Res. 2019 Nov 29. pii: S0920-9964(19)30542.
    PubMed     Abstract available


  527. WEDERVANG-RESELL K, Friis S, Lonning V, Smelror RE, et al
    Lipid alterations in adolescents with early-onset psychosis may be independent of antipsychotic medication.
    Schizophr Res. 2019 Nov 29. pii: S0920-9964(19)30546.
    PubMed     Abstract available


  528. KUGATHASAN P, Wu H, Gaughran F, Nielsen RE, et al
    Association of physical health multimorbidity with mortality in people with schizophrenia spectrum disorders: Using a novel semantic search system that captures physical diseases in electronic patient records.
    Schizophr Res. 2019 Nov 28. pii: S0920-9964(19)30496.
    PubMed     Abstract available


  529. SUNWOO M, O'Connell J, Brown E, Lin A, et al
    Prevalence and outcomes of young people with concurrent autism spectrum disorder and first episode of psychosis.
    Schizophr Res. 2019 Nov 28. pii: S0920-9964(19)30544.
    PubMed     Abstract available


  530. SHIMOMURA Y, Kikuchi Y, Suzuki T, Uchida H, et al
    Antipsychotic treatment in the maintenance phase of schizophrenia: An updated systematic review of the guidelines and algorithms.
    Schizophr Res. 2019 Nov 26. pii: S0920-9964(19)30423.
    PubMed     Abstract available


  531. LIU LL, Wang Y, Cui JF, Li Y, et al
    The effect of implementation intentions on prospective memory performance in patients with schizophrenia: A multinomial modeling approach.
    Schizophr Res. 2019 Nov 26. pii: S0920-9964(19)30501.
    PubMed     Abstract available


  532. ZHANG S, Yang G, Ou Y, Guo W, et al
    Abnormal default-mode network homogeneity and its correlations with neurocognitive deficits in drug-naive first-episode adolescent-onset schizophrenia.
    Schizophr Res. 2019 Nov 26. pii: S0920-9964(19)30491.
    PubMed     Abstract available


  533. LUNDIN NB, Hochheiser J, Minor KS, Hetrick WP, et al
    Piecing together fragments: Linguistic cohesion mediates the relationship between executive function and metacognition in schizophrenia.
    Schizophr Res. 2019 Nov 26. pii: S0920-9964(19)30539.
    PubMed     Abstract available


  534. WENNEBERG C, Glenthoj BY, Hjorthoj C, Buchardt Zingenberg FJ, et al
    Cerebral glutamate and GABA levels in high-risk of psychosis states: A focused review and meta-analysis of (1)H-MRS studies.
    Schizophr Res. 2019 Nov 26. pii: S0920-9964(19)30485.
    PubMed     Abstract available


  535. JANSEN JE, Gleeson J, Bendall S, Rice S, et al
    Acceptance- and mindfulness-based interventions for persons with psychosis: A systematic review and meta-analysis.
    Schizophr Res. 2019 Nov 26. pii: S0920-9964(19)30522.
    PubMed    


  536. WILSON RS, Shryane N, Yung AR, Morrison AP, et al
    Distress related to psychotic symptoms in individuals at high risk of psychosis.
    Schizophr Res. 2019 Nov 26. pii: S0920-9964(19)30534.
    PubMed     Abstract available


  537. DENNISON CA, Legge SE, Pardinas AF, Walters JTR, et al
    Genome-wide association studies in schizophrenia: Recent advances, challenges and future perspective.
    Schizophr Res. 2019 Nov 25. pii: S0920-9964(19)30483.
    PubMed     Abstract available


  538. DESTE G, Vita A, Penn DL, Pinkham AE, et al
    Autistic symptoms predict social cognitive performance in patients with schizophrenia.
    Schizophr Res. 2019 Nov 25. pii: S0920-9964(19)30506.
    PubMed     Abstract available


  539. ELOWE J, Golay P, Baumann PS, Solida-Tozzi A, et al
    Moderating role of cannabis use between insight and depression in early psychosis.
    Schizophr Res. 2019 Nov 25. pii: S0920-9964(19)30537.
    PubMed     Abstract available


  540. XIA L, Yuan L, Du XD, Wang D, et al
    P50 inhibition deficit in patients with chronic schizophrenia: Relationship with cognitive impairment of MATRICS consensus cognitive battery.
    Schizophr Res. 2019 Nov 25. pii: S0920-9964(19)30510.
    PubMed     Abstract available


  541. EMSLEY R, Asmal L, Rubio JM, Correll CU, et al
    Predictors of psychosis breakthrough during 24 months of long-acting antipsychotic maintenance treatment in first episode schizophrenia.
    Schizophr Res. 2019 Nov 22. pii: S0920-9964(19)30532.
    PubMed     Abstract available


  542. TIKKA DL, Singh AR, Tikka SK
    Social cognitive endophenotypes in schizophrenia: A study comparing first episode schizophrenia patients and, individuals at clinical- and familial- 'at-risk' for psychosis.
    Schizophr Res. 2019 Nov 22. pii: S0920-9964(19)30488.
    PubMed     Abstract available


  543. HAN S, Becker B, Duan X, Cui Q, et al
    Distinct striatum pathways connected to salience network predict symptoms improvement and resilient functioning in schizophrenia following risperidone monotherapy.
    Schizophr Res. 2019 Nov 20. pii: S0920-9964(19)30524.
    PubMed     Abstract available


  544. VARGAS T, Rakhshan Rouhakhtar PJ, Schiffman J, Zou DS, et al
    Neighborhood crime, socioeconomic status, and suspiciousness in adolescents and young adults at Clinical High Risk (CHR) for psychosis.
    Schizophr Res. 2019 Nov 20. pii: S0920-9964(19)30531.
    PubMed     Abstract available


  545. HOCHBERGER WC, Thomas ML, Joshi YB, Molina J, et al
    Oscillatory biomarkers of early auditory information processing predict cognitive gains following targeted cognitive training in schizophrenia patients.
    Schizophr Res. 2019 Nov 20. pii: S0920-9964(19)30521.
    PubMed     Abstract available


  546. LI Z, Liu L, Lin W, Zhou Y, et al
    NRG3 contributes to cognitive deficits in chronic patients with schizophrenia.
    Schizophr Res. 2019 Nov 18. pii: S0920-9964(19)30495.
    PubMed     Abstract available


  547. HANSSEN E, Krabbendam L, Robberegt S, Fett AK, et al
    Social and non-social reward learning reduced and related to a familial vulnerability in schizophrenia spectrum disorders.
    Schizophr Res. 2019 Nov 18. pii: S0920-9964(19)30431.
    PubMed     Abstract available


  548. ZHANG Y, Quinones GM, Ferrarelli F
    Sleep spindle and slow wave abnormalities in schizophrenia and other psychotic disorders: Recent findings and future directions.
    Schizophr Res. 2019 Nov 18. pii: S0920-9964(19)30500.
    PubMed     Abstract available


  549. ARMIO RL, Laurikainen H, Ilonen T, Walta M, et al
    Amygdala subnucleus volumes in psychosis high-risk state and first-episode psychosis.
    Schizophr Res. 2019 Nov 16. pii: S0920-9964(19)30445.
    PubMed     Abstract available


  550. HOCHBERGER WC, Thomas ML, Joshi YB, Swerdlow NR, et al
    Deviation from expected cognitive ability is a core cognitive feature of schizophrenia related to neurophysiologic, clinical and psychosocial functioning.
    Schizophr Res. 2019 Nov 16. pii: S0920-9964(19)30442.
    PubMed     Abstract available


  551. ZIKIDI K, Gajwani R, Gross J, Gumley AI, et al
    Grey-matter abnormalities in clinical high-risk participants for psychosis.
    Schizophr Res. 2019 Nov 15. pii: S0920-9964(19)30390.
    PubMed     Abstract available


  552. CHAKRAVARTY MM
    Guest editorial: Special issue on machine learning in schizophrenia.
    Schizophr Res. 2019 Nov 8. pii: S0920-9964(19)30479.
    PubMed    


  553. SILVERSTEIN SM, Fradkin SI, Demmin DL
    Schizophrenia and the retina: Towards a 2020 perspective.
    Schizophr Res. 2019 Nov 7. pii: S0920-9964(19)30426.
    PubMed     Abstract available


  554. RUAN H, Luo Q, Palaniyappan L, Lu W, et al
    Topographic diversity of structural connectivity in schizophrenia.
    Schizophr Res. 2019 Nov 6. pii: S0920-9964(19)30469.
    PubMed     Abstract available


  555. KARPOUZIAN-ROGERS T, Stocks J, Meltzer HY, Reilly JL, et al
    The effect of high vs. low dose lurasidone on eye movement biomarkers of prefrontal abilities in treatment-resistant schizophrenia.
    Schizophr Res. 2019 Nov 6. pii: S0920-9964(19)30439.
    PubMed     Abstract available


  556. CANDELARIA-COOK FT, Schendel ME, Ojeda CJ, Bustillo JR, et al
    Reduced parietal alpha power and psychotic symptoms: Test-retest reliability of resting-state magnetoencephalography in schizophrenia and healthy controls.
    Schizophr Res. 2019 Nov 6. pii: S0920-9964(19)30449.
    PubMed     Abstract available


  557. YOON JH, Maddock RJ, DongBo Cui E, Minzenberg MJ, et al
    Reduced in vivo visual cortex GABA in schizophrenia, a replication in a recent onset sample.
    Schizophr Res. 2019 Nov 6. pii: S0920-9964(19)30451.
    PubMed     Abstract available


  558. KRISTINE E, Jens-Christian S, Lars A, Jorgen B, et al
    Natural surroundings in childhood are associated with lower schizophrenia rates.
    Schizophr Res. 2019 Nov 4. pii: S0920-9964(19)30443.
    PubMed     Abstract available


  559. SNEEBOER MAM, van der Doef T, Litjens M, Psy NBB, et al
    Microglial activation in schizophrenia: Is translocator 18kDa protein (TSPO) the right marker?
    Schizophr Res. 2019 Nov 4. pii: S0920-9964(19)30480.
    PubMed     Abstract available


  560. TIKKANEN V, Siira V, Wahlberg KE, Hakko H, et al
    Adolescent social functioning in offspring at high risk for schizophrenia spectrum disorders in the Finnish Adoptive Family Study of Schizophrenia.
    Schizophr Res. 2019 Nov 4. pii: S0920-9964(19)30444.
    PubMed     Abstract available


  561. BOWIE CR, Bell MD, Fiszdon JM, Johannesen JK, et al
    Cognitive remediation for schizophrenia: An expert working group white paper on core techniques.
    Schizophr Res. 2019 Nov 4. pii: S0920-9964(19)30482.
    PubMed     Abstract available


  562. PEH OH, Rapisarda A, Lee J
    Quality of parental bonding is associated with symptom severity and functioning among individuals at ultra-high risk for psychosis.
    Schizophr Res. 2019 Nov 4. pii: S0920-9964(19)30464.
    PubMed     Abstract available


    October 2019
  563. ANDRADE C, Harshe D, Tharayil HM, Tekkalaki B, et al
    Blonanserin patch for schizophrenia.
    Schizophr Res. 2019 Oct 29. pii: S0920-9964(19)30477.
    PubMed    


  564. SNEEBOER MAM, van Mierlo HC, Stotijn E, MacIntyre DJ, et al
    Increased number of T-lymphocytes in post-mortem brain tissue of patients with schizophrenia.
    Schizophr Res. 2019 Oct 29. pii: S0920-9964(19)30467.
    PubMed    


  565. SAITO Y, Sakurai H, Kane JM, Schooler NR, et al
    Predicting relapse with residual symptoms in schizophrenia: A secondary analysis of the PROACTIVE trial.
    Schizophr Res. 2019 Oct 28. pii: S0920-9964(19)30472.
    PubMed     Abstract available


  566. DICKSON H, Roberts RE, To M, Wild K, et al
    Adolescent trajectories of fine motor and coordination skills and risk for schizophrenia.
    Schizophr Res. 2019 Oct 28. pii: S0920-9964(19)30429.
    PubMed     Abstract available


  567. BHAVSAR V
    Is neighbourhood effects research in psychosis fit for purpose? Commentary on Eaton et al.
    Schizophr Res. 2019 Oct 28. pii: S0920-9964(19)30441.
    PubMed    


  568. EACK SM
    Are schizophrenia and autism spectrum disorder diametrically opposed conditions?
    Schizophr Res. 2019 Oct 28. pii: S0920-9964(19)30475.
    PubMed    


  569. DITLEVSEN JV, Simonsen A, Bliksted VF
    Predicting mentalizing deficits in first-episode schizophrenia from different subdomains of negative symptoms.
    Schizophr Res. 2019 Oct 28. pii: S0920-9964(19)30471.
    PubMed    


  570. PAUDEL S, Coman D, Freudenreich O
    Subjective experience of cognitive difficulties as an important attribute of quality of life among individuals with schizophrenia spectrum disorders.
    Schizophr Res. 2019 Oct 28. pii: S0920-9964(19)30421.
    PubMed    


  571. DASKALAKIS AA, Zomorrodi R, Blumberger DM, Rajji TK, et al
    Evidence for prefrontal cortex hypofunctioning in schizophrenia through somatosensory evoked potentials.
    Schizophr Res. 2019 Oct 26. pii: S0920-9964(19)30465.
    PubMed     Abstract available


  572. GUO Y, Singh LN, Zhu Y, Gur RE, et al
    Association of a functional Claudin-5 variant with schizophrenia in female patients with the 22q11.2 deletion syndrome.
    Schizophr Res. 2019 Oct 23. pii: S0920-9964(19)30424.
    PubMed    


  573. ADHAN I, Bannai D, Lizano P
    Commentary: Can retinal imaging biomarkers inform psychosis pathophysiology?
    Schizophr Res. 2019 Oct 23. pii: S0920-9964(19)30427.
    PubMed    


  574. GUAN F, Zhang T, Han W, Zhu L, et al
    Relationship of SNAP25 variants with schizophrenia and antipsychotic-induced weight change in large-scale schizophrenia patients.
    Schizophr Res. 2019 Oct 22. pii: S0920-9964(19)30418.
    PubMed     Abstract available


  575. DU PLESSIS S, Scheffler F, Luckhoff H, Asmal L, et al
    Childhood trauma and hippocampal subfield volumes in first-episode schizophrenia and healthy controls.
    Schizophr Res. 2019 Oct 22. pii: S0920-9964(19)30440.
    PubMed     Abstract available


  576. DEL MISSIER F, Galfano G, Venerus E, Ferrara D, et al
    Decision-making competence in schizophrenia.
    Schizophr Res. 2019 Oct 22. pii: S0920-9964(19)30422.
    PubMed    


  577. TIAN Y, Liu D, Wang D, Wang J, et al
    Obesity in Chinese patients with chronic schizophrenia: Prevalence, clinical correlates and relationship with cognitive deficits.
    Schizophr Res. 2019 Oct 22. pii: S0920-9964(19)30448.
    PubMed     Abstract available


  578. UCOK A, Kara IA
    Relapse rates following antipsychotic discontinuation in the maintenance phase after first-episode of schizophrenia: Results of a long-term follow-up study.
    Schizophr Res. 2019 Oct 22. pii: S0920-9964(19)30446.
    PubMed     Abstract available


  579. SUMIYOSHI T
    Cognitive enhancement in schizophrenia by buspirone: Role of serotonin1A receptor agonism.
    Schizophr Res. 2019 Oct 21. pii: S0920-9964(19)30419.
    PubMed    


  580. DALE CL, Brown EG, Herman AB, Hinkley LBN, et al
    Intervention-specific patterns of cortical function plasticity during auditory encoding in people with schizophrenia.
    Schizophr Res. 2019 Oct 21. pii: S0920-9964(19)30430.
    PubMed     Abstract available


  581. RYAN JE, Veliz P, McCabe SE, Stoddard SA, et al
    Association of early onset of cannabis, cigarette, other drug use and schizophrenia or psychosis.
    Schizophr Res. 2019 Oct 15. pii: S0920-9964(19)30433.
    PubMed    


  582. PILLNY M, Lincoln TM
    The demotivating effect of social exclusion: An experimental test of a psychosocial model on the development of negative symptoms in psychosis.
    Schizophr Res. 2019 Oct 14. pii: S0920-9964(19)30436.
    PubMed     Abstract available


  583. STEINBERG ML, Billingsley B, Rosen RL, Epstein EE, et al
    A novel intervention increases task persistence in smokers with schizophrenia: A proof of concept study.
    Schizophr Res. 2019 Oct 12. pii: S0920-9964(19)30420.
    PubMed    


  584. DONDE C, Brunelin J, Haesebaert F
    Duration, pitch and intensity features reveal different magnitudes of tone-matching deficit in schizophrenia.
    Schizophr Res. 2019 Oct 12. pii: S0920-9964(19)30434.
    PubMed    


  585. MOGHIMI P, Torres Jimenez N, McLoon LK, Netoff TI, et al
    Electoretinographic evidence of retinal ganglion cell-dependent function in schizophrenia.
    Schizophr Res. 2019 Oct 12. pii: S0920-9964(19)30414.
    PubMed     Abstract available


  586. SANKARANARAYANAN A, Jenkins Z, Castle D, Andrade C, et al
    Serum lipids and suicidality among patients with schizophrenia.
    Schizophr Res. 2019 Oct 11. pii: S0920-9964(19)30435.
    PubMed    


  587. ALQARNI A, Mitchell TW, McGorry PD, Nelson B, et al
    Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis.
    Schizophr Res. 2019 Oct 9. pii: S0920-9964(19)30389.
    PubMed     Abstract available


  588. MONCRIEFF J, Crellin NE, Long MA, Cooper RE, et al
    Definitions of relapse in trials comparing antipsychotic maintenance with discontinuation or reduction for schizophrenia spectrum disorders: A systematic review.
    Schizophr Res. 2019 Oct 8. pii: S0920-9964(19)30391.
    PubMed     Abstract available


    September 2019
  589. MITTAL VA, Walker EF
    Advances in the neurobiology of stress and psychosis.
    Schizophr Res. 2019 Sep 28. pii: S0920-9964(19)30386.
    PubMed    


  590. LI H, Ou Y, Liu F, Chen J, et al
    Reduced connectivity in anterior cingulate cortex as an early predictor for treatment response in drug-naive, first-episode schizophrenia: A global-brain functional connectivity analysis.
    Schizophr Res. 2019 Sep 12. pii: S0920-9964(19)30395.
    PubMed     Abstract available


  591. HOWELL KR, Law AJ
    Neurodevelopmental concepts of schizophrenia in the genome-wide association era: AKT/mTOR signaling as a pathological mediator of genetic and environmental programming during development.
    Schizophr Res. 2019 Sep 12. pii: S0920-9964(19)30392.
    PubMed     Abstract available


  592. KEGELES LS, Ciarleglio A, Leon-Ortiz P, Reyes-Madrigal F, et al
    An imaging-based risk calculator for prediction of conversion to psychosis in clinical high-risk individuals using glutamate (1)H MRS.
    Schizophr Res. 2019 Sep 12. pii: S0920-9964(19)30413.
    PubMed     Abstract available


  593. WEI Y, Wang X, Wang Y, Qiu B, et al
    Functional magnetic resonance imaging in a single schizophrenia patient with voluntary control over auditory verbal hallucinations.
    Schizophr Res. 2019 Sep 12. pii: S0920-9964(19)30394.
    PubMed    


  594. WALTHER S, Alexaki D, Stegmayer K, Vanbellingen T, et al
    Conceptual disorganization impairs hand gesture performance in schizophrenia.
    Schizophr Res. 2019 Sep 7. pii: S0920-9964(19)30393.
    PubMed    


  595. TANDON N, Tandon R
    Using machine learning to explain the heterogeneity of schizophrenia. Realizing the promise and avoiding the hype.
    Schizophr Res. 2019 Sep 6. pii: S0920-9964(19)30388.
    PubMed     Abstract available


  596. NGUYEN T, Seiler N, Maguire J, Sizer H, et al
    Reduction in the prescription of Olanzapine as a first-line treatment for first episode psychosis following the implementation of clinical practice guidelines.
    Schizophr Res. 2019 Sep 4. pii: S0920-9964(19)30383.
    PubMed    


  597. WALLACE A, Isenberg K, York W, Shinde M, et al
    Detecting schizophrenia early: Prediagnosis healthcare utilization characteristics of patients with schizophrenia may aid early detection.
    Schizophr Res. 2019 Sep 1. pii: S0920-9964(19)30352.
    PubMed     Abstract available


    August 2019
  598. SCHLIER B, Ludwig L, Wiesjahn M, Jung E, et al
    Fostering coping as a mechanism of symptom change in cognitive behavioural therapy for psychosis.
    Schizophr Res. 2019 Aug 31. pii: S0920-9964(19)30327.
    PubMed     Abstract available


  599. ERMEL JA, Moran EK, Culbreth AJ, Barch DM, et al
    Correction to psychotic like experiences as part of a continuum of psychosis: associations with effort-based decision-making and reward responsivity.
    Schizophr Res. 2019 Aug 30. pii: S0920-9964(19)30374.
    PubMed    


  600. OISHI K, Niitsu T, Kanahara N, Hashimoto T, et al
    Genetic combination risk for schizophrenia.
    Schizophr Res. 2019 Aug 30. pii: S0920-9964(19)30376.
    PubMed    


  601. FITZSIMMONS J, Rosa P, Sydnor VJ, Reid BE, et al
    Cingulum bundle abnormalities and risk for schizophrenia.
    Schizophr Res. 2019 Aug 30. pii: S0920-9964(19)30358.
    PubMed     Abstract available


  602. GLENTHOJ LB, Kristensen TD, Gibson CM, Jepsen JRM, et al
    Assessing social skills in individuals at ultra-high risk for psychosis: Validation of the High Risk Social Challenge task (HiSoC).
    Schizophr Res. 2019 Aug 30. pii: S0920-9964(19)30380.
    PubMed     Abstract available


  603. FEKETE K, Torok E, Makkos Z, Kelemen O, et al
    Mentalization across the psychosis spectrum.
    Schizophr Res. 2019 Aug 28. pii: S0920-9964(19)30378.
    PubMed    


  604. ISHIKAWA R, Ishigaki T, Shimada T, Tanoue H, et al
    The efficacy of extended metacognitive training for psychosis: A randomized controlled trial.
    Schizophr Res. 2019 Aug 27. pii: S0920-9964(19)30347.
    PubMed     Abstract available


  605. IWATA N, Ishigooka J, Kim WH, Yoon BH, et al
    Efficacy and safety of blonanserin transdermal patch in patients with schizophrenia: A 6-week randomized, double-blind, placebo-controlled, multicenter study.
    Schizophr Res. 2019 Aug 27. pii: S0920-9964(19)30335.
    PubMed     Abstract available


  606. APPAJI A, Nagendra B, Chako DM, Padmanabha A, et al
    Retinal vascular tortuosity in schizophrenia and bipolar disorder.
    Schizophr Res. 2019 Aug 26. pii: S0920-9964(19)30375.
    PubMed     Abstract available


  607. SODER E, Clamor A, Lincoln TM
    Hair cortisol concentrations as an indicator of potential HPA axis hyperactivation in risk for psychosis.
    Schizophr Res. 2019 Aug 24. pii: S0920-9964(19)30353.
    PubMed     Abstract available


  608. TALPALARU A, Bhagwat N, Devenyi GA, Lepage M, et al
    Identifying schizophrenia subgroups using clustering and supervised learning.
    Schizophr Res. 2019 Aug 24. pii: S0920-9964(19)30221.
    PubMed     Abstract available


  609. BEHERE RV, Thirthalli J, Varambally SS, Gangadhar BN, et al
    Mind-body practices in schizophrenia - Opportunities and challenges.
    Schizophr Res. 2019 Aug 23. pii: S0920-9964(19)30373.
    PubMed    


  610. ZHOU FC, Zheng W, Lu L, Wang YY, et al
    Prospective memory in schizophrenia: A meta-analysis of comparative studies.
    Schizophr Res. 2019 Aug 22. pii: S0920-9964(19)30351.
    PubMed     Abstract available


  611. GASSE C, Wimberley T, Wang Y, Mors O, et al
    Schizophrenia polygenic risk scores, urbanicity and treatment-resistant schizophrenia.
    Schizophr Res. 2019 Aug 22. pii: S0920-9964(19)30349.
    PubMed     Abstract available


  612. VARUN CN, Venkataswamy MM, Ravikumar R, Nagaraju R, et al
    Th17 and MAIT cell mediated inflammation in antipsychotic free schizophrenia patients.
    Schizophr Res. 2019 Aug 19. pii: S0920-9964(19)30354.
    PubMed     Abstract available


  613. JI L, Meda SA, Tamminga CA, Clementz BA, et al
    Characterizing functional regional homogeneity (ReHo) as a B-SNIP psychosis biomarker using traditional and machine learning approaches.
    Schizophr Res. 2019 Aug 19. pii: S0920-9964(19)30293.
    PubMed     Abstract available


  614. WYNN JK, Roach BJ, McCleery A, Marder SR, et al
    Evaluating visual neuroplasticity with EEG in schizophrenia outpatients.
    Schizophr Res. 2019 Aug 19. pii: S0920-9964(19)30356.
    PubMed     Abstract available


  615. WOOD PL
    Targeted lipidomics and metabolomics evaluations of cortical neuronal stress in schizophrenia.
    Schizophr Res. 2019 Aug 18. pii: S0920-9964(19)30343.
    PubMed     Abstract available


  616. SCHLIER B, Krkovic K, Clamor A, Lincoln TM, et al
    Autonomic arousal during psychosis spectrum experiences: Results from a high resolution ambulatory assessment study over the course of symptom on- and offset.
    Schizophr Res. 2019 Aug 15. pii: S0920-9964(19)30326.
    PubMed     Abstract available


  617. MARTINEZ-ANDRES JA, Garcia-Carmona JA
    Clozapine, a controversial gold standard antipsychotic for the 21st century: Switching to paliperidone palmitate 3-monthly improves the metabolic profile and lowers antipsychotic dose equivalents in a treatment-resistant schizophrenia cohort.
    Schizophr Res. 2019 Aug 14. pii: S0920-9964(19)30342.
    PubMed    


  618. POLETTI M, Raballo A
    Obsessively thinking through the schizophrenia spectrum: Disentangling pseudo-obsessive schizophrenia from OCD.
    Schizophr Res. 2019 Aug 14. pii: S0920-9964(19)30355.
    PubMed    


  619. GUPTA R, Brown HK, Barker LC, Dennis CL, et al
    Rapid repeat pregnancy in women with schizophrenia.
    Schizophr Res. 2019 Aug 14. pii: S0920-9964(19)30348.
    PubMed     Abstract available


  620. LUM JS, du Bois TM, Mattner F, Katsifis A, et al
    Increased translocator protein (TSPO) binding throughout neurodevelopment in the perinatal phencyclidine rodent model of schizophrenia.
    Schizophr Res. 2019 Aug 13. pii: S0920-9964(19)30321.
    PubMed    


  621. CHEN B, Klarmann R, Israel M, Ning Y, et al
    Difference of olfactory deficit in patients with acute episode of schizophrenia and major depressive episode.
    Schizophr Res. 2019 Aug 12. pii: S0920-9964(19)30345.
    PubMed     Abstract available


  622. BRADLEY ER, Seitz A, Niles AN, Rankin KP, et al
    Oxytocin increases eye gaze in schizophrenia.
    Schizophr Res. 2019 Aug 12. pii: S0920-9964(19)30319.
    PubMed     Abstract available


  623. ZHANG L, Zheng H, Wu R, Kosten TR, et al
    The effect of minocycline on amelioration of cognitive deficits and pro-inflammatory cytokines levels in patients with schizophrenia.
    Schizophr Res. 2019 Aug 12. pii: S0920-9964(19)30346.
    PubMed     Abstract available


  624. CHIEN WT, Cheng HY, McMaster TW, Yip ALK, et al
    Effectiveness of a mindfulness-based psychoeducation group programme for early-stage schizophrenia: An 18-month randomised controlled trial.
    Schizophr Res. 2019 Aug 12. pii: S0920-9964(19)30333.
    PubMed     Abstract available


  625. BORGMANN-WINTER KE, Wang K, Bandyopadhyay S, Torshizi AD, et al
    The proteome and its dynamics: A missing piece for integrative multi-omics in schizophrenia.
    Schizophr Res. 2019 Aug 12. pii: S0920-9964(19)30303.
    PubMed     Abstract available


  626. KINDLER J, Michel C, Schultze-Lutter F, Felber G, et al
    Functional and structural correlates of abnormal involuntary movements in psychosis risk and first episode psychosis.
    Schizophr Res. 2019 Aug 9. pii: S0920-9964(19)30312.
    PubMed     Abstract available


  627. AMIRI AM, Hiremath SV, Salzer MS, Snethen G, et al
    Predicting physical activity levels in individuals with schizophrenia through integrated global positioning system and accelerometer data.
    Schizophr Res. 2019 Aug 9. pii: S0920-9964(19)30307.
    PubMed    


  628. SHUHAMA R, Carmo LSRD, Busatto Filho G, Santos JLF, et al
    From where we came: Absence of internal migration effect on psychosis in two case-control Brazilian samples.
    Schizophr Res. 2019 Aug 8. pii: S0920-9964(19)30322.
    PubMed    


  629. MEHTA UM, Keshavan MS
    Leveraging neurological "soft" signs in the prediction of schizophrenia: A 35-year follow-up case illustration.
    Schizophr Res. 2019 Aug 8. pii: S0920-9964(19)30339.
    PubMed    


  630. AVERY SN, Armstrong K, Blackford JU, Woodward ND, et al
    Impaired relational memory in the early stage of psychosis.
    Schizophr Res. 2019 Aug 8. pii: S0920-9964(19)30340.
    PubMed     Abstract available


  631. KIM E, Keskey Z, Kang M, Kitchen C, et al
    Validation of oxidative stress assay for schizophrenia.
    Schizophr Res. 2019 Aug 6. pii: S0920-9964(19)30337.
    PubMed     Abstract available


  632. SEVILLA-LLEWELLYN-JONES J, Perez J, Cano-Dominguez P, de-Luis-Matilla A, et al
    Clinical personality traits and parental bonding in patients with recent onset of psychosis.
    Schizophr Res. 2019 Aug 6. pii: S0920-9964(19)30332.
    PubMed    


  633. FANG SC, Huang CY, Liao DL, Hsu CC, et al
    Associations among antipsychotics, metabolism-related diseases, and cataracts in patients with schizophrenia: A retrospective cohort study.
    Schizophr Res. 2019 Aug 6. pii: S0920-9964(19)30329.
    PubMed     Abstract available


  634. KRIEGER I, Tzur Bitan D, Comaneshter D, Cohen A, et al
    Increased risk of smoking-related illnesses in schizophrenia patients: A nationwide cohort study.
    Schizophr Res. 2019 Aug 6. pii: S0920-9964(19)30338.
    PubMed     Abstract available


  635. SPALTHOFF R, Degenhardt F, Awasthi S, Heilmann-Heimbach S, et al
    Effects of a neurodevelopmental genes based polygenic risk score for schizophrenia and single gene variants on brain structure in non-clinical subjects: A preliminary report.
    Schizophr Res. 2019 Aug 6. pii: S0920-9964(19)30341.
    PubMed     Abstract available


  636. BURTON CZ, Tso IF, Carrion RE, Niendam T, et al
    Baseline psychopathology and relationship to longitudinal functional outcome in attenuated and early first episode psychosis.
    Schizophr Res. 2019 Aug 5. pii: S0920-9964(19)30328.
    PubMed     Abstract available


  637. OH K, Kim W, Shen G, Piao Y, et al
    Classification of schizophrenia and normal controls using 3D convolutional neural network and outcome visualization.
    Schizophr Res. 2019 Aug 5. pii: S0920-9964(19)30314.
    PubMed     Abstract available


  638. HESS JL, Tylee DS, Barve R, de Jong S, et al
    Transcriptomic abnormalities in peripheral blood in bipolar disorder, and discrimination of the major psychoses.
    Schizophr Res. 2019 Aug 4. pii: S0920-9964(19)30316.
    PubMed     Abstract available


  639. GRATTAN RE, Linscott RJ
    Components of schizophrenia liability affect the growth of psychological stress sensitivity following major life events.
    Schizophr Res. 2019 Aug 3. pii: S0920-9964(19)30336.
    PubMed     Abstract available


  640. LOPEZ-GARCIA P, Ashby S, Patel P, Pierce KM, et al
    Clinical and neurodevelopmental correlates of aggression in early psychosis.
    Schizophr Res. 2019 Aug 3. pii: S0920-9964(19)30325.
    PubMed     Abstract available


  641. OXENKRUG G, Bernstein HG, Guest PC, van der Hart M, et al
    Plasma xanthurenic acid in a context of insulin resistance and obesity in schizophrenia.
    Schizophr Res. 2019 Aug 2. pii: S0920-9964(19)30318.
    PubMed    


  642. SOMMER IE, Hugdahl K
    Auditory hallucinations in schizophrenia: Where are we now and where do we go from here? A personal commentary.
    Schizophr Res. 2019 Aug 2. pii: S0920-9964(19)30295.
    PubMed    


  643. TOPYUREK M, Tibbo P, Nunez C, Stephan-Otto C, et al
    Caffeine effects and schizophrenia: Is there a need for more research?
    Schizophr Res. 2019 Aug 2. pii: S0920-9964(19)30306.
    PubMed    


  644. ALCOVER KC, Oluwoye O, Kriegel L, McPherson S, et al
    Impact of first episode psychosis treatment on heavy cannabis use: Secondary analysis on RAISE-ETP study.
    Schizophr Res. 2019 Aug 2. pii: S0920-9964(19)30277.
    PubMed    


  645. BJORNESTAD J, Davidson L, Ten Velden Hegelstad W, Stain H, et al
    Re-thinking social functioning in psychosis.
    Schizophr Res. 2019 Aug 2. pii: S0920-9964(19)30334.
    PubMed    


  646. SABE M, Sentissi O, Kaiser S
    Meditation-based mind-body therapies for negative symptoms of schizophrenia: Systematic review of randomized controlled trials and meta-analysis.
    Schizophr Res. 2019 Aug 1. pii: S0920-9964(19)30310.
    PubMed     Abstract available


  647. MEHTA UM, Basavaraju R, Thirthalli J
    Motor cortical reactivity to action observation: A biomarker to differentiate mania and schizophrenia?
    Schizophr Res. 2019 Aug 1. pii: S0920-9964(19)30324.
    PubMed    


    July 2019
  648. NGUYEN TT, Jeste DV
    Positive light on schizophrenia and aging: Commentary on course and predictors of symptomatic remission in schizophrenia: A 5-year follow-up study in a Dutch psychiatric catchment area, by Lange et al.
    Schizophr Res. 2019 Jul 31. pii: S0920-9964(19)30317.
    PubMed    


  649. DEMMIN DL, Netser R, Roche MW, Thompson JL, et al
    People with current major depression resemble healthy controls on flash Electroretinogram indices associated with impairment in people with stabilized schizophrenia.
    Schizophr Res. 2019 Jul 30. pii: S0920-9964(19)30302.
    PubMed     Abstract available


  650. RABINOWITZ J, Badescu S, Palamarchuk P, Filyk V, et al
    Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: Results from an exploratory outcome of a randomized placebo-controlled trial.
    Schizophr Res. 2019 Jul 30. pii: S0920-9964(19)30309.
    PubMed    


  651. KUROKAWA S, Kishimoto T, Su KP, Chang JP, et al
    Psychiatrists' perceptions of medication adherence among patients with schizophrenia: An international survey.
    Schizophr Res. 2019 Jul 29. pii: S0920-9964(19)30308.
    PubMed    


  652. BERNARDIN F, Schwitzer T, Angioi-Duprez K, Giersch A, et al
    Retinal ganglion cells dysfunctions in schizophrenia patients with or without visual hallucinations.
    Schizophr Res. 2019 Jul 25. pii: S0920-9964(19)30270.
    PubMed     Abstract available


  653. RODRIGUEZ-JIMENEZ R, Santos JL, Dompablo M, Santabarbara J, et al
    MCCB cognitive profile in Spanish first episode schizophrenia patients.
    Schizophr Res. 2019 Jul 22. pii: S0920-9964(19)30274.
    PubMed     Abstract available


  654. DOLLFUS S, Delouche C, Hervochon C, Mach C, et al
    Specificity and sensitivity of the Self-assessment of Negative Symptoms (SNS) in patients with schizophrenia.
    Schizophr Res. 2019 Jul 22. pii: S0920-9964(19)30275.
    PubMed     Abstract available


  655. ELLMAN LM, Murphy SK, Maxwell SD, Calvo EM, et al
    Maternal cortisol during pregnancy and offspring schizophrenia: Influence of fetal sex and timing of exposure.
    Schizophr Res. 2019 Jul 22. pii: S0920-9964(19)30265.
    PubMed     Abstract available


  656. CHAN NK, Kim J, Shah P, Brown EE, et al
    Resting-state functional connectivity in treatment response and resistance in schizophrenia: A systematic review.
    Schizophr Res. 2019 Jul 19. pii: S0920-9964(19)30298.
    PubMed     Abstract available


  657. GICA S, Buyukavsar A, Poyraz BC, Gulec H, et al
    The clinical correlation and predictive value of electrophysiological variables on clinical response to clozapine in patients with treatment-resistant schizophrenia.
    Schizophr Res. 2019 Jul 19. pii: S0920-9964(19)30299.
    PubMed    


  658. CHUA YC, Abdin E, Tang C, Subramaniam M, et al
    First-episode psychosis and vocational outcomes: A predictive model.
    Schizophr Res. 2019 Jul 18. pii: S0920-9964(19)30272.
    PubMed     Abstract available


  659. FREEMAN D, Taylor KM, Molodynski A, Waite F, et al
    Treatable clinical intervention targets for patients with schizophrenia.
    Schizophr Res. 2019 Jul 17. pii: S0920-9964(19)30294.
    PubMed     Abstract available


  660. SENTHIL G, Lehner T
    Schizophrenia research in the era of Team Science and big data.
    Schizophr Res. 2019 Jul 16. pii: S0920-9964(19)30271.
    PubMed     Abstract available


  661. CASTRO MK, Bailey DH, Zinger JF, Martin EA, et al
    Late electrophysiological potentials and emotion in schizophrenia: A meta-analytic review.
    Schizophr Res. 2019 Jul 16. pii: S0920-9964(19)30276.
    PubMed     Abstract available


  662. GAGNE AM, Moreau I, St-Amour I, Marquet P, et al
    Retinal function anomalies in young offspring at genetic risk of schizophrenia and mood disorder: The meaning for the illness pathophysiology.
    Schizophr Res. 2019 Jul 15. pii: S0920-9964(19)30242.
    PubMed     Abstract available


  663. MADEIRA L, Pienkos E, Filipe T, Melo M, et al
    Self and world experience in non-affective first episode of psychosis.
    Schizophr Res. 2019 Jul 12. pii: S0920-9964(19)30264.
    PubMed     Abstract available


  664. CHERIAN K, Schatzberg AF, Keller J
    HPA axis in psychotic major depression and schizophrenia spectrum disorders: Cortisol, clinical symptomatology, and cognition.
    Schizophr Res. 2019 Jul 12. pii: S0920-9964(19)30266.
    PubMed     Abstract available


  665. BARBER GS, Sturgeon C, Fasano A, Cascella NG, et al
    Elevated zonulin, a measure of tight-junction permeability, may be implicated in schizophrenia.
    Schizophr Res. 2019 Jul 12. pii: S0920-9964(19)30269.
    PubMed    


  666. ALQARNI A, Mitchell TW, McGorry PD, Nelson B, et al
    Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people.
    Schizophr Res. 2019 Jul 10. pii: S0920-9964(19)30241.
    PubMed     Abstract available


  667. SISKIND D, Honarparvar F, Hasan A, Wagner E, et al
    rTMS for clozapine refractory schizophrenia - A systematic review and pairwise meta-analysis.
    Schizophr Res. 2019 Jul 10. pii: S0920-9964(19)30267.
    PubMed    


  668. ADDINGTON J, Shakeel MK, Braun A, Bonneville D, et al
    Metacognition in youth at-risk for psychosis.
    Schizophr Res. 2019 Jul 9. pii: S0920-9964(19)30268.
    PubMed    


  669. LEE CH, Sinclair D, O'Donnell M, Galletly C, et al
    Transcriptional changes in the stress pathway are related to symptoms in schizophrenia and to mood in schizoaffective disorder.
    Schizophr Res. 2019 Jul 8. pii: S0920-9964(19)30247.
    PubMed     Abstract available


  670. HAYAKAWA E, Ohgidani M, Fujimura Y, Kanba S, et al
    Cuprizone-treated mice, a possible model of schizophrenia, highlighting the simultaneous abnormalities of GABA, serine and glycine in hippocampus.
    Schizophr Res. 2019 Jul 8. pii: S0920-9964(19)30231.
    PubMed    


  671. DIENEL SJ, Enwright JF 3rd, Hoftman GD, Lewis DA, et al
    Markers of glutamate and GABA neurotransmission in the prefrontal cortex of schizophrenia subjects: Disease effects differ across anatomical levels of resolution.
    Schizophr Res. 2019 Jul 8. pii: S0920-9964(19)30224.
    PubMed     Abstract available


  672. FAN F, Tan Y, Wang Z, Yang F, et al
    Functional fractionation of default mode network in first episode schizophrenia.
    Schizophr Res. 2019 Jul 8. pii: S0920-9964(19)30215.
    PubMed     Abstract available


  673. MALHI GS, Bell E
    Transdiagnostic conceptualization: Giving psychosis and mood a personality.
    Schizophr Res. 2019 Jul 6. pii: S0920-9964(19)30228.
    PubMed    


  674. NORDGAARD J, Henriksen MG, Berge J, Nilsson LS, et al
    First-rank symptoms and self-disorders in schizophrenia.
    Schizophr Res. 2019 Jul 5. pii: S0920-9964(19)30263.
    PubMed    


  675. DEMMIN DL, Mote J, Beaudette DM, Thompson JL, et al
    Retinal functioning and reward processing in schizophrenia.
    Schizophr Res. 2019 Jul 4. pii: S0920-9964(19)30240.
    PubMed     Abstract available


  676. PIGNON B, Eaton S, Schurhoff F, Szoke A, et al
    Residential social drift in the two years following a first episode of psychosis.
    Schizophr Res. 2019 Jul 4. pii: S0920-9964(19)30229.
    PubMed    


  677. RAJARAJAN P, Flaherty E, Akbarian S, Brennand KJ, et al
    CRISPR-based functional evaluation of schizophrenia risk variants.
    Schizophr Res. 2019 Jul 2. pii: S0920-9964(19)30238.
    PubMed     Abstract available


  678. FERRARO L, Murray RM, Di Forti M, Quattrone D, et al
    IQ differences between patients with first episode psychosis in London and Palermo reflect differences in patterns of cannabis use.
    Schizophr Res. 2019 Jul 1. pii: S0920-9964(19)30225.
    PubMed     Abstract available


  679. LUPERDI SC, Tabares-Seisdedos R, Livianos L, Vieta E, et al
    Neurocognitive endophenotypes in schizophrenia and bipolar disorder: A systematic review of longitudinal family studies.
    Schizophr Res. 2019 Jul 1. pii: S0920-9964(19)30235.
    PubMed     Abstract available


  680. PLITMAN E, Guma E, Lepage M, Near J, et al
    Using proton magnetic resonance spectroscopic imaging to study glutamatergic alterations in patients with schizophrenia: A systematic review.
    Schizophr Res. 2019 Jul 1. pii: S0920-9964(19)30232.
    PubMed     Abstract available


    June 2019
  681. PIOTROWSKI P, Kotowicz K, Rymaszewska J, Beszlej JA, et al
    Allostatic load index and its clinical correlates at various stages of psychosis.
    Schizophr Res. 2019 Jun 28. pii: S0920-9964(19)30230.
    PubMed     Abstract available


  682. CLOSSON K, McLinden T, Patterson TL, Eyawo O, et al
    HIV, schizophrenia, and all-cause mortality: A population-based cohort study of individuals accessing universal medical care from 1998 to 2012 in British Columbia, Canada.
    Schizophr Res. 2019 Jun 26. pii: S0920-9964(19)30153.
    PubMed     Abstract available


  683. GERRITSEN C, Bagby RM, Sanches M, Kiang M, et al
    Stress precedes negative symptom exacerbations in clinical high risk and early psychosis: A time-lagged experience sampling study.
    Schizophr Res. 2019 Jun 24. pii: S0920-9964(19)30236.
    PubMed     Abstract available


  684. SUTTERLAND AL, Blom MT, Ladee K, Lubbers JJM, et al
    Increased prevalence of ECG suspicious for Brugada Syndrome in recent onset schizophrenia spectrum disorders.
    Schizophr Res. 2019 Jun 24. pii: S0920-9964(19)30234.
    PubMed     Abstract available


  685. YANG S, Meng Y, Li J, Fan YS, et al
    Temporal dynamic changes of intrinsic brain activity in schizophrenia with cigarette smoking.
    Schizophr Res. 2019 Jun 22. pii: S0920-9964(19)30233.
    PubMed     Abstract available


  686. CLELLAND JD, Smeed J, Cremers S, Clelland CL, et al
    A tetrahydrobiopterin deficit finding in schizophrenia: A confirmation study.
    Schizophr Res. 2019 Jun 21. pii: S0920-9964(19)30227.
    PubMed    


  687. BOBILEV AM, Perez JM, Tamminga CA
    Molecular alterations in the medial temporal lobe in schizophrenia.
    Schizophr Res. 2019 Jun 18. pii: S0920-9964(19)30222.
    PubMed     Abstract available


  688. HENRY JD, Moore P, Terrett G, Rendell PG, et al
    A comparison of different types of prospective memory reminders in schizophrenia.
    Schizophr Res. 2019 Jun 18. pii: S0920-9964(19)30223.
    PubMed     Abstract available


  689. FERRARA M, Guloksuz S, Li F, Burke S, et al
    Parsing the impact of early detection on duration of untreated psychosis (DUP): Applying quantile regression to data from the Scandinavian TIPS study.
    Schizophr Res. 2019 Jun 13. pii: S0920-9964(19)30212.
    PubMed     Abstract available


  690. YANG K, Kondo MA, Jaaro-Peled H, Cash-Padgett T, et al
    The transcriptome landscape associated with Disrupted-in-Schizophrenia-1 locus impairment in early development and adulthood.
    Schizophr Res. 2019 Jun 13. pii: S0920-9964(19)30209.
    PubMed     Abstract available


  691. REZANSOFF SN, Moniruzzaman A, Somers JM
    Temporal associations between medication adherence for patients with schizophrenia and opioid dependence: A 17-year Canadian Cohort Study.
    Schizophr Res. 2019 Jun 12. pii: S0920-9964(19)30208.
    PubMed     Abstract available


  692. HARVEY PD, Khan A, Atkins A, Walker TM, et al
    Comprehensive review of the research employing the schizophrenia cognition rating scale (SCoRS).
    Schizophr Res. 2019 Jun 10. pii: S0920-9964(19)30217.
    PubMed     Abstract available


  693. AHN SJ, Cornea E, Murphy V, Styner M, et al
    White matter development in infants at risk for schizophrenia.
    Schizophr Res. 2019 Jun 7. pii: S0920-9964(19)30216.
    PubMed     Abstract available


  694. NIKITOVA N, Keane BP, Demmin D, Silverstein SM, et al
    The Audio-Visual Abnormalities Questionnaire (AVAQ): Development and validation of a new instrument for assessing anomalies in sensory perception in schizophrenia spectrum disorders.
    Schizophr Res. 2019 Jun 7. pii: S0920-9964(19)30110.
    PubMed     Abstract available


  695. MATSUI K, Tokumasu T, Takekita Y, Inada K, et al
    Switching to antipsychotic monotherapy vs. staying on antipsychotic polypharmacy in schizophrenia: A systematic review and meta-analysis.
    Schizophr Res. 2019 Jun 7. pii: S0920-9964(19)30206.
    PubMed     Abstract available


  696. FRITZE S, Bertolino AL, Kubera KM, Topor CE, et al
    Differential contributions of brainstem structures to neurological soft signs in first- and multiple-episode schizophrenia spectrum disorders.
    Schizophr Res. 2019 Jun 6. pii: S0920-9964(19)30218.
    PubMed     Abstract available


  697. MARTINEZ G, Mosconi E, Daban-Huard C, Parellada M, et al
    "A circle and a triangle dancing together": Alteration of social cognition in schizophrenia compared to autism spectrum disorders.
    Schizophr Res. 2019 Jun 6. pii: S0920-9964(19)30220.
    PubMed     Abstract available


  698. DONDE C, Mondino M, Leitman DI, Javitt DC, et al
    Are basic auditory processes involved in source-monitoring deficits in patients with schizophrenia?
    Schizophr Res. 2019 Jun 5. pii: S0920-9964(19)30211.
    PubMed     Abstract available


  699. REYNOLDS S, Brown E, Kim DJ, Geros H, et al
    The association between community and service level factors and rates of disengagement in individuals with first episode psychosis.
    Schizophr Res. 2019 Jun 5. pii: S0920-9964(19)30214.
    PubMed     Abstract available


  700. JEREMIAN R, Bani-Fatemi A, Strauss JS, Tasmim S, et al
    Investigation of accelerated epigenetic aging in individuals suffering from schizophrenia in the context of lifetime suicide attempt.
    Schizophr Res. 2019 Jun 4. pii: S0920-9964(19)30184.
    PubMed    


    May 2019
  701. TAM FYK, Suen YN, Hui CLM, Woo HSY, et al
    Spontaneous eye blink in patients with psychosis in perceptions of stimulus salience.
    Schizophr Res. 2019 May 29. pii: S0920-9964(19)30205.
    PubMed    


  702. STEULLET P
    Thalamus-related anomalies as candidate mechanism-based biomarkers for psychosis.
    Schizophr Res. 2019 May 27. pii: S0920-9964(19)30203.
    PubMed     Abstract available


  703. SCHENNACH R, Obermeier M, Spellmann I, Seemuller F, et al
    Remission in schizophrenia - What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remission in major depression.
    Schizophr Res. 2019 May 25. pii: S0920-9964(19)30155.
    PubMed     Abstract available


  704. CHENG YF, Chen VC, Yang YH, Chen KJ, et al
    Risk of schizophrenia among people with obsessive-compulsive disorder: A nationwide population-based cohort study.
    Schizophr Res. 2019 May 24. pii: S0920-9964(19)30185.
    PubMed     Abstract available


  705. EATON S, Harrap B, Downey L, Thien K, et al
    Incidence of treated first episode psychosis from an Australian early intervention service and its association with neighbourhood characteristics.
    Schizophr Res. 2019 May 23. pii: S0920-9964(19)30142.
    PubMed     Abstract available


  706. VAN MIERLO HC, Schot A, Boks MPM, de Witte LD, et al
    The association between schizophrenia and the immune system: Review of the evidence from unbiased 'omic-studies'.
    Schizophr Res. 2019 May 23. pii: S0920-9964(19)30204.
    PubMed     Abstract available


  707. SANFRATELLO L, Houck JM, Calhoun VD
    Relationship between MEG global dynamic functional network connectivity measures and symptoms in schizophrenia.
    Schizophr Res. 2019 May 23. pii: S0920-9964(19)30168.
    PubMed     Abstract available


  708. COOPER RE, Laxhman N, Crellin N, Moncrieff J, et al
    Psychosocial interventions for people with schizophrenia or psychosis on minimal or no antipsychotic medication: A systematic review.
    Schizophr Res. 2019 May 21. pii: S0920-9964(19)30182.
    PubMed     Abstract available


  709. MULIYALA KP, Thirthalli J
    Expressed emotions and relapse of psychosis: New vistas for an old concept.
    Schizophr Res. 2019 May 21. pii: S0920-9964(19)30202.
    PubMed    


  710. STYLA R, Stolarski M, Szymanowska A
    Linking childhood adversities with schizophrenia: A mediating role of the balanced time perspective.
    Schizophr Res. 2019 May 21. pii: S0920-9964(19)30180.
    PubMed    


  711. MAHER S, Ekstrom T, Ongur D, Levy DL, et al
    Functional disconnection between the visual cortex and right fusiform face area in schizophrenia.
    Schizophr Res. 2019 May 21. pii: S0920-9964(19)30177.
    PubMed     Abstract available


  712. LEIRER DJ, Iyegbe CO, Di Forti M, Patel H, et al
    Differential gene expression analysis in blood of first episode psychosis patients.
    Schizophr Res. 2019 May 19. pii: S0920-9964(19)30172.
    PubMed     Abstract available


  713. ESCARTI MJ, Garcia-Marti G, Sanz-Requena R, Marti-Bonmati L, et al
    Auditory hallucinations in first-episode psychosis: A voxel-based morphometry study.
    Schizophr Res. 2019 May 18. pii: S0920-9964(19)30162.
    PubMed     Abstract available


  714. KANAT-MAYMON Y, Ben-David BM
    Small numbers are not predictive: Congenital blindness may or may not be protective for schizophrenia.
    Schizophr Res. 2019 May 16. pii: S0920-9964(19)30156.
    PubMed    


  715. DING Y, Ou Y, Pan P, Shan X, et al
    Brain structural abnormalities as potential markers for detecting individuals with ultra-high risk for psychosis: A systematic review and meta-analysis.
    Schizophr Res. 2019 May 16. pii: S0920-9964(19)30176.
    PubMed     Abstract available


  716. STAMATE D, Katrinecz A, Stahl D, Verhagen SJW, et al
    Identifying psychosis spectrum disorder from experience sampling data using machine learning approaches.
    Schizophr Res. 2019 May 16. pii: S0920-9964(19)30161.
    PubMed     Abstract available


  717. ADAMCZYK P, Wyczesany M, Daren A
    Dynamics of impaired humour processing in schizophrenia - An EEG effective connectivity study.
    Schizophr Res. 2019 May 15. pii: S0920-9964(19)30169.
    PubMed     Abstract available


  718. SANCHEZ-GISTAU V, Marine R, Martorell L, Cabezas A, et al
    Relationship between ANKK1 rs1800497 polymorphism, overweight and executive dysfunction in early psychosis.
    Schizophr Res. 2019 May 15. pii: S0920-9964(19)30183.
    PubMed    


  719. LEWANDOWSKI KE, Du F, Fan X, Chen X, et al
    Role of glia in prefrontal white matter abnormalities in first episode psychosis or mania detected by diffusion tensor spectroscopy.
    Schizophr Res. 2019 May 14. pii: S0920-9964(19)30179.
    PubMed     Abstract available


  720. WANG Y, Yang X, Song X, Zhao L, et al
    Co-treatment of buspirone with atypical antipsychotic drugs (AAPDs) improved neurocognitive function in chronic schizophrenia.
    Schizophr Res. 2019 May 14. pii: S0920-9964(19)30167.
    PubMed     Abstract available


  721. JACOB A, Shukla A, Thonse U, Nagendra B, et al
    Cultural differences and neural correlates of cognitive insight in schizophrenia.
    Schizophr Res. 2019 May 14. pii: S0920-9964(19)30171.
    PubMed     Abstract available


  722. DERVAUX A, Plancke L, Amariei A, Trouiller P, et al
    Methadone and buprenorphine treatments in patients with schizophrenia.
    Schizophr Res. 2019 May 14. pii: S0920-9964(19)30174.
    PubMed    


  723. MORGAN VA, Badcock JC, Di Prinzio P, Ambrosi T, et al
    Invited response to commentary. Small numbers are not predictive: Congenital blindness may or may not be protective for schizophrenia.
    Schizophr Res. 2019 May 11. pii: S0920-9964(19)30164.
    PubMed    


  724. WEICKERT CS, Lee CH, Lenroot RK, Bruggemann J, et al
    Increased plasma Brain-Derived Neurotrophic Factor (BDNF) levels in females with schizophrenia.
    Schizophr Res. 2019 May 11. pii: S0920-9964(19)30140.
    PubMed     Abstract available


  725. SRIRETNAKUMAR V, Zai CC, Wasim S, Barsanti-Innes B, et al
    Copy number variant syndromes are frequent in schizophrenia: Progressing towards a CNV-schizophrenia model.
    Schizophr Res. 2019 May 9. pii: S0920-9964(19)30159.
    PubMed     Abstract available


  726. LANGE SMM, Meesters PD, Stek ML, Wunderink L, et al
    Course and predictors of symptomatic remission in late-life schizophrenia: A 5-year follow-up study in a Dutch psychiatric catchment area.
    Schizophr Res. 2019 May 9. pii: S0920-9964(19)30158.
    PubMed     Abstract available


  727. MELLER T, Schmitt S, Stein F, Brosch K, et al
    Associations of schizophrenia risk genes ZNF804A and CACNA1C with schizotypy and modulation of attention in healthy subjects.
    Schizophr Res. 2019 May 7. pii: S0920-9964(19)30143.
    PubMed     Abstract available


  728. PONTILLO M, Menghini D, Vicari S
    Neurocognitive profile and onset of psychosis symptoms in children, adolescents and young adults with 22q11 deletion syndrome: A longitudinal study.
    Schizophr Res. 2019 May 2. pii: S0920-9964(19)30137.
    PubMed     Abstract available


    April 2019
  729. GUIMOND S, Keshavan MS, Torous JB
    Towards remote digital phenotyping of cognition in schizophrenia.
    Schizophr Res. 2019 Apr 29. pii: S0920-9964(19)30141.
    PubMed    


  730. VAN ROOIJEN G, van Rooijen M, Maat A, Vermeulen JM, et al
    Longitudinal evidence for a relation between depressive symptoms and quality of life in schizophrenia using structural equation modeling.
    Schizophr Res. 2019 Apr 29. pii: S0920-9964(19)30136.
    PubMed     Abstract available


  731. PIGNON B, Lajnef M, Godin O, Geoffray MM, et al
    Relationship between childhood trauma and level of insight in schizophrenia: A path-analysis in the national FACE-SZ dataset.
    Schizophr Res. 2019 Apr 23. pii: S0920-9964(19)30129.
    PubMed     Abstract available


  732. O'DRISCOLL C, Sener SB, Angmark A, Shaikh M, et al
    Caregiving processes and expressed emotion in psychosis, a cross-cultural, meta-analytic review.
    Schizophr Res. 2019 Apr 23. pii: S0920-9964(19)30114.
    PubMed     Abstract available


  733. VAN DONKERSGOED RJM, de Jong S, Aan Het Rot M, Wunderink L, et al
    Measuring empathy in schizophrenia: The Empathic Accuracy Task and its correlation with other empathy measures.
    Schizophr Res. 2019 Apr 18. pii: S0920-9964(19)30118.
    PubMed     Abstract available


  734. ORIBE N, Hirano Y, Del Re E, Seidman LJ, et al
    Progressive reduction of auditory evoked gamma in first episode schizophrenia but not clinical high risk individuals.
    Schizophr Res. 2019 Apr 17. pii: S0920-9964(19)30119.
    PubMed     Abstract available


  735. DAMME KSF, Gallagher N, Vargas T, Osborne KJ, et al
    Motor sequence learning and pattern recognition in youth at clinical high-risk for psychosis.
    Schizophr Res. 2019 Apr 15. pii: S0920-9964(19)30117.
    PubMed    


  736. MILLMAN ZB, Gallagher K, Demro C, Schiffman J, et al
    Evidence of reward system dysfunction in youth at clinical high-risk for psychosis from two event-related fMRI paradigms.
    Schizophr Res. 2019 Apr 14. pii: S0920-9964(19)30111.
    PubMed     Abstract available


  737. FARIA AV, Crawford J, Ye C, Hsu J, et al
    Relationship between neuropsychological behavior and brain white matter in first-episode psychosis.
    Schizophr Res. 2019 Apr 13. pii: S0920-9964(19)30135.
    PubMed     Abstract available


  738. HAIGH SM, Laher RM, Murphy TK, Coffman BA, et al
    Normal categorical perception to syllable-like stimuli in long term and in first episode schizophrenia.
    Schizophr Res. 2019 Apr 11. pii: S0920-9964(19)30122.
    PubMed     Abstract available


  739. SCHONFELDT-LECUONA C, Kregel T, Schmidt A, Kassubek J, et al
    Retinal single-layer analysis with optical coherence tomography (OCT) in schizophrenia spectrum disorder.
    Schizophr Res. 2019 Apr 11. pii: S0920-9964(19)30116.
    PubMed     Abstract available


  740. SCORIELS L, Zimbron J, Garcia-Leon N, Coll-Negre M, et al
    Cross-sectional study of diet patterns in early and chronic schizophrenia.
    Schizophr Res. 2019 Apr 11. pii: S0920-9964(19)30123.
    PubMed    


  741. SNYDER MA, Gao WJ
    NMDA receptor hypofunction for schizophrenia revisited: Perspectives from epigenetic mechanisms.
    Schizophr Res. 2019 Apr 9. pii: S0920-9964(19)30104.
    PubMed     Abstract available


  742. VARGAS T, Damme KSF, Hooker CI, Gupta T, et al
    Differentiating implicit and explicit theory of mind and associated neural networks in youth at Clinical High Risk (CHR) for psychosis.
    Schizophr Res. 2019 Apr 9. pii: S0920-9964(19)30107.
    PubMed     Abstract available


  743. OMIDPANAH N, Darvishi FZ, Saadat M
    No alteration in leukocyte telomere length in schizophrenia; evidence from a meta-analysis.
    Schizophr Res. 2019 Apr 9. pii: S0920-9964(19)30127.
    PubMed    


  744. WESTMAN J, Eberhard J, Gaughran FP, Lundin L, et al
    Outcome of a psychosocial health promotion intervention aimed at improving physical health and reducing alcohol use in patients with schizophrenia and psychotic disorders (MINT).
    Schizophr Res. 2019 Apr 9. pii: S0920-9964(19)30120.
    PubMed     Abstract available


  745. WANG LX, Guo F, Zhu YQ, Wang HN, et al
    Effect of second-generation antipsychotics on brain network topology in first-episode schizophrenia: A longitudinal rs-fMRI study.
    Schizophr Res. 2019 Apr 7. pii: S0920-9964(19)30109.
    PubMed     Abstract available


  746. PARK S, Miller BJ
    Meta-analysis of cytokine and C-reactive protein levels in high-risk psychosis.
    Schizophr Res. 2019 Apr 7. pii: S0920-9964(19)30106.
    PubMed     Abstract available


  747. PALMER CM, Gilbert-Jaramillo J, Westman EC
    The ketogenic diet and remission of psychotic symptoms in schizophrenia: Two case studies.
    Schizophr Res. 2019 Apr 6. pii: S0920-9964(19)30113.
    PubMed    


  748. PETROS N, Mechelli A, Fusar-Poli P, Vieira S, et al
    Towards a framework for good outcome in people at clinical high risk for psychosis: A Delphi consensus study.
    Schizophr Res. 2019 Apr 1. pii: S0920-9964(19)30079.
    PubMed     Abstract available


  749. MENKES MW, Armstrong K, Blackford JU, Heckers S, et al
    Neuropsychological functioning in early and chronic stages of schizophrenia and psychotic bipolar disorder.
    Schizophr Res. 2019;206:413-419.
    PubMed     Abstract available


    March 2019
  750. BUCK B, Scherer E, Brian R, Wang R, et al
    Relationships between smartphone social behavior and relapse in schizophrenia: A preliminary report.
    Schizophr Res. 2019 Mar 30. pii: S0920-9964(19)30108.
    PubMed     Abstract available


  751. STEENKAMP L, Weijers J, Gerrmann J, Eurelings-Bontekoe E, et al
    The relationship between childhood abuse and severity of psychosis is mediated by loneliness: an experience sampling study.
    Schizophr Res. 2019 Mar 30. pii: S0920-9964(19)30115.
    PubMed     Abstract available


  752. CAO T, Li N, Cai H
    Candidate metabolic biomarkers for schizophrenia in CNS and periphery: Do any possible associations exist?
    Schizophr Res. 2019 Mar 29. pii: S0920-9964(19)30103.
    PubMed     Abstract available


  753. VAESSEN T, Viechtbauer W, van der Steen Y, Gayer-Anderson C, et al
    Recovery from daily-life stressors in early and chronic psychosis.
    Schizophr Res. 2019 Mar 28. pii: S0920-9964(19)30105.
    PubMed     Abstract available


  754. MORISHITA H, Vinogradov S
    Neuroplasticity and dysplasticity processes in schizophrenia.
    Schizophr Res. 2019 Mar 28. pii: S0920-9964(19)30090.
    PubMed    


  755. MAHNCKE HW, Kim SJ, Rose A, Stasio C, et al
    Evaluation of a plasticity-based cognitive training program in schizophrenia: Results from the eCaesar trial.
    Schizophr Res. 2019 Mar 28. pii: S0920-9964(19)30088.
    PubMed     Abstract available


  756. MAH W, Won H
    The three-dimensional landscape of the genome in human brain tissue unveils regulatory mechanisms leading to schizophrenia risk.
    Schizophr Res. 2019 Mar 17. pii: S0920-9964(19)30089.
    PubMed     Abstract available


  757. LYSAKER PH, Vohs J
    Insight in schizophrenia, its fundamental connection to fragmentation and potential as a treatment target: A commentary on Phahladira et al.
    Schizophr Res. 2019 Mar 13. pii: S0920-9964(19)30087.
    PubMed    


  758. KAO AC, Safarikova J, Marquardt T, Mullins B, et al
    Pro-cognitive effect of a prebiotic in psychosis: A double blind placebo controlled cross-over study.
    Schizophr Res. 2019 Mar 12. pii: S0920-9964(19)30085.
    PubMed    


  759. DAL MAS C, Nani JV, Noto C, Yonamine CM, et al
    Ndel1 oligopeptidase activity as a potential biomarker of early stages of schizophrenia.
    Schizophr Res. 2019 Mar 8. pii: S0920-9964(19)30081.
    PubMed     Abstract available


  760. MAZZA E, Spangaro M, Poletti S, Cavallaro R, et al
    Genetic variability of glutamate reuptake: Effect on white matter integrity and working memory in schizophrenia.
    Schizophr Res. 2019 Mar 8. pii: S0920-9964(19)30086.
    PubMed    


  761. MALASPINA D, Kranz T, Kleinhaus K, Daboul S, et al
    Short duration of marriage at conception as an independent risk factor for schizophrenia.
    Schizophr Res. 2019 Mar 8. pii: S0920-9964(19)30083.
    PubMed     Abstract available


  762. CABUNGCAL JH, Steullet P, Kraftsik R, Cuenod M, et al
    A developmental redox dysregulation leads to spatio-temporal deficit of parvalbumin neuron circuitry in a schizophrenia mouse model.
    Schizophr Res. 2019 Mar 8. pii: S0920-9964(19)30077.
    PubMed     Abstract available


  763. OTA M, Sato N, Yoshida F, Hattori K, et al
    A polymorphism of the methylenetetrahydrofolate reductase gene confers susceptibility to schizophrenia and related brain changes.
    Schizophr Res. 2019 Mar 6. pii: S0920-9964(19)30084.
    PubMed    


  764. STOCHL J, Whittier A, Wagner AP, Veijola J, et al
    Association between developmental milestones and age of schizophrenia onset: Results from the Northern Finland Birth Cohort 1966.
    Schizophr Res. 2019 Mar 6. pii: S0920-9964(19)30073.
    PubMed     Abstract available


  765. BIRNBAUM R, Weinberger DR
    A Genetics Perspective on the Role of the (Neuro)Immune System in Schizophrenia.
    Schizophr Res. 2019 Mar 5. pii: S0920-9964(19)30065.
    PubMed     Abstract available


  766. CURTO M, Lionetto L, Fazio F, Corigliano V, et al
    Serum xanthurenic acid levels: Reduced in subjects at ultra high risk for psychosis.
    Schizophr Res. 2019 Mar 2. pii: S0920-9964(19)30080.
    PubMed    


  767. VALIENTE C, Espinosa R, Trucharte A, Nieto J, et al
    The challenge of well-being and quality of life: A meta-analysis of psychological interventions in schizophrenia.
    Schizophr Res. 2019 Mar 1. pii: S0920-9964(19)30043.
    PubMed    


    February 2019
  768. HALL MH, Holton KM, Ongur D, Montrose D, et al
    Longitudinal trajectory of early functional recovery in patients with first episode psychosis.
    Schizophr Res. 2019 Feb 27. pii: S0920-9964(19)30053.
    PubMed     Abstract available


  769. KALAYASIRI R, Kraijak K, Mutirangura A, Maes M, et al
    Paranoid schizophrenia and methamphetamine-induced paranoia are both characterized by a similar LINE-1 partial methylation profile, which is more pronounced in paranoid schizophrenia.
    Schizophr Res. 2019 Feb 27. pii: S0920-9964(19)30075.
    PubMed     Abstract available


  770. KOSHIYAMA D, Kirihara K, Tada M, Nagai T, et al
    Gamma-band auditory steady-state response is associated with plasma levels of d-serine in schizophrenia: An exploratory study.
    Schizophr Res. 2019 Feb 25. pii: S0920-9964(19)30072.
    PubMed    


  771. MENNIGEN E, Jiang W, Calhoun VD, van Erp TGM, et al
    Positive and general psychopathology associated with specific gray matter reductions in inferior temporal regions in patients with schizophrenia.
    Schizophr Res. 2019 Feb 25. pii: S0920-9964(19)30070.
    PubMed     Abstract available


  772. TANG Y, Wang J, Zhang T, Xu L, et al
    P300 as an index of transition to psychosis and of remission: Data from a clinical high risk for psychosis study and review of literature.
    Schizophr Res. 2019 Feb 25. pii: S0920-9964(19)30074.
    PubMed     Abstract available


  773. AUKST MARGETIC B, Peitl V, Vukasovic I, Karlovic D, et al
    Neuregulin-1 is increased in schizophrenia patients with chronic cannabis abuse: Preliminary results.
    Schizophr Res. 2019 Feb 21. pii: S0920-9964(19)30067.
    PubMed    


  774. SEVERAID KB, Osborne KJ, Mittal VA
    Implications of religious and spiritual practices for youth at clinical high risk for psychosis.
    Schizophr Res. 2019 Feb 21. pii: S0920-9964(19)30035.
    PubMed    


  775. MARGETIC B
    Comments on "Distinctive profiles of traits predisposing to violence in schizophrenia and in the general population".
    Schizophr Res. 2019 Feb 21. pii: S0920-9964(19)30068.
    PubMed    


  776. YANG LH, Woodberry KA, Link BG, Corcoran CM, et al
    Impact of "psychosis risk" identification: Examining predictors of how youth view themselves.
    Schizophr Res. 2019 Feb 19. pii: S0920-9964(19)30040.
    PubMed     Abstract available


  777. KIM S, Lee SH, Bang M
    Double-sidedness of "laughing gas" on the N-methyl-d-aspartate receptor: A case report of acute psychosis associated with nitrous oxide-induced hyperhomocysteinemia.
    Schizophr Res. 2019 Feb 19. pii: S0920-9964(19)30066.
    PubMed    


  778. BRODEY BB, Girgis RR, Favorov OV, Bearden CE, et al
    The Early Psychosis Screener for Internet (EPSI)-SR: Predicting 12month psychotic conversion using machine learning.
    Schizophr Res. 2019 Feb 14. pii: S0920-9964(19)30015.
    PubMed     Abstract available


  779. WANG X, Liao W, Han S, Li J, et al
    Altered dynamic global signal topography in antipsychotic-naive adolescents with early-onset schizophrenia.
    Schizophr Res. 2019 Feb 14. pii: S0920-9964(19)30038.
    PubMed     Abstract available


  780. AYESA-ARRIOLA R, Pelayo Teran JM, Setien-Suero E, Neergaard K, et al
    Patterns of recovery course in early intervention for FIRST episode non-affective psychosis patients: The role of timing.
    Schizophr Res. 2019 Feb 14. pii: S0920-9964(19)30030.
    PubMed     Abstract available


  781. MONDELLI V, Dazzan P
    Childhood trauma and psychosis: Moving the field forward.
    Schizophr Res. 2019 Feb 11. pii: S0920-9964(19)30051.
    PubMed    


  782. SHIMAMOTO-MITSUYAMA C, Ohnishi T, Balan S, Ohba H, et al
    Evaluation of the role of fatty acid-binding protein 7 in controlling schizophrenia-relevant phenotypes using newly established knockout mice.
    Schizophr Res. 2019 Feb 11. pii: S0920-9964(19)30052.
    PubMed     Abstract available


  783. WIJTENBURG SA, Kapogiannis D, Korenic SA, Mullins RJ, et al
    Brain insulin resistance and altered brain glucose are related to memory impairments in schizophrenia.
    Schizophr Res. 2019 Feb 11. pii: S0920-9964(19)30034.
    PubMed     Abstract available


  784. VAN PATTEN R, Lee EE, Daly R, Twamley E, et al
    Assessment of 3-dimensional wisdom in schizophrenia: Associations with neuropsychological functions and physical and mental health.
    Schizophr Res. 2019 Feb 11. pii: S0920-9964(19)30026.
    PubMed     Abstract available


  785. LOPILATO AM, Goines K, Addington J, Bearden CE, et al
    Impact of childhood adversity on corticolimbic volumes in youth at clinical high-risk for psychosis.
    Schizophr Res. 2019 Feb 7. pii: S0920-9964(19)30050.
    PubMed     Abstract available


  786. MILLER BJ, Claxton A, Du Y, Weiden PJ, et al
    Switching patients with schizophrenia from paliperidone palmitate to aripiprazole lauroxil: A 6-month, prospective, open-label study.
    Schizophr Res. 2019 Feb 7. pii: S0920-9964(19)30041.
    PubMed     Abstract available


  787. CHUNG Y, Addington J, Bearden CE, Cadenhead K, et al
    Adding a neuroanatomical biomarker to an individualized risk calculator for psychosis: A proof-of-concept study.
    Schizophr Res. 2019 Feb 7. pii: S0920-9964(19)30023.
    PubMed     Abstract available


  788. DYKXHOORN J, Hollander AC, Lewis G, Dalman C, et al
    Family networks during migration and risk of non-affective psychosis: A population-based cohort study.
    Schizophr Res. 2019 Feb 7. pii: S0920-9964(19)30047.
    PubMed     Abstract available


  789. SOLLYCHIN M, Jack BN, Polari A, Ando A, et al
    Frontal slow wave resting EEG power is higher in individuals at Ultra High Risk for psychosis than in healthy controls but is not associated with negative symptoms or functioning.
    Schizophr Res. 2019 Feb 6. pii: S0920-9964(19)30042.
    PubMed     Abstract available


  790. JOSHI YB, Thomas ML, Hochberger WC, Bismark AW, et al
    Verbal learning deficits associated with increased anticholinergic burden are attenuated with targeted cognitive training in treatment refractory schizophrenia patients.
    Schizophr Res. 2019 Feb 6. pii: S0920-9964(19)30025.
    PubMed     Abstract available


  791. FRIEDMAN-YAKOOBIAN M, Parrish EM, Thomas A, Lesser R, et al
    An integrated neurocognitive and social-cognitive treatment for youth at clinical high risk for psychosis: Cognition for Learning and for Understanding Everyday Social Situations (CLUES).
    Schizophr Res. 2019 Feb 4. pii: S0920-9964(19)30033.
    PubMed     Abstract available


  792. SANTILLO AF, Lundgren S, Xu C, Orhan F, et al
    Neurogranin as a potential synaptic marker in the cerebrospinal fluid of patients with a first episode psychosis.
    Schizophr Res. 2019 Feb 4. pii: S0920-9964(19)30010.
    PubMed    


  793. BIAGIANTI B, Fisher M, Brandrett B, Schlosser D, et al
    Development and testing of a web-based battery to remotely assess cognitive health in individuals with schizophrenia.
    Schizophr Res. 2019 Feb 4. pii: S0920-9964(19)30036.
    PubMed     Abstract available


  794. RODRIGUES R, MacDougall AG, Zou G, Lebenbaum M, et al
    Involuntary hospitalization among young people with early psychosis: A population-based study using health administrative data.
    Schizophr Res. 2019 Feb 4. pii: S0920-9964(19)30046.
    PubMed     Abstract available


  795. PALANIYAPPAN L, Das TK, Winmill L, Hough M, et al
    Progressive post-onset reorganisation of MRI-derived cortical thickness in adolescents with schizophrenia.
    Schizophr Res. 2019 Feb 2. pii: S0920-9964(19)30044.
    PubMed    


  796. SHI C, Kang L, Yao S, Ma Y, et al
    What is the optimal neuropsychological test battery for schizophrenia in China?
    Schizophr Res. 2019 Feb 1. pii: S0920-9964(19)30037.
    PubMed     Abstract available


  797. TREEN D, Savulich G, Mezquida G, Garcia-Portilla MP, et al
    Influence of secondary sources in the Brief Negative Symptom Scale.
    Schizophr Res. 2019;204:452-454.
    PubMed    


  798. LAI JK, Margolese HC
    A qualitative study of patient experience when switching from paliperidone palmitate once monthly (PP1M) to paliperidone palmitate three monthly (PP3M) long-acting injectable antipsychotic.
    Schizophr Res. 2019;204:443-444.
    PubMed    


  799. ROWLAND T, Birchwood M, Singh S, Freemantle N, et al
    Short-term outcome of first episode delusional disorder in an early intervention population.
    Schizophr Res. 2019;204:72-79.
    PubMed     Abstract available


  800. MORITZ S, Fritzsche A, Engel M, Meiseberg J, et al
    A plea for a transdiagnostic conceptualization of negative symptoms and for consistent psychiatric vocabulary.
    Schizophr Res. 2019;204:427-429.
    PubMed    


  801. BRYCE SD, Ponsford JL, Tan EJ, Rossell SL, et al
    How cognitive remediation can be utilized strategically to enhance social and independent living self-efficacy.
    Schizophr Res. 2019;204:421-422.
    PubMed    


  802. VAN DER ZALM YC, Termorshuizen F, Selten JP
    Concerns about bias in studies on clozapine and mortality.
    Schizophr Res. 2019;204:425-426.
    PubMed    


  803. DEENIK J, Tenback DE, Tak ECPM, Rutters F, et al
    Changes in physical and psychiatric health after a multidisciplinary lifestyle enhancing treatment for inpatients with severe mental illness: The MULTI study I.
    Schizophr Res. 2019;204:360-367.
    PubMed     Abstract available


  804. CASTILLEJOS MC, Martin-Perez C, Moreno-Kustner B
    Incidence of psychotic disorders and its association with methodological issues. A systematic review and meta-analyses.
    Schizophr Res. 2019;204:458-459.
    PubMed    


    January 2019
  805. YANG YS, Davis MC, Wynn JK, Hellemann G, et al
    N-acetylcysteine improves EEG measures of auditory deviance detection and neural synchronization in schizophrenia: A randomized, controlled pilot study.
    Schizophr Res. 2019 Jan 31. pii: S0920-9964(19)30039.
    PubMed    


  806. BRADLEY ER, van Nieuwenhuizen A, Abram S, Niles AN, et al
    Oxytocin does not improve working memory in schizophrenia.
    Schizophr Res. 2019 Jan 31. pii: S0920-9964(19)30017.
    PubMed    


  807. XU P, Klaasen NG, Opmeer EM, Pijnenborg GHM, et al
    Intrinsic mesocorticolimbic connectivity is negatively associated with social amotivation in people with schizophrenia.
    Schizophr Res. 2019 Jan 31. pii: S0920-9964(19)30031.
    PubMed     Abstract available


  808. HANLON FM, Yeo RA, Shaff NA, Wertz CJ, et al
    A symptom-based continuum of psychosis explains cognitive and real-world functional deficits better than traditional diagnoses.
    Schizophr Res. 2019 Jan 30. pii: S0920-9964(19)30027.
    PubMed     Abstract available


  809. GOMES FV, Zhu X, Grace AA
    Stress during critical periods of development and risk for schizophrenia.
    Schizophr Res. 2019 Jan 30. pii: S0920-9964(19)30020.
    PubMed     Abstract available


  810. GOFF DC, Freudenreich O, Cather C, Holt D, et al
    Citalopram in first episode schizophrenia: The DECIFER trial.
    Schizophr Res. 2019 Jan 29. pii: S0920-9964(19)30018.
    PubMed     Abstract available


  811. LI X, Wu K, Zhang Y, Kong L, et al
    Altered topological characteristics of morphological brain network relate to language impairment in high genetic risk subjects and schizophrenia patients.
    Schizophr Res. 2019 Jan 28. pii: S0920-9964(19)30028.
    PubMed     Abstract available


  812. LARSEN EM, Herrera S, Bilgrami ZR, Shaik RB, et al
    Self-stigma related feelings of shame and facial fear recognition in individuals at clinical high risk for psychosis: A brief report.
    Schizophr Res. 2019 Jan 28. pii: S0920-9964(19)30019.
    PubMed    


  813. CAO H, Chung Y, McEwen SC, Bearden CE, et al
    Progressive reconfiguration of resting-state brain networks as psychosis develops: Preliminary results from the North American Prodrome Longitudinal Study (NAPLS) consortium.
    Schizophr Res. 2019 Jan 28. pii: S0920-9964(19)30024.
    PubMed     Abstract available


  814. WAGNER E, Wobrock T, Kunze B, Langguth B, et al
    Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine.
    Schizophr Res. 2019 Jan 28. pii: S0920-9964(19)30029.
    PubMed     Abstract available


  815. FUENTES-CLARAMONTE P, Soler J, Hinzen W, Ramiro-Sousa N, et al
    The interfering effects of frequent auditory verbal hallucinations on shadowing performance in schizophrenia.
    Schizophr Res. 2019 Jan 27. pii: S0920-9964(19)30032.
    PubMed    


  816. SHAH P, Iwata Y, Caravaggio F, Plitman E, et al
    Alterations in body mass index and waist-to-hip ratio in never and minimally treated patients with psychosis: A systematic review and meta-analysis.
    Schizophr Res. 2019 Jan 23. pii: S0920-9964(19)30005.
    PubMed     Abstract available


  817. TANG Y, Zhou Q, Chang M, Chekroud A, et al
    Altered functional connectivity and low-frequency signal fluctuations in early psychosis and genetic high risk.
    Schizophr Res. 2019 Jan 23. pii: S0920-9964(18)30737.
    PubMed     Abstract available


  818. CIHAKOVA D, Eaton WW, Talor MV, Harkus UH, et al
    Gut permeability and mimicry of the Glutamate Ionotropic Receptor NMDA type Subunit Associated with protein 1 (GRINA) as potential mechanisms related to a subgroup of people with schizophrenia with elevated antigliadin antibodies (AGA IgG).
    Schizophr Res. 2019 Jan 23. pii: S0920-9964(19)30007.
    PubMed     Abstract available


  819. GRABER K, Bosquet Enlow M, Duffy FH, D'Angelo E, et al
    P300 amplitude attenuation in high risk and early onset psychosis youth.
    Schizophr Res. 2019 Jan 23. pii: S0920-9964(18)30725.
    PubMed     Abstract available


  820. LEPOCK JR, Ahmed S, Mizrahi R, Gerritsen CJ, et al
    Relationships between cognitive event-related brain potential measures in patients at clinical high risk for psychosis.
    Schizophr Res. 2019 Jan 22. pii: S0920-9964(19)30014.
    PubMed     Abstract available


  821. FLUCKIGER R, Michel C, Grant P, Ruhrmann S, et al
    The interrelationship between schizotypy, clinical high risk for psychosis and related symptoms: Cognitive disturbances matter.
    Schizophr Res. 2019 Jan 22. pii: S0920-9964(18)30734.
    PubMed     Abstract available


  822. MEDALIA A, Saperstein AM, Qian M, Javitt DC, et al
    Impact of baseline early auditory processing on response to cognitive remediation for schizophrenia.
    Schizophr Res. 2019 Jan 18. pii: S0920-9964(19)30012.
    PubMed     Abstract available


  823. MORITA K, Miura K, Fujimoto M, Yamamori H, et al
    Eye movement abnormalities and their association with cognitive impairments in schizophrenia.
    Schizophr Res. 2019 Jan 17. pii: S0920-9964(18)30769.
    PubMed     Abstract available


  824. AAS M, Pizzagalli DA, Laskemoen JF, Reponen EJ, et al
    Elevated hair cortisol is associated with childhood maltreatment and cognitive impairment in schizophrenia and in bipolar disorders.
    Schizophr Res. 2019 Jan 16. pii: S0920-9964(19)30011.
    PubMed     Abstract available


  825. TREICHLER EBH, Thomas ML, Bismark AW, Hochberger WC, et al
    Divergence of subjective and performance-based cognitive gains following cognitive training in schizophrenia.
    Schizophr Res. 2019 Jan 16. pii: S0920-9964(18)30730.
    PubMed     Abstract available


  826. LIZANO P, Prasad KM, Keshavan MS
    Do Complement factors "connect the dots" in schizophrenia?
    Schizophr Res. 2019 Jan 15. pii: S0920-9964(18)30738.
    PubMed    


  827. RABINOVITZ S, Goldman K, Rosca P, Barda J, et al
    The role of substance use and adult sexual assault severity in the course of schizophrenia: An epidemiological catchment study of sexual assault victims.
    Schizophr Res. 2019 Jan 14. pii: S0920-9964(19)30008.
    PubMed     Abstract available


  828. BECK K, Andreou C, Studerus E, Heitz U, et al
    Clinical and functional long-term outcome of patients at clinical high risk (CHR) for psychosis without transition to psychosis: A systematic review.
    Schizophr Res. 2019 Jan 14. pii: S0920-9964(18)30743.
    PubMed     Abstract available


  829. BAER LH, Shah JL, Lepage M
    Anxiety in youth at clinical high risk for psychosis: A case study and conceptual model.
    Schizophr Res. 2019 Jan 14. pii: S0920-9964(19)30006.
    PubMed     Abstract available


  830. COMACCHIO C, Howard LM, Bonetto C, Lo Parrino R, et al
    The impact of gender and childhood abuse on age of psychosis onset, psychopathology and needs for care in psychosis patients.
    Schizophr Res. 2019 Jan 11. pii: S0920-9964(18)30742.
    PubMed     Abstract available


  831. TASMIM S, Bani-Fatemi A, Dada OD, Wang KZ, et al
    Recent health-related stressful life events predictive of emergent suicidal ideation in schizophrenia.
    Schizophr Res. 2019 Jan 11. pii: S0920-9964(19)30003.
    PubMed    


  832. TUCKER JD, Bertke AS
    Assessment of cognitive impairment in HSV-1 positive schizophrenia and bipolar patients: Systematic review and meta-analysis.
    Schizophr Res. 2019 Jan 11. pii: S0920-9964(19)30001.
    PubMed     Abstract available


  833. BORTOLON C, Yazbek H, Norton J, Capdevielle D, et al
    The contribution of optimism and hallucinations to grandiose delusions in individuals with schizophrenia.
    Schizophr Res. 2019 Jan 10. pii: S0920-9964(18)30733.
    PubMed     Abstract available


  834. CHANG CC, Kao YC, Chao CY, Chang HA, et al
    Enhancement of cognitive insight and higher-order neurocognitive function by fronto-temporal transcranial direct current stimulation (tDCS) in patients with schizophrenia.
    Schizophr Res. 2019 Jan 8. pii: S0920-9964(18)30770.
    PubMed     Abstract available


  835. KOREN D, Scheyer R, Stern Y, Adres M, et al
    Metacognition strengthens the association between neurocognition and attenuated psychosis syndrome: Preliminary evidence from a pilot study among treatment-seeking versus healthy adolescents.
    Schizophr Res. 2019 Jan 8. pii: S0920-9964(18)30732.
    PubMed     Abstract available


  836. INAMI R, Kirino E
    Nicotine effect on mismatch negativity in smoking and nonsmoking patients with schizophrenia.
    Schizophr Res. 2019 Jan 8. pii: S0920-9964(19)30002.
    PubMed    


  837. HUANG AS, Rogers BP, Woodward ND
    Disrupted modulation of thalamus activation and thalamocortical connectivity during dual task performance in schizophrenia.
    Schizophr Res. 2019 Jan 7. pii: S0920-9964(18)30718.
    PubMed     Abstract available


  838. KRAGULJAC NV, Morgan CJ, Reid MA, White DM, et al
    A longitudinal magnetic resonance spectroscopy study investigating effects of risperidone in the anterior cingulate cortex and hippocampus in schizophrenia.
    Schizophr Res. 2019 Jan 7. pii: S0920-9964(18)30724.
    PubMed     Abstract available


  839. JOHN J, Kukshal P, Bhatia T, Nimgaonkar VL, et al
    Rare variant based evidence for oligogenic contribution of neurodevelopmental pathway genes to schizophrenia.
    Schizophr Res. 2019 Jan 3. pii: S0920-9964(18)30741.
    PubMed    


  840. MALMQVIST A, Schwieler L, Orhan F, Fatouros-Bergman H, et al
    Increased peripheral levels of TARC/CCL17 in first episode psychosis patients.
    Schizophr Res. 2019 Jan 3. pii: S0920-9964(18)30729.
    PubMed     Abstract available


  841. ANDERSON-SCHMIDT H, Gade K, Malzahn D, Papiol S, et al
    The influence of religious activity and polygenic schizophrenia risk on religious delusions in schizophrenia.
    Schizophr Res. 2019 Jan 3. pii: S0920-9964(18)30721.
    PubMed     Abstract available


  842. KLINE ER
    Commentary: Unmet need for mental health services among people screened but not admitted to an early psychosis intervention program.
    Schizophr Res. 2019 Jan 2. pii: S0920-9964(18)30745.
    PubMed    


  843. BEST MW, Gale D, Tran T, Haque MK, et al
    Brief executive function training for individuals with severe mental illness: Effects on EEG synchronization and executive functioning.
    Schizophr Res. 2019;203:32-40.
    PubMed     Abstract available


  844. WARD T, Garety PA
    Fast and slow thinking in distressing delusions: A review of the literature and implications for targeted therapy.
    Schizophr Res. 2019;203:80-87.
    PubMed     Abstract available


  845. TWAMLEY EW, Thomas KR, Burton CZ, Vella L, et al
    Compensatory cognitive training for people with severe mental illnesses in supported employment: A randomized controlled trial.
    Schizophr Res. 2019;203:41-48.
    PubMed     Abstract available


  846. MEDALIA A, Erlich MD, Soumet-Leman C, Saperstein AM, et al
    Translating cognitive behavioral interventions from bench to bedside: The feasibility and acceptability of cognitive remediation in research as compared to clinical settings.
    Schizophr Res. 2019;203:49-54.
    PubMed     Abstract available


    December 2018
  847. PYASIK M, Capozzi F, Sigaudo M, Cardillo S, et al
    I do not know whether you did that: Abnormal implicit attribution of social causality in patients with schizophrenia.
    Schizophr Res. 2018 Dec 29. pii: S0920-9964(18)30726.
    PubMed    


  848. SAUNDERS TS, Mondelli V, Cullen AE
    Pituitary volume in individuals at elevated risk for psychosis: A systematic review and meta-analysis.
    Schizophr Res. 2018 Dec 29. pii: S0920-9964(18)30722.
    PubMed     Abstract available


  849. PALOMAKI J, Koskela J, Suvisaari J, Yolken R, et al
    Cat ownership in childhood and development of schizophrenia.
    Schizophr Res. 2018 Dec 29. pii: S0920-9964(18)30716.
    PubMed    


  850. GLENTHOJ LB, Albert N, Fagerlund B, Kristensen TD, et al
    Emotion recognition latency, but not accuracy, relates to real life functioning in individuals at ultra-high risk for psychosis.
    Schizophr Res. 2018 Dec 28. pii: S0920-9964(18)30735.
    PubMed     Abstract available


  851. LEWANDOWSKI KE
    Mapping cognitive trajectories across the course of illness in psychosis.
    Schizophr Res. 2018 Dec 27. pii: S0920-9964(18)30728.
    PubMed    


  852. JOHN J, Kukshal P, Sharma A, Bhatia T, et al
    Rare variants in Protein tyrosine phosphatase, receptor type A (PTPRA) in schizophrenia: Evidence from a family based study.
    Schizophr Res. 2018 Dec 26. pii: S0920-9964(18)30700.
    PubMed     Abstract available


  853. MOSLEM M, Olive J, Falk A
    Stem cell models of schizophrenia, what have we learned and what is the potential?
    Schizophr Res. 2018 Dec 23. pii: S0920-9964(18)30719.
    PubMed     Abstract available


  854. XIE S, Liu B, Wang J, Zhou Y, et al
    Hyperconnectivity in perisylvian language pathways in schizophrenia with auditory verbal hallucinations: A multi-site diffusion MRI study.
    Schizophr Res. 2018 Dec 23. pii: S0920-9964(18)30720.
    PubMed     Abstract available


  855. KALIUZHNA M, Stein T, Rusch T, Sekutowicz M, et al
    No evidence for abnormal priors in early vision in schizophrenia.
    Schizophr Res. 2018 Dec 23. pii: S0920-9964(18)30723.
    PubMed     Abstract available


  856. BELLAVIA A, Centorrino F, Jackson JW, Fitzmaurice G, et al
    The role of weight gain in explaining the effects of antipsychotic drugs on positive and negative symptoms: An analysis of the CATIE schizophrenia trial.
    Schizophr Res. 2018 Dec 21. pii: S0920-9964(18)30694.
    PubMed     Abstract available


  857. HANSEN MC, Jones BD, Eack SM, Glenthoj LB, et al
    Validation of the MUSIC Model of Motivation Inventory for use with cognitive training for schizophrenia spectrum disorders: A multinational study.
    Schizophr Res. 2018 Dec 20. pii: S0920-9964(18)30688.
    PubMed     Abstract available


  858. LUTHER L, Fischer MW, Firmin RL, Salyers MP, et al
    Clarifying the overlap between motivation and negative symptom measures in schizophrenia research: A meta-analysis.
    Schizophr Res. 2018 Dec 18. pii: S0920-9964(18)30612.
    PubMed     Abstract available


  859. VARCIN KJ, Nangle MR, Henry JD, Bailey PE, et al
    Intact spontaneous emotional expressivity to non-facial but not facial stimuli in schizophrenia: An electromyographic study.
    Schizophr Res. 2018 Dec 18. pii: S0920-9964(18)30707.
    PubMed     Abstract available


  860. CLAMOR A, Sundag J, Lincoln TM
    Specificity of resting-state heart rate variability in psychosis: A comparison with clinical high risk, anxiety, and healthy controls.
    Schizophr Res. 2018 Dec 17. pii: S0920-9964(18)30697.
    PubMed     Abstract available


  861. KARAGEORGIOU V, Milas GP, Michopoulos I
    Neutrophil-to-lymphocyte ratio in schizophrenia: A systematic review and meta-analysis.
    Schizophr Res. 2018 Dec 17. pii: S0920-9964(18)30703.
    PubMed     Abstract available


  862. ZHENG W, Zhu XM, Zhang QE, Yang XH, et al
    Adjunctive intranasal oxytocin for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Schizophr Res. 2018 Dec 17. pii: S0920-9964(18)30695.
    PubMed     Abstract available


  863. TOVAR A, Fuentes-Claramonte P, Soler-Vidal J, Ramiro-Sousa N, et al
    The linguistic signature of hallucinated voice talk in schizophrenia.
    Schizophr Res. 2018 Dec 17. pii: S0920-9964(18)30689.
    PubMed     Abstract available


  864. REKHI G, Ang MS, Yuen CKY, Ng WY, et al
    Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore.
    Schizophr Res. 2018 Dec 14. pii: S0920-9964(18)30681.
    PubMed     Abstract available


  865. NORDGAARD J, Buch Pedersen M, Hastrup LH, Haahr UH, et al
    Assessing psychosis in the general population: Self-rated versus clinician-rated.
    Schizophr Res. 2018 Dec 14. pii: S0920-9964(18)30702.
    PubMed    


  866. PINHEIRO AP, Niznikiewicz M
    Altered attentional processing of happy prosody in schizophrenia.
    Schizophr Res. 2018 Dec 13. pii: S0920-9964(18)30675.
    PubMed     Abstract available


  867. DONDE C, Silipo G, Dias EC, Javitt DC, et al
    Hierarchical deficits in auditory information processing in schizophrenia.
    Schizophr Res. 2018 Dec 12. pii: S0920-9964(18)30692.
    PubMed     Abstract available


  868. ACHTYES ED, Ben-Zeev D, Luo Z, Mayle H, et al
    Off-hours use of a smartphone intervention to extend support for individuals with schizophrenia spectrum disorders recently discharged from a psychiatric hospital.
    Schizophr Res. 2018 Dec 11. pii: S0920-9964(18)30677.
    PubMed     Abstract available


  869. YAN C, Lui SSY, Zou LQ, Wang CY, et al
    Anticipatory pleasure for future rewards is attenuated in patients with schizophrenia but not in individuals with schizotypal traits.
    Schizophr Res. 2018 Dec 10. pii: S0920-9964(18)30690.
    PubMed     Abstract available


  870. DENG Y, Liu K, Cheng D, Zhang J, et al
    Ventral and dorsal visual pathways exhibit abnormalities of static and dynamic connectivities, respectively, in patients with schizophrenia.
    Schizophr Res. 2018 Dec 10. pii: S0920-9964(18)30693.
    PubMed     Abstract available


  871. BANERJEE N, Polushina T, Bettella F, Steen VM, et al
    Analysis of differentially methylated regions in great apes and extinct hominids provides support for the evolutionary hypothesis of schizophrenia.
    Schizophr Res. 2018 Dec 10. pii: S0920-9964(18)30676.
    PubMed     Abstract available


  872. HOLMEN TL, Engh JA, Andersen E, Andreassen OA, et al
    Cardio-respiratory fitness is associated with a verbal factor across cognitive domains in schizophrenia.
    Schizophr Res. 2018 Dec 7. pii: S0920-9964(18)30684.
    PubMed     Abstract available


  873. GOETZ RL, Miller BJ
    Meta-analysis of ghrelin alterations in schizophrenia: Effects of olanzapine.
    Schizophr Res. 2018 Dec 7. pii: S0920-9964(18)30687.
    PubMed     Abstract available


  874. LASKARIS L, Zalesky A, Weickert CS, Di Biase MA, et al
    Investigation of peripheral complement factors across stages of psychosis.
    Schizophr Res. 2018 Dec 5. pii: S0920-9964(18)30686.
    PubMed     Abstract available


  875. MCARDLE PA, De Mel V, DeMonte V, Winckel K, et al
    An investigation into the relationship between clozapine treatment and cognitive performance in patients with treatment resistant schizophrenia.
    Schizophr Res. 2018 Dec 5. pii: S0920-9964(18)30679.
    PubMed    


  876. BRINK M, Green A, Bojesen AB, Lamberti JS, et al
    Excess medical comorbidity and mortality across the lifespan in schizophrenia.: A nationwide Danish register study.
    Schizophr Res. 2018 Dec 5. pii: S0920-9964(18)30622.
    PubMed     Abstract available


  877. TAKAHASHI T, Nakamura M, Sasabayashi D, Nishikawa Y, et al
    Reduced pineal gland volume across the stages of schizophrenia.
    Schizophr Res. 2018 Dec 4. pii: S0920-9964(18)30683.
    PubMed     Abstract available


  878. PEREZ SM, Donegan JJ, Boley AM, Aguilar DD, et al
    Ventral hippocampal overexpression of Cannabinoid Receptor Interacting Protein 1 (CNRIP1) produces a schizophrenia-like phenotype in the rat.
    Schizophr Res. 2018 Dec 3. pii: S0920-9964(18)30636.
    PubMed     Abstract available


  879. LEE EHM, Camchong J, Skouras S, Hui CLM, et al
    Differential cortical thinning of auditory cortex in first episode schizophrenia: Association with auditory verbal hallucinations.
    Schizophr Res. 2018 Dec 1. pii: S0920-9964(18)30665.
    PubMed    


  880. OLSSON AK, Hjarthag F, Helldin L
    Overestimated function in patients with schizophrenia: A possible risk factor for inadequate support?
    Schizophr Res. 2018 Dec 1. pii: S0920-9964(18)30678.
    PubMed     Abstract available


  881. SAUVE G, Kline RB, Shah JL, Joober R, et al
    Cognitive capacity similarly predicts insight into symptoms in first- and multiple-episode psychosis.
    Schizophr Res. 2018 Dec 1. pii: S0920-9964(18)30664.
    PubMed     Abstract available


  882. MORGAN VA, Clark M, Crewe J, Valuri G, et al
    Congenital blindness is protective for schizophrenia and other psychotic illness. A whole-population study.
    Schizophr Res. 2018;202:414-416.
    PubMed     Abstract available


  883. POON YPY, Kan CK, Yeung WF, Chung KF, et al
    Delayed sleep-wake phase disorder and delayed sleep-wake phase in schizophrenia: Clinical and functional correlates.
    Schizophr Res. 2018;202:412-413.
    PubMed    


  884. YUEN HP, Mackinnon A, Hartmann J, Amminger GP, et al
    Dynamic prediction of transition to psychosis using joint modelling.
    Schizophr Res. 2018;202:333-340.
    PubMed     Abstract available


  885. DETORE NR, Ventura J, Subotnik KL, Nuechterlein KH, et al
    Family burden predicts functional outcome in the early course of schizophrenia beyond psychiatric symptoms and baseline functioning.
    Schizophr Res. 2018;202:328-332.
    PubMed     Abstract available


  886. RUBIN LH, Li S, Yao L, Keedy SK, et al
    Peripheral oxytocin and vasopressin modulates regional brain activity differently in men and women with schizophrenia.
    Schizophr Res. 2018;202:173-179.
    PubMed     Abstract available


  887. WOODWARD ML, Gicas KM, Warburton DE, White RF, et al
    Hippocampal volume and vasculature before and after exercise in treatment-resistant schizophrenia.
    Schizophr Res. 2018;202:158-165.
    PubMed     Abstract available


  888. BERGER P, Bitsch F, Nagels A, Straube B, et al
    Frontal hypoactivation and alterations in the reward-system during humor processing in patients with schizophrenia spectrum disorders.
    Schizophr Res. 2018;202:149-157.
    PubMed     Abstract available


  889. SPANGARO M, Bosia M, Bechi M, Buonocore M, et al
    Neurobiology of cognitive remediation in schizophrenia: Effects of EAAT2 polymorphism.
    Schizophr Res. 2018;202:106-110.
    PubMed     Abstract available


    November 2018
  890. LUCKHOFF H, Phahladira L, Scheffler F, Asmal L, et al
    Weight gain and metabolic change as predictors of symptom improvement in first-episode schizophrenia spectrum disorder patients treated over 12months.
    Schizophr Res. 2018 Nov 29. pii: S0920-9964(18)30682.
    PubMed     Abstract available


  891. HE Y, Yuan L, Li Z, Zhou Y, et al
    Plasma protein levels of brain-derived neurotrophic factor pathways and their association with cognitive performance in patients with clinical high risk for psychosis and first episode psychosis.
    Schizophr Res. 2018 Nov 28. pii: S0920-9964(18)30667.
    PubMed    


  892. RASMUSSEN AR, Saebye D, Parnas J
    Anomalies of imagination in the schizophrenia-spectrum: Empirical findings.
    Schizophr Res. 2018 Nov 28. pii: S0920-9964(18)30669.
    PubMed    


  893. BREIER A, Buchanan RW, D'Souza D, Nuechterlein K, et al
    Herpes simplex virus 1 infection and valacyclovir treatment in schizophrenia: Results from the VISTA study.
    Schizophr Res. 2018 Nov 23. pii: S0920-9964(18)30632.
    PubMed     Abstract available


  894. POLETTI M, Gebhardt E, Iannuzzi V, Tortorella A, et al
    Social dysfunction in preclinical, at risk stages of psychosis: A developmental view.
    Schizophr Res. 2018 Nov 23. pii: S0920-9964(18)30671.
    PubMed    


  895. FERRONI F, Ardizzi M, Sestito M, Lucarini V, et al
    Shared multisensory experience affects Others' boundary: The enfacement illusion in schizophrenia.
    Schizophr Res. 2018 Nov 23. pii: S0920-9964(18)30670.
    PubMed     Abstract available


  896. FERRARELLI F, Kaskie RE, Graziano B, Reis CC, et al
    Abnormalities in the evoked frontal oscillatory activity of first-episode psychosis: A TMS/EEG study.
    Schizophr Res. 2018 Nov 22. pii: S0920-9964(18)30638.
    PubMed     Abstract available


  897. KOOLA MM
    Can Nacetylcysteine, varenicline, or the combination prevent psychosis by enhancing mismatch negativity?
    Schizophr Res. 2018 Nov 22. pii: S0920-9964(18)30673.
    PubMed    


  898. SIDDIQUI I, Saperia S, Fervaha G, Da Silva S, et al
    Goal-directed planning and action impairments in schizophrenia evaluated in a virtual environment.
    Schizophr Res. 2018 Nov 22. pii: S0920-9964(18)30614.
    PubMed     Abstract available


  899. GARIEPY G, McIlwaine SV, Schmitz N, Shah JL, et al
    An approach to sample size calculation for research on duration of untreated psychosis.
    Schizophr Res. 2018 Nov 21. pii: S0920-9964(18)30663.
    PubMed    


  900. COSTA AC, Joaquim HPG, Talib LL, Serpa MH, et al
    Plasma metabolites in first episode psychoses.
    Schizophr Res. 2018 Nov 20. pii: S0920-9964(18)30661.
    PubMed    


  901. KRAEUTER AK, van den Buuse M, Sarnyai Z
    Ketogenic diet prevents impaired prepulse inhibition of startle in an acute NMDA receptor hypofunction model of schizophrenia.
    Schizophr Res. 2018 Nov 19. pii: S0920-9964(18)30662.
    PubMed     Abstract available


  902. WEISER M, Levi L, Burshtein S, Chirita R, et al
    The effect of minocycline on symptoms in schizophrenia: Results from a randomized controlled trial.
    Schizophr Res. 2018 Nov 16. pii: S0920-9964(18)30625.
    PubMed     Abstract available


  903. LEE EHM, Hui CLM, Chan KPK, Chan PY, et al
    The role of symptoms and insight in mediating cognition and functioning in first episode psychosis.
    Schizophr Res. 2018 Nov 15. pii: S0920-9964(18)30660.
    PubMed     Abstract available


  904. LAURSEN TM, Plana-Ripoll O, Andersen PK, McGrath JJ, et al
    Cause-specific life years lost among persons diagnosed with schizophrenia: Is it getting better or worse?
    Schizophr Res. 2018 Nov 13. pii: S0920-9964(18)30633.
    PubMed     Abstract available


  905. PIJNENBORG GHM, de Vos AE, Timmerman ME, Van der Gaag M, et al
    Social cognitive group treatment for impaired insight in psychosis: A multicenter randomized controlled trial.
    Schizophr Res. 2018 Nov 12. pii: S0920-9964(18)30620.
    PubMed     Abstract available


  906. CHEN S, Tian L, Chen N, Xiu MH, et al
    More dampened monocytic Toll-like receptor 4 response to lipopolysaccharide and its association with cognitive function in Chinese Han first-episode patients with schizophrenia.
    Schizophr Res. 2018 Nov 12. pii: S0920-9964(18)30631.
    PubMed     Abstract available


  907. ERMEL JA, Moran EK, Culbreth AJ, Barch DM, et al
    Psychotic like experiences as part of a continuum of psychosis: Associations with effort-based decision-making and reward responsivity.
    Schizophr Res. 2018 Nov 12. pii: S0920-9964(18)30628.
    PubMed     Abstract available


  908. SAPERIA S, Da Silva S, Siddiqui I, Agid O, et al
    Reward-driven decision-making impairments in schizophrenia.
    Schizophr Res. 2018 Nov 12. pii: S0920-9964(18)30634.
    PubMed     Abstract available


  909. SMITH MR, Readhead B, Dudley JT, Morishita H, et al
    Critical period plasticity-related transcriptional aberrations in schizophrenia and bipolar disorder.
    Schizophr Res. 2018 Nov 12. pii: S0920-9964(18)30623.
    PubMed     Abstract available


  910. DELANEY S, Fallon B, Alaedini A, Yolken R, et al
    Inflammatory biomarkers in psychosis and clinical high risk populations.
    Schizophr Res. 2018 Nov 8. pii: S0920-9964(18)30619.
    PubMed     Abstract available


  911. SCHNEIDER M, Armando M, Schultze-Lutter F, Pontillo M, et al
    Prevalence, course and psychosis-predictive value of negative symptoms in 22q11.2 deletion syndrome.
    Schizophr Res. 2018 Nov 7. pii: S0920-9964(18)30616.
    PubMed     Abstract available


  912. HUA J, Blair NIS, Paez A, Choe A, et al
    Altered functional connectivity between sub-regions in the thalamus and cortex in schizophrenia patients measured by resting state BOLD fMRI at 7T.
    Schizophr Res. 2018 Nov 5. pii: S0920-9964(18)30618.
    PubMed     Abstract available


  913. MEHTA UM, Thanki MV, Padmanabhan J, Pascual-Leone A, et al
    Motor cortical plasticity in schizophrenia: A meta-analysis of Transcranial Magnetic Stimulation - Electromyography studies.
    Schizophr Res. 2018 Nov 5. pii: S0920-9964(18)30630.
    PubMed     Abstract available


  914. SCHIFANI C, Hafizi S, Tseng HH, Gerritsen C, et al
    Preliminary data indicating a connection between stress-induced prefrontal dopamine release and hippocampal TSPO expression in the psychosis spectrum.
    Schizophr Res. 2018 Nov 5. pii: S0920-9964(18)30610.
    PubMed     Abstract available


  915. SUMIYOSHI C, Fujino H, Yamamori H, Kudo N, et al
    Predicting work outcome in patients with schizophrenia: Influence of IQ decline.
    Schizophr Res. 2018;201:172-179.
    PubMed     Abstract available


    October 2018
  916. PHAHLADIRA L, Asmal L, Kilian S, Chiliza B, et al
    Changes in insight over the first 24months of treatment in schizophrenia spectrum disorders.
    Schizophr Res. 2018 Oct 29. pii: S0920-9964(18)30615.
    PubMed     Abstract available


  917. KASKIE RE, Gill KM, Ferrarelli F
    Reduced frontal slow wave density during sleep in first-episode psychosis.
    Schizophr Res. 2018 Oct 27. pii: S0920-9964(18)30626.
    PubMed     Abstract available


  918. KNOWLES EEM, Mathias SR, Pearlson GD, Barrett J, et al
    Clinical correlates of subsyndromal depression in African American individuals with psychosis: The relationship with positive symptoms and comorbid substance dependence.
    Schizophr Res. 2018 Oct 26. pii: S0920-9964(18)30624.
    PubMed     Abstract available


  919. YUNG AR, Nelson B, McGorry PD, Wood SJ, et al
    Persistent negative symptoms in individuals at Ultra High Risk for psychosis.
    Schizophr Res. 2018 Oct 26. pii: S0920-9964(18)30621.
    PubMed     Abstract available


  920. SORMUNEN E, Saarinen MM, Salokangas RKR, Hutri-Kahonen N, et al
    Body mass index trajectories in childhood and adolescence - Risk for non-affective psychosis.
    Schizophr Res. 2018 Oct 25. pii: S0920-9964(18)30627.
    PubMed     Abstract available


  921. CHEN T, Liu LL, Cui JF, Li Y, et al
    Implementation intention training for prospective memory in schizophrenia: A 3-month follow-up study.
    Schizophr Res. 2018 Oct 23. pii: S0920-9964(18)30617.
    PubMed     Abstract available


  922. HAN W, Zhang T, Ni T, Zhu L, et al
    Relationship of common variants in CHRNA5 with early-onset schizophrenia and executive function.
    Schizophr Res. 2018 Oct 23. pii: S0920-9964(18)30613.
    PubMed     Abstract available


  923. RICE SM, McGorry PD, Amminger GP, Nelson B, et al
    Current versus recently resolved attenuated psychotic symptoms: Same level of risk for transition to psychosis?
    Schizophr Res. 2018 Oct 18. pii: S0920-9964(18)30601.
    PubMed    


  924. BERGER M, Lavoie S, McGorry PD, Nelson B, et al
    Relationship between allostatic load and clinical outcomes in youth at ultra-high risk for psychosis in the NEURAPRO study.
    Schizophr Res. 2018 Oct 16. pii: S0920-9964(18)30604.
    PubMed     Abstract available


  925. GAO J, Tang X, Kang J, Xie C, et al
    Correlation between neurocognitive impairment and DNA methylation of MMP-9 gene in patients with deficit schizophrenia.
    Schizophr Res. 2018 Oct 15. pii: S0920-9964(18)30607.
    PubMed    


  926. WEINTRAUB MJ, Weisman de Mamani A, Villano WJ, Evans TC, et al
    Affective and physiological reactivity to emotional comments in individuals at elevated risk for psychosis.
    Schizophr Res. 2018 Oct 15. pii: S0920-9964(18)30608.
    PubMed     Abstract available


  927. PU S, Nakagome K, Satake T, Ohtachi H, et al
    Comparison of prefrontal hemodynamic responses and cognitive deficits between adult patients with autism spectrum disorder and schizophrenia.
    Schizophr Res. 2018 Oct 10. pii: S0920-9964(18)30609.
    PubMed     Abstract available


  928. MAHMOOD Z, Clark JMR, Twamley EW
    Compensatory Cognitive Training for psychosis: Effects on negative symptom subdomains.
    Schizophr Res. 2018 Oct 4. pii: S0920-9964(18)30602.
    PubMed     Abstract available


    September 2018
  929. STORCHAK H, Hudak J, Haeussinger FB, Rosenbaum D, et al
    Reducing auditory verbal hallucinations by means of fNIRS neurofeedback - A case study with a paranoid schizophrenic patient.
    Schizophr Res. 2018 Sep 27. pii: S0920-9964(18)30576.
    PubMed    


  930. ZHANG Z, Wang Y, Zhang Q, Zhao W, et al
    The effects of CACNA1C gene polymorphism on prefrontal cortex in both schizophrenia patients and healthy controls.
    Schizophr Res. 2018 Sep 27. pii: S0920-9964(18)30557.
    PubMed     Abstract available


  931. KRAUS MS, Walker TM, Jarskog LF, Millet RA, et al
    Basic auditory processing deficits and their association with auditory emotion recognition in schizophrenia.
    Schizophr Res. 2018 Sep 26. pii: S0920-9964(18)30542.
    PubMed     Abstract available


  932. NGUYEN TT, Kosciolek T, Maldonado Y, Daly RE, et al
    Differences in gut microbiome composition between persons with chronic schizophrenia and healthy comparison subjects.
    Schizophr Res. 2018 Sep 26. pii: S0920-9964(18)30572.
    PubMed     Abstract available


  933. BETZ LT, Brambilla P, Ilankovic A, Premkumar P, et al
    Deciphering reward-based decision-making in schizophrenia: A meta-analysis and behavioral modeling of the Iowa Gambling Task.
    Schizophr Res. 2018 Sep 25. pii: S0920-9964(18)30559.
    PubMed    


  934. LOCH AA, Freitas EL, Hortencio L, Chianca C, et al
    Hearing spirits? Religiosity in individuals at risk for psychosis-Results from the Brazilian SSAPP cohort.
    Schizophr Res. 2018 Sep 25. pii: S0920-9964(18)30578.
    PubMed     Abstract available


  935. CHIEN TW, Wang HY, Chang Y, Kan WC, et al
    Using Google Maps to display the pattern of coauthor collaborations on the topic of schizophrenia: A systematic review between 1937 and 2017.
    Schizophr Res. 2018 Sep 24. pii: S0920-9964(18)30573.
    PubMed     Abstract available


  936. LOPEZ-MORINIGO JD, Di Forti M, Ajnakina O, Wiffen BD, et al
    Insight and risk of suicidal behaviour in two first-episode psychosis cohorts: Effects of previous suicide attempts and depression.
    Schizophr Res. 2018 Sep 22. pii: S0920-9964(18)30574.
    PubMed     Abstract available


  937. KAMP D, Engelke C, Wobrock T, Wolwer W, et al
    Left prefrontal high-frequency rTMS may improve movement disorder in schizophrenia patients with predominant negative symptoms - A secondary analysis of a sham-controlled, randomized multicenter trial.
    Schizophr Res. 2018 Sep 21. pii: S0920-9964(18)30575.
    PubMed    


  938. CADENHEAD KS, Minichino A, Kelsven S, Addington J, et al
    Metabolic abnormalities and low dietary Omega 3 are associated with symptom severity and worse functioning prior to the onset of psychosis: Findings from the North American Prodrome Longitudinal Studies Consortium.
    Schizophr Res. 2018 Sep 21. pii: S0920-9964(18)30580.
    PubMed     Abstract available


  939. KOUIDRAT Y, Amad A
    GLP-1 agonists for metabolic disorders in schizophrenia.
    Schizophr Res. 2018 Sep 19. pii: S0920-9964(18)30577.
    PubMed    


  940. PALMIER-CLAUS JE, Shiers D, French P, Harris R, et al
    Oral health in psychosis: An unmet need.
    Schizophr Res. 2018 Sep 19. pii: S0920-9964(18)30561.
    PubMed    


  941. HALVERSON T, Jarskog LF, Pedersen C, Penn D, et al
    Effects of oxytocin on empathy, introspective accuracy, and social symptoms in schizophrenia: A 12-week twice-daily randomized controlled trial.
    Schizophr Res. 2018 Sep 19. pii: S0920-9964(18)30571.
    PubMed     Abstract available


  942. ROBINSON DG, Gallego JA, John M, Hanna LA, et al
    A potential role for adjunctive omega-3 polyunsaturated fatty acids for depression and anxiety symptoms in recent onset psychosis: Results from a 16week randomized placebo-controlled trial for participants concurrently treated with risperidone.
    Schizophr Res. 2018 Sep 18. pii: S0920-9964(18)30556.
    PubMed     Abstract available


  943. KIM S, Jo Y, Webster MJ, Lee D, et al
    Shared co-expression networks in frontal cortex of the normal aged brain and schizophrenia.
    Schizophr Res. 2018 Sep 14. pii: S0920-9964(18)30560.
    PubMed     Abstract available


  944. MOSTAID MS, Dimitrakopoulos S, Wannan C, Cropley V, et al
    An Interleukin-1 beta (IL1B) haplotype linked with psychosis transition is associated with IL1B gene expression and brain structure.
    Schizophr Res. 2018 Sep 14. pii: S0920-9964(18)30558.
    PubMed     Abstract available


  945. FUERMAIER ABM, Piersma D, Huntjens RJC, de Waard D, et al
    Simulated car driving and its association with cognitive abilities in patients with schizophrenia.
    Schizophr Res. 2018 Sep 12. pii: S0920-9964(18)30555.
    PubMed     Abstract available


  946. MATSUMOTO K, Katsura M, Tsujino N, Nishiyama S, et al
    Federated multi-site longitudinal study of at-risk mental state for psychosis in Japan.
    Schizophr Res. 2018 Sep 12. pii: S0920-9964(18)30550.
    PubMed     Abstract available


  947. THOMPSON E, Rakhshan P, Pitts SC, Demro C, et al
    Family functioning moderates the impact of psychosis-risk symptoms on social and role functioning.
    Schizophr Res. 2018 Sep 8. pii: S0920-9964(18)30548.
    PubMed     Abstract available


  948. MISIAK B, Kotowicz K, Loska O, Stramecki F, et al
    Elevated allostatic load index is associated with working memory deficits in first-episode psychosis.
    Schizophr Res. 2018 Sep 7. pii: S0920-9964(18)30552.
    PubMed    


  949. FERNANDES TMP, Silverstein SM, Butler PD, Keri S, et al
    Color vision impairments in schizophrenia and the role of antipsychotic medication type.
    Schizophr Res. 2018 Sep 7. pii: S0920-9964(18)30551.
    PubMed     Abstract available


  950. LEPOCK JR, Mizrahi R, Korostil M, Maheandiran M, et al
    N400 event-related brain potential evidence for semantic priming deficits in persons at clinical high risk for psychosis.
    Schizophr Res. 2018 Sep 4. pii: S0920-9964(18)30546.
    PubMed    


  951. MACEK TA, McCue M, Dong X, Hanson E, et al
    A phase 2, randomized, placebo-controlled study of the efficacy and safety of TAK-063 in subjects with an acute exacerbation of schizophrenia.
    Schizophr Res. 2018 Sep 3. pii: S0920-9964(18)30540.
    PubMed     Abstract available


  952. SHAKEEL MK, Lu L, Cannon TD, Cadenhead KS, et al
    Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: An outcome based analysis.
    Schizophr Res. 2018 Sep 1. pii: S0920-9964(18)30545.
    PubMed     Abstract available


  953. LI J, Loebel A, Meltzer HY
    Identifying the genetic risk factors for treatment response to lurasidone by genome-wide association study: A meta-analysis of samples from three independent clinical trials.
    Schizophr Res. 2018;199:203-213.
    PubMed     Abstract available


  954. ROSEN C, McCarthy-Jones S, Jones N, Chase KA, et al
    Negative voice-content as a full mediator of a relation between childhood adversity and distress ensuing from hearing voices.
    Schizophr Res. 2018;199:361-366.
    PubMed     Abstract available


  955. ZHOU HY, Wong KK, Shi LJ, Cui XL, et al
    Suspiciousness in young minds: Convergent evidence from non-clinical, clinical and community twin samples.
    Schizophr Res. 2018;199:135-141.
    PubMed     Abstract available


  956. KNOPH KN, Morgan RJ 3rd, Palmer BA, Schak KM, et al
    Clozapine-induced cardiomyopathy and myocarditis monitoring: A systematic review.
    Schizophr Res. 2018;199:17-30.
    PubMed     Abstract available


  957. LI KJ, Gurrera RJ, Delisi LE
    Potentially fatal outcomes associated with clozapine.
    Schizophr Res. 2018;199:386-389.
    PubMed     Abstract available


  958. LAPPIN JM, Wijaya M, Watkins A, Morell R, et al
    Cardio-metabolic risk and its management in a cohort of clozapine-treated outpatients.
    Schizophr Res. 2018;199:367-373.
    PubMed     Abstract available


  959. DUCHATEL RJ, Meehan CL, Harms LR, Michie PT, et al
    Increased complement component 4 (C4) gene expression in the cingulate cortex of rats exposed to late gestation immune activation.
    Schizophr Res. 2018;199:442-444.
    PubMed    


  960. LEUNG JG, Barreto JN, Thompson CA
    Lymphoma following clozapine exposure: More information needed.
    Schizophr Res. 2018;199:420-421.
    PubMed    


    August 2018
  961. CARRA G, Crocamo C, Angermeyer M, Brugha T, et al
    Positive and negative symptoms in schizophrenia: A longitudinal analysis using latent variable structural equation modelling.
    Schizophr Res. 2018 Aug 31. pii: S0920-9964(18)30510.
    PubMed     Abstract available


  962. MENG L, Li K, Li W, Xiao Y, et al
    Widespread white-matter microstructure integrity reduction in first-episode schizophrenia patients after acute antipsychotic treatment.
    Schizophr Res. 2018 Aug 31. pii: S0920-9964(18)30513.
    PubMed     Abstract available


  963. EARLEY W, Guo H, Daniel D, Nasrallah H, et al
    Efficacy of cariprazine on negative symptoms in patients with acute schizophrenia: A post hoc analysis of pooled data.
    Schizophr Res. 2018 Aug 29. pii: S0920-9964(18)30512.
    PubMed     Abstract available


  964. SICHLINGER L, Cibelli E, Goldrick M, Mittal VA, et al
    Clinical correlates of aberrant conversational turn-taking in youth at clinical high-risk for psychosis.
    Schizophr Res. 2018 Aug 29. pii: S0920-9964(18)30501.
    PubMed    


  965. POPOV T, Kustermann T, Popova P, Miller GA, et al
    Oscillatory brain dynamics supporting impaired Stroop task performance in schizophrenia-spectrum disorder.
    Schizophr Res. 2018 Aug 26. pii: S0920-9964(18)30538.
    PubMed     Abstract available


  966. KOSUGI N, Oshiyama C, Kodama N, Niwa SI, et al
    Incorporating music therapy into cognitive remediation to improve both cognitive dysfunction and negative symptoms in schizophrenia.
    Schizophr Res. 2018 Aug 26. pii: S0920-9964(18)30504.
    PubMed    


  967. LALLY J, Ajnakina O, Singh N, Gardner-Sood P, et al
    Vitamin D and clinical symptoms in First Episode Psychosis (FEP): A prospective cohort study.
    Schizophr Res. 2018 Aug 25. pii: S0920-9964(18)30503.
    PubMed     Abstract available


  968. KRZYSTANEK M, Borkowski M, Skalacka K, Krysta K, et al
    A telemedicine platform to improve clinical parameters in paranoid schizophrenia patients: Results of a one-year randomized study.
    Schizophr Res. 2018 Aug 25. pii: S0920-9964(18)30508.
    PubMed     Abstract available


  969. BELAND S, Makowski C, Konsztowicz S, Buchy L, et al
    Clarifying associations between cortical thickness, subcortical structures, and a comprehensive assessment of clinical insight in enduring schizophrenia.
    Schizophr Res. 2018 Aug 24. pii: S0920-9964(18)30516.
    PubMed     Abstract available


  970. KIM SY, Park MH, Jung KI
    Chronic schizophrenia with the absence of the septum pellucidum: A case report.
    Schizophr Res. 2018 Aug 24. pii: S0920-9964(18)30541.
    PubMed     Abstract available


  971. LEE EHM, Chan PY, Law EYL, Lin JJX, et al
    Efficacy of transcranial direct current stimulation (tDCS) as a treatment for persistent hallucinations in patients with schizophrenia: A systematic review and meta-analysis.
    Schizophr Res. 2018 Aug 24. pii: S0920-9964(18)30413.
    PubMed    


  972. MUESER KT, Meyer-Kalos PS, Glynn SM, Lynde DW, et al
    Implementation and fidelity assessment of the NAVIGATE treatment program for first episode psychosis in a multi-site study.
    Schizophr Res. 2018 Aug 20. pii: S0920-9964(18)30507.
    PubMed     Abstract available


  973. LEWANDOWSKI KE, McCarthy JM, Ongur D, Norris LA, et al
    Functional connectivity in distinct cognitive subtypes in psychosis.
    Schizophr Res. 2018 Aug 17. pii: S0920-9964(18)30505.
    PubMed     Abstract available


  974. TAN EJ, Rossell SL
    Language comprehension and neurocognition independently and concurrently contribute to formal thought disorder severity in schizophrenia.
    Schizophr Res. 2018 Aug 17. pii: S0920-9964(18)30511.
    PubMed     Abstract available


  975. CHAN SKW, Hui CLM, Chang WC, Lee EHM, et al
    Ten-year follow up of patients with first-episode schizophrenia spectrum disorder from an early intervention service: Predictors of clinical remission and functional recovery.
    Schizophr Res. 2018 Aug 17. pii: S0920-9964(18)30514.
    PubMed     Abstract available


  976. DEROSSE P, Gopin CB, Barber AD, Malhotra AK, et al
    Affective modulation of target detection in deficit and non-deficit schizophrenia.
    Schizophr Res. 2018 Aug 17. pii: S0920-9964(18)30515.
    PubMed     Abstract available


  977. REEVE S, Nickless A, Sheaves B, Stewart SLK, et al
    Sleep duration and psychotic experiences in patients at risk of psychosis: A secondary analysis of the EDIE-2 trial.
    Schizophr Res. 2018 Aug 16. pii: S0920-9964(18)30498.
    PubMed     Abstract available


  978. JOHANSSON V, Hultman CM, Kizling I, Martinsson L, et al
    The schizophrenia and bipolar twin study in Sweden (STAR).
    Schizophr Res. 2018 Aug 15. pii: S0920-9964(18)30496.
    PubMed     Abstract available


  979. EDWARDS J, Norman R, Kurdyak P, MacDougall AG, et al
    Unmet need for mental health services among people screened but not admitted to an early psychosis intervention program.
    Schizophr Res. 2018 Aug 15. pii: S0920-9964(18)30495.
    PubMed     Abstract available


  980. LIU J, Yao L, Zhang W, Deng W, et al
    Dissociation of fractional anisotropy and resting-state functional connectivity alterations in antipsychotic-naive first-episode schizophrenia.
    Schizophr Res. 2018 Aug 15. pii: S0920-9964(18)30497.
    PubMed     Abstract available


  981. MARTIN EA, Siegle GJ, Steinhauer SR, Condray R, et al
    Timing matters in elaborative processing of positive stimuli: Gamma band reactivity in schizophrenia compared to depression and healthy adults.
    Schizophr Res. 2018 Aug 15. pii: S0920-9964(18)30500.
    PubMed     Abstract available


  982. CLAYSON PE, Kern RS, Nuechterlein KH, Knowlton BJ, et al
    Social vs. non-social measures of learning potential for predicting community functioning across phase of illness in schizophrenia.
    Schizophr Res. 2018 Aug 15. pii: S0920-9964(18)30492.
    PubMed     Abstract available


  983. PERRY BI, Kular A, Brown L, Gajwani R, et al
    The association between treatment beliefs and engagement in care in first episode psychosis.
    Schizophr Res. 2018 Aug 9. pii: S0920-9964(18)30485.
    PubMed    


  984. CADENA EJ, White DM, Kraguljac NV, Reid MA, et al
    Cognitive control network dysconnectivity and response to antipsychotic treatment in schizophrenia.
    Schizophr Res. 2018 Aug 8. pii: S0920-9964(18)30491.
    PubMed     Abstract available


  985. PELLETIER-BALDELLI A, Orr JM, Bernard JA, Mittal VA, et al
    Social reward processing: A biomarker for predicting psychosis risk?
    Schizophr Res. 2018 Aug 7. pii: S0920-9964(18)30488.
    PubMed     Abstract available


  986. BAGEWADI VI, Mehta UM, Naik SS, Govindaraj R, et al
    Diminished modulation of motor cortical reactivity during context-based action observation in schizophrenia.
    Schizophr Res. 2018 Aug 7. pii: S0920-9964(18)30489.
    PubMed     Abstract available


  987. PRIKKEN M, Konings MJ, Lei WU, Begemann MJH, et al
    The efficacy of computerized cognitive drill and practice training for patients with a schizophrenia-spectrum disorder: A meta-analysis.
    Schizophr Res. 2018 Aug 7. pii: S0920-9964(18)30479.
    PubMed     Abstract available


  988. SCHANDRIN A, Norton J, Raffard S, Aouizerate B, et al
    A multi-dimensional approach to the relationship between insight and aggressiveness in schizophrenia: Findings from the FACE-SZ cohort.
    Schizophr Res. 2018 Aug 3. pii: S0920-9964(18)30474.
    PubMed     Abstract available


  989. VELTHORST E, Meyer EC, Giuliano AJ, Addington J, et al
    Neurocognitive profiles in the prodrome to psychosis in NAPLS-1.
    Schizophr Res. 2018 Aug 2. pii: S0920-9964(18)30482.
    PubMed     Abstract available


  990. PINKHAM AE, Klein HS, Hardaway GB, Kemp KC, et al
    Neural correlates of social cognitive introspective accuracy in schizophrenia.
    Schizophr Res. 2018 Aug 1. pii: S0920-9964(18)30416.
    PubMed     Abstract available


  991. D'ANGELO EJ, Morelli N, Lincoln SH, Graber K, et al
    Social impairment and social language deficits in children and adolescents with and at risk for psychosis.
    Schizophr Res. 2018 Aug 1. pii: S0920-9964(18)30473.
    PubMed     Abstract available


  992. QUEDNOW BB, Ejebe K, Wagner M, Giakoumaki SG, et al
    Meta-analysis on the association between genetic polymorphisms and prepulse inhibition of the acoustic startle response.
    Schizophr Res. 2018;198:52-59.
    PubMed     Abstract available


    July 2018
  993. BOSE A, Nawani H, Agarwal SM, Shivakumar V, et al
    Effect of fronto-temporal transcranial direct current stimulation on corollary discharge in schizophrenia: A randomized, double-blind, sham-controlled mediation analysis study.
    Schizophr Res. 2018 Jul 31. pii: S0920-9964(18)30486.
    PubMed    


  994. BOWTELL M, McGorry P, O'Donoghue B
    Is a higher dose of antipsychotic medication required to treat a relapse following discontinuation in first episode psychosis?
    Schizophr Res. 2018 Jul 31. pii: S0920-9964(18)30477.
    PubMed    


  995. GOZE T, Moskalewicz M, Schwartz MA, Naudin J, et al
    Is "praecox feeling" a phenomenological fossil? A preliminary study on diagnostic decision making in schizophrenia.
    Schizophr Res. 2018 Jul 30. pii: S0920-9964(18)30487.
    PubMed    


  996. THEZE R, Manuel AL, Pedrazzini E, Chantraine F, et al
    Neural correlates of reality filtering in schizophrenia spectrum disorder.
    Schizophr Res. 2018 Jul 26. pii: S0920-9964(18)30481.
    PubMed     Abstract available


  997. BROWNE J, Bass E, Mueser KT, Meyer-Kalos P, et al
    Client predictors of the therapeutic alliance in individual resiliency training for first episode psychosis.
    Schizophr Res. 2018 Jul 26. pii: S0920-9964(18)30480.
    PubMed     Abstract available


  998. CATTANE N, Mora C, Lopizzo N, Borsini A, et al
    Identification of a miRNAs signature associated with exposure to stress early in life and enhanced vulnerability for schizophrenia: New insights for the key role of miR-125b-1-3p in neurodevelopmental processes.
    Schizophr Res. 2018 Jul 26. pii: S0920-9964(18)30475.
    PubMed     Abstract available


  999. TALARICO F, Santoro M, Ota VK, Gadelha A, et al
    Implications of an admixed Brazilian population in schizophrenia polygenic risk score.
    Schizophr Res. 2018 Jul 26. pii: S0920-9964(18)30471.
    PubMed    


  1000. THOMAS ML, Bismark AW, Joshi YB, Tarasenko M, et al
    Targeted cognitive training improves auditory and verbal outcomes among treatment refractory schizophrenia patients mandated to residential care.
    Schizophr Res. 2018 Jul 25. pii: S0920-9964(18)30470.
    PubMed     Abstract available


  1001. JAUHAR S, Krishnadas R, Nour MM, Cunningham-Owens D, et al
    Is there a symptomatic distinction between the affective psychoses and schizophrenia? A machine learning approach.
    Schizophr Res. 2018 Jul 24. pii: S0920-9964(18)30414.
    PubMed     Abstract available


  1002. SPALTHOFF R, Gaser C, Nenadic I
    Altered gyrification in schizophrenia and its relation to other morphometric markers.
    Schizophr Res. 2018 Jul 24. pii: S0920-9964(18)30429.
    PubMed     Abstract available


  1003. ALVAREZ-JIMENEZ M, Gleeson JF, Bendall S, Penn DL, et al
    Enhancing social functioning in young people at Ultra High Risk (UHR) for psychosis: A pilot study of a novel strengths and mindfulness-based online social therapy.
    Schizophr Res. 2018 Jul 18. pii: S0920-9964(18)30440.
    PubMed     Abstract available


  1004. ZHOU D, Liu S, Zhou X, Berman R, et al
    7 T MRI reveals hippocampal structural abnormalities associated with memory intrusions in childhood-onset schizophrenia.
    Schizophr Res. 2018 Jul 18. pii: S0920-9964(18)30468.
    PubMed    


  1005. KRAKOWSKI MI, Czobor P
    Distinctive profiles of traits predisposing to violence in schizophrenia and in the general population.
    Schizophr Res. 2018 Jul 16. pii: S0920-9964(18)30423.
    PubMed     Abstract available


  1006. GALLEGO JA, Blanco EA, Husain-Krautter S, Madeline Fagen E, et al
    Cytokines in cerebrospinal fluid of patients with schizophrenia spectrum disorders: New data and an updated meta-analysis.
    Schizophr Res. 2018 Jul 16. pii: S0920-9964(18)30436.
    PubMed     Abstract available


  1007. NISHIDA K, Toyomaki A, Koshikawa Y, Niimura H, et al
    Social cognition and metacognition contribute to accuracy for self-evaluation of real-world functioning in patients with schizophrenia.
    Schizophr Res. 2018 Jul 13. pii: S0920-9964(18)30415.
    PubMed    


  1008. KASAP M, Rajani V, Rajani J, Dwyer DS, et al
    Surprising conservation of schizophrenia risk genes in lower organisms reflects their essential function and the evolution of genetic liability.
    Schizophr Res. 2018 Jul 12. pii: S0920-9964(18)30434.
    PubMed     Abstract available


  1009. MORITA K, Miura K, Fujimoto M, Shishido E, et al
    Abnormalities of eye movement are associated with work hours in schizophrenia.
    Schizophr Res. 2018 Jul 12. pii: S0920-9964(18)30408.
    PubMed     Abstract available


  1010. SPENCER HM, McMenamin M, Emsley R, Turkington D, et al
    Cognitive Behavioral Therapy for antipsychotic-free schizophrenia spectrum disorders: Does therapy dose influence outcome?
    Schizophr Res. 2018 Jul 12. pii: S0920-9964(18)30433.
    PubMed     Abstract available


  1011. O'DONOVAN SM, Franco-Villanueva A, Ghisays V, Caldwell JL, et al
    Sex differences in DEK expression in the anterior cingulate cortex and its association with dementia severity in schizophrenia.
    Schizophr Res. 2018 Jul 12. pii: S0920-9964(18)30425.
    PubMed     Abstract available


  1012. SVENDSEN IH, Oie MG, Moller P, Nelson B, et al
    Stability in basic self-disturbances and diagnosis in a first treated psychosis: A seven year follow-up study.
    Schizophr Res. 2018 Jul 11. pii: S0920-9964(18)30426.
    PubMed     Abstract available


  1013. TANG SX, Moberg PJ, Yi JJ, Wiemken AS, et al
    Olfactory deficits and psychosis-spectrum symptoms in 22q11.2 deletion syndrome.
    Schizophr Res. 2018 Jul 11. pii: S0920-9964(18)30427.
    PubMed     Abstract available


  1014. NIELSEN RE, Hessellund KB, Valentin JB, Licht RW, et al
    Second-generation LAI are associated to favorable outcome in a cohort of incident patients diagnosed with schizophrenia.
    Schizophr Res. 2018 Jul 10. pii: S0920-9964(18)30438.
    PubMed     Abstract available


  1015. MOSKOWITZ A
    Comment on 'Conceptual disorganization and dissociative symptoms in women with first episode psychosis' ().
    Schizophr Res. 2018 Jul 10. pii: S0920-9964(18)30435.
    PubMed    


  1016. WATSON P, Zhang JP, Rizvi A, Tamaiev J, et al
    A meta-analysis of factors associated with quality of life in first episode psychosis.
    Schizophr Res. 2018 Jul 10. pii: S0920-9964(18)30428.
    PubMed     Abstract available


  1017. KOSHIYAMA D, Fukunaga M, Okada N, Morita K, et al
    Role of frontal white matter and corpus callosum on social function in schizophrenia.
    Schizophr Res. 2018 Jul 10. pii: S0920-9964(18)30424.
    PubMed     Abstract available


  1018. HANSSEN E, Fett AK, White TP, Caddy C, et al
    Cooperation and sensitivity to social feedback during group interactions in schizophrenia.
    Schizophr Res. 2018 Jul 10. pii: S0920-9964(18)30409.
    PubMed     Abstract available


  1019. RUSSO P, Prinzi G, Proietti S, Lamonaca P, et al
    Shorter telomere length in schizophrenia: Evidence from a real-world population and meta-analysis of most recent literature.
    Schizophr Res. 2018 Jul 9. pii: S0920-9964(18)30430.
    PubMed     Abstract available


  1020. HASSON-OHAYON I, Goldzweig G, Lavi-Rotenberg A, Luther L, et al
    The centrality of cognitive symptoms and metacognition within the interacting network of symptoms, neurocognition, social cognition and metacognition in schizophrenia.
    Schizophr Res. 2018 Jul 9. pii: S0920-9964(18)30422.
    PubMed     Abstract available


  1021. EDWARDS CJ, Cella M, Emsley R, Tarrier N, et al
    Exploring the relationship between the anticipation and experience of pleasure in people with schizophrenia: An experience sampling study.
    Schizophr Res. 2018 Jul 6. pii: S0920-9964(18)30374.
    PubMed     Abstract available


  1022. JUAN-PEREZ C, Farrand S, Velakoulis D
    Schizophrenia and epilepsy as a result of maternally inherited CNTN6 copy number variant.
    Schizophr Res. 2018 Jul 5. pii: S0920-9964(18)30406.
    PubMed     Abstract available


  1023. HUBL D, Schultze-Lutter F, Hauf M, Dierks T, et al
    Striatal cerebral blood flow, executive functioning, and fronto-striatal functional connectivity in clinical high risk for psychosis.
    Schizophr Res. 2018 Jul 5. pii: S0920-9964(18)30351.
    PubMed     Abstract available


  1024. CROUSE JJ, Moustafa AA, Bogaty SER, Hickie IB, et al
    Parcellating cognitive heterogeneity in early psychosis-spectrum illnesses: A cluster analysis.
    Schizophr Res. 2018 Jul 2. pii: S0920-9964(18)30402.
    PubMed     Abstract available


  1025. JEON DW, Jung DU, Kim SJ, Shim JC, et al
    Adjunct transcranial direct current stimulation improves cognitive function in patients with schizophrenia: A double-blind 12-week study.
    Schizophr Res. 2018;197:378-385.
    PubMed     Abstract available


    June 2018
  1026. TOPAK OZ, Ozdel O, Dodurga Y, Secme M, et al
    An evaluation of the differences in DNA damage in lymphocytes and repair efficiencies in patients with schizophrenia and schizoaffective disorder.
    Schizophr Res. 2018 Jun 27. pii: S0920-9964(18)30392.
    PubMed     Abstract available


  1027. BRUINS J, Bartels-Velthuis AA, van Weeghel J, Helmus K, et al
    Letter to the editors: Reducing stigmatizing attitudes in high school adolescents - a cluster RCT on the effectiveness of a schizophrenia documentary.
    Schizophr Res. 2018 Jun 26. pii: S0920-9964(18)30395.
    PubMed    


  1028. MUSTONEN A, Niemela S, McGrath JJ, Murray GK, et al
    Adolescent inhalant use and psychosis risk - a prospective longitudinal study.
    Schizophr Res. 2018 Jun 26. pii: S0920-9964(18)30270.
    PubMed     Abstract available


  1029. LEE HS, Corbera S, Poltorak A, Park K, et al
    Measuring theory of mind in schizophrenia research: Cross-cultural validation.
    Schizophr Res. 2018 Jun 26. pii: S0920-9964(18)30355.
    PubMed     Abstract available


  1030. MEDALIA A, Beck AT, Grant PM
    Cognitive therapies for psychosis: Advances and challenges.
    Schizophr Res. 2018 Jun 26. pii: S0920-9964(18)30278.
    PubMed    


  1031. JONGENEEL A, Pot-Kolder R, Counotte J, van der Gaag M, et al
    Self-esteem moderates affective and psychotic responses to social stress in psychosis: A virtual reality study.
    Schizophr Res. 2018 Jun 26. pii: S0920-9964(18)30376.
    PubMed     Abstract available


  1032. SALGADO-PINEDA P, Radua J, Sarro S, Guerrero-Pedraza A, et al
    Sensitivity and specificity of hypoactivations and failure of de-activation in schizophrenia.
    Schizophr Res. 2018 Jun 25. pii: S0920-9964(18)30347.
    PubMed     Abstract available


  1033. CHEN SF, Chiang JH, Hsu CY, Shen YC, et al
    Schizophrenia is associated with an increased risk of sexually transmitted infections: A nationwide population-based cohort study in Taiwan.
    Schizophr Res. 2018 Jun 25. pii: S0920-9964(18)30390.
    PubMed     Abstract available


  1034. LIEMBURG EJ, Dlabac-De Lange JJ, Bais L, Knegtering H, et al
    Effects of bilateral prefrontal rTMS on brain activation during social-emotional evaluation in schizophrenia: A double-blind, randomized, exploratory study.
    Schizophr Res. 2018 Jun 25. pii: S0920-9964(18)30391.
    PubMed     Abstract available


  1035. PAPAZOVA I, Strube W, Becker B, Henning B, et al
    Improving working memory in schizophrenia: Effects of 1mA and 2mA transcranial direct current stimulation to the left DLPFC.
    Schizophr Res. 2018 Jun 25. pii: S0920-9964(18)30366.
    PubMed     Abstract available


  1036. JIRSARAIE RJ, Sheffield JM, Barch DM
    Neural correlates of global and specific cognitive deficits in schizophrenia.
    Schizophr Res. 2018 Jun 25. pii: S0920-9964(18)30350.
    PubMed     Abstract available


  1037. ARMSTRONG K, Avery S, Blackford JU, Woodward N, et al
    Impaired associative inference in the early stage of psychosis.
    Schizophr Res. 2018 Jun 25. pii: S0920-9964(18)30389.
    PubMed     Abstract available


  1038. CALDIROLI A, Buoli M, van Haren NEM, de Nijs J, et al
    The relationship of IQ and emotional processing with insula volume in schizophrenia.
    Schizophr Res. 2018 Jun 25. pii: S0920-9964(18)30388.
    PubMed     Abstract available


  1039. JUNCAL-RUIZ M, Riesco-Davila L, Ortiz-Garcia de la Foz V, Martinez-Garcia O, et al
    Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-naive first episode psychosis individuals: A 3months randomized study.
    Schizophr Res. 2018 Jun 22. pii: S0920-9964(18)30372.
    PubMed     Abstract available


  1040. NELSON CLM, Amsbaugh HM, Reilly JL, Rosen C, et al
    Beneficial and adverse effects of antipsychotic medication on cognitive flexibility are related to COMT genotype in first episode psychosis.
    Schizophr Res. 2018 Jun 22. pii: S0920-9964(18)30363.
    PubMed     Abstract available


  1041. ROUX P, Urbach M, Fonteneau S, Berna F, et al
    Psychiatric disability as mediator of the neurocognition-functioning link in schizophrenia spectrum disorders: SEM analysis using the Evaluation of Cognitive Processes involved in Disability in Schizophrenia (ECPDS) scale.
    Schizophr Res. 2018 Jun 22. pii: S0920-9964(18)30354.
    PubMed     Abstract available


  1042. KANAHARA N, Hirabayashi M, Mamada T, Nishimoto M, et al
    Combination therapy of electroconvulsive therapy and aripiprazole for dopamine supersensitivity psychosis.
    Schizophr Res. 2018 Jun 21. pii: S0920-9964(18)30373.
    PubMed    


  1043. WATTERS AJ, Rupert PE, Wolf DH, Calkins ME, et al
    Social aversive conditioning in youth at clinical high risk for psychosis and with psychosis: An ERP study.
    Schizophr Res. 2018 Jun 21. pii: S0920-9964(18)30360.
    PubMed     Abstract available


  1044. NUNES MV, Adelino MPM, Ajub E, Quarantini LC, et al
    Efficacy of esketamine in the treatment of negative symptoms in schizophrenia - A case series.
    Schizophr Res. 2018 Jun 21. pii: S0920-9964(18)30367.
    PubMed    


  1045. PRUESSNER M, King S, Vracotas N, Abadi S, et al
    Gender differences in childhood trauma in first episode psychosis: Association with symptom severity over two years.
    Schizophr Res. 2018 Jun 21. pii: S0920-9964(18)30381.
    PubMed     Abstract available


  1046. WINKELBEINER S, Cavelti M, Federspiel A, Kunzelmann K, et al
    Decreased blood flow in the right insula and middle temporal gyrus predicts negative formal thought disorder in schizophrenia.
    Schizophr Res. 2018 Jun 20. pii: S0920-9964(18)30342.
    PubMed    


  1047. PREDA A, Nguyen DD, Bustillo JR, Belger A, et al
    A positive take on schizophrenia negative symptom scales: Converting scores between the SANS, NSA and SDS.
    Schizophr Res. 2018 Jun 20. pii: S0920-9964(18)30346.
    PubMed     Abstract available


  1048. LOUREIRO CM, Shuhama R, Fachim HA, Menezes PR, et al
    Low plasma concentrations of N-methyl-d-aspartate receptor subunits as a possible biomarker for psychosis.
    Schizophr Res. 2018 Jun 20. pii: S0920-9964(18)30371.
    PubMed     Abstract available


  1049. ZAHEER J, Jacob B, de Oliveira C, Rudoler D, et al
    Service utilization and suicide among people with schizophrenia spectrum disorders.
    Schizophr Res. 2018 Jun 20. pii: S0920-9964(18)30358.
    PubMed     Abstract available


  1050. BRYCE SD, Lee SJ, Ponsford JL, Lawrence RJ, et al
    The impact of intrinsic motivation on session attendance and reliable cognitive improvement in cognitive remediation in schizophrenia.
    Schizophr Res. 2018 Jun 20. pii: S0920-9964(18)30361.
    PubMed     Abstract available


  1051. CHANG WC, Lee HC, Chan SI, Chiu SY, et al
    Negative symptom dimensions differentially impact on functioning in individuals at-risk for psychosis.
    Schizophr Res. 2018 Jun 20. pii: S0920-9964(18)30375.
    PubMed    


  1052. IASEVOLI F, D'Ambrosio L, Notar Francesco D, Razzino E, et al
    Clinical evaluation of functional capacity in treatment resistant schizophrenia patients: Comparison and differences with non-resistant schizophrenia patients.
    Schizophr Res. 2018 Jun 19. pii: S0920-9964(18)30364.
    PubMed     Abstract available


  1053. VARGAS T, Snyder H, Banich M, Newberry R, et al
    Altered selection during language processing in individuals at high risk for psychosis.
    Schizophr Res. 2018 Jun 19. pii: S0920-9964(18)30370.
    PubMed     Abstract available


  1054. TIIHONEN J
    Response to the editorial on antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia.
    Schizophr Res. 2018 Jun 19. pii: S0920-9964(18)30369.
    PubMed    


  1055. BANG M, Park HJ, Pae C, Park K, et al
    Aberrant cerebro-cerebellar functional connectivity and minimal self-disturbance in individuals at ultra-high risk for psychosis and with first-episode schizophrenia.
    Schizophr Res. 2018 Jun 18. pii: S0920-9964(18)30365.
    PubMed     Abstract available


  1056. XU L, Wang Y, Cui H, Tang Y, et al
    Identification and prediction of clinical high risk of psychosis in Chinese outpatients using two-stage screening.
    Schizophr Res. 2018 Jun 18. pii: S0920-9964(18)30359.
    PubMed     Abstract available


  1057. THOMAS ML, Treichler EBH, Bismark A, Shiluk AL, et al
    Computerized cognitive training is associated with improved psychosocial treatment engagement in schizophrenia.
    Schizophr Res. 2018 Jun 18. pii: S0920-9964(18)30357.
    PubMed     Abstract available


  1058. SONI S, Muthukrishnan SP, Sood M, Kaur S, et al
    Hyperactivation of left inferior parietal lobule and left temporal gyri shortens resting EEG microstate in schizophrenia.
    Schizophr Res. 2018 Jun 17. pii: S0920-9964(18)30353.
    PubMed     Abstract available


  1059. WANG LY, Chen SF, Chiang JH, Hsu CY, et al
    Autoimmune diseases are associated with an increased risk of schizophrenia: A nationwide population-based cohort study.
    Schizophr Res. 2018 Jun 17. pii: S0920-9964(18)30368.
    PubMed     Abstract available


  1060. MOHITE S, de Campos-Carli SM, Rocha NP, Sharma S, et al
    Lower circulating levels of angiotensin-converting enzyme (ACE) in patients with schizophrenia.
    Schizophr Res. 2018 Jun 17. pii: S0920-9964(18)30356.
    PubMed     Abstract available


  1061. MURRAY RM
    Is the grass greener for those at risk of psychosis?
    Schizophr Res. 2018 Jun 16. pii: S0920-9964(18)30252.
    PubMed    


  1062. DZAFIC I, Burianova H, Martin AK, Mowry B, et al
    Neural correlates of dynamic emotion perception in schizophrenia and the influence of prior expectations.
    Schizophr Res. 2018 Jun 14. pii: S0920-9964(18)30348.
    PubMed     Abstract available


  1063. LINDENMAYER JP, Khan A, McGurk SR, Kulsa MKC, et al
    Does social cognition training augment response to computer-assisted cognitive remediation for schizophrenia?
    Schizophr Res. 2018 Jun 14. pii: S0920-9964(18)30345.
    PubMed     Abstract available


  1064. LECLERC MP, Regenbogen C, Hamilton RH, Habel U, et al
    Some neuroanatomical insights to impulsive aggression in schizophrenia.
    Schizophr Res. 2018 Jun 13. pii: S0920-9964(18)30349.
    PubMed     Abstract available


  1065. NEWBERRY RE, Dean DJ, Sayyah MD, Mittal VA, et al
    What prevents youth at clinical high risk for psychosis from engaging in physical activity? An examination of the barriers to physical activity.
    Schizophr Res. 2018 Jun 13. pii: S0920-9964(18)30343.
    PubMed     Abstract available


  1066. MENNIGEN E, Miller RL, Rashid B, Fryer SL, et al
    Reduced higher-dimensional resting state fMRI dynamism in clinical high-risk individuals for schizophrenia identified by meta-state analysis.
    Schizophr Res. 2018 Jun 12. pii: S0920-9964(18)30340.
    PubMed     Abstract available


  1067. NAKAHARA S, Medland S, Turner JA, Calhoun VD, et al
    Polygenic risk score, genome-wide association, and gene set analyses of cognitive domain deficits in schizophrenia.
    Schizophr Res. 2018 Jun 12. pii: S0920-9964(18)30306.
    PubMed     Abstract available


  1068. ROCCA P, Galderisi S, Rossi A, Bertolino A, et al
    Disorganization and real-world functioning in schizophrenia: Results from the multicenter study of the Italian Network for Research on Psychoses.
    Schizophr Res. 2018 Jun 10. pii: S0920-9964(18)30314.
    PubMed     Abstract available


  1069. HARDY M, Jackson C, Byrne J
    Antipsychotic adherence and emergency department utilization among patients with schizophrenia.
    Schizophr Res. 2018 Jun 10. pii: S0920-9964(18)30339.
    PubMed     Abstract available


  1070. LEE SW, Lee A, Choi TK, Kim B, et al
    White matter abnormalities of the tapetum and their associations with duration of untreated psychosis and symptom severity in first-episode psychosis.
    Schizophr Res. 2018 Jun 9. pii: S0920-9964(18)30315.
    PubMed    


  1071. TAYLOR MJ, Yim S
    Is there rebound psychosis on withdrawal of antipsychotic medication in schizophrenia?
    Schizophr Res. 2018 Jun 8. pii: S0920-9964(18)30341.
    PubMed    


  1072. TOUSKOVA TP, Bob P, Pec O, Mishara A, et al
    Insight and cortisol responses in women with first episode psychosis.
    Schizophr Res. 2018 Jun 6. pii: S0920-9964(18)30313.
    PubMed    


  1073. PERALTA V, Cuesta MJ
    Modeling neuromotor pathology in schizophrenia: A window to brain mechanisms and clinical insight into the syndrome.
    Schizophr Res. 2018 Jun 5. pii: S0920-9964(18)30305.
    PubMed    


  1074. BIJJAL S, Ganesh S, Rawat VS, Agarwal V, et al
    Six months' course and outcome of metabolic abnormalities in a cohort of patients with schizophrenia in rural India.
    Schizophr Res. 2018 Jun 4. pii: S0920-9964(18)30273.
    PubMed    


  1075. NADALIN S, Rebic J, Ruzic K, Buretic-Tomljanovic A, et al
    The relationship between components of metabolic syndrome and disease onset in patients with schizophrenia.
    Schizophr Res. 2018 Jun 4. pii: S0920-9964(18)30298.
    PubMed    


    May 2018
  1076. ANDERSEN E, Holmen TL, Egeland J, Martinsen EW, et al
    Physical activity pattern and cardiorespiratory fitness in individuals with schizophrenia compared with a population-based sample.
    Schizophr Res. 2018 May 31. pii: S0920-9964(18)30303.
    PubMed     Abstract available


  1077. SETIEN-SUERO E, Martinez-Garcia O, de la Foz VO, Vazquez-Bourgon J, et al
    Age of onset of Cannabis use and cognitive function in first-episode non-affective psychosis patients: Outcome at three-year follow-up.
    Schizophr Res. 2018 May 31. pii: S0920-9964(18)30301.
    PubMed     Abstract available


  1078. YUAN X, Zhang P, Wang Y, Liu Y, et al
    Changes in metabolism and microbiota after 24-week risperidone treatment in drug naive, normal weight patients with first episode schizophrenia.
    Schizophr Res. 2018 May 30. pii: S0920-9964(18)30274.
    PubMed     Abstract available


  1079. MORADI H, Harvey PD, Helldin L
    Correlates of risk factors for reduced life expectancy in schizophrenia: Is it possible to develop a predictor profile?
    Schizophr Res. 2018 May 30. pii: S0920-9964(18)30300.
    PubMed     Abstract available


  1080. LEE J, Yoon YB, Wijtenburg SA, Rowland LM, et al
    Lower glutamate level in temporo-parietal junction may predict a better response to tDCS in schizophrenia.
    Schizophr Res. 2018 May 30. pii: S0920-9964(18)30297.
    PubMed    


  1081. SAHOO S, Grover S, Nehra R
    Comparison of neurocognitive domains in patients with schizophrenia with and without co-morbid obsessive compulsive disorder.
    Schizophr Res. 2018 May 29. pii: S0920-9964(18)30286.
    PubMed     Abstract available


  1082. TOLMACHEVA EA, Ognivov VV, Shevelenkova TD, Bastakov VA, et al
    The Muller-Lyer illusion in patients with schizophrenia and Parkinson's disease.
    Schizophr Res. 2018 May 28. pii: S0920-9964(18)30288.
    PubMed    


  1083. FOND G, Boyer L, Schurhoff F, Berna F, et al
    Latent toxoplasma infection in real-world schizophrenia: Results from the national FACE-SZ cohort.
    Schizophr Res. 2018 May 27. pii: S0920-9964(18)30265.
    PubMed     Abstract available


  1084. XU DR, Gong W, Gloyd S, Caine ED, et al
    Measuring adherence to antipsychotic medications for schizophrenia: Concordance and validity among a community sample in rural China.
    Schizophr Res. 2018 May 25. pii: S0920-9964(18)30271.
    PubMed     Abstract available


  1085. MOTHI SS, Sudarshan M, Tandon N, Tamminga C, et al
    Machine learning improved classification of psychoses using clinical and biological stratification: Update from the bipolar-schizophrenia network for intermediate phenotypes (B-SNIP).
    Schizophr Res. 2018 May 25. pii: S0920-9964(18)30250.
    PubMed    


  1086. RABALLO A, Monducci E, Ferrara M, Nastro PF, et al
    Developmental vulnerability to psychosis: Selective aggregation of basic self-disturbance in early onset schizophrenia.
    Schizophr Res. 2018 May 24. pii: S0920-9964(18)30269.
    PubMed     Abstract available


  1087. LEUCHT S, Chaimani A, Leucht C, Huhn M, et al
    60years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Meta-regression of predictors of placebo response.
    Schizophr Res. 2018 May 24. pii: S0920-9964(18)30266.
    PubMed     Abstract available


  1088. YANG Y, Yang ZY, Zou YM, Shi HS, et al
    Low-pleasure beliefs in patients with schizophrenia and individuals with social anhedonia.
    Schizophr Res. 2018 May 24. pii: S0920-9964(18)30275.
    PubMed     Abstract available


  1089. YANG Z, Lim K, Lam M, Keefe R, et al
    Factor structure of the positive and negative syndrome scale (PANSS) in people at ultra high risk (UHR) for psychosis.
    Schizophr Res. 2018 May 24. pii: S0920-9964(18)30281.
    PubMed     Abstract available


  1090. YANG TX, Cui XL, Wang Y, Huang J, et al
    Effect of emotional cues on prospective memory performance in patients with schizophrenia and major depressive disorder.
    Schizophr Res. 2018 May 24. pii: S0920-9964(18)30280.
    PubMed     Abstract available


  1091. LECEI A, Decoster J, De Hert M, Derom C, et al
    Evidence that the association of childhood trauma with psychosis and related psychopathology is not explained by gene-environment correlation: A monozygotic twin differences approach.
    Schizophr Res. 2018 May 21. pii: S0920-9964(18)30282.
    PubMed     Abstract available


  1092. BENSON TL, Park S
    Increased plasticity of bodily self-experience in individuals who may carry latent liability for schizophrenia.
    Schizophr Res. 2018 May 21. pii: S0920-9964(18)30261.
    PubMed     Abstract available


  1093. STUBBS B, Mueller C, Gaughran F, Lally J, et al
    Predictors of falls and fractures leading to hospitalization in people with schizophrenia spectrum disorder: A large representative cohort study.
    Schizophr Res. 2018 May 21. pii: S0920-9964(18)30267.
    PubMed     Abstract available


  1094. LIU J, Li M, Luo XJ, Su B, et al
    Systems-level analysis of risk genes reveals the modular nature of schizophrenia.
    Schizophr Res. 2018 May 19. pii: S0920-9964(18)30272.
    PubMed     Abstract available


  1095. CIUFOLINI S, Ponteduro MF, Reis-Marques T, Taylor H, et al
    Cortical thickness correlates of minor neurological signs in patients with first episode psychosis.
    Schizophr Res. 2018 May 18. pii: S0920-9964(18)30262.
    PubMed     Abstract available


  1096. LOEWY RL, Corey S, Amirfathi F, Dabit S, et al
    Childhood trauma and clinical high risk for psychosis.
    Schizophr Res. 2018 May 18. pii: S0920-9964(18)30259.
    PubMed     Abstract available


  1097. DEE EC
    Of minds and men: Suits, spirits, and psychosis.
    Schizophr Res. 2018 May 17. pii: S0920-9964(18)30264.
    PubMed    


  1098. CIUFOLINI S, Gayer-Anderson C, Fisher HL, Marques TR, et al
    Cortisol awakening response is decreased in patients with first-episode psychosis and increased in healthy controls with a history of severe childhood abuse.
    Schizophr Res. 2018 May 15. pii: S0920-9964(18)30260.
    PubMed     Abstract available


  1099. GOMEZ-PILAR J, Poza J, Gomez C, Northoff G, et al
    Altered predictive capability of the brain network EEG model in schizophrenia during cognition.
    Schizophr Res. 2018 May 12. pii: S0920-9964(18)30257.
    PubMed     Abstract available


  1100. MORGAN RJ, Singh B
    Reality testing of the efficacy of tDCS on auditory hallucinations in schizophrenia.
    Schizophr Res. 2018 May 12. pii: S0920-9964(18)30230.
    PubMed    


  1101. KONOPASKE GT, Balu DT, Presti KT, Chan G, et al
    Dysbindin-1 contributes to prefrontal cortical dendritic arbor pathology in schizophrenia.
    Schizophr Res. 2018 May 11. pii: S0920-9964(18)30256.
    PubMed     Abstract available


  1102. YANG M, Chen P, He MX, Lu M, et al
    Poor oral health in patients with schizophrenia: A systematic review and meta-analysis.
    Schizophr Res. 2018 May 11. pii: S0920-9964(18)30244.
    PubMed     Abstract available


  1103. BEBBINGTON PE
    Sexual abuse and psychosis: The security of research findings.
    Schizophr Res. 2018 May 10. pii: S0920-9964(18)30251.
    PubMed    


  1104. DAVIDSON CA, Piskulic D, Addington J, Cadenhead KS, et al
    Age-related trajectories of social cognition in youth at clinical high risk for psychosis: An exploratory study.
    Schizophr Res. 2018 May 8. pii: S0920-9964(18)30258.
    PubMed     Abstract available


  1105. ARRANZ S, Monferrer N, Jose Algora M, Cabezas A, et al
    The relationship between the level of exposure to stress factors and cannabis in recent onset psychosis.
    Schizophr Res. 2018 May 6. pii: S0920-9964(18)30255.
    PubMed     Abstract available


  1106. MEYER-KALOS PS, Ludwig KA, Gaylord S, Perkins DO, et al
    Enhancing stress reactivity and wellbeing in early schizophrenia: A pilot study of individual coping awareness therapy (I-CAT).
    Schizophr Res. 2018 May 4. pii: S0920-9964(18)30253.
    PubMed    


  1107. POLETTI M, Raballo A
    Polygenic Risk Score and the (neuro)developmental ontogenesis of the schizophrenia spectrum vulnerability phenotypes.
    Schizophr Res. 2018 May 4. pii: S0920-9964(18)30249.
    PubMed    


  1108. WANG H, Zhang B, Zeng B, Tang Y, et al
    Association between catechol-O-methyltransferase genetic variation and functional connectivity in patients with first-episode schizophrenia.
    Schizophr Res. 2018 May 3. pii: S0920-9964(18)30236.
    PubMed     Abstract available


  1109. GUERCIO GD, Thomas ME, Cisneros-Franco JM, Voss P, et al
    Improving cognitive training for schizophrenia using neuroplasticity enhancers: Lessons from decades of basic and clinical research.
    Schizophr Res. 2018 May 2. pii: S0920-9964(18)30241.
    PubMed     Abstract available


  1110. TOROUS J, Keshavan M
    Clinical Highlights in this issue.
    Schizophr Res. 2018;195:1-2.
    PubMed    


  1111. RABALLO A, Preti A
    Temporal stability of self-disorders and longitudinal unfolding of symptom dimensions: A complementary analysis.
    Schizophr Res. 2018;195:78-79.
    PubMed    


  1112. BRAND RM, McEnery C, Rossell S, Bendall S, et al
    Do trauma-focussed psychological interventions have an effect on psychotic symptoms? A systematic review and meta-analysis.
    Schizophr Res. 2018;195:13-22.
    PubMed     Abstract available


  1113. MILLER BJ, Buckley PF, McEvoy JP
    Inflammation, substance use, psychopathology, and cognition in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.
    Schizophr Res. 2018;195:275-282.
    PubMed     Abstract available


  1114. STEINERT T
    Clinicians should better invest in de-escalation than in fish-oil to prevent violence.
    Schizophr Res. 2018;195:567.
    PubMed    


  1115. SHEN A, Zhao W, Han B, Zhang Q, et al
    The contribution of the contingent negative variation (CNV) to goal maintenance.
    Schizophr Res. 2018;195:372-377.
    PubMed     Abstract available


    April 2018
  1116. LEE WH, Doucet GE, Leibu E, Frangou S, et al
    Resting-state network connectivity and metastability predict clinical symptoms in schizophrenia.
    Schizophr Res. 2018 Apr 27. pii: S0920-9964(18)30242.
    PubMed     Abstract available


  1117. BHALLA IP, Stefanovics EA, Rosenheck RA
    Mental health multimorbidity and poor quality of life in patients with schizophrenia.
    Schizophr Res. 2018 Apr 27. pii: S0920-9964(18)30248.
    PubMed     Abstract available


  1118. MUSTAFA S, Joober R, Lepage M, Iyer S, et al
    Predictors of 'all-cause discontinuation' of initial oral antipsychotic medication in first episode psychosis.
    Schizophr Res. 2018 Apr 26. pii: S0920-9964(18)30240.
    PubMed     Abstract available


  1119. MOSTAID MS, Pantelis C, Everall IP, Bousman CA, et al
    Decreased peripheral TNF alpha (TNF-alpha) mRNA expression in patients with treatment-resistant schizophrenia.
    Schizophr Res. 2018 Apr 26. pii: S0920-9964(18)30245.
    PubMed    


  1120. BARAN B, Correll D, Vuper TC, Morgan A, et al
    Spared and impaired sleep-dependent memory consolidation in schizophrenia.
    Schizophr Res. 2018 Apr 26. pii: S0920-9964(18)30231.
    PubMed     Abstract available


  1121. HASTRUP LH, Haahr UH, Nordgaard J, Simonsen E, et al
    The effect of implementation of an early detection team: A nationwide register-based study of characteristics and help-seeking behavior in first-episode schizophrenia in Denmark.
    Schizophr Res. 2018 Apr 26. pii: S0920-9964(18)30247.
    PubMed     Abstract available


  1122. GOMES FV, Edelson JR, Volk DW, Grace AA, et al
    Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia.
    Schizophr Res. 2018 Apr 26. pii: S0920-9964(18)30243.
    PubMed     Abstract available


  1123. KALMADY SV, Shivakumar V, Jose D, Ravi V, et al
    Plasma cytokines in minimally treated schizophrenia.
    Schizophr Res. 2018 Apr 26. pii: S0920-9964(18)30234.
    PubMed     Abstract available


  1124. GOLAY P, Baumann PS, Jenni R, Do KQ, et al
    Patients participating to neurobiological research in early psychosis: A selected subgroup?
    Schizophr Res. 2018 Apr 26. pii: S0920-9964(18)30246.
    PubMed     Abstract available


  1125. VOSS P, Thomas ME, Guercio GD, de Villers-Sidani E, et al
    Dysregulation of auditory neuroplasticity in schizophrenia.
    Schizophr Res. 2018 Apr 24. pii: S0920-9964(18)30238.
    PubMed     Abstract available


  1126. KHOURY R, Nasrallah HA
    Inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P): State or trait?
    Schizophr Res. 2018 Apr 24. pii: S0920-9964(18)30229.
    PubMed     Abstract available


  1127. BROSEY EA, Woodward ND
    Corrigendum to "Neuroanatomical correlates of perceptual aberrations in psychosis" [Schizophr. Res. 179 (2017) 125-131].
    Schizophr Res. 2018 Apr 23. pii: S0920-9964(18)30232.
    PubMed    


  1128. PANIZZUTTI R, Fisher M, Garrett C, Man WH, et al
    Association between increased serum d-serine and cognitive gains induced by intensive cognitive training in schizophrenia.
    Schizophr Res. 2018 Apr 23. pii: S0920-9964(18)30200.
    PubMed     Abstract available


  1129. WEINSTEIN Y, Levav I, Gelkopf M, Roe D, et al
    Association of maternal exposure to terror attacks during pregnancy and the risk of schizophrenia in the offspring: A population-based study.
    Schizophr Res. 2018 Apr 20. pii: S0920-9964(18)30237.
    PubMed     Abstract available


  1130. KARPINSKI P, Samochowiec J, Frydecka D, Sasiadek MM, et al
    Further evidence for depletion of peripheral blood natural killer cells in patients with schizophrenia: A computational deconvolution study.
    Schizophr Res. 2018 Apr 19. pii: S0920-9964(18)30239.
    PubMed     Abstract available


  1131. MCKETIN R, Hides L, Kavanagh DJ, Saunders JB, et al
    First psychotic episode risk markers for primary psychosis amongst people who use methamphetamine.
    Schizophr Res. 2018 Apr 18. pii: S0920-9964(18)30233.
    PubMed    


  1132. SILBERSTEIN JM, Pinkham AE, Penn DL, Harvey PD, et al
    Self-assessment of social cognitive ability in schizophrenia: Association with social cognitive test performance, informant assessments of social cognitive ability, and everyday outcomes.
    Schizophr Res. 2018 Apr 17. pii: S0920-9964(18)30227.
    PubMed     Abstract available


  1133. HAIDL T, Rosen M, Schultze-Lutter F, Nieman D, et al
    Expressed emotion as a predictor of the first psychotic episode - Results of the European prediction of psychosis study.
    Schizophr Res. 2018 Apr 13. pii: S0920-9964(18)30171.
    PubMed     Abstract available


  1134. GRANT P, Munk AJL, Hennig J
    A positive-psychological intervention reduces acute psychosis-proneness.
    Schizophr Res. 2018 Apr 13. pii: S0920-9964(18)30196.
    PubMed     Abstract available


  1135. TEASDALE SB, Firth J, Stubbs B, Burrows TL, et al
    'You are what you eat' (not what you said you ate yesterday): Why a one-off 24-hour dietary recall fails capture usual dietary intake in schizophrenia.
    Schizophr Res. 2018 Apr 13. pii: S0920-9964(18)30192.
    PubMed    


  1136. PRENDERGAST DM, Karlsgodt KH, Fales CL, Ardekani BA, et al
    Corpus callosum shape and morphology in youth across the psychosis Spectrum.
    Schizophr Res. 2018 Apr 12. pii: S0920-9964(18)30197.
    PubMed     Abstract available


  1137. DAHLE D, Noordsy D
    Factors motivating spontaneous exercise in individuals with schizophrenia-spectrum disorders.
    Schizophr Res. 2018 Apr 12. pii: S0920-9964(18)30174.
    PubMed    


  1138. SCHIJVEN D, Kofink D, Tragante V, Verkerke M, et al
    Comprehensive pathway analyses of schizophrenia risk loci point to dysfunctional postsynaptic signaling.
    Schizophr Res. 2018 Apr 11. pii: S0920-9964(18)30183.
    PubMed     Abstract available


  1139. TROTTA A, Iyegbe C, Yiend J, Dazzan P, et al
    Interaction between childhood adversity and functional polymorphisms in the dopamine pathway on first-episode psychosis.
    Schizophr Res. 2018 Apr 10. pii: S0920-9964(18)30199.
    PubMed     Abstract available


  1140. LAI C, Luciani M, Di Giorgio C, Fiorini R, et al
    Brain functional connectivity of meaning attribution in patients with psychosis: Preliminary electroencephalographic observations.
    Schizophr Res. 2018 Apr 10. pii: S0920-9964(18)30194.
    PubMed    


  1141. LAMMER E, Klingelhofer D, Bendels MHK, Ohlendorf D, et al
    Development of the global schizophrenia research under epidemiological and socio-economic influences.
    Schizophr Res. 2018 Apr 8. pii: S0920-9964(18)30191.
    PubMed    


  1142. BERNSTEIN HG, Hildebrandt J, Dobrowolny H, Steiner J, et al
    Corrigendum to "Morphometric analysis of the cerebral expression of ATP-binding cassette transporter protein ABCB1 in chronic schizophrenia: Circumscribed deficits in the habenula" [Schizophr. Res. 2016 Nov;177(1-3):52-58].
    Schizophr Res. 2018 Apr 8. pii: S0920-9964(18)30188.
    PubMed    


  1143. HUTTON P
    Should people with psychosis be supported in choosing cognitive therapy as an alternative to antipsychotic medication: A commentary on a commentary.
    Schizophr Res. 2018 Apr 6. pii: S0920-9964(18)30190.
    PubMed    


  1144. SWERDLOW NR, Bhakta SG, Light GA
    Room to move: Plasticity in early auditory information processing and auditory learning in schizophrenia revealed by acute pharmacological challenge.
    Schizophr Res. 2018 Apr 4. pii: S0920-9964(18)30189.
    PubMed     Abstract available


  1145. CHECA A, Malmqvist A, Flyckt L, Schwieler L, et al
    Cerebrospinal fluid levels of sphingolipids associate with disease severity in first episode psychosis patients.
    Schizophr Res. 2018 Apr 4. pii: S0920-9964(18)30181.
    PubMed    


  1146. RILEY G, Perrin M, Vaez-Azizi LM, Ruby E, et al
    Telomere length and early trauma in schizophrenia.
    Schizophr Res. 2018 Apr 2. pii: S0920-9964(18)30139.
    PubMed     Abstract available


  1147. KHOKHAR JY, Todd TP
    Behavioral predictors of alcohol drinking in a neurodevelopmental rat model of schizophrenia and co-occurring alcohol use disorder.
    Schizophr Res. 2018;194:91-97.
    PubMed     Abstract available


  1148. HARTZ SM, Horton AC, Hancock DB, Baker TB, et al
    Genetic correlation between smoking behaviors and schizophrenia.
    Schizophr Res. 2018;194:86-90.
    PubMed     Abstract available


  1149. RABIN RA, Kozak K, Zakzanis KK, Remington G, et al
    Effects of extended cannabis abstinence on clinical symptoms in cannabis dependent schizophrenia patients versus non-psychiatric controls.
    Schizophr Res. 2018;194:55-61.
    PubMed     Abstract available


    March 2018
  1150. SANCHEZ-GUTIERREZ T, Garcia-Portilla MP, Parellada M, Bobes J, et al
    Smoking does not impact social and non-social cognition in patients with first episode psychosis.
    Schizophr Res. 2018 Mar 29. pii: S0920-9964(18)30177.
    PubMed     Abstract available


  1151. MORRISON AP
    Should people with psychosis be supported in choosing cognitive therapy as an alternative to antipsychotic medication: A commentary on current evidence.
    Schizophr Res. 2018 Mar 29. pii: S0920-9964(18)30162.
    PubMed     Abstract available


  1152. EGLOFF L, Lenz C, Studerus E, Harrisberger F, et al
    Sexually dimorphic subcortical brain volumes in emerging psychosis.
    Schizophr Res. 2018 Mar 28. pii: S0920-9964(18)30185.
    PubMed     Abstract available


  1153. CASTRO-DE-ARAUJO LFS, Allin M, Picchioni MM, Mcdonald C, et al
    Schizophrenia moderates the relationship between white matter integrity and cognition.
    Schizophr Res. 2018 Mar 27. pii: S0920-9964(18)30186.
    PubMed     Abstract available


  1154. SUDESH R, Thalamuthu A, John S, Thara R, et al
    Replication of GWAS identified miR-137 and its target gene polymorphisms in Schizophrenia of South Indian population and meta-analysis with Psychiatric Genomics Consortium.
    Schizophr Res. 2018 Mar 26. pii: S0920-9964(18)30180.
    PubMed     Abstract available


  1155. CHOE E, Lee TY, Kim M, Hur JW, et al
    Aberrant within- and between-network connectivity of the mirror neuron system network and the mentalizing network in first episode psychosis.
    Schizophr Res. 2018 Mar 26. pii: S0920-9964(18)30175.
    PubMed     Abstract available


  1156. BREIER A, Liffick E, Hummer TA, Vohs JL, et al
    Effects of 12-month, double-blind N-acetyl cysteine on symptoms, cognition and brain morphology in early phase schizophrenia spectrum disorders.
    Schizophr Res. 2018 Mar 24. pii: S0920-9964(18)30164.
    PubMed     Abstract available


  1157. RIKANDI E, Mantyla T, Lindgren M, Kieseppa T, et al
    Connectivity of the precuneus-posterior cingulate cortex with the anterior cingulate cortex-medial prefrontal cortex differs consistently between control subjects and first-episode psychosis patients during a movie stimulus.
    Schizophr Res. 2018 Mar 24. pii: S0920-9964(18)30170.
    PubMed     Abstract available


  1158. HELLEMOSE LAA, Laursen TM, Larsen JT, Toender A, et al
    Accidental deaths among persons with schizophrenia: A nationwide population-based cohort study.
    Schizophr Res. 2018 Mar 23. pii: S0920-9964(18)30184.
    PubMed     Abstract available


  1159. ENGEMANN K, Pedersen CB, Arge L, Tsirogiannis C, et al
    Childhood exposure to green space - A novel risk-decreasing mechanism for schizophrenia?
    Schizophr Res. 2018 Mar 21. pii: S0920-9964(18)30178.
    PubMed     Abstract available


  1160. HARE SM, Law AS, Ford JM, Mathalon DH, et al
    Disrupted network cross talk, hippocampal dysfunction and hallucinations in schizophrenia.
    Schizophr Res. 2018 Mar 20. pii: S0920-9964(18)30152.
    PubMed     Abstract available


  1161. LAPPIN JM, Heslin M, Lomas B, Jones PB, et al
    Early sustained recovery following first episode psychosis: Evidence from the AESOP10 follow-up study.
    Schizophr Res. 2018 Mar 20. pii: S0920-9964(18)30166.
    PubMed     Abstract available


  1162. KUGATHASAN P, Laursen TM, Grontved S, Jensen SE, et al
    Increased long-term mortality after myocardial infarction in patients with schizophrenia.
    Schizophr Res. 2018 Mar 16. pii: S0920-9964(18)30167.
    PubMed     Abstract available


  1163. JAKOBSEN AS, Speyer H, Norgaard HCB, Karlsen M, et al
    Dietary patterns and physical activity in people with schizophrenia and increased waist circumference.
    Schizophr Res. 2018 Mar 16. pii: S0920-9964(18)30168.
    PubMed     Abstract available


  1164. GURHOLT TP, Nerhus M, Osnes K, Berg AO, et al
    Hippocampus volume reduction in psychosis spectrum could be ameliorated by vitamin D.
    Schizophr Res. 2018 Mar 16. pii: S0920-9964(18)30163.
    PubMed    


  1165. WEHRING HJ, Buchanan RW, Feldman S, Carpenter WT, et al
    Oxytocin and sexual function in males and females with schizophrenia.
    Schizophr Res. 2018 Mar 15. pii: S0920-9964(18)30165.
    PubMed    


  1166. YANG Z, Abdul Rashid NA, Quek YF, Lam M, et al
    Montreal Cognitive Assessment as a screening instrument for cognitive impairments in schizophrenia.
    Schizophr Res. 2018 Mar 14. pii: S0920-9964(18)30156.
    PubMed     Abstract available


  1167. KONSZTOWICZ S, Schmitz N, Lepage M
    Dimensions of insight in schizophrenia: Exploratory factor analysis of items from multiple self- and interviewer-rated measures of insight.
    Schizophr Res. 2018 Mar 10. pii: S0920-9964(18)30135.
    PubMed     Abstract available


  1168. O'BRIEN NL, Fiorentino A, Curtis D, Rayner C, et al
    Rare variant analysis in multiply affected families, association studies and functional analysis suggest a role for the ITGBeta4 gene in schizophrenia and bipolar disorder.
    Schizophr Res. 2018 Mar 9. pii: S0920-9964(18)30149.
    PubMed     Abstract available


  1169. REDDY LF, Reavis EA, Wynn JK, Green MF, et al
    Pupillary responses to a cognitive effort task in schizophrenia.
    Schizophr Res. 2018 Mar 8. pii: S0920-9964(18)30153.
    PubMed     Abstract available


  1170. LIU F, Zhang B, Xie L, Ruan Y, et al
    Changes in plasma levels of nitric oxide metabolites and negative symptoms after 16-week minocycline treatment in patients with schizophrenia.
    Schizophr Res. 2018 Mar 8. pii: S0920-9964(18)30151.
    PubMed     Abstract available


  1171. MENA C, Gonzalez-Valderrama A, Iruretagoyena B, Undurraga J, et al
    Early treatment resistance in a Latin-American cohort of patients with schizophrenia.
    Schizophr Res. 2018 Mar 8. pii: S0920-9964(18)30136.
    PubMed     Abstract available


  1172. BROBERG BV, Sommer IE, Benros ME, Glenthoj BY, et al
    Glucocorticoids and the risk of schizophrenia spectrum disorder in childhood and adolescence - A Danish nationwide study.
    Schizophr Res. 2018 Mar 8. pii: S0920-9964(18)30155.
    PubMed     Abstract available


  1173. HERBSLEB M, Schumann A, Malchow B, Puta C, et al
    Chronotropic incompetence of the heart is associated with exercise intolerance in patients with schizophrenia.
    Schizophr Res. 2018 Mar 8. pii: S0920-9964(18)30094.
    PubMed     Abstract available


  1174. ANDORKO ND, Millman ZB, Klingaman E, Medoff D, et al
    Association between sleep, childhood trauma and psychosis-like experiences.
    Schizophr Res. 2018 Mar 8. pii: S0920-9964(18)30132.
    PubMed     Abstract available


  1175. TAYLOR N, Hollis JP, Corcoran S, Gross R, et al
    Impaired reward responsiveness in schizophrenia.
    Schizophr Res. 2018 Mar 8. pii: S0920-9964(18)30137.
    PubMed     Abstract available


  1176. THIEN K, Bowtell M, Eaton S, Bardell-Williams M, et al
    Clozapine use in early psychosis.
    Schizophr Res. 2018 Mar 8. pii: S0920-9964(18)30134.
    PubMed     Abstract available


  1177. SCHIFFMAN J
    Considerations for the development and implementation of brief screening tools in the identification of early psychosis.
    Schizophr Res. 2018 Mar 7. pii: S0920-9964(18)30150.
    PubMed    


  1178. SWERDLOW NR, Light GA
    Sensorimotor gating deficits in schizophrenia: Advancing our understanding of the phenotype, its neural circuitry and genetic substrates.
    Schizophr Res. 2018 Mar 7. pii: S0920-9964(18)30122.
    PubMed    


  1179. JUSTO A, Risso A, Moskowitz A, Gonzalez A, et al
    Schizophrenia and dissociation: Its relation with severity, self-esteem and awareness of illness.
    Schizophr Res. 2018 Mar 7. pii: S0920-9964(18)30106.
    PubMed     Abstract available


  1180. SCHEFFLER F, Kilian S, Chiliza B, Asmal L, et al
    Effects of cannabis use on body mass, fasting glucose and lipids during the first 12months of treatment in schizophrenia spectrum disorders.
    Schizophr Res. 2018 Mar 6. pii: S0920-9964(18)30128.
    PubMed     Abstract available


  1181. MORIYAMA Y, Kotani T, Ushida T, Imai K, et al
    Altered proteomic profile in umbilical arterial serum from mothers with schizophrenia.
    Schizophr Res. 2018 Mar 3. pii: S0920-9964(18)30101.
    PubMed    


  1182. CAVELTI M, Kircher T, Nagels A, Strik W, et al
    Is formal thought disorder in schizophrenia related to structural and functional aberrations in the language network? A systematic review of neuroimaging findings.
    Schizophr Res. 2018 Mar 3. pii: S0920-9964(18)30131.
    PubMed     Abstract available


  1183. CHENG WJ, Chen CH, Chen CK, Huang MC, et al
    Similar psychotic and cognitive profile between ketamine dependence with persistent psychosis and schizophrenia.
    Schizophr Res. 2018 Mar 3. pii: S0920-9964(18)30130.
    PubMed     Abstract available


  1184. SHAN L, Liu T, Zhang Z, Liu Q, et al
    Schizophrenia-like olfactory dysfunction induced by acute and postnatal phencyclidine exposure in rats.
    Schizophr Res. 2018 Mar 3. pii: S0920-9964(18)30125.
    PubMed     Abstract available


  1185. RUND BR
    The association between schizophrenia and violence.
    Schizophr Res. 2018 Mar 2. pii: S0920-9964(18)30123.
    PubMed    


  1186. MENG XD, Cao X, Li T, Li JP, et al
    Creatine kinase (CK) and its association with aggressive behavior in patients with schizophrenia.
    Schizophr Res. 2018 Mar 2. pii: S0920-9964(18)30104.
    PubMed     Abstract available


  1187. PAIPA N, Stephan-Otto C, Cuevas-Esteban J, Nunez-Navarro A, et al
    Second-to-fourth digit length ratio is associated with negative and affective symptoms in schizophrenia patients.
    Schizophr Res. 2018 Mar 1. pii: S0920-9964(18)30113.
    PubMed     Abstract available


  1188. MALLA A, Mustafa S, Rho A, Abadi S, et al
    Corrigendum to "Therapeutic Effectiveness and Tolerability of Aripiprazole as Initial Choice of Treatment in First Episode Psychosis in an Early Intervention Service: A One-Year Outcome Study" [Schizophr. Res. 147, 120-125].
    Schizophr Res. 2018;193:490.
    PubMed    


  1189. MARTINEZ G, Alexandre C, Mam-Lam-Fook C, Bendjemaa N, et al
    Corrigendum to "Phenotype continuum between autism and schizophrenia: Evidence from the Movie for the Assessment of the social cognition (MASC)" [Schizophr. Res. 185 (2017) 161-166].
    Schizophr Res. 2018;193:489.
    PubMed    


  1190. ROTHE PH, Heres S, Leucht S
    Dose equivalents for second generation long-acting injectable antipsychotics: The minimum effective dose method.
    Schizophr Res. 2018;193:23-28.
    PubMed     Abstract available


  1191. NAGENDRA A, Schooler NR, Kane JM, Robinson DG, et al
    Demographic, psychosocial, clinical, and neurocognitive baseline characteristics of Black Americans in the RAISE-ETP study.
    Schizophr Res. 2018;193:64-68.
    PubMed     Abstract available


  1192. ANDRADE C
    Risperidone and sulpiride: Brands vs generics.
    Schizophr Res. 2018;193:486.
    PubMed    


  1193. GAO L, Feng S, Liu ZY, Wang JQ, et al
    A computational network analysis based on targets of antipsychotic agents.
    Schizophr Res. 2018;193:154-160.
    PubMed     Abstract available


  1194. NORDON C, Bovagnet T, Belger M, Jimenez J, et al
    Trial exclusion criteria and their impact on the estimation of antipsychotic drugs effect: A case study using the SOHO database.
    Schizophr Res. 2018;193:146-153.
    PubMed     Abstract available


    February 2018
  1195. BILLINGSLEY KJ, Manca M, Gianfrancesco O, Collier DA, et al
    Regulatory characterisation of the schizophrenia-associated CACNA1C proximal promoter and the potential role for the transcription factor EZH2 in schizophrenia aetiology.
    Schizophr Res. 2018 Feb 28. pii: S0920-9964(18)30111.
    PubMed     Abstract available


  1196. VOGEL BO, Stasch J, Walter H, Neuhaus AH, et al
    Emotional context restores cortical prediction error responses in schizophrenia.
    Schizophr Res. 2018 Feb 28. pii: S0920-9964(18)30107.
    PubMed     Abstract available


  1197. STORCH JAKOBSEN A, Speyer H, Norgaard HCB, Hjorthoj C, et al
    Associations between clinical and psychosocial factors and metabolic and cardiovascular risk factors in overweight patients with schizophrenia spectrum disorders - Baseline and two-years findings from the CHANGE trial.
    Schizophr Res. 2018 Feb 28. pii: S0920-9964(18)30127.
    PubMed     Abstract available


  1198. HOU Y, Liang W, Zhang J, Li Q, et al
    Schizophrenia-associated rs4702 G allele-specific downregulation of FURIN expression by miR-338-3p reduces BDNF production.
    Schizophr Res. 2018 Feb 27. pii: S0920-9964(18)30116.
    PubMed     Abstract available


  1199. FERNANDEZ VG, Asarnow R, Narr KL, Subotnik KL, et al
    Temporal lobe thickness and verbal memory in first-degree relatives of individuals with schizophrenia.
    Schizophr Res. 2018 Feb 27. pii: S0920-9964(18)30114.
    PubMed     Abstract available


  1200. GOLDSMITH DR, Haroon E, Miller AH, Strauss GP, et al
    TNF-alpha and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia.
    Schizophr Res. 2018 Feb 27. pii: S0920-9964(18)30129.
    PubMed     Abstract available


  1201. STRAUSS GP, Visser KF, Keller WR, Gold JM, et al
    Anhedonia reflects impairment in making relative value judgments between positive and neutral stimuli in schizophrenia.
    Schizophr Res. 2018 Feb 27. pii: S0920-9964(18)30090.
    PubMed     Abstract available


  1202. BALZAN RP, Dhillon VS, Liu D, Hahn L, et al
    Shorter telomere length in people with schizophrenia who live alone?
    Schizophr Res. 2018 Feb 27. pii: S0920-9964(18)30115.
    PubMed    


  1203. MOHNKE M, Bach C, Roesch-Ely D
    Proverb comprehension deficits in patients with schizophrenia-Neurocognitive and social cognitive correlates.
    Schizophr Res. 2018 Feb 27. pii: S0920-9964(18)30124.
    PubMed    


  1204. KIM P, Scott MR, Meador-Woodruff JH
    Abnormal expression of ER quality control and ER associated degradation proteins in the dorsolateral prefrontal cortex in schizophrenia.
    Schizophr Res. 2018 Feb 26. pii: S0920-9964(18)30059.
    PubMed     Abstract available


  1205. RAMSAUER B, Achtergarde S
    Mothers with acute and chronic postpartum psychoses and impact on the mother-infant interaction.
    Schizophr Res. 2018 Feb 26. pii: S0920-9964(18)30109.
    PubMed     Abstract available


  1206. JAKOBSEN MI, Fink-Jensen A
    Eosinopenia in women with schizophrenia: Drug-induced or a sign of gender specific difference in pathogenesis?
    Schizophr Res. 2018 Feb 25. pii: S0920-9964(18)30056.
    PubMed    


  1207. KOZAK K, Sharif-Razi M, Morozova M, Gaudette EV, et al
    Effects of short-term, high-frequency repetitive transcranial magnetic stimulation to bilateral dorsolateral prefrontal cortex on smoking behavior and cognition in patients with schizophrenia and non-psychiatric controls.
    Schizophr Res. 2018 Feb 24. pii: S0920-9964(18)30089.
    PubMed     Abstract available


  1208. KHAN FF, Melton PE, McCarthy NS, Morar B, et al
    Whole genome sequencing of 91 multiplex schizophrenia families reveals increased burden of rare, exonic copy number variation in schizophrenia probands and genetic heterogeneity.
    Schizophr Res. 2018 Feb 24. pii: S0920-9964(18)30095.
    PubMed     Abstract available


  1209. DU SERT OP, Potvin S, Lipp O, Dellazizzo L, et al
    Virtual reality therapy for refractory auditory verbal hallucinations in schizophrenia: A pilot clinical trial.
    Schizophr Res. 2018 Feb 24. pii: S0920-9964(18)30108.
    PubMed     Abstract available


  1210. TOMASIK J, Smits SL, Leweke FM, Eljasz P, et al
    Virus discovery analyses on post-mortem brain tissue and cerebrospinal fluid of schizophrenia patients.
    Schizophr Res. 2018 Feb 22. pii: S0920-9964(18)30088.
    PubMed    


  1211. TAVARES M, Reimao S, Chendo I, Carvalho M, et al
    Neuromelanin magnetic resonance imaging of the substantia nigra in first episode psychosis patients consumers of illicit substances.
    Schizophr Res. 2018 Feb 21. pii: S0920-9964(18)30110.
    PubMed    


  1212. ABEL KM, Elliott RE, Downey D, Strachan H, et al
    Preliminary evidence for neural responsiveness to infants in mothers with schizophrenia and the implications for healthy parenting.
    Schizophr Res. 2018 Feb 19. pii: S0920-9964(17)30731.
    PubMed     Abstract available


  1213. TOUSKOVA TP, Bob P, Pec O, Raboch J, et al
    Conceptual disorganization and dissociative symptoms in women with first episode psychosis.
    Schizophr Res. 2018 Feb 19. pii: S0920-9964(18)30086.
    PubMed    


  1214. ITAHASHI T, Mimura M, Hasegawa S, Tani M, et al
    Aberrant cerebellar-default-mode functional connectivity underlying auditory verbal hallucinations in schizophrenia revealed by multi-voxel pattern analysis of resting-state functional connectivity MRI data.
    Schizophr Res. 2018 Feb 19. pii: S0920-9964(18)30087.
    PubMed    


  1215. STRASSNIG M, Kotov R, Fochtmann L, Kalin M, et al
    Associations of independent living and labor force participation with impairment indicators in schizophrenia and bipolar disorder at 20-year follow-up.
    Schizophr Res. 2018 Feb 19. pii: S0920-9964(18)30058.
    PubMed     Abstract available


  1216. AJNAKINA O, Horsdal HT, Lally J, MacCabe JH, et al
    Validation of an algorithm-based definition of treatment resistance in patients with schizophrenia.
    Schizophr Res. 2018 Feb 19. pii: S0920-9964(18)30091.
    PubMed     Abstract available


  1217. MAGLIANO L, Marassi R
    "Schizophrenia" and "psychosis" in Italian national newspapers: Do these terms convey different messages?
    Schizophr Res. 2018 Feb 19. pii: S0920-9964(18)30098.
    PubMed    


  1218. POLARI A, Lavoie S, Yuen HP, Amminger P, et al
    Clinical trajectories in the ultra-high risk for psychosis population.
    Schizophr Res. 2018 Feb 18. pii: S0920-9964(18)30044.
    PubMed     Abstract available


  1219. KANTROWITZ JT
    N-methyl-d-aspartate-type glutamate receptor modulators and related medications for the enhancement of auditory system plasticity in schizophrenia.
    Schizophr Res. 2018 Feb 17. pii: S0920-9964(18)30051.
    PubMed     Abstract available


  1220. FUJITO R, Minese M, Hatada S, Kamimura N, et al
    Musical deficits and cortical thickness in people with schizophrenia.
    Schizophr Res. 2018 Feb 14. pii: S0920-9964(18)30049.
    PubMed     Abstract available


  1221. MELBOURNE JK, Rosen C, Feiner B, Sharma RP, et al
    C4A mRNA expression in PBMCs predicts the presence and severity of delusions in schizophrenia and bipolar disorder with psychosis.
    Schizophr Res. 2018 Feb 12. pii: S0920-9964(18)30038.
    PubMed     Abstract available


  1222. COMPTON MT, Lunden A, Cleary SD, Pauselli L, et al
    The aprosody of schizophrenia: Computationally derived acoustic phonetic underpinnings of monotone speech.
    Schizophr Res. 2018 Feb 12. pii: S0920-9964(18)30027.
    PubMed     Abstract available


  1223. MORALES-MUNOZ I, Suvisaari J, Therman S, Torniainen-Holm M, et al
    Childhood adversities and cognitive deficits in first-episode psychosis.
    Schizophr Res. 2018 Feb 7. pii: S0920-9964(18)30050.
    PubMed    


  1224. KUKLA M, Bell MD, Lysaker PH
    A randomized controlled trial examining a cognitive behavioral therapy intervention enhanced with cognitive remediation to improve work and neurocognition outcomes among persons with schizophrenia spectrum disorders.
    Schizophr Res. 2018 Feb 5. pii: S0920-9964(18)30032.
    PubMed     Abstract available


  1225. KRUG A, Dietsche B, Zollner R, Yuksel D, et al
    Polygenic risk for schizophrenia affects working memory and its neural correlates in healthy subjects.
    Schizophr Res. 2018 Feb 3. pii: S0920-9964(18)30033.
    PubMed     Abstract available


  1226. SHAHZADE C, Chun J, DeLisi LE, Manschreck TC, et al
    Patterns in adolescent cannabis use predict the onset and symptom structure of schizophrenia-spectrum disorder.
    Schizophr Res. 2018 Feb 2. pii: S0920-9964(18)30028.
    PubMed     Abstract available


  1227. PALANIYAPPAN L, Deshpande G, Lanka P, Rangaprakash D, et al
    Effective connectivity within a triple network brain system discriminates schizophrenia spectrum disorders from psychotic bipolar disorder at the single-subject level.
    Schizophr Res. 2018 Feb 2. pii: S0920-9964(18)30026.
    PubMed     Abstract available


  1228. FUKUDOME D, Hayes LN, Faust TE, Foss CA, et al
    Translocator protein (TSPO) and stress cascades in mouse models of psychosis with inflammatory disturbances.
    Schizophr Res. 2018 Feb 2. pii: S0920-9964(18)30035.
    PubMed     Abstract available


  1229. LEWANDOWSKI KE, Ongur D, Keshavan MS
    Development of novel behavioral interventions in an experimental therapeutics world: Challenges, and directions for the future.
    Schizophr Res. 2018;192:6-8.
    PubMed     Abstract available


  1230. SHADMI E, Gelkopf M, Garber-Epstein P, Baloush-Kleinman V, et al
    Routine patient reported outcomes as predictors of psychiatric rehospitalization.
    Schizophr Res. 2018;192:119-123.
    PubMed     Abstract available


  1231. EISNER E, Drake R, Lobban F, Bucci S, et al
    Comparing early signs and basic symptoms as methods for predicting psychotic relapse in clinical practice.
    Schizophr Res. 2018;192:124-130.
    PubMed     Abstract available


  1232. CLARK SR, Warren NS, Kim G, Jankowiak D, et al
    Elevated clozapine levels associated with infection: A systematic review.
    Schizophr Res. 2018;192:50-56.
    PubMed     Abstract available


  1233. LI Y, Li WX, Xie DJ, Wang Y, et al
    Grey matter reduction in the caudate nucleus in patients with persistent negative symptoms: An ALE meta-analysis.
    Schizophr Res. 2018;192:9-15.
    PubMed     Abstract available


  1234. KRIVOY A, Hochman E, Sendt KV, Hollander S, et al
    Association between serum levels of glutamate and neurotrophic factors and response to clozapine treatment.
    Schizophr Res. 2018;192:226-231.
    PubMed     Abstract available


  1235. KLINE ER, Seidman LJ, Cornblatt BA, Woodberry KA, et al
    Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort.
    Schizophr Res. 2018;192:357-363.
    PubMed     Abstract available


  1236. MALANDAIN L, Thibaut F, Grimaldi-Bensouda L, Falissard B, et al
    Correlates and predictors of antipsychotic drug polypharmacy in real-life settings: Results from a nationwide cohort study.
    Schizophr Res. 2018;192:213-218.
    PubMed     Abstract available


  1237. ROJNIC KUZMAN M, Andlauer O, Burmeister K, Dvoracek B, et al
    Effective assessment of psychotropic medication side effects using PsyLOG mobile application.
    Schizophr Res. 2018;192:211-212.
    PubMed    


  1238. AYALA L, Sauer T, Ulloa RE
    Is a guideline based treatment cost-effective for a middle income country? Results from a study with Mexican adolescents.
    Schizophr Res. 2018;192:485-486.
    PubMed    


  1239. THOMA RJ, Haghani Tehrani P, Turner JA, Houck J, et al
    Neuropsychological analysis of auditory verbal hallucinations.
    Schizophr Res. 2018;192:459-460.
    PubMed    


    January 2018
  1240. OSOEGAWA C, Gomes JS, Grigolon RB, Brietzke E, et al
    Non-invasive brain stimulation for negative symptoms in schizophrenia: An updated systematic review and meta-analysis.
    Schizophr Res. 2018 Jan 31. pii: S0920-9964(18)30031.
    PubMed     Abstract available


  1241. PAUSELLI L, Birnbaum ML, Vazquez Jaime BP, Paolini E, et al
    Demographic and socioenvironmental predictors of premorbid marijuana use among patients with first-episode psychosis.
    Schizophr Res. 2018 Jan 31. pii: S0920-9964(18)30042.
    PubMed     Abstract available


  1242. CHIO FHN, Mak WWS, Chan RCH, Tong ACY, et al
    Unraveling the insight paradox: One-year longitudinal study on the relationships between insight, self-stigma, and life satisfaction among people with schizophrenia spectrum disorders.
    Schizophr Res. 2018 Jan 30. pii: S0920-9964(18)30034.
    PubMed     Abstract available


  1243. LIN JJ, Liang FW, Li CY, Lu TH, et al
    Leading causes of death among decedents with mention of schizophrenia on the death certificates in the United States.
    Schizophr Res. 2018 Jan 30. pii: S0920-9964(18)30030.
    PubMed     Abstract available


  1244. TSAI MT, Lee SM, Chen HK, Wu BJ, et al
    Association between frailty and its individual components with the risk of falls in patients with schizophrenia spectrum disorders.
    Schizophr Res. 2018 Jan 30. pii: S0920-9964(18)30045.
    PubMed     Abstract available


  1245. KIM BH, Shin YB, Kyeong S, Lee SK, et al
    Disrupted salience processing involved in motivational deficits for real-life activities in patients with schizophrenia.
    Schizophr Res. 2018 Jan 27. pii: S0920-9964(18)30039.
    PubMed     Abstract available


  1246. CHANG WC, Chu AOK, Kwong VWY, Wong CSM, et al
    Patterns and predictors of trajectories for social and occupational functioning in patients presenting with first-episode non-affective psychosis: A three-year follow-up study.
    Schizophr Res. 2018 Jan 27. pii: S0920-9964(18)30043.
    PubMed     Abstract available


  1247. ZHU XM, Zheng W, Li XH, Cai DB, et al
    Adjunctive raloxifene for postmenopausal women with schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Schizophr Res. 2018 Jan 23. pii: S0920-9964(18)30037.
    PubMed     Abstract available


  1248. BRODEY BB, Girgis RR, Favorov OV, Addington J, et al
    The Early Psychosis Screener (EPS): Quantitative validation against the SIPS using machine learning.
    Schizophr Res. 2018 Jan 18. pii: S0920-9964(17)30728.
    PubMed     Abstract available


  1249. SHEN Y, Xu J, Li Z, Huang Y, et al
    Analysis of gut microbiota diversity and auxiliary diagnosis as a biomarker in patients with schizophrenia: A cross-sectional study.
    Schizophr Res. 2018 Jan 15. pii: S0920-9964(18)30002.
    PubMed     Abstract available


  1250. TOROUS J, Keshavan M
    A new window into psychosis: The rise digital phenotyping, smartphone assessment, and mobile monitoring.
    Schizophr Res. 2018 Jan 12. pii: S0920-9964(18)30005.
    PubMed     Abstract available


  1251. CHESTKOV IV, Jestkova EM, Ershova ES, Golimbet VE, et al
    Abundance of ribosomal RNA gene copies in the genomes of schizophrenia patients.
    Schizophr Res. 2018 Jan 11. pii: S0920-9964(18)30001.
    PubMed     Abstract available


  1252. LIMONGI R, Bohaterewicz B, Nowicka M, Plewka A, et al
    Knowing when to stop: Aberrant precision and evidence accumulation in schizophrenia.
    Schizophr Res. 2018 Jan 10. pii: S0920-9964(17)30770.
    PubMed     Abstract available


  1253. ADAMCZYK P, Wyczesany M, Domagalik A, Cepuch K, et al
    Diminished activation of the right Inferior Parietal Lobule as a neural substrate of impaired cartoon-jokes comprehension in schizophrenia outpatients.
    Schizophr Res. 2018 Jan 9. pii: S0920-9964(18)30004.
    PubMed    


  1254. ROTSTEIN A, Roe D, Gelkopf M, Shadmi E, et al
    Quality of life disparities between persons with schizophrenia and their professional caregivers: Network analysis in a National Cohort.
    Schizophr Res. 2018 Jan 8. pii: S0920-9964(17)30769.
    PubMed     Abstract available


  1255. WATSKY RE, Gotts SJ, Berman RA, McAdams HM, et al
    Attenuated resting-state functional connectivity in patients with childhood- and adult-onset schizophrenia.
    Schizophr Res. 2018 Jan 6. pii: S0920-9964(18)30003.
    PubMed     Abstract available


  1256. WEBER NS, Gressitt KL, Cowan DN, Niebuhr DW, et al
    Monocyte activation detected prior to a diagnosis of schizophrenia in the US Military New Onset Psychosis Project (MNOPP).
    Schizophr Res. 2018 Jan 5. pii: S0920-9964(17)30768.
    PubMed     Abstract available


    December 2017
  1257. LI H, Zhang T, Xu L, Tang Y, et al
    A comparison of conversion rates, clinical profiles and predictors of outcomes in two independent samples of individuals at clinical high risk for psychosis in China.
    Schizophr Res. 2017 Dec 26. pii: S0920-9964(17)30727.
    PubMed     Abstract available


  1258. RYAN AT, Addington J, Bearden CE, Cadenhead KS, et al
    Latent class cluster analysis of symptom ratings identifies distinct subgroups within the clinical high risk for psychosis syndrome.
    Schizophr Res. 2017 Dec 23. pii: S0920-9964(17)30753.
    PubMed     Abstract available


  1259. KOPCZYNSKA M, Zelek W, Touchard S, Gaughran F, et al
    Complement system biomarkers in first episode psychosis.
    Schizophr Res. 2017 Dec 23. pii: S0920-9964(17)30764.
    PubMed     Abstract available


  1260. NAKAGAMI Y, Sugihara G, Ikeda A, Murai T, et al
    Is the prevalence of anti-N-methyl-d-aspartate receptor antibodies in schizophrenia overestimated?
    Schizophr Res. 2017 Dec 21. pii: S0920-9964(17)30759.
    PubMed    


  1261. AYESA-ARRIOLA R, Setien-Suero E, Neergaard KD, Belzunces AA, et al
    Premorbid IQ subgroups in first episode non affective psychosis patients: Long-term sex differences in function and neurocognition.
    Schizophr Res. 2017 Dec 21. pii: S0920-9964(17)30758.
    PubMed     Abstract available


  1262. WALKER CK, Roche JK, Sinha V, Roberts RC, et al
    Substantia nigra ultrastructural pathology in schizophrenia.
    Schizophr Res. 2017 Dec 20. pii: S0920-9964(17)30756.
    PubMed     Abstract available


  1263. WINTERBURN JL, Voineskos AN, Devenyi GA, Plitman E, et al
    Can we accurately classify schizophrenia patients from healthy controls using magnetic resonance imaging and machine learning? A multi-method and multi-dataset study.
    Schizophr Res. 2017 Dec 20. pii: S0920-9964(17)30736.
    PubMed     Abstract available


  1264. HONNORAT N, Dong A, Meisenzahl-Lechner E, Koutsouleris N, et al
    Neuroanatomical heterogeneity of schizophrenia revealed by semi-supervised machine learning methods.
    Schizophr Res. 2017 Dec 20. pii: S0920-9964(17)30760.
    PubMed     Abstract available


  1265. TAIPALE H, Mittendorfer-Rutz E, Alexanderson K, Majak M, et al
    Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia.
    Schizophr Res. 2017 Dec 20. pii: S0920-9964(17)30762.
    PubMed     Abstract available


  1266. PENADES R, Lopez-Vilchez I, Catalan R, Arias B, et al
    BDNF as a marker of response to cognitive remediation in patients with schizophrenia: A randomized and controlled trial.
    Schizophr Res. 2017 Dec 20. pii: S0920-9964(17)30754.
    PubMed     Abstract available


  1267. DI COSMO G, Costantini M, Salone A, Martinotti G, et al
    Peripersonal space boundary in schizotypy and schizophrenia.
    Schizophr Res. 2017 Dec 18. pii: S0920-9964(17)30755.
    PubMed    


  1268. BRODEY BB, Addington J, First MB, Perkins DO, et al
    The Early Psychosis Screener (EPS): Item development and qualitative validation.
    Schizophr Res. 2017 Dec 15. pii: S0920-9964(17)30725.
    PubMed     Abstract available


  1269. EYLER LT, Jeste DV
    Aging of the body and the brain in schizophrenia.
    Schizophr Res. 2017 Dec 9. pii: S0920-9964(17)30734.
    PubMed    


  1270. HASHIMOTO N, Toyomaki A, Miyamoto T, Miyazaki A, et al
    Olanzapine, blonanserin, and aripiprazole associated with different frontostriatal reward system activation in patients with schizophrenia.
    Schizophr Res. 2017 Dec 7. pii: S0920-9964(17)30733.
    PubMed    


  1271. RIEMER M
    Delusions of control in schizophrenia: Resistant to the mind's best trick?
    Schizophr Res. 2017 Dec 2. pii: S0920-9964(17)30730.
    PubMed     Abstract available


  1272. XIAO Y, Yan Z, Zhao Y, Tao B, et al
    Support vector machine-based classification of first episode drug-naive schizophrenia patients and healthy controls using structural MRI.
    Schizophr Res. 2017 Dec 2. pii: S0920-9964(17)30735.
    PubMed     Abstract available


  1273. RAFFARD S, Bortolon C, Cohen L, Khoramshahi M, et al
    Does this robot have a mind? Schizophrenia patients' mind perception toward humanoid robots.
    Schizophr Res. 2017 Dec 1. pii: S0920-9964(17)30732.
    PubMed    


    November 2017
  1274. BADCOCK JC, Clark M, Morgan VA
    Hallucinations in Indigenous and non-Indigenous Australians: Findings from the second Australian national survey of psychosis.
    Schizophr Res. 2017 Nov 28. pii: S0920-9964(17)30723.
    PubMed    


  1275. DEMILY C, Hubert L, Franck N, Poisson A, et al
    Somatic mosaicism for SLC1A1 mutation supports threshold effect and familial aggregation in schizophrenia spectrum disorders.
    Schizophr Res. 2017 Nov 28. pii: S0920-9964(17)30726.
    PubMed    


  1276. ZHU Y, Hu X, Yang B, Wu G, et al
    Association between migrant worker experience, limitations on insurance coverage, and hospitalization for schizophrenia in Hunan Province, China.
    Schizophr Res. 2017 Nov 28. pii: S0920-9964(17)30724.
    PubMed     Abstract available


  1277. HATTORI S, Suda A, Kishida I, Miyauchi M, et al
    Associations of ABCB1 gene polymorphisms with aripiprazole-induced autonomic nervous system dysfunction in schizophrenia.
    Schizophr Res. 2017 Nov 27. pii: S0920-9964(17)30716.
    PubMed    


  1278. RODRIGUES-AMORIM D, Rivera-Baltanas T, Spuch C, Caruncho HJ, et al
    Cytokines dysregulation in schizophrenia: A systematic review of psychoneuroimmune relationship.
    Schizophr Res. 2017 Nov 24. pii: S0920-9964(17)30718.
    PubMed     Abstract available


  1279. BUENO-ANTEQUERA J, Oviedo-Caro MA, Munguia-Izquierdo D
    Relationship between objectively measured sedentary behavior and health outcomes in schizophrenia patients: The PsychiActive project.
    Schizophr Res. 2017 Nov 21. pii: S0920-9964(17)30719.
    PubMed     Abstract available


  1280. RODRIGUEZ-LOPEZ J, Amigo J, Sobrino B, Paz E, et al
    Identification of genes carrying rare variants of moderate to large effect in schizophrenia: A replication study.
    Schizophr Res. 2017 Nov 21. pii: S0920-9964(17)30717.
    PubMed    


  1281. BECK AT, Himelstein R, Grant PM
    In and out of schizophrenia: Activation and deactivation of the negative and positive schemas.
    Schizophr Res. 2017 Nov 20. pii: S0920-9964(17)30674.
    PubMed     Abstract available


  1282. CURTIS D, Emmett W
    Association study of schizophrenia with variants in miR-137 binding sites.
    Schizophr Res. 2017 Nov 17. pii: S0920-9964(17)30713.
    PubMed     Abstract available


  1283. WILLITS JA, Rubin T, Jones MN, Minor KS, et al
    Evidence of disturbances of deep levels of semantic cohesion within personal narratives in schizophrenia.
    Schizophr Res. 2017 Nov 16. pii: S0920-9964(17)30710.
    PubMed     Abstract available


  1284. DONG D, Wang Y, Jia X, Li Y, et al
    Abnormal brain activation during threatening face processing in schizophrenia: A meta-analysis of functional neuroimaging studies.
    Schizophr Res. 2017 Nov 15. pii: S0920-9964(17)30708.
    PubMed     Abstract available


  1285. GUO S, Zhao W, Tao H, Liu Z, et al
    The instability of functional connectivity in patients with schizophrenia and their siblings: A dynamic connectivity study.
    Schizophr Res. 2017 Nov 15. pii: S0920-9964(17)30597.
    PubMed     Abstract available


  1286. CRADDOCK KES, Zhou X, Liu S, Gochman P, et al
    Symptom dimensions and subgroups in childhood-onset schizophrenia.
    Schizophr Res. 2017 Nov 13. pii: S0920-9964(17)30673.
    PubMed     Abstract available


  1287. BOWTELL M, Ratheesh A, McGorry P, Killackey E, et al
    Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis. A systematic review.
    Schizophr Res. 2017 Nov 13. pii: S0920-9964(17)30687.
    PubMed     Abstract available


  1288. JUSTON OSBORNE K, Mittal VA
    Every-day coincidences and referential thinking: Differentiating normative experiences from symptoms in psychosis.
    Schizophr Res. 2017 Nov 13. pii: S0920-9964(17)30685.
    PubMed    


  1289. JALBRZIKOWSKI M, Murty VP, Stan PL, Saifullan J, et al
    Differentiating between clinical and behavioral phenotypes in first-episode psychosis during maintenance of visuospatial working memory.
    Schizophr Res. 2017 Nov 11. pii: S0920-9964(17)30689.
    PubMed     Abstract available


  1290. LAVOIE S, Jack BN, Griffiths O, Ando A, et al
    Impaired mismatch negativity to frequency deviants in individuals at ultra-high risk for psychosis, and preliminary evidence for further impairment with transition to psychosis.
    Schizophr Res. 2017 Nov 10. pii: S0920-9964(17)30677.
    PubMed     Abstract available


  1291. AVISSAR M, Javitt D
    Mismatch negativity: A simple and useful biomarker of N-methyl-d-aspartate receptor (NMDAR)-type glutamate dysfunction in schizophrenia.
    Schizophr Res. 2017 Nov 10. pii: S0920-9964(17)30683.
    PubMed    


  1292. SELTEN JP, Termorshuizen F
    "Ethnic density of neighbourhood at age 15 modifies the risk for psychosis". So what?
    Schizophr Res. 2017 Nov 10. pii: S0920-9964(17)30680.
    PubMed    


  1293. KINGDON D, Turkington D
    Cognitive therapy of psychosis: Research and implementation.
    Schizophr Res. 2017 Nov 10. pii: S0920-9964(17)30585.
    PubMed    


  1294. GJERDE PB, Dieset I, Simonsen C, Hoseth EZ, et al
    Increase in serum HDL level is associated with less negative symptoms after one year of antipsychotic treatment in first-episode psychosis.
    Schizophr Res. 2017 Nov 9. pii: S0920-9964(17)30670.
    PubMed     Abstract available


  1295. TIKASZ A, Potvin S, Richard-Devantoy S, Lipp O, et al
    Reduced dorsolateral prefrontal cortex activation during affective Go/NoGo in violent schizophrenia patients: An fMRI study.
    Schizophr Res. 2017 Nov 9. pii: S0920-9964(17)30688.
    PubMed     Abstract available


  1296. MISTRY S, Harrison JR, Smith DJ, Escott-Price V, et al
    The use of polygenic risk scores to identify phenotypes associated with genetic risk of schizophrenia: Systematic review.
    Schizophr Res. 2017 Nov 9. pii: S0920-9964(17)30665.
    PubMed     Abstract available


  1297. EMSLEY R
    Discontinuing antipsychotic treatment after a first-episode of psychosis: Who, when and how?
    Schizophr Res. 2017 Nov 9. pii: S0920-9964(17)30675.
    PubMed    


  1298. WUNDERINK L
    Who needs antipsychotic maintenance treatment and who does not? Our need to profile and personalize the treatment of first episode psychosis.
    Schizophr Res. 2017 Nov 9. pii: S0920-9964(17)30684.
    PubMed    


  1299. VENTURA J, Subotnik KL, Gretchen-Doorly D, Casaus L, et al
    Cognitive remediation can improve negative symptoms and social functioning in first-episode schizophrenia: A randomized controlled trial.
    Schizophr Res. 2017 Nov 8. pii: S0920-9964(17)30614.
    PubMed     Abstract available


  1300. SHE S, Kuang Q, Zheng Y
    Aripiprazole-induced tardive dyskinesia in patients with schizophrenia: A case report of twins.
    Schizophr Res. 2017 Nov 8. pii: S0920-9964(17)30664.
    PubMed    


  1301. LATHAM K, Kirkpatrick B
    Meta-analysis of adult height and birth length in schizophrenia.
    Schizophr Res. 2017 Nov 7. pii: S0920-9964(17)30543.
    PubMed     Abstract available


  1302. WANG YY, Wang Y, Zou YM, Ni K, et al
    Theory of mind impairment and its clinical correlates in patients with schizophrenia, major depressive disorder and bipolar disorder.
    Schizophr Res. 2017 Nov 6. pii: S0920-9964(17)30678.
    PubMed     Abstract available


  1303. HUANG H, Jiang Y, Xia M, Tang Y, et al
    Increased resting-state global functional connectivity density of default mode network in schizophrenia subjects treated with electroconvulsive therapy.
    Schizophr Res. 2017 Nov 6. pii: S0920-9964(17)30671.
    PubMed     Abstract available


  1304. KOTLICKA-ANTCZAK M, Pawelczyk A, Pawelczyk T, Strzelecki D, et al
    A history of obstetric complications is associated with the risk of progression from an at risk mental state to psychosis.
    Schizophr Res. 2017 Nov 5. pii: S0920-9964(17)30669.
    PubMed     Abstract available


  1305. RABALLO A
    Further angles to this story: Time consumption in mind-reading, psychosis risk and phenomenology of social cognition.
    Schizophr Res. 2017 Nov 4. pii: S0920-9964(17)30666.
    PubMed    


  1306. VOHS JL, Leonhardt BL, James AV, Francis MM, et al
    Metacognitive Reflection and Insight Therapy for Early Psychosis: A preliminary study of a novel integrative psychotherapy.
    Schizophr Res. 2017 Nov 3. pii: S0920-9964(17)30667.
    PubMed     Abstract available


  1307. VANCAMPFORT D, Probst M, Firth J, Rosenbaum S, et al
    Gender differences in motives for physical activity across the stages of change in Ugandan outpatients with psychosis.
    Schizophr Res. 2017 Nov 2. pii: S0920-9964(17)30668.
    PubMed    


    October 2017
  1308. CUESTA MJ, Moreno-Izco L, Ribeiro M, Lopez-Ilundain JM, et al
    Motor abnormalities and cognitive impairment in first-episode psychosis patients, their unaffected siblings and healthy controls.
    Schizophr Res. 2017 Oct 30. pii: S0920-9964(17)30663.
    PubMed     Abstract available


  1309. POLIMANTI R, Gelernter J, Stein DJ
    Genetically determined schizophrenia is not associated with impaired glucose homeostasis.
    Schizophr Res. 2017 Oct 29. pii: S0920-9964(17)30661.
    PubMed     Abstract available


  1310. GUPTA T, DeVylder JE, Auerbach RP, Schiffman J, et al
    Speech illusions and working memory performance in non-clinical psychosis.
    Schizophr Res. 2017 Oct 28. pii: S0920-9964(17)30659.
    PubMed     Abstract available


  1311. CHEN HK, Hsieh CJ
    Risk of gastrointestinal Hypomotility in schizophrenia and schizoaffective disorder treated with antipsychotics: A retrospective cohort study.
    Schizophr Res. 2017 Oct 27. pii: S0920-9964(17)30652.
    PubMed     Abstract available


  1312. BLANCO EA, Duque LM, Rachamallu V, Yuen E, et al
    Predictors of aggression in 3.322 patients with affective disorders and schizophrenia spectrum disorders evaluated in an emergency department setting.
    Schizophr Res. 2017 Oct 25. pii: S0920-9964(17)30611.
    PubMed     Abstract available


  1313. GLENTHOJ LB, Fagerlund B, Bak N, Hjorthoj C, et al
    Examining speed of processing of facial emotion recognition in individuals at ultra-high risk for psychosis: Associations with symptoms and cognition.
    Schizophr Res. 2017 Oct 25. pii: S0920-9964(17)30660.
    PubMed    


  1314. PAWELCZYK T, Piatkowska-Janko E, Bogorodzki P, Gebski P, et al
    Omega-3 fatty acid supplementation may prevent loss of gray matter thickness in the left parieto-occipital cortex in first episode schizophrenia: A secondary outcome analysis of the OFFER randomized controlled study.
    Schizophr Res. 2017 Oct 24. pii: S0920-9964(17)30621.
    PubMed     Abstract available


  1315. SCHNACK HG
    Improving individual predictions: Machine learning approaches for detecting and attacking heterogeneity in schizophrenia (and other psychiatric diseases).
    Schizophr Res. 2017 Oct 24. pii: S0920-9964(17)30649.
    PubMed     Abstract available


  1316. HIRJAK D, Kubera KM, Thomann PA, Wolf RC, et al
    Motor dysfunction as an intermediate phenotype across schizophrenia and other psychotic disorders: Progress and perspectives.
    Schizophr Res. 2017 Oct 23. pii: S0920-9964(17)30616.
    PubMed     Abstract available


  1317. LEE JTM, Law EYL, Lo LLH, Lin J, et al
    Psychosocial factors associated with physical activity behavior among patients with psychosis.
    Schizophr Res. 2017 Oct 22. pii: S0920-9964(17)30604.
    PubMed     Abstract available


  1318. FOWLER D, Hodgekins J, French P
    Social Recovery Therapy in improving activity and social outcomes in early psychosis: Current evidence and longer term outcomes.
    Schizophr Res. 2017 Oct 22. pii: S0920-9964(17)30615.
    PubMed     Abstract available


  1319. COFFMAN BA, Haigh SM, Murphy TK, Leiter-Mcbeth J, et al
    Reduced auditory segmentation potentials in first-episode schizophrenia.
    Schizophr Res. 2017 Oct 22. pii: S0920-9964(17)30619.
    PubMed     Abstract available


  1320. KHAN A, Powell SB
    Sensorimotor gating deficits in "two-hit" models of schizophrenia risk factors.
    Schizophr Res. 2017 Oct 22. pii: S0920-9964(17)30618.
    PubMed     Abstract available


  1321. ZHENG J, Zhang Y, Li M, Liao W, et al
    Aberrant corticostriatal connectivity predict positive symptoms of antipsychotic-naive patients with adolescent-onset schizophrenia during brain maturation.
    Schizophr Res. 2017 Oct 21. pii: S0920-9964(17)30653.
    PubMed    


  1322. BOWTELL M, Eaton S, Thien K, Bardell-Williams M, et al
    Rates and predictors of relapse following discontinuation of antipsychotic medication after a first episode of psychosis.
    Schizophr Res. 2017 Oct 21. pii: S0920-9964(17)30658.
    PubMed     Abstract available


  1323. HUANG HK, Wang YW, Hsieh JG, Hsieh CJ, et al
    Disparity of end-of-life care in cancer patients with and without schizophrenia: A nationwide population-based cohort study.
    Schizophr Res. 2017 Oct 21. pii: S0920-9964(17)30657.
    PubMed     Abstract available


  1324. CUI J, Liu H, Shao J, Xu DM, et al
    Prevalence, risk factors and clinical characteristics of osteoporosis in Chinese inpatients with schizophrenia.
    Schizophr Res. 2017 Oct 19. pii: S0920-9964(17)30655.
    PubMed     Abstract available


  1325. DEROSSE P, Nitzburg GC, Blair M, Malhotra AK, et al
    Dimensional symptom severity and global cognitive function predict subjective quality of life in patients with schizophrenia and healthy adults.
    Schizophr Res. 2017 Oct 19. pii: S0920-9964(17)30627.
    PubMed     Abstract available


  1326. LIU J, Su B
    Integrated analysis supports ATXN1 as a schizophrenia risk gene.
    Schizophr Res. 2017 Oct 18. pii: S0920-9964(17)30620.
    PubMed     Abstract available


  1327. MCHUGH MJ, McGorry PD, Yuen HP, Hickie IB, et al
    The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo.
    Schizophr Res. 2017 Oct 18. pii: S0920-9964(17)30546.
    PubMed     Abstract available


  1328. SUGAWARA N, Maruo K, Sugai T, Suzuki Y, et al
    Prevalence of underweight in patients with schizophrenia: A meta-analysis.
    Schizophr Res. 2017 Oct 17. pii: S0920-9964(17)30626.
    PubMed     Abstract available


  1329. XAVIER RM, Vorderstrasse A, Keefe RSE, Dungan JR, et al
    Genetic correlates of insight in schizophrenia.
    Schizophr Res. 2017 Oct 17. pii: S0920-9964(17)30630.
    PubMed     Abstract available


  1330. LEWIS AS, Olincy A, Buchanan RW, Kem WR, et al
    Effects of a nicotinic agonist on the Brief Psychiatric Rating Scale five-factor subscale model in schizophrenia.
    Schizophr Res. 2017 Oct 16. pii: S0920-9964(17)30625.
    PubMed    


  1331. GREEN AI, Khokhar JY
    Addiction and schizophrenia: A translational perspective.
    Schizophr Res. 2017 Oct 15. pii: S0920-9964(17)30617.
    PubMed    


  1332. MCNABB CB, Tait RJ, McIlwain ME, Anderson VM, et al
    Functional network dysconnectivity as a biomarker of treatment resistance in schizophrenia.
    Schizophr Res. 2017 Oct 14. pii: S0920-9964(17)30624.
    PubMed     Abstract available


  1333. CORCORAN CM, Stoops A, Lee M, Martinez A, et al
    Developmental trajectory of mismatch negativity and visual event-related potentials in healthy controls: Implications for neurodevelopmental vs. neurodegenerative models of schizophrenia.
    Schizophr Res. 2017 Oct 12. pii: S0920-9964(17)30609.
    PubMed     Abstract available


  1334. BROWNE J, Estroff SE, Ludwig K, Merritt C, et al
    Character strengths of individuals with first episode psychosis in Individual Resiliency Training.
    Schizophr Res. 2017 Oct 12. pii: S0920-9964(17)30598.
    PubMed     Abstract available


  1335. BUENO-ANTEQUERA J, Oviedo-Caro MA, Munguia-Izquierdo D
    Sedentary behaviour, physical activity, cardiorespiratory fitness and cardiometabolic risk in psychosis: The PsychiActive project.
    Schizophr Res. 2017 Oct 12. pii: S0920-9964(17)30622.
    PubMed     Abstract available


  1336. KLUGE A, Kirschner M, Hager OM, Bischof M, et al
    Combining actigraphy, ecological momentary assessment and neuroimaging to study apathy in patients with schizophrenia.
    Schizophr Res. 2017 Oct 10. pii: S0920-9964(17)30596.
    PubMed     Abstract available


  1337. MCKINNEY BC, Lin H, Ding Y, Lewis DA, et al
    DNA methylation age is not accelerated in brain or blood of subjects with schizophrenia.
    Schizophr Res. 2017 Oct 5. pii: S0920-9964(17)30587.
    PubMed     Abstract available


  1338. KOSHIYAMA D, Kirihara K, Tada M, Nagai T, et al
    Association between mismatch negativity and global functioning is specific to duration deviance in early stages of psychosis.
    Schizophr Res. 2017 Oct 3. pii: S0920-9964(17)30607.
    PubMed     Abstract available


  1339. CELLA M, Okruszek L, Lawrence M, Zarlenga V, et al
    Using wearable technology to detect the autonomic signature of illness severity in schizophrenia.
    Schizophr Res. 2017 Oct 3. pii: S0920-9964(17)30590.
    PubMed     Abstract available


  1340. GOWDA GS, Rai D, Nadella RK, Tiwari S, et al
    Schizophrenia in Wolfram Syndrome (DIDMOAD Syndrome): A case report in support of the mitochondrial dysfunction hypothesis.
    Schizophr Res. 2017 Oct 3. pii: S0920-9964(17)30606.
    PubMed    


  1341. BLOKLAND GAM, Del Re EC, Mesholam-Gately RI, Jovicich J, et al
    The Genetics of Endophenotypes of Neurofunction to Understand Schizophrenia (GENUS) consortium: A collaborative cognitive and neuroimaging genetics project.
    Schizophr Res. 2017 Oct 2. pii: S0920-9964(17)30586.
    PubMed     Abstract available


  1342. MCGINTY J, Sayeed Haque M, Upthegrove R
    Depression during first episode psychosis and subsequent suicide risk: A systematic review and meta-analysis of longitudinal studies.
    Schizophr Res. 2017 Oct 2. pii: S0920-9964(17)30602.
    PubMed     Abstract available


    September 2017
  1343. TURETSKY BI, Moberg PJ, Quarmley M, Dress E, et al
    Structural anomalies of the peripheral olfactory system in psychosis high-risk subjects.
    Schizophr Res. 2017 Sep 30. pii: S0920-9964(17)30577.
    PubMed     Abstract available


  1344. FOND G, Boyer L, Leboyer M, Godin O, et al
    Influence of Venus and Mars in the cognitive sky of schizophrenia. Results from the first-step national FACE-SZ cohort.
    Schizophr Res. 2017 Sep 30. pii: S0920-9964(17)30589.
    PubMed     Abstract available


  1345. GONZALEZ LE, Lopez-Carrilero R, Barrigon ML, Grasa E, et al
    Neuropsychological functioning and jumping to conclusions in recent onset psychosis patients.
    Schizophr Res. 2017 Sep 29. pii: S0920-9964(17)30601.
    PubMed     Abstract available


  1346. SCHOFIELD P, Thygesen M, Das-Munshi J, Becares L, et al
    Neighbourhood ethnic density and psychosis - Is there a difference according to generation?
    Schizophr Res. 2017 Sep 29. pii: S0920-9964(17)30591.
    PubMed     Abstract available


  1347. ROMER THOMSEN K, Thylstrup B, Pedersen MM, Pedersen MU, et al
    Drug-related predictors of readmission for schizophrenia among patients admitted to treatment for drug use disorders.
    Schizophr Res. 2017 Sep 28. pii: S0920-9964(17)30588.
    PubMed     Abstract available


  1348. WYNN JK, Green MF, Hellemann G, Karunaratne K, et al
    The effects of curcumin on brain-derived neurotrophic factor and cognition in schizophrenia: A randomized controlled study.
    Schizophr Res. 2017 Sep 28. pii: S0920-9964(17)30608.
    PubMed    


  1349. KELLY SM, Eack SM
    White matter microstructure and cognitive remediation outcomes in schizophrenia.
    Schizophr Res. 2017 Sep 28. pii: S0920-9964(17)30599.
    PubMed    


  1350. RUBIN LH, Wehring HJ, Demyanovich H, Sue Carter C, et al
    Peripheral oxytocin and vasopressin are associated with clinical symptom severity and cognitive functioning in midlife women with chronic schizophrenia.
    Schizophr Res. 2017 Sep 28. pii: S0920-9964(17)30603.
    PubMed    


  1351. LEE EE, Liu J, Tu X, Palmer BW, et al
    A widening longevity gap between people with schizophrenia and general population: A literature review and call for action.
    Schizophr Res. 2017 Sep 27. pii: S0920-9964(17)30542.
    PubMed     Abstract available


  1352. VOGEL BO, Lett TA, Erk S, Mohnke S, et al
    The influence of MIR137 on white matter fractional anisotropy and cortical surface area in individuals with familial risk for psychosis.
    Schizophr Res. 2017 Sep 25. pii: S0920-9964(17)30592.
    PubMed     Abstract available


  1353. WLODARCZYK A
    Benzodiazepine use in schizophrenia.
    Schizophr Res. 2017 Sep 25. pii: S0920-9964(17)30594.
    PubMed    


  1354. SIDDIQUI I, Remington G, Fletcher PJ, Voineskos AN, et al
    Objective assessment of exploratory behaviour in schizophrenia using wireless motion capture.
    Schizophr Res. 2017 Sep 24. pii: S0920-9964(17)30570.
    PubMed     Abstract available


  1355. ORHAN F, Fatouros-Bergman H, Schwieler L, Cervenka S, et al
    First-episode psychosis patients display increased plasma IL-18 that correlates with cognitive dysfunction.
    Schizophr Res. 2017 Sep 23. pii: S0920-9964(17)30576.
    PubMed    


  1356. DAVISON J, O'Gorman A, Brennan L, Cotter DR, et al
    A systematic review of metabolite biomarkers of schizophrenia.
    Schizophr Res. 2017 Sep 22. pii: S0920-9964(17)30580.
    PubMed     Abstract available


  1357. LI H, Li J, Yu X, Zheng H, et al
    The incidence rate of cancer in patients with schizophrenia: A meta-analysis of cohort studies.
    Schizophr Res. 2017 Sep 21. pii: S0920-9964(17)30541.
    PubMed     Abstract available


  1358. BERRIOS GE, Markova IS
    Historical and conceptual aspects of motor disorders in the psychoses.
    Schizophr Res. 2017 Sep 20. pii: S0920-9964(17)30549.
    PubMed     Abstract available


  1359. ZAROGIANNI E, Storkey AJ, Borgwardt S, Smieskova R, et al
    Individualized prediction of psychosis in subjects with an at-risk mental state.
    Schizophr Res. 2017 Sep 19. pii: S0920-9964(17)30537.
    PubMed     Abstract available


  1360. COMBS T, Roseberry JE, Rubin LH, Hill SK, et al
    Deficient single item maintenance following intact updating in schizophrenia.
    Schizophr Res. 2017 Sep 18. pii: S0920-9964(17)30578.
    PubMed    


  1361. GRIVEL MM, Leong W, Masucci MD, Altschuler RA, et al
    Impact of lifetime traumatic experiences on suicidality and likelihood of conversion in a cohort of individuals at clinical high-risk for psychosis.
    Schizophr Res. 2017 Sep 18. pii: S0920-9964(17)30547.
    PubMed     Abstract available


  1362. MUNOZ-ESTRADA J, Lora-Castellanos A, Meza I, Alarcon Elizalde S, et al
    Primary cilia formation is diminished in schizophrenia and bipolar disorder: A possible marker for these psychiatric diseases.
    Schizophr Res. 2017 Sep 16. pii: S0920-9964(17)30530.
    PubMed     Abstract available


  1363. JOSHI YB, Breitenstein B, Tarasenko M, Thomas ML, et al
    Mismatch negativity impairment is associated with deficits in identifying real-world environmental sounds in schizophrenia.
    Schizophr Res. 2017 Sep 15. pii: S0920-9964(17)30279.
    PubMed     Abstract available


  1364. GILL KM, Miller SA, Grace AA
    Impaired contextual fear-conditioning in MAM rodent model of schizophrenia.
    Schizophr Res. 2017 Sep 15. pii: S0920-9964(17)30540.
    PubMed     Abstract available


  1365. SCHJERNING O, Damkier P, Lykkegaard SE, Jakobsen KD, et al
    Pregabalin for anxiety in patients with schizophrenia - A randomized, double-blind placebo-controlled study.
    Schizophr Res. 2017 Sep 14. pii: S0920-9964(17)30575.
    PubMed     Abstract available


  1366. HURFORD IM, Ventura J, Marder SR, Reise SP, et al
    A 10-minute measure of global cognition: Validation of the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS).
    Schizophr Res. 2017 Sep 13. pii: S0920-9964(17)30510.
    PubMed     Abstract available


  1367. BOUSMAN CA, Lee TY, Kim M, Lee J, et al
    Genetic variation in cytokine genes and risk for transition to psychosis among individuals at ultra-high risk.
    Schizophr Res. 2017 Sep 12. pii: S0920-9964(17)30516.
    PubMed    


  1368. DUGRE JR, Guay JP, Dumais A
    Risk factors of compliance with self-harm command hallucinations in individuals with affective and non-affective psychosis.
    Schizophr Res. 2017 Sep 11. pii: S0920-9964(17)30545.
    PubMed     Abstract available


  1369. LIU Y, Rao S, Xu Y, Zhang F, et al
    Changes in the level of Long Non-Coding RNA Gomafu gene expression in schizophrenia patients before and after antipsychotic medication.
    Schizophr Res. 2017 Sep 11. pii: S0920-9964(17)30502.
    PubMed    


  1370. JOHANSSON M, Hjarthag F, Helldin L
    What could be learned from a decade with standardized remission criteria in schizophrenia spectrum disorders: An exploratory follow-up study.
    Schizophr Res. 2017 Sep 9. pii: S0920-9964(17)30548.
    PubMed     Abstract available


  1371. SELVARAJ S, Bloomfield PS, Cao B, Veronese M, et al
    Brain TSPO imaging and gray matter volume in schizophrenia patients and in people at ultra high risk of psychosis: An [11C]PBR28 study.
    Schizophr Res. 2017 Sep 8. pii: S0920-9964(17)30539.
    PubMed     Abstract available


  1372. CUESTA MJ, Garcia de Jalon E, Campos MS, Moreno-Izco L, et al
    Motor abnormalities in first-episode psychosis patients and long-term psychosocial functioning.
    Schizophr Res. 2017 Sep 7. pii: S0920-9964(17)30526.
    PubMed     Abstract available


  1373. FOND G, Boyer L, Andrianarisoa M, Godin O, et al
    Risk factors for increased duration of untreated psychosis. Results from the FACE-SZ dataset.
    Schizophr Res. 2017 Sep 6. pii: S0920-9964(17)30534.
    PubMed     Abstract available


  1374. JOAQUIM HPG, Zanetti MV, Serpa MH, Van de Bilt MT, et al
    Increased platelet glycogen sysnthase kinase 3beta in first-episode psychosis.
    Schizophr Res. 2017 Sep 6. pii: S0920-9964(17)30538.
    PubMed     Abstract available


  1375. NORMAN RMG, MacDougall A, Manchanda R, Harricharan R, et al
    An examination of components of recovery after five years of treatment in an early intervention program for psychosis.
    Schizophr Res. 2017 Sep 6. pii: S0920-9964(17)30531.
    PubMed     Abstract available


  1376. WAMPERS M, Schrauwen S, De Hert M, Gielen L, et al
    Patients with psychosis struggle with scalar implicatures.
    Schizophr Res. 2017 Sep 6. pii: S0920-9964(17)30529.
    PubMed     Abstract available


  1377. HO RWH, Chang WC, Kwong VWY, Lau ESK, et al
    Prediction of self-stigma in early psychosis: 3-Year follow-up of the randomized-controlled trial on extended early intervention.
    Schizophr Res. 2017 Sep 6. pii: S0920-9964(17)30544.
    PubMed     Abstract available


  1378. CIHAKOVA D, Eaton WW, Talor MV, Harkus UH, et al
    Gliadin-related antibodies in schizophrenia.
    Schizophr Res. 2017 Sep 5. pii: S0920-9964(17)30527.
    PubMed    


  1379. MOLINA V, Bachiller A, Gomez-Pilar J, Lubeiro A, et al
    Deficit of entropy modulation of the EEG in schizophrenia associated to cognitive performance and symptoms. A replication study.
    Schizophr Res. 2017 Sep 5. pii: S0920-9964(17)30533.
    PubMed     Abstract available


  1380. SANDOVAL LR, Gonzalez BL, Stone WS, Guimond S, et al
    Effects of peer social interaction on performance during computerized cognitive remediation therapy in patients with early course schizophrenia: A pilot study.
    Schizophr Res. 2017 Sep 4. pii: S0920-9964(17)30525.
    PubMed     Abstract available


  1381. GOMES JS, Ducos DV, Gadelha A, Ortiz BB, et al
    Hemoencephalography self-regulation training and its impact on cognition: A study with schizophrenia and healthy participants.
    Schizophr Res. 2017 Sep 4. pii: S0920-9964(17)30520.
    PubMed     Abstract available


    August 2017
  1382. LI Z, Yan C, Lv QY, Yi ZH, et al
    Striatal dysfunction in patients with schizophrenia and their unaffected first-degree relatives.
    Schizophr Res. 2017 Aug 31. pii: S0920-9964(17)30519.
    PubMed     Abstract available


  1383. SEVILLA-LLEWELLYN-JONES J, Cano-Dominguez P, de-Luis-Matilla A, Espina-Eizaguirre A, et al
    Personality traits in recent-onset-of-psychosis patients compared to a control sample by gender.
    Schizophr Res. 2017 Aug 31. pii: S0920-9964(17)30518.
    PubMed     Abstract available


  1384. ACAR S, Chen X, Cayirdag N
    Schizophrenia and creativity: A meta-analytic review.
    Schizophr Res. 2017 Aug 31. pii: S0920-9964(17)30512.
    PubMed     Abstract available


  1385. SILVA RO, Amato IA, Santos A Jr, Bobbo VC, et al
    Paradoxical elevation of systemic inflammatory markers and physical activity in patients with schizophrenia.
    Schizophr Res. 2017 Aug 30. pii: S0920-9964(17)30514.
    PubMed    


  1386. BOSE A, Shivakumar V, Agarwal SM, Kalmady SV, et al
    Efficacy of fronto-temporal transcranial direct current stimulation for refractory auditory verbal hallucinations in schizophrenia: A randomized, double-blind, sham-controlled study.
    Schizophr Res. 2017 Aug 30. pii: S0920-9964(17)30523.
    PubMed     Abstract available


  1387. PERALTA V, de Jalon EG, Campos MS, Cuesta MJ, et al
    Covariation between motor signs and negative symptoms in drug-naive subjects with schizophrenia-spectrum disorders before and after antipsychotic treatment.
    Schizophr Res. 2017 Aug 29. pii: S0920-9964(17)30515.
    PubMed     Abstract available


  1388. SHAD MU
    What do we know about insight into illness and its association with the underlying biology of schizophrenia?
    Schizophr Res. 2017 Aug 29. pii: S0920-9964(17)30493.
    PubMed    


  1389. KLINE E, Thomas L
    Commentary: Cultural factors in first episode psychosis treatment engagement.
    Schizophr Res. 2017 Aug 29. pii: S0920-9964(17)30511.
    PubMed     Abstract available


  1390. VAN DER GAAG M, van den Berg D, Ising H
    CBT in the prevention of psychosis and other severe mental disorders in patients with an at risk mental state: A review and proposed next steps.
    Schizophr Res. 2017 Aug 28. pii: S0920-9964(17)30494.
    PubMed     Abstract available


  1391. ZOU YM, Ni K, Yang ZY, Li Y, et al
    Profiling of experiential pleasure, emotional regulation and emotion expression in patients with schizophrenia.
    Schizophr Res. 2017 Aug 28. pii: S0920-9964(17)30524.
    PubMed     Abstract available


  1392. HUDGENS-HANEY ME, Ethridge LE, McDowell JE, Keedy SK, et al
    Psychosis subgroups differ in intrinsic neural activity but not task-specific processing.
    Schizophr Res. 2017 Aug 24. pii: S0920-9964(17)30498.
    PubMed     Abstract available


  1393. BOU KHALIL R
    Maternal infection and anemia as prenatal predisposing factors for schizophrenia: The link with zinc deficiency.
    Schizophr Res. 2017 Aug 24. pii: S0920-9964(17)30506.
    PubMed    


  1394. TREEN CALVO D, Gimenez-Donoso S, Setien-Suero E, Toll Privat A, et al
    Targeting recovery in first episode psychosis: The importance of neurocognition and premorbid adjustment in a 3-year longitudinal study.
    Schizophr Res. 2017 Aug 24. pii: S0920-9964(17)30509.
    PubMed     Abstract available


  1395. SINT K, Rosenheck R, Robinson DG, Schooler NR, et al
    Accounting for group differences in study retention in a randomized trial of specialized treatment for first episode psychosis.
    Schizophr Res. 2017 Aug 24. pii: S0920-9964(17)30505.
    PubMed     Abstract available


  1396. MATHIAS SR, Knowles EEM, Barrett J, Beetham T, et al
    Deficits in visual working-memory capacity and general cognition in African Americans with psychosis.
    Schizophr Res. 2017 Aug 23. pii: S0920-9964(17)30490.
    PubMed     Abstract available


  1397. TAKEUCHI H, Thiyanavadivel S, Agid O, Remington G, et al
    Rapid vs. slow antipsychotic initiation in schizophrenia: A systematic review and meta-analysis.
    Schizophr Res. 2017 Aug 22. pii: S0920-9964(17)30487.
    PubMed     Abstract available


  1398. VAN ROOIJEN G, Isvoranu AM, Kruijt OH, van Borkulo CD, et al
    A state-independent network of depressive, negative and positive symptoms in male patients with schizophrenia spectrum disorders.
    Schizophr Res. 2017 Aug 22. pii: S0920-9964(17)30446.
    PubMed     Abstract available


  1399. QIAO Y, Mei Y, Han H, Liu F, et al
    Effects of Omega-3 in the treatment of violent schizophrenia patients.
    Schizophr Res. 2017 Aug 19. pii: S0920-9964(17)30501.
    PubMed     Abstract available


  1400. UPTHEGROVE R, Abu-Akel A, Chisholm K, Lin A, et al
    Autism and psychosis: Clinical implications for depression and suicide.
    Schizophr Res. 2017 Aug 18. pii: S0920-9964(17)30504.
    PubMed     Abstract available


  1401. WHITFIELD-GABRIELI S, Fischer AS, Henricks AM, Khokhar JY, et al
    Understanding marijuana's effects on functional connectivity of the default mode network in patients with schizophrenia and co-occurring cannabis use disorder: A pilot investigation.
    Schizophr Res. 2017 Aug 17. pii: S0920-9964(17)30431.
    PubMed     Abstract available


  1402. ZHANG T, Cui H, Wei Y, Tang Y, et al
    Progressive decline of cognition during the conversion from prodrome to psychosis with a characteristic pattern of the theory of mind compensated by neurocognition.
    Schizophr Res. 2017 Aug 17. pii: S0920-9964(17)30496.
    PubMed     Abstract available


  1403. LOPEZ-DIAZ A, Galiano-Rus S, Herruzo-Rivas A
    Differences in the impairment of insight between deficit syndrome and non-deficit syndrome patients with first-episode schizophrenia.
    Schizophr Res. 2017 Aug 15. pii: S0920-9964(17)30491.
    PubMed    


  1404. DEMJAHA A
    On the brink of precision medicine for psychosis: Treating the patient, not the disease: A commentary on: Association between serum levels of glutamate and neurotrophic factors and response to clozapine treatment by Krivoj et al. 2017.
    Schizophr Res. 2017 Aug 15. pii: S0920-9964(17)30485.
    PubMed    


  1405. UNGVARI GS, Gerevich J, Takacs R, Gazdag G, et al
    Schizophrenia with prominent catatonic features: A selective review.
    Schizophr Res. 2017 Aug 14. pii: S0920-9964(17)30474.
    PubMed     Abstract available


  1406. GRUBER J, Strauss GP, Dombrecht L, Mittal VA, et al
    Neuroleptic-free youth at ultrahigh risk for psychosis evidence diminished emotion reactivity that is predicted by depression and anxiety.
    Schizophr Res. 2017 Aug 12. pii: S0920-9964(17)30486.
    PubMed     Abstract available


  1407. MARAJ A, Veru F, Morrison L, Joober R, et al
    Disengagement in immigrant groups receiving services for a first episode of psychosis.
    Schizophr Res. 2017 Aug 10. pii: S0920-9964(17)30465.
    PubMed     Abstract available


  1408. NOGUERA A, Castro-Fornieles J, Romero S, de la Serna E, et al
    Attenuated psychotic symptoms in children and adolescent offspring of patients with schizophrenia.
    Schizophr Res. 2017 Aug 9. pii: S0920-9964(17)30461.
    PubMed    


  1409. VLATKOVIC S, Sagud M, Svob Strac D, Sviben M, et al
    Increased prevalence of Toxoplasma gondii seropositivity in patients with treatment-resistant schizophrenia.
    Schizophr Res. 2017 Aug 9. pii: S0920-9964(17)30472.
    PubMed    


  1410. MAGLIANO L, Petrillo M, Ruggiero G, Schioppa G, et al
    Schizophrenia and psychosis: Does changing the label change the beliefs?
    Schizophr Res. 2017 Aug 9. pii: S0920-9964(17)30473.
    PubMed    


  1411. PALMER BW, Moore RC, Eyler LT, Pinto LL, et al
    Avoidance of accelerated aging in schizophrenia?: Clinical and biological characterization of an exceptionally high functioning individual.
    Schizophr Res. 2017 Aug 8. pii: S0920-9964(17)30463.
    PubMed     Abstract available


  1412. LEUNG LS, Ma J
    Medial septum modulates hippocampal gamma activity and prepulse inhibition in an N-methyl-d-aspartate receptor antagonist model of schizophrenia.
    Schizophr Res. 2017 Aug 8. pii: S0920-9964(17)30464.
    PubMed     Abstract available


  1413. COOPER PS, Hughes ME
    Impaired theta and alpha oscillations underlying stopsignal response inhibition deficits in schizophrenia.
    Schizophr Res. 2017 Aug 7. pii: S0920-9964(17)30469.
    PubMed    


  1414. JOE P, Getz M, Redman S, Kranz TM, et al
    Transglutaminase-5 related schizophrenia.
    Schizophr Res. 2017 Aug 7. pii: S0920-9964(17)30470.
    PubMed    


  1415. KOUTSOUKOS E, Angelopoulos E
    Investigating the role of metastability in the disturbed brain functional connectivity observed under the experience of thought blocks in schizophrenia.
    Schizophr Res. 2017 Aug 5. pii: S0920-9964(17)30466.
    PubMed    


  1416. STRAUSS GP, Chapman HC
    Preliminary psychometric properties of the brief Negative Symptom Scale in youth at Clinical High-Risk for psychosis.
    Schizophr Res. 2017 Aug 2. pii: S0920-9964(17)30462.
    PubMed     Abstract available


  1417. MCCARTHY JM, Bradshaw KR, Catalano LT, Garcia CP, et al
    Negative symptoms and the formation of social affiliative bonds in schizophrenia.
    Schizophr Res. 2017 Aug 2. pii: S0920-9964(17)30445.
    PubMed     Abstract available


  1418. LEE M, Sehatpour P, Dias EC, Silipo GS, et al
    A tale of two sites: Differential impairment of frequency and duration mismatch negativity across a primarily inpatient versus a primarily outpatient site in schizophrenia.
    Schizophr Res. 2017 Aug 2. pii: S0920-9964(17)30443.
    PubMed     Abstract available


  1419. SRIHARI VH
    Working toward changing the Duration of Untreated Psychosis (DUP).
    Schizophr Res. 2017 Aug 2. pii: S0920-9964(17)30456.
    PubMed    


  1420. MURALIDHARAN A, Finch A, Bowie CR, Harvey PD, et al
    Thought, language, and communication deficits and association with everyday functional outcomes among community-dwelling middle-aged and older adults with schizophrenia.
    Schizophr Res. 2017 Aug 1. pii: S0920-9964(17)30418.
    PubMed     Abstract available


    July 2017
  1421. HOOPER SR, Shashi V
    Completing the puzzle: The search for pieces in the understanding of psychosis risk in 22q11.2 deletion syndrome.
    Schizophr Res. 2017 Jul 30. pii: S0920-9964(17)30451.
    PubMed    


  1422. EACK SM
    Promoting long-term functional improvement after cognitive remediation in schizophrenia.
    Schizophr Res. 2017 Jul 30. pii: S0920-9964(17)30454.
    PubMed    


  1423. FEATHERSTONE RE, Melnychenko O, Siegel SJ
    Mismatch negativity in preclinical models of schizophrenia.
    Schizophr Res. 2017 Jul 30. pii: S0920-9964(17)30450.
    PubMed     Abstract available


  1424. BRAEUTIGAM S, Dima D, Frangou S, James A, et al
    Dissociable auditory mismatch response and connectivity patterns in adolescents with schizophrenia and adolescents with bipolar disorder with psychosis: A magnetoencephalography study.
    Schizophr Res. 2017 Jul 28. pii: S0920-9964(17)30459.
    PubMed     Abstract available


  1425. LALLY J, Ajnakina O, Stubbs B, Williams HR, et al
    Hyperprolactinaemia in first episode psychosis - A longitudinal assessment.
    Schizophr Res. 2017 Jul 27. pii: S0920-9964(17)30448.
    PubMed     Abstract available


  1426. ADAMS SA, Nasrallah HA
    Multiple retinal anomalies in schizophrenia.
    Schizophr Res. 2017 Jul 26. pii: S0920-9964(17)30419.
    PubMed     Abstract available


  1427. AJNAKINA O, Lally J, Di Forti M, Stilo SA, et al
    Utilising symptom dimensions with diagnostic categories improves prediction of time to first remission in first-episode psychosis.
    Schizophr Res. 2017 Jul 25. pii: S0920-9964(17)30453.
    PubMed     Abstract available


  1428. GILLESPIE SM, Abu-Akel AM
    Evidence for benefits in comorbid psychopathy and schizophrenia.
    Schizophr Res. 2017 Jul 25. pii: S0920-9964(17)30457.
    PubMed    


  1429. CHIU PW, Lui SSY, Hung KSY, Chan RCK, et al
    In vivo gamma-aminobutyric acid and glutamate levels in people with first-episode schizophrenia: A proton magnetic resonance spectroscopy study.
    Schizophr Res. 2017 Jul 24. pii: S0920-9964(17)30422.
    PubMed     Abstract available


  1430. WANG HY, Guo WJ, Li XJ, Tao YJ, et al
    Higher required dosage of antipsychotics to relieve the symptoms of first-onset Acute and Transient Psychotic Disorder (ATPD) predicted the subsequent diagnostic transition to schizophrenia: A longitudinal study.
    Schizophr Res. 2017 Jul 21. pii: S0920-9964(17)30412.
    PubMed    


  1431. EBISCH SJH, Gallese V, Salone A, Martinotti G, et al
    Disrupted relationship between "resting state" connectivity and task-evoked activity during social perception in schizophrenia.
    Schizophr Res. 2017 Jul 20. pii: S0920-9964(17)30421.
    PubMed     Abstract available


  1432. GANELLA EP, Seguin C, Bartholomeusz CF, Whittle S, et al
    Risk and resilience brain networks in treatment-resistant schizophrenia.
    Schizophr Res. 2017 Jul 20. pii: S0920-9964(17)30415.
    PubMed     Abstract available


  1433. FUSAR-POLI P, Palombini E, Davies C, Oliver D, et al
    Why transition risk to psychosis is not declining at the OASIS ultra high risk service: The hidden role of stable pretest risk enrichment.
    Schizophr Res. 2017 Jul 19. pii: S0920-9964(17)30353.
    PubMed     Abstract available


  1434. PILLAI A, Schooler NR, Peter D, Looney SW, et al
    Predicting relapse in schizophrenia: Is BDNF a plausible biological marker?
    Schizophr Res. 2017 Jul 19. pii: S0920-9964(17)30398.
    PubMed     Abstract available


  1435. MORITZ S, Bentall RP, Kolbeck K, Roesch-Ely D, et al
    Monocausal attribution and its relationship with reasoning biases in schizophrenia.
    Schizophr Res. 2017 Jul 18. pii: S0920-9964(17)30396.
    PubMed     Abstract available


  1436. FARGOTSTEIN M, Hasenkamp W, Gross R, Cuthbert B, et al
    The effect of antipsychotic medications on acoustic startle latency in schizophrenia.
    Schizophr Res. 2017 Jul 18. pii: S0920-9964(17)30432.
    PubMed     Abstract available


  1437. ZULIANI R, Delvecchio G, Bonivento C, Cattarinussi G, et al
    Increased gyrification in schizophrenia and non affective first episode of psychosis.
    Schizophr Res. 2017 Jul 17. pii: S0920-9964(17)30399.
    PubMed     Abstract available


  1438. LU ML, Chen CH, Kuo PT, Lin CH, et al
    Application of plasma levels of olanzapine and N-desmethyl-olanzapine to monitor metabolic parameters in patients with schizophrenia.
    Schizophr Res. 2017 Jul 15. pii: S0920-9964(17)30423.
    PubMed     Abstract available


  1439. O'REILLY K, O'Connell P, Corvin A, O'Sullivan D, et al
    Moral cognition and homicide amongst forensic patients with schizophrenia and schizoaffective disorder: A cross-sectional cohort study.
    Schizophr Res. 2017 Jul 14. pii: S0920-9964(17)30428.
    PubMed     Abstract available


  1440. GAWEDA L, Prochwicz K, Adamczyk P, Frydecka D, et al
    The role of self-disturbances and cognitive biases in the relationship between traumatic life events and psychosis proneness in a non-clinical sample.
    Schizophr Res. 2017 Jul 13. pii: S0920-9964(17)30424.
    PubMed     Abstract available


  1441. HORAN WP, Green MF
    Treatment of social cognition in schizophrenia: Current status and future directions.
    Schizophr Res. 2017 Jul 13. pii: S0920-9964(17)30414.
    PubMed     Abstract available


  1442. REKHI G, Ng WY, Lee J
    Clinical utility of the Calgary Depression Scale for Schizophrenia in individuals at ultra-high risk of psychosis.
    Schizophr Res. 2017 Jul 13. pii: S0920-9964(17)30395.
    PubMed     Abstract available


  1443. COMPARELLI A, Corigliano V, Lamis DA, De Carolis A, et al
    Positive symptoms and social cognition impairment affect severity of suicidal ideation in schizophrenia.
    Schizophr Res. 2017 Jul 13. pii: S0920-9964(17)30427.
    PubMed    


  1444. HATTORI S, Kishida I, Suda A, Miyauchi M, et al
    Effects of four atypical antipsychotics on autonomic nervous system activity in schizophrenia.
    Schizophr Res. 2017 Jul 12. pii: S0920-9964(17)30405.
    PubMed     Abstract available


  1445. LINDGREN M, Torniainen-Holm M, Harkanen T, Dickerson F, et al
    The association between toxoplasma and the psychosis continuum in a general population setting.
    Schizophr Res. 2017 Jul 12. pii: S0920-9964(17)30391.
    PubMed     Abstract available


  1446. RETSA C, Knebel JF, Geiser E, Ferrari C, et al
    Treatment in early psychosis with N-acetyl-cysteine for 6months improves low-level auditory processing: Pilot study.
    Schizophr Res. 2017 Jul 12. pii: S0920-9964(17)30409.
    PubMed     Abstract available


  1447. VERAS AB, Peixoto C, Messinger JW, Getz M, et al
    Early trauma and clinical features of schizophrenia cases influenced by the BDNF met allele.
    Schizophr Res. 2017 Jul 12. pii: S0920-9964(17)30400.
    PubMed    


  1448. HAMILTON HK, D'Souza DC, Ford JM, Roach BJ, et al
    Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.
    Schizophr Res. 2017 Jul 12. pii: S0920-9964(17)30379.
    PubMed     Abstract available


  1449. HOLMEN TL, Egeland J, Andersen E, Bigseth TT, et al
    The association between cardio-respiratory fitness and cognition in schizophrenia.
    Schizophr Res. 2017 Jul 11. pii: S0920-9964(17)30416.
    PubMed     Abstract available


  1450. BONFIOLI E, Mazzi MA, Berti L, Burti L, et al
    Physical health promotion in patients with functional psychoses receiving community psychiatric services: Results of the PHYSICO-DSM-VR study.
    Schizophr Res. 2017 Jul 11. pii: S0920-9964(17)30356.
    PubMed     Abstract available


  1451. DUTSCHKE LL, Stegmayer K, Ramseyer F, Bohlhalter S, et al
    Gesture impairments in schizophrenia are linked to increased movement and prolonged motor planning and execution.
    Schizophr Res. 2017 Jul 11. pii: S0920-9964(17)30413.
    PubMed     Abstract available


  1452. AVISSAR M, Xie S, Vail B, Lopez-Calderon J, et al
    Meta-analysis of mismatch negativity to simple versus complex deviants in schizophrenia.
    Schizophr Res. 2017 Jul 11. pii: S0920-9964(17)30410.
    PubMed     Abstract available


  1453. KOOLA MM, Sklar J, Davis W, Nikiforuk A, et al
    Kynurenine pathway in schizophrenia: Galantamine-memantine combination for cognitive impairments.
    Schizophr Res. 2017 Jul 10. pii: S0920-9964(17)30406.
    PubMed    


  1454. KONRADI C, Ongur D
    Role of mitochondria and energy metabolism in schizophrenia and psychotic disorders.
    Schizophr Res. 2017 Jul 10. pii: S0920-9964(17)30408.
    PubMed    


  1455. GARDSJORD ES, Romm KL, Rossberg JI, Friis S, et al
    Is going into stable symptomatic remission associated with a more positive development of life satisfaction? A 10-year follow-up study of first episode psychosis.
    Schizophr Res. 2017 Jul 9. pii: S0920-9964(17)30407.
    PubMed     Abstract available


  1456. BRUNETTE MF, Mueser KT, Babbin S, Meyer-Kalos P, et al
    Demographic and clinical correlates of substance use disorders in first episode psychosis.
    Schizophr Res. 2017 Jul 8. pii: S0920-9964(17)30378.
    PubMed     Abstract available


  1457. XAVIER RM, Pan W, Dungan JR, Keefe RSE, et al
    Unraveling interrelationships among psychopathology symptoms, cognitive domains and insight dimensions in chronic schizophrenia.
    Schizophr Res. 2017 Jul 7. pii: S0920-9964(17)30403.
    PubMed     Abstract available


  1458. BERRY C, Greenwood K
    Direct and indirect associations between dysfunctional attitudes, self-stigma, hopefulness and social inclusion in young people experiencing psychosis.
    Schizophr Res. 2017 Jul 7. pii: S0920-9964(17)30377.
    PubMed     Abstract available


  1459. SUBRAMANIAM K, Gill J, Fisher M, Mukherjee P, et al
    White matter microstructure predicts cognitive training-induced improvements in attention and executive functioning in schizophrenia.
    Schizophr Res. 2017 Jul 6. pii: S0920-9964(17)30401.
    PubMed     Abstract available


  1460. RAMYEAD A, Kometer M, Studerus E, Andreou C, et al
    Abnormal brain connectivity during error-monitoring in the psychosis high-risk state.
    Schizophr Res. 2017 Jul 6. pii: S0920-9964(17)30394.
    PubMed    


  1461. SEDGWICK O, Young S, Greer B, Arnold J, et al
    Sensorimotor gating characteristics of violent men with comorbid psychosis and dissocial personality disorder: Relationship with antisocial traits and psychosocial deprivation.
    Schizophr Res. 2017 Jul 6. pii: S0920-9964(17)30384.
    PubMed     Abstract available


  1462. KIRKPATRICK B, Kennedy BK
    Accelerated aging in schizophrenia and related disorders: Future research.
    Schizophr Res. 2017 Jul 6. pii: S0920-9964(17)30373.
    PubMed     Abstract available


  1463. LU ML, Chen TT, Kuo PH, Hsu CC, et al
    Effects of adjunctive fluvoxamine on metabolic parameters and psychopathology in clozapine-treated patients with schizophrenia: A 12-week, randomized, double-blind, placebo-controlled study.
    Schizophr Res. 2017 Jul 5. pii: S0920-9964(17)30368.
    PubMed     Abstract available


  1464. WHITFORD V, O'Driscoll GA, Titone D
    Reading deficits in schizophrenia and their relationship to developmental dyslexia: A review.
    Schizophr Res. 2017 Jul 5. pii: S0920-9964(17)30388.
    PubMed     Abstract available


  1465. DONG D, Wang Y, Chang X, Chen X, et al
    Common and diagnosis-specific fractional anisotropy of white matter in schizophrenia, bipolar disorder, and major depressive disorder: Evidence from comparative voxel-based meta-analysis.
    Schizophr Res. 2017 Jul 4. pii: S0920-9964(17)30404.
    PubMed    


  1466. LUCK M, Turner M, Shad MU
    Effectiveness of genetically-guided treatment in first-episode schizophrenia.
    Schizophr Res. 2017 Jul 2. pii: S0920-9964(17)30390.
    PubMed    


  1467. COHEN CI, Murante T
    A prospective analysis of the role of cognition in three models of aging and schizophrenia.
    Schizophr Res. 2017 Jul 2. pii: S0920-9964(17)30361.
    PubMed     Abstract available


  1468. MORAR B, Badcock JC, Phillips M, Almeida OP, et al
    The longevity gene Klotho is differentially associated with cognition in subtypes of schizophrenia.
    Schizophr Res. 2017 Jul 1. pii: S0920-9964(17)30393.
    PubMed     Abstract available


    June 2017
  1469. JANSSENS S, Moens H, Coppens V, Vandendriessche F, et al
    Psychomotor assessment as a tool to differentiate schizophrenia from other psychotic disorders.
    Schizophr Res. 2017 Jun 30. pii: S0920-9964(17)30386.
    PubMed     Abstract available


  1470. BISMARK AW, Thomas ML, Tarasenko M, Shiluk AL, et al
    Relationship between effortful motivation and neurocognition in schizophrenia.
    Schizophr Res. 2017 Jun 30. pii: S0920-9964(17)30381.
    PubMed     Abstract available


  1471. MAK M, Misiak B, Frydecka D, Pelka-Wysiecka J, et al
    Polymorphisms in immune-inflammatory response genes and the risk of deficit schizophrenia.
    Schizophr Res. 2017 Jun 30. pii: S0920-9964(17)30389.
    PubMed     Abstract available


  1472. SVERAK T, Albrechtova L, Lamos M, Rektorova I, et al
    Intensive repetitive transcranial magnetic stimulation changes EEG microstates in schizophrenia: A pilot study.
    Schizophr Res. 2017 Jun 30. pii: S0920-9964(17)30383.
    PubMed    


  1473. BUCHY L, Makowski C, Malla A, Joober R, et al
    A longitudinal study of cognitive insight and cortical thickness in first-episode psychosis.
    Schizophr Res. 2017 Jun 29. pii: S0920-9964(17)30387.
    PubMed     Abstract available


  1474. MAZIADE M, Paccalet T, Gilbert E
    Defective compensation over early dysneurogenesis in schizophrenia and mood disorder.
    Schizophr Res. 2017 Jun 27. pii: S0920-9964(17)30380.
    PubMed    


  1475. JAVITT DC, Lee M, Kantrowitz JT, Martinez A, et al
    Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia.
    Schizophr Res. 2017 Jun 27. pii: S0920-9964(17)30362.
    PubMed     Abstract available


  1476. MISDRAHI D, Tessier A, Husky M, Lange AC, et al
    Evaluation of adherence patterns in schizophrenia using electronic monitoring (MEMS(R)): A six-month post-discharge prospective study.
    Schizophr Res. 2017 Jun 26. pii: S0920-9964(17)30365.
    PubMed     Abstract available


  1477. BIOQUE M, Garcia-Portilla MAP, Garcia-Rizo C, Cabrera B, et al
    Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis.
    Schizophr Res. 2017 Jun 26. pii: S0920-9964(17)30370.
    PubMed     Abstract available


  1478. VILLA J, Choi J, Kangas JL, Kaufmann CN, et al
    Associations of suicidality with cognitive ability and cognitive insight in outpatients with Schizophrenia.
    Schizophr Res. 2017 Jun 24. pii: S0920-9964(17)30351.
    PubMed     Abstract available


  1479. LIANG S, Brown MRG, Deng W, Wang Q, et al
    Convergence and divergence of neurocognitive patterns in schizophrenia and depression.
    Schizophr Res. 2017 Jun 23. pii: S0920-9964(17)30332.
    PubMed     Abstract available


  1480. DAI J, Du X, Yin G, Zhang Y, et al
    Prevalence, demographic and clinical features of comorbid depressive symptoms in drug naive patients with schizophrenia presenting with first episode psychosis.
    Schizophr Res. 2017 Jun 23. pii: S0920-9964(17)30369.
    PubMed     Abstract available


  1481. DAVIDSON CA, Lesser R, Parente LT, Fiszdon JM, et al
    Psychometrics of social cognitive measures for psychosis treatment research.
    Schizophr Res. 2017 Jun 22. pii: S0920-9964(17)30357.
    PubMed     Abstract available


  1482. HORN M, D'Hondt F, Gharib A, Gangloff L, et al
    Association between familiarity disorders and serious violence among inmates with schizophrenia.
    Schizophr Res. 2017 Jun 21. pii: S0920-9964(17)30371.
    PubMed    


  1483. SUN Z, Ma Y, Li W, He J, et al
    Associations between the DBH gene, plasma dopamine beta-hydroxylase activity and cognitive measures in Han Chinese patients with schizophrenia.
    Schizophr Res. 2017 Jun 21. pii: S0920-9964(17)30367.
    PubMed     Abstract available


  1484. MEHTA UM, Ravishankar V, Thirthalli J
    Eszopiclone for persistent negative symptoms in schizophrenia - An unintended N-of-1 study.
    Schizophr Res. 2017 Jun 21. pii: S0920-9964(17)30374.
    PubMed     Abstract available


  1485. UHL I, Kulik A, Roser P, Theodoridou A, et al
    Central serotonergic function in patients with predominantly negative symptoms of schizophrenia.
    Schizophr Res. 2017 Jun 19. pii: S0920-9964(17)30327.
    PubMed    


  1486. FRIES GR, Dimitrov DH, Lee S, Braida N, et al
    Genome-wide expression in veterans with schizophrenia further validates the immune hypothesis for schizophrenia.
    Schizophr Res. 2017 Jun 19. pii: S0920-9964(17)30355.
    PubMed     Abstract available


  1487. STUBBS B, Vancampfort D, Firth J, Hallgren M, et al
    Physical activity correlates among people with psychosis: Data from 47 low- and middle-income countries.
    Schizophr Res. 2017 Jun 18. pii: S0920-9964(17)30364.
    PubMed     Abstract available


  1488. BORA E, Yalincetin B, Akdede BB, Alptekin K, et al
    Duration of untreated psychosis and neurocognition in first-episode psychosis: A meta-analysis.
    Schizophr Res. 2017 Jun 17. pii: S0920-9964(17)30360.
    PubMed     Abstract available


  1489. KOH MT, Shao Y, Rosenzweig-Lipson S, Gallagher M, et al
    Treatment with levetiracetam improves cognition in a ketamine rat model of schizophrenia.
    Schizophr Res. 2017 Jun 17. pii: S0920-9964(17)30366.
    PubMed     Abstract available


  1490. MILLMAN ZB, Pitts SC, Thompson E, Kline ER, et al
    Perceived social stress and symptom severity among help-seeking adolescents with versus without clinical high-risk for psychosis.
    Schizophr Res. 2017 Jun 16. pii: S0920-9964(17)30330.
    PubMed     Abstract available


  1491. HSU CW, Lee SY, Wang LJ
    Comparison of the effectiveness of brand-name and generic antipsychotic drugs for treating patients with schizophrenia in Taiwan.
    Schizophr Res. 2017 Jun 16. pii: S0920-9964(17)30359.
    PubMed     Abstract available


  1492. ZHANG T, Guo X, Tang Y, Cui H, et al
    Time consumption in mind-reading: A potentially important factor for social cognition assessment in early psychosis.
    Schizophr Res. 2017 Jun 15. pii: S0920-9964(17)30354.
    PubMed    


  1493. BENDELS MHK, Bauer J, Schoffel N, Groneberg DA, et al
    The gender gap in schizophrenia research.
    Schizophr Res. 2017 Jun 15. pii: S0920-9964(17)30358.
    PubMed    


  1494. LEE TY, Lee J, Kim M, Kwon JS, et al
    The effect of transcranial direct current stimulation on auditory hallucination in patients with schizophrenia.
    Schizophr Res. 2017 Jun 15. pii: S0920-9964(17)30352.
    PubMed    


  1495. AN H, Zhou L,